10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-K

(Mark One)

☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended September 30, 2024

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number 001-11593

______________________________________________________________

The Scotts Miracle-Gro Company

(Exact name of registrant as specified in its charter)

Ohio	31-1414921
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

14111 Scottslawn Road, Marysville, Ohio 43041

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code:

(937) 644-0011

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Shares, $0.01 stated value	SMG	NYSE

Securities registered pursuant to Section 12(g) of the Act:

None

______________________________________________________________ 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  þ    No  o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  o    No  þ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  þ    No  o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  þ    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☑	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.         o

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☑

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.         o

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).         o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ☐    No  þ

The aggregate market value of Common Shares (the only common equity of the registrant) held by non-affiliates (for this purpose, executive officers and directors of the registrant are considered affiliates) as of March 28, 2024 (the last business day of the most recently completed second quarter) was approximately $3,178,556,405.

There were 57,406,064 Common Shares of the registrant outstanding as of November 18, 2024.

______________________________________________________________ 

DOCUMENTS INCORPORATED BY REFERENCE:

Portions of the definitive Proxy Statement for the registrant’s 2025 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended September 30, 2024.

Table of Contents

The Scotts Miracle-Gro Company

Annual Report on Form 10-K

For the Fiscal Year Ended September 30, 2024

Table of Contents

			Page
Part I	Item 1.	Business	2
	Item 1A.	Risk Factors	8
	Item 1B.	Unresolved Staff Comments	22
	Item 1C.	Cybersecurity	23
	Item 2.	Properties	25
	Item 3.	Legal Proceedings	26
	Item 4.	Mine Safety Disclosures	27
Part II	Supplemental Item	Executive Officers of the Registrant	27
	Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	28
	Item 6.	[Reserved]	29
	Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
	Item 7A.	Quantitative And Qualitative Disclosures About Market Risk	49
	Item 8.	Financial Statements and Supplementary Data	50
	Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	50
	Item 9A.	Controls and Procedures	50
	Item 9B.	Other Information	51
	Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	52
Part III	Item 10.	Directors, Executive Officers, and Corporate Governance	53
	Item 11.	Executive Compensation	54
	Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	54
	Item 13.	Certain Relationships and Related Transactions, and Director Independence	54
	Item 14.	Principal Accountant Fees and Services	54
Part IV	Item 15.	Exhibits and Financial Statement Schedules	55
	Item 16.	Form 10-K Summary	55
		Signatures	56
		Index to Exhibits	111

Table of Contents

PART I

ITEM 1.    BUSINESS

Company Description and Development of the Business

The discussion below describes the business conducted by The Scotts Miracle-Gro Company, an Ohio corporation (“Scotts Miracle-Gro” and, together with its subsidiaries, the “Company,” “we,” “our” or “us”), including general developments in our business during fiscal 2024. Each reference in this Annual Report on Form 10-K (“Form 10-K”) to a “fiscal” year is to our fiscal year ended or ending, as applicable, on September 30 of the referenced year. For additional information on recent business developments, see “ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS” of this Form 10-K.

Through our U.S. Consumer and Other segments, we are the leading manufacturer and marketer of branded consumer lawn and garden products in North America. Our products are marketed under some of the most recognized brand names in the consumer lawn and garden industry. Our key consumer lawn and garden brands include Scotts® Turf Builder® lawn fertilizer and Scotts® grass seed products; Miracle-Gro® soil, plant food and gardening products; Ortho® herbicide and pesticide products; and Tomcat® rodent control and animal repellent products. We are the exclusive agent of Monsanto Company, a subsidiary of Bayer AG (“Monsanto”), for the marketing and distribution of certain of Monsanto’s consumer Roundup®1 branded products within the United States (“U.S.”) and certain other specified countries. In addition, we have an equity interest in Bonnie Plants, LLC, a joint venture with Alabama Farmers Cooperative, Inc. (“AFC”), focused on planting, growing, developing, distributing, marketing and selling live plants.

Through our Hawthorne segment, we are a leading provider of nutrients, lighting and other materials used for indoor and hydroponic gardening in North America. Our key brands include General Hydroponics®, Gavita®, Botanicare®, Agrolux®, Gro Pro®, Mother Earth®, Grower’s Edge®, HydroLogic Purification System® and CYCO®.

Scotts Miracle-Gro traces its heritage to a company founded by O.M. Scott in Marysville, Ohio in 1868. In the mid-1900s, we became widely known for the development of quality lawn fertilizers and grass seeds that led to the creation of a new industry – consumer lawn care. In the 1990s, we significantly expanded our product offering with three leading brands in the U.S. home lawn and garden industry. In fiscal 1995, through a merger with Stern’s Miracle-Gro Products, Inc., which was founded by Horace Hagedorn and Otto Stern in Long Island, New York in 1951, we acquired the Miracle-Gro® brand, the industry leader in water-soluble garden plant foods. In fiscal 1999, we acquired the Ortho® brand in the U.S. and obtained exclusive rights to market Monsanto’s consumer Roundup® brand within the U.S. and other contractually specified countries, thereby adding industry-leading weed, pest and disease control products to our portfolio. Today, the Scotts®, Turf Builder®, Miracle-Gro®, Ortho® and Roundup® brands make us the most widely recognized company in the consumer lawn and garden industry in the U.S.

Business Segments

We divide our business into the following reportable segments:

•U.S. Consumer

•Hawthorne

•Other

U.S. Consumer consists of our consumer lawn and garden business in the United States. Hawthorne consists of our indoor and hydroponic gardening business. Other primarily consists of our consumer lawn and garden business in Canada. This division of reportable segments is consistent with how the segments report to and are managed by our Chief Executive Officer (the chief operating decision maker of the Company). In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the reportable business segments. Financial information about these segments for each of the three fiscal years ended September 30, 2024, 2023 and 2022 is presented in “NOTE 20. SEGMENT INFORMATION” of the Notes to Consolidated Financial Statements included in this Form 10-K.

1 Roundup® is a registered trademark of Monsanto Technology LLC, a company affiliated with Monsanto Company.

2

Table of Contents

Principal Products and Services

In our reportable segments, we manufacture, market and sell lawn and garden products in the following categories:

Lawn Care: The lawn care category is designed to help users grow and enjoy the lawn they want. Products within this category include lawn fertilizer products under the Scotts® and Turf Builder® brand and sub-brand names; grass seed products under the Scotts®, EZ Seed®, PatchMaster® and Thick’R LawnTM brand and sub-brand names; and lawn-related weed, pest and disease control products primarily under the Scotts® brand name, including sub-brands such as GrubEx®. The lawn care category also includes spreaders and other durables under the Scotts® brand name, including Turf Builder® EdgeGuard® spreaders and WhirlTM and WizzTM handheld spreaders.

Gardening and Landscape: The gardening and landscape category is designed to help consumers grow and enjoy flower and vegetable gardens and beautify landscaped areas. Products within this category include a complete line of water-soluble plant foods under the Miracle-Gro® brand and sub-brands such as LiquaFeed®; continuous-release plant foods under the Miracle-Gro® brand and sub-brands such as Shake ‘N Feed®; potting mixes, garden soils, ground cover and mulches under the Miracle-Gro®, Scotts®, Hyponex® and Earthgro® brand names; plant-related pest and disease control products under the Ortho® brand; organic garden products under the Miracle-Gro® Performance Organics®, Miracle-Gro® Organic, Miracle-Gro® Organic ChoiceTM, Scotts® and Whitney Farms® brand names; and live goods and seeding solutions under the Miracle-Gro® brand. Hydroponic and indoor gardening focused growing media and nutrients products are marketed under the Mother Earth®, Botanicare®, General Hydroponics® and CYCO® brand names.

Hydroponic hardware and growing environments: This category is designed to provide durable goods to grow plants, flowers and vegetables using little or no soil. Products within this category include growing systems, trays, fans, filters, humidifiers, dehumidifiers, water pumps, irrigation supplies and hand tools. These products are marketed under the Botanicare®, CAN-FANTM, CAN-FILTERS®, EcoPlus®, Gro Pro®, Grower’s Edge® and Hydro-Logic Purification System® brand names.

Lighting: The lighting category is designed to provide growers a complete selection of lighting systems and components for use in hydroponic and indoor gardening applications. Products in this category include lighting sensors, controls, fixtures, cords and hangars, and are marketed under the Gavita®, Agrolux® and Titan® brand names.

Controls: The controls category is designed to help consumers protect their homes from pests and maintain external home areas. Insect control products are marketed under the Ortho® brand name, including Ortho Max®, Home Defense® and Bug B Gon® sub-brands; rodent control products are marketed under the Tomcat® and Ortho® brands; selective weed control products are marketed under the Ortho Weed B GonTM sub-brand; and non-selective weed killer products are marketed under the Groundclear® brand name. Hydroponic gardening focused controls products are marketed under the Alchemist®, Grower’s Edge® and General Hydroponics® brand names.

Marketing Agreement: We are Monsanto’s exclusive agent for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries.

Effective August 1, 2019, we entered into the Third Amended and Restated Exclusive Agency and Marketing Agreement (the “Third Restated Agreement”) pursuant to which we provide certain consumer and trade marketing program services, sales, merchandising, warehousing and other selling and marketing support for certain of Monsanto’s consumer Roundup® branded products. The Company also performs other services on behalf of Monsanto, including manufacturing conversion services, pursuant to ancillary agreements. For additional details regarding the Third Restated Agreement, see “ITEM 1A. RISK FACTORS — Risks Related to Our Business — In the event the Third Restated Agreement for Monsanto’s consumer Roundup® products terminates or Monsanto’s consumer Roundup® business materially declines, we would lose a substantial source of future earnings and overhead expense absorption” in this Form 10-K and “NOTE 6. MARKETING AGREEMENT” of the Notes to Consolidated Financial Statements included in this Form 10-K.

Acquisitions and Divestitures

There were no material acquisitions or divestitures during fiscal 2024 or fiscal 2023. Refer to “NOTE 7. ACQUISITIONS AND INVESTMENTS” of the Notes to the Consolidated Financial Statements included in this Form 10-K for more information regarding fiscal 2022 acquisitions.

Principal Markets and Methods of Distribution

We sell our products through our direct sales force, e-commerce website and network of brokers and distributors primarily to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers.

3

Table of Contents

The majority of our shipments to customers are made via common carriers or through distributors in the U.S. We primarily utilize third parties to manage the key distribution centers for our consumer lawn and garden business, which are strategically located across the U.S. and Canada. Growing media products are generally shipped direct-to-store without passing through a distribution center.

Raw Materials

We purchase raw materials for our products from various sources. We are subject to market risk as a result of the fluctuating prices of raw materials, including urea and other fertilizer inputs, resins, diesel, gasoline, natural gas, sphagnum peat, bark and grass seed. Our objectives surrounding the procurement of these materials are to ensure continuous supply, minimize costs and improve supply and pricing predictability. We seek to achieve these objectives through negotiation of contracts with favorable terms directly with vendors. When appropriate, we commit to purchase a certain percentage of our needs in advance of the lawn and garden season to secure pre-determined prices. We also hedge certain commodities, particularly diesel and urea, to improve cost predictability and control. Sufficient raw materials were available during fiscal 2024.

Trademarks, Patents, Trade Secrets and Licenses

We believe that our trademarks, patents, trade secrets and licenses provide us with significant competitive advantages. We pursue a vigorous trademark protection strategy consisting of registration, renewal and maintenance of key trademarks and proactive monitoring and enforcement activities to protect against infringement. The Scotts®, Miracle-Gro®, Ortho®, Tomcat®, Hyponex®, Earthgro®, General Hydroponics®, Gavita®, Botanicare®, Agrolux® and Mother Earth® brand names and logos, as well as a number of product trademarks, including Turf Builder®, EZ Seed®, Organic Choice®, Home Defense Max®, Nature Scapes®, and Weed B Gon Max® are registered in the United States and/or internationally and are considered material to our business.

In addition, we actively develop and maintain an extensive portfolio of utility and design patents covering a variety of subject matters and technologies relevant to the business such as fertilizer, weed killer, chemical and growing media compositions and processes; grass seed varieties; mechanical dispensing devices such as applicators, spreaders and sprayers; lighting applications; and hydroponic growing systems. Our utility patents provide protection generally extending to 20 years from the date of filing, and some of our patents will continue well into the next decade. We also hold exclusive and non-exclusive patent licenses and supply arrangements permitting the use and sale of additional patented fertilizers, pesticides, electrical and mechanical devices. Although our portfolio of trade secrets, patents and patent licenses is important to our success, no single trade secret, patent or group of related patents, alone, is considered critical to the operation of any of our business segments or the business as a whole.

Seasonality and Backlog

Our North America consumer lawn and garden business is highly seasonal, with approximately 75% of our annual net sales occurring in our second and third fiscal quarters combined. Our annual net sales for this business are further concentrated in our second and third fiscal quarters by retailers who rely on our ability to deliver products closer to when consumers buy our products. We anticipate significant orders for our North America consumer lawn and garden business for the upcoming spring season will start to be received late in the winter and continue through the spring season. Historically, substantially all orders have been received and shipped within the same fiscal year with minimal carryover of open orders at the end of the fiscal year.

Our Hawthorne segment is also impacted by seasonal sales patterns for certain product categories due to the timing of growing patterns in North America during our second and third fiscal quarters, and the timing of certain controlled agricultural lighting project sales during our third and fourth fiscal quarters.

Significant Customers

The Home Depot and Lowe’s are our two largest customers and are the only customers that individually represent more than 10% of reported consolidated net sales during any of the three most recent fiscal years. For additional details regarding significant customers, see “ITEM 1A. RISK FACTORS — Risks Related to Our Business — Because of the concentration of our sales to a small number of retail customers, the loss of one or more of, or a significant reduction in orders from, any of our top customers, or a material reduction in the inventory of our products that they carry, could adversely affect our financial results” of this Form 10-K and “NOTE 20.  SEGMENT INFORMATION” of the Notes to Consolidated Financial Statements included in this Form 10-K.

Competitive Marketplace

The markets in which we sell our products are highly competitive. We compete primarily on the basis of brand strength, product innovation, product quality, product performance, advertising, value, supply chain competency, field sales support, in-store sales support and the strength of our relationships with major retailers and distributors.

4

Table of Contents

In the lawn and garden, pest control and indoor gardening and hydroponic markets, our products compete against private label as well as branded products. Primary competitors include Spectrum Brands Holdings, Inc., Central Garden & Pet Company, Kellogg Garden Products, Oldcastle Retail, Inc., Lebanon Seaboard Corporation, Reckitt Benckiser Group plc, FoxFarm Soil & Fertilizer Company, Nanolux Technology, Inc., Sun Gro Horticulture, Inc., Advanced Nutrients, Ltd., SBM Life Science Corp., Woodstream Corporation, Sunday Lawn Care and Hydrofarm Holdings Group, Inc. In addition, we face competition from smaller regional competitors that operate in many of the areas where we compete.

In Canada, we face competition in the lawn and garden market from Premier Tech Ltd. and a variety of local companies including private label brands.

Research and Development

We continually invest in research and development to design new or improve existing product formulae and packaging, as well as to streamline our manufacturing processes. Spending on research and development was $34.6 million, $35.7 million and $45.3 million in fiscal 2024, fiscal 2023 and fiscal 2022, respectively, including product registration costs of $9.0 million, $12.4 million and $13.0 million, respectively. In addition to our own research and development activities, we actively seek ways to leverage the research and development activities of our suppliers and other business partners.

Regulatory Considerations

Laws and regulations in the United States and other countries affect the manufacture, sale, distribution, use and/or application of our products in several ways. For example, in the United States, all pesticide products must comply with the Federal Insecticide, Fungicide, and Rodenticide Act (“FIFRA”), and most pesticide products require registration with the U.S. Environmental Protection Agency (the “U.S. EPA”) and similar state agencies before they can be sold or distributed. The use of certain pesticide products is also regulated by the U.S. EPA in addition to various local, state and federal environmental and/or public health agencies. These regulations may restrict or ban the use of certain ingredients or categories of products altogether. Analogous regulatory regimes apply to certain pesticides that we sell or distribute in other countries.

Fertilizer and growing media products are also subject to various laws and regulations, some of which require registration, mandate labeling requirements, and/or govern the sale and distribution of the products. Our grass seed products are regulated in the U.S. by the Federal Seed Act and various state regulations. In addition, governmental agencies regulate the disposal, transport, handling and storage of waste, the remediation of contaminated sites, air and water discharges from our facilities, and workplace health and safety.

Governmental authorities generally require operating facilities to obtain permits (sometimes on an annual basis) relating to site-specific conditions and/or activities. For example, permits must be obtained in order to harvest peat and to discharge storm water run-off or water pumped from peat deposits. The permits typically specify the condition in which the property must be left after the peat is fully harvested, with the residual use typically being natural wetland habitats combined with open water areas. We are generally required by these permits to limit our harvesting and to restore the property consistent with the intended residual use. In some locations, these facilities have been required to create water retention ponds to control the sediment content of discharged water.

In addition, in 2021 the Biden Administration announced a multi-agency plan to address per- and polyfluoroalkyl substances (“PFAS”) contamination nationwide. Agencies, including the U.S. EPA, the Department of Defense, the Food and Drug Administration, the U.S. Department of Agriculture, the Department of Homeland Security, and the Department of Health and Human Services, will take actions to prevent the release of PFAS into the air, drinking systems, and food supply and to expand cleanup efforts to remediate the impacts of PFAS pollution. As part of this announcement, the U.S. EPA released its PFAS Strategic Roadmap: EPA’s Commitments to Action 2021-2024, which sets timelines by which the U.S. EPA plans to take specific actions during the Biden Administration. Further, many states have taken action to address PFAS concerns ranging from appropriation legislation to funding scientific research, bans on certain categories of consumer products containing PFAS and/or broad prohibitions on PFAS across all products. Complicating this patchwork of state regulation is that various jurisdictions may define PFAS differently. It is possible, therefore, that some of these actions will have an impact – direct or indirect – on our business.

Packaging has also become subject to increased governmental scrutiny in many states. Specifically, state legislation is seeking to reduce single use plastics and establish extended producer responsibility programs, which are designed to bolster the recycling industry by transferring the cost of packaging disposal to the manufacturers. Extended producer responsibility programs typically include targets and reporting responsibilities for, among other things, post-consumer recycling usage, compostable packaging, material reduction and refill strategies.

The expansion of our business may expand the regulatory oversight to which we are subject. If we enter new product categories and/or new jurisdictions, we may become subject to additional applicable legal and regulatory requirements.

5

Table of Contents

For more information regarding how compliance with local, state, federal and foreign laws and regulations may affect us, see “ITEM 1A. RISK FACTORS — Risks Related to Regulation of Our Company — Compliance with environmental and other public health regulations or changes in such regulations or regulatory enforcement priorities could increase our costs of doing business or limit our ability to market all of our products” of this Form 10-K.

Regulatory Matters

We are subject to various regulatory proceedings, none of which are expected to be material to our business. At September 30, 2024, $2.6 million was accrued for environmental matters. During fiscal 2024, fiscal 2023 and fiscal 2022, we expensed $0.1 million, $0.4 million and $0.2 million, respectively, for such environmental matters. We had no material capital expenditures during the last three fiscal years related to environmental or regulatory matters.

Human Capital

We believe our culture and commitment to our associates provides unique value to us and our shareholders. Every associate, and every job, is important to our success and helping us achieve our purpose. We seek to create an environment that values the health, safety and wellness of our teams, and we work to equip them with the knowledge and skills to serve our business and develop in their careers.

This discussion includes information regarding human capital matters that we believe may be of interest to shareholders generally. We recognize that certain other stakeholders (such as customers, associates and non-governmental organizations) may be interested in more detailed information on these topics. We encourage you to review the “Supporting Our People” section of our 2024 Corporate Responsibility Report, located on our website at https://scottsmiraclegro.com/responsibility/environmental-social-and-governance, for more detailed information regarding our human capital programs and initiatives. The contents of our corporate website are not incorporated by reference in this Form 10-K or in any other report or document we file with the Securities and Exchange Commission (the “SEC”).

Associates

As of September 30, 2024, we employed approximately 5,300 associates. During peak sales and production periods in fiscal 2024, our workforce totaled approximately 7,100, comprised of approximately 6,200 associates including seasonal associates and approximately 900 in temporary labor. Included within these numbers, during fiscal 2024, we employed a total of approximately 2,500 full-time and seasonal in-store associates within the United States to help our retail partners merchandise our products in their lawn and garden departments directly to consumers.

Engagement

Our success depends on the engagement of our associates. To drive engagement, we take a purposeful approach focused on enhancing the associate experience centering on creating a positive workplace and fostering trust in leadership.

We recognize that two-way communication enhances trust and improves collaboration and overall engagement. We gather associate feedback both formally and informally throughout the year through such initiatives as pulse surveys, leadership meetings and roundtable discussions. In fiscal 2024, we surveyed our global associate population on topics spanning the employee experience. Categories included positive workplace, strong leadership, health & well-being, meaningful work, growth opportunity, trust in the organization and ethics. Engagement surveys provide us with insight into what we are doing well and where we have opportunities to improve. Results from the fiscal 2024 Associate Experience Survey highlighted focus areas for fiscal 2024 and beyond. Another source of associate sentiment comes from exit interviews, when we ask for ratings, rankings and feedback from all salaried associates who voluntarily leave our organization. These valuable inputs are shared with senior leadership and integrated into practice as human capital initiatives are deployed.

We believe that an informed workforce contributes to an engaged workforce. As such, we have prioritized ensuring our associates have access to the information they need to understand the business decisions being made, the reasons behind them and how changes will impact them in their role. Recognizing there is significant value in hearing directly from our leadership team, we continue to host Town Hall meetings each quarter to disseminate enterprise-wide information and to allow for interactive communication.

Diversity

We value our associates’ diversity and encourage them to leverage their varied life experiences at our Company. This includes diversity in terms of gender, sexuality, race, thoughts, interests, languages, beliefs and more.

6

Table of Contents

Our employee resource groups (“ERGs”) are voluntary, associate-led groups typically formed by people with a common affinity such as gender, race, national origin, sexual orientation, military status or other attributes. Each ERG establishes a mission to positively impact the business by cultivating relationships through networking and developing talent through experiences, programs and mentoring. Our ERGs drive continuous improvement of our inclusive work environment and are open to all associates. Our ERGs consist of the Scotts Associate Board, Scotts Associates For A Greener Earth, the Scotts Black Employees Network, the Scotts Christian Fellowship, Scotts Gro-Masters, Scotts GroPride, the Scotts Veterans Network, the Scotts Women’s Network and the Scotts Young Professionals.

Professional Development

We view development and retention of our associates as valuable components of our business operations and critical to creating a culture of leadership throughout our Company. Our associates have the opportunity to learn new skills through exposure and involvement in business challenges. Our managers support associates as development happens on the job through cross-functional team assignments, expanded roles and rotational assignments. Our ongoing development processes are designed to grow knowledge, improve skills and capabilities, and achieve competence in specific behaviors to meet performance expectations and prepare for potential future roles within our Company. In fiscal 2024, we developed and implemented a leadership development framework for our people leaders, delivering on two key areas — leader accountabilities at the Company and critical skill training for our front line leaders.

Compensation and Benefits

We believe financial health and mental wellness are core components of our associates’ overall well-being and we are committed to ensuring fair and competitive compensation to our associates based on their roles. Each year we conduct an analysis of our pay and compensation practices, from both an external market and internal consistency perspective, to ensure that our pay decisions are fair and equitable, adjusting as needed. To ensure transparency and understanding of our compensation programs, we have enhanced our education opportunities and communications for our managers and associates. We also prioritize sharing our financial successes with associates through our incentive plans for eligible participants and our profit-sharing program and discretionary bonuses for those who are not incentive eligible.

Through our LiveTotal Health program, we demonstrate our commitment to the overall well-being of our associates. In response to feedback from our most recent Associate Experience Survey, we enhanced our benefits to provide more comprehensive mental health support, including a broader range of services and improved access to mental healthcare. This focus on mental well-being is complemented by our suite of benefits, designed to meet the diverse needs of our workforce. Our offerings include healthcare coverage, family leave, 401(k) matching, and other essential benefits that support both our associates and their families. Additionally, we provide tailored benefits such as a discounted stock purchase plan, healthcare navigation and advocacy concierge services, structured reimbursement for adoption and surrogacy expenses, a Marysville onsite fitness facility, and limited reimbursement for well-being expenses.

Health and Safety

We maintain several health and safety programs to protect our team members, including our comprehensive Environmental Health and Safety (“EHS”) management system. All associates and business partners, including contractors, are covered by our EHS management system. Our associates are encouraged to participate in safety committees to spur associate engagement with safety on a local and national level. To further manage health and safety risks, we develop compliance calendars that highlight dates for health and safety inspections and deadlines to meet voluntary and regulatory requirements. We use an EHS scorecard composed of leading and lagging indicators to evaluate our health and safety performance including progress measurements for safety training, behavioral-based safety observations, near-miss reporting, total recordable incident rate and lost time accident rate.

7

Table of Contents

Environmental, Social and Governance

Our stakeholders, including shareholders, customers, suppliers, associates, communities as well as the environment and society, are essential to our business. We endeavor to make our workforce more inclusive, our business more sustainable, and our communities more engaged by maintaining strong environmental, social and governance (“ESG”) practices. In fiscal 2024, we published our annual Corporate Responsibility Report, prepared in reference to the Global Reporting Initiative Standards (2021) and with consideration for the Sustainability Accounting Standards Board’s Chemicals industry standard. The report maps our sustainability efforts to the United Nations Sustainable Development Goals and provides detailed information regarding our ESG strategy, focus areas and governance structure. The Company’s ESG focus areas are Product Stewardship and Safety, Operations and Supply Chain, Associate Engagement and Wellness, Community Engagement and Governance and Transparency. The Company continues to benchmark, set and make progress towards goals and seek continuous improvement around these focus areas.

We publish our Corporate Responsibility Report and several ESG-related policies and statements on the ESG section of our corporate website, which is located at https://scottsmiraclegro.com/responsibility/environmental-social-and-governance. These policies and statements address environmental, health and safety and human rights concerns. We maintain a Supplier Code of Conduct that establishes the minimum standards that suppliers must satisfy to sell goods to or do business with the Company. Further ESG initiatives in fiscal 2024 included responding to the Carbon Disclosure Project’s climate change and water questionnaires. The contents of our corporate website are not incorporated by reference in this Form 10-K or in any other report or document we file with the SEC.

Website and General Information

We maintain a website at http://investor.scotts.com. Information on our websites will not be deemed incorporated by reference into, and do not form any part of, this Form 10-K or any other report or document that we file with or furnish to the SEC. We file reports with the SEC and make available, free of charge, on or through our website, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as well as our proxy and information statements, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.

ITEM 1A.    RISK FACTORS

Cautionary Note Regarding Forward-Looking Statements

This Form 10-K, including the exhibits hereto and the information incorporated by reference herein, as well as our 2024 Annual Report to Shareholders (our “2024 Annual Report”), contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to risks and uncertainties. Information regarding activities, events and developments that we expect or anticipate will or may occur in the future, including, but not limited to, information relating to our future growth and profitability targets and strategies designed to increase total shareholder value, are forward-looking statements based on management’s estimates, assumptions and projections. Forward-looking statements also include, but are not limited to, statements regarding our future economic and financial condition and results of operations, the plans and objectives of management and our assumptions regarding our performance and such plans and objectives, as well as the amount and timing of dividends and repurchases of common shares of Scotts Miracle-Gro (“Common Shares”) or other uses of cash flows. Forward-looking statements generally can be identified through the use of words such as “guidance,” “outlook,” “projected,” “believe,” “target,” “predict,” “estimate,” “forecast,” “strategy,” “may,” “goal,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “should” and other similar words and variations.

Forward-looking statements in this Form 10-K and our 2024 Annual Report are predictions only and actual results could differ materially from management’s expectations due to a variety of factors, including those described below. All forward-looking statements attributable to us or persons working on our behalf are expressly qualified in their entirety by such risk factors and other cautionary statements that we make from time to time in our other SEC filings and public communications.

You should evaluate forward-looking statements in the context of these risks and uncertainties and are cautioned not to place undue reliance on such statements. These factors may not contain all of the factors that are important to you. We cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our operations in the way we expect. The forward-looking statements that we make in this Form 10-K and our 2024 Annual Report are based on management’s current views and assumptions regarding future events and speak only as of their dates. We disclaim any obligation to update developments of these risk factors or to announce publicly any revisions to any of the forward-looking statements that we make, or to make corrections to reflect future events or developments, except as required by law.

8

Table of Contents

Risks Related to Our Business

If we underestimate or overestimate demand for our products and do not maintain appropriate inventory levels, our net sales and/or working capital could be negatively impacted.

Our ability to manage our inventory levels to meet our customers’ demand for our products is important for our business. Our production levels and inventory management goals for our products are based on estimates of demand, taking into account production capacity, timing of shipments, and inventory levels. Due to a number of factors, including manufacturing lead-times, seasonal purchasing patterns, and the potential for material price increases, we may carry additional inventory and increase our working capital and related financing requirements. This may increase our warehousing costs or result in excess inventory that may become difficult to manage, unusable or obsolete and adversely impact our ability to realize anticipated returns from product sales. If we overestimate or underestimate either channel or retail demand for any of our products during a given season, we may not maintain appropriate inventory levels, which could negatively impact our net sales, profit margins, net earnings, working capital and/or cash flow, hinder our ability to meet customer demand, result in loss of customers, or cause us to incur excess and obsolete inventory charges or excess warehouse storage costs.

An economic downturn and economic uncertainty may adversely affect demand for our products.

We have observed increased economic uncertainty in the U.S. including the potential for an economic recession. Impacts of such general economic weakness include, without limitation: reduced credit availability; reduced liquidity; volatility in credit, equity and foreign exchange markets; bankruptcies and rising interest rates. In addition, consumers may reduce discretionary spending during periods of economic uncertainty, which could reduce sales volumes of our products or result in a shift in our product mix from higher margin to lower margin products. Adverse economic conditions have included or resulted, and could continue to include or result, in a significant increase in inflation, which could have a material adverse impact on our business, including our operating margins. Continued high inflation has had a negative impact on our operating margins in recent periods including, for example, through persistently high manufacturing costs.

Disruptions in availability or increases in the prices of raw materials, fuel or transportation costs could adversely affect our results of operations.

We source many of our commodities and other raw materials on a global basis. The general availability and price of those raw materials can be affected by numerous forces beyond our control, including political instability, trade restrictions and other government regulations, duties and tariffs, price controls, changes in currency exchange rates and weather. A significant disruption in the availability or price of any of our key raw materials could negatively impact our business.

Increases in the prices of key commodities and other raw materials could adversely affect our ability to manage our cost structure. Market conditions may limit our ability to raise selling prices to offset increases in our raw material costs. Further, sustained price increases may lead to declines in volume as competitors may not adjust their prices or customers and/or consumers may decide not to pay the higher prices, which could lead to sales declines and loss of market share. Our projections may not accurately predict the volume impact of price increases, which could adversely affect our business, financial condition and results of operations.

Our proprietary technologies can limit our ability to locate or utilize alternative inputs for certain products. For certain inputs, new sources of supply may have to be qualified under regulatory standards, which can require additional investment and delay bringing a product to market. We utilize hedge agreements periodically to fix the prices of a portion of our urea and fuel needs. The hedge agreements are designed to mitigate the earnings and cash flow fluctuations associated with the costs of urea and fuel. In periods of declining prices, utilizing these hedge agreements may effectively increase our expenditures for these raw materials.

Because of the concentration of our sales to a small number of retail customers, the loss of one or more of, or a significant reduction in orders from, any of our top customers, or a material reduction in the inventory of our products that they carry, could adversely affect our financial results.

Our top two retail customers, The Home Depot and Lowe’s, together accounted for 48% of our fiscal 2024 net sales and 18% of our outstanding accounts receivable as of September 30, 2024. The loss of, or reduction in orders from any major customer for any reason (including, for example, changes in a retailer’s strategy, reduction in inventories of our products that they maintain, claims or allegations that our products or products we market on behalf of third parties are unsafe, a decline in consumer demand, regulatory, legal or other external pressures or a change in marketing strategy), and customer disputes regarding shipments, fees, merchandise condition or related matters could have a material adverse effect on our business, financial condition, results of operations and cash flows. Our inability to collect accounts receivable from one of our major customers, or a significant deterioration in the financial condition of one of these customers, including a bankruptcy filing or a liquidation, could also have a material adverse effect on our financial condition, results of operations and cash flows.

9

Table of Contents

We do not have long-term sales agreements with, or other contractual assurances as to future sales to, any of our major retail customers. In addition, continued consolidation in the retail industry has resulted in an increasingly concentrated retail base, and as a result, we are significantly dependent upon sales to key retailers who have significant bargaining strength. To the extent such concentration continues to occur, our net sales and income from operations may be increasingly sensitive to deterioration in the financial condition of, or other adverse developments involving our relationship with, one or more of our key customers. In addition, our business may be negatively affected by changes in the policies of our retailers, such as inventory reductions, limitations on access to shelf space, price demands and other conditions.

We may not successfully develop new product lines and products or improve existing product lines and products.

Our future success depends on creating and successfully competing in markets for our products including our ability to improve our existing product lines and products and to develop and manufacture new product lines and products to meet evolving consumer needs. We cannot provide any assurance that we will successfully develop and manufacture new product lines and products or product innovations that satisfy consumer needs or achieve market acceptance, or that we will develop, manufacture and market new product lines and products or product innovations in a timely manner. If we fail to successfully develop and manufacture new product lines and products or product innovations, our ability to maintain or grow our market share may be adversely affected, which could materially adversely affect our business, financial condition and results of operations. In addition, the development and introduction of new product lines and products and product innovations require substantial research and development expenditures, which we may be unable to recoup if such new product lines, products or innovations do not achieve market acceptance.

Many of the products we manufacture and market contain active ingredients that are subject to regulatory approval. The need to obtain such approval could delay the launch of new products or product innovations that contain active ingredients or otherwise prevent us from developing and manufacturing certain products and product innovations.

Our marketing activities may not be successful.

We invest substantial resources in advertising, consumer promotions and other marketing activities to maintain, extend and expand our brand image. Negative publicity about us or our brands, including publicity regarding product safety, quality, efficacy, environmental impacts (including packaging, energy and water use and matters related to climate impact and waste management) and other sustainability or similar issues, whether real or perceived, could occur and could be widely and rapidly disseminated, including through the use of social media sites. There can be no assurances that our marketing strategies will be effective or that the amount we invest in advertising activities will result in a corresponding increase in sales of our products. If our marketing initiatives are unsuccessful, including our ability to leverage digital media and social networks to reach existing and potential customers or our brands suffer damage to reputation due to real or perceived quality issues (which damage can be quickly multiplied by social media), we will have incurred significant expenses without the benefit of higher revenues.

The highly competitive nature of our markets could adversely affect our ability to maintain or grow revenues.

Each of our operating segments participates in highly competitive markets. Our products compete against national and regional products and private label products produced by various suppliers. Many of our competitors sell their products at prices lower than ours. Our most price sensitive consumers may trade down to lower priced products during challenging economic times or if current economic conditions worsen. We compete primarily on the basis of product innovation, product quality, product performance, value, brand strength, supply chain competency, field sales support, in-store sales support, the strength of our relationships with major retailers and advertising. Some of our competitors have significant financial resources. The strong competition that we face in all of our markets may prevent us from achieving our revenue goals, which may have a material adverse effect on our financial condition, results of operations and cash flows.

Our manufacturing operations, including our reliance on third-party manufacturers, could harm our business.

We may not be able to maintain or develop efficient, low-cost manufacturing capability and processes that will enable us to meet the quality, price, design and product standards or production volumes required to successfully manufacture our products. Even if we successfully maintain and develop our manufacturing capabilities and processes, we may not be able to do so in time to satisfy the needs of our customers.

We rely on third parties to manufacture certain products. This reliance generates a number of risks, including decreased control over the production and related processes, which could lead to production delays or interruptions and inferior product quality control. In addition, performance problems at these third-party manufacturers could lead to cost overruns, shortages or other problems, which could increase our costs of production or result in delivery shortages or delays to our customers.

10

Table of Contents

In addition, if one or more of our third-party manufacturers becomes insolvent or unwilling to continue to manufacture products of acceptable quality, at acceptable costs and in a timely manner, our ability to deliver products to our retail customers could be significantly impaired. Substitute manufacturers may not be available or, if available, may be unwilling or unable to manufacture the products we need on acceptable terms. Moreover, if customer demand for our products increases, we may be unable to secure sufficient additional capacity from our current third-party manufacturers, or others, on commercially reasonable terms, or at all.

Our business is subject to risks associated with sourcing and manufacturing outside of the U.S. and risks from tariffs and/or international trade wars.

We import many of our raw materials and finished goods from countries outside of the United States, including but not limited to China. Our import operations are subject to complex customs laws, regulations, tax requirements, forced labor laws and trade regulations, such as tariffs set by governments, either through mutual agreements or bilateral actions. Tariffs on goods imported into the U.S., particularly goods from China, have increased the cost of the goods we purchase. Additional tariffs and protectionist duties could be imposed by the U.S. with relatively short notice to us. These governmental actions could have, and any similar future actions may have, a material adverse effect on our business, financial condition and results of operations. The overall effect of these risks is that our costs may increase or we may experience supply disruptions, which in turn may result in lower profitability if we are unable to offset such increases through higher prices, and/or that we may suffer a decline in sales if our customers do not accept price increases.

Our reliance on a limited base of suppliers may result in disruptions to our business and adversely affect our financial results.

Although we continue to implement risk mitigation strategies for single-source suppliers, we also rely on a limited number of suppliers for certain of our raw materials, product components and other necessary supplies, including certain active ingredients used in our products. If we are unable to maintain supplier arrangements and relationships, if we are unable to contract with suppliers at the quantity and quality levels needed for our business, or if any of our key suppliers becomes insolvent or experience other financial distress, we could experience disruptions in production, which could have a material adverse effect on our financial condition, results of operations and cash flows.

A significant interruption in the operation of our or our suppliers’ facilities could impact our capacity to produce products and service our customers, which could adversely affect revenues and earnings.

Operations at our and our suppliers’ facilities are subject to disruption for a variety of reasons, including fire, flooding or other natural disasters, disease outbreaks or pandemics, acts of war, terrorism, government shutdowns and work stoppages. A significant interruption in the operation of our or our suppliers’ facilities could significantly impact our capacity to produce products and service our customers in a timely manner, which could have a material adverse effect on our revenues, earnings and financial position, particularly with respect to products that we manufacture at a limited number of facilities, such as our fertilizer and liquid products.

In the event of a disaster, our disaster recovery and business continuity plans may fail, which could adversely interrupt our operations.

Our operations are dependent on our ability to protect our infrastructure against damage from catastrophe, natural disaster, or severe weather, as well as events resulting from unauthorized security breach, power loss, telecommunications failure, terrorist attack, pandemic, or other events that could have a significant disruptive effect on our operations. We have disaster recovery and business continuity plans in place that are ready to be executed if we encounter a disruptive event. However, we cannot be certain that our plans, or those of third-party service providers we rely on, will be successful in the event of a disaster. If our disaster recovery or business continuity plans are unsuccessful in a disaster recovery scenario, we could potentially experience material adverse impacts including loss of data, damage to important facilities, disruption to our operations, regulatory intervention, reputational harm and loss of customers.

Disruptions to transportation channels that we use to distribute our products may adversely affect our margins and profitability.

We may experience disruptions to the transportation channels used to distribute our products, including increased congestion, a lack of transportation capacity, increased fuel expenses, import or export controls or delays, and labor disputes or shortages. Disruptions in our trucking capacity may result in reduced sales or increased costs, including the additional use of more expensive or less efficient alternatives to meet demand. Congestion can affect previously negotiated contracts with shipping companies, resulting in unexpected increases in shipping costs, reduction in our profitability or reduced sales.

11

Table of Contents

Climate change and unfavorable weather conditions could adversely impact financial results.

Our consumer lawn and garden net sales in any year are susceptible to weather conditions in the markets in which our products are sold. For instance, periods of abnormally wet or dry weather can adversely impact the sale of certain products, while increasing demand for other products making the overall impact on the Company difficult to predict.

The effects of climate change could include changes in rainfall patterns, water shortages, changing storm patterns and intensities, and changing temperature levels. These changes could over time affect, for example, the availability and cost of raw materials, commodities and energy, which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.

Consumers and businesses may independently change their behavior because of concerns regarding the impact of climate change and public perceptions. For example, consumers may elect to garden less frequently than historic patterns due to the unpredictability of weather patterns. Those consumers who are less directly impacted by climate change may also engage in less gardening due to discomfort or concerns about perceptions stemming from the direct impact of climate change on others. Current or potential retail customers may pull back from all or parts of the lawn and garden category in response to softening consumer demand. Also, our ability to finance the development of climate resilient product offerings may suffer if consumers become less engaged in lawn and gardening.

Our failure to adequately manage the consumer and retail impacts of climate change could have a material adverse effect on our financial condition, results of operations and cash flows.

Our business could be negatively impacted by corporate citizenship and sustainability matters - including climate change - and/or our reporting of such matters.

Certain investors, customers, consumers, associates, governmental authorities and other stakeholders are increasing their focus on corporate citizenship and sustainability matters (including climate changes). From time to time, we communicate certain initiatives, including goals, regarding environmental matters, responsible sourcing and social investments, including pursuant to our Corporate Responsibility Report. We could fail, or be perceived to fail, to achieve such initiatives or goals, or we could fail to fully and accurately report our progress on such initiatives and goals. In addition, we could be criticized for the scope of such initiatives or goals or perceived as not acting responsibly in connection with these matters.

Moreover, there are adopted and proposed international accords and treaties, as well as federal, state and local laws and regulations, that would attempt to control or limit the causes of climate change, including the effect of greenhouse gas emissions on the environment. In the event that the U.S. government or foreign governments enact new climate change laws or regulations or make changes to existing laws or regulations, compliance with applicable laws or regulations may result in increased manufacturing costs for our products, such as by requiring investment in new pollution control equipment or changing the ways in which certain of our products are made. Additional compliance burdens could be imposed by laws requiring the collection, measurement and analysis of climate-related data which can be costly, time-consuming, dependent on third-party cooperation and unreliable. Furthermore, methodologies for measuring, tracking and reporting on such matters continue to change over time, which requires our processes and controls for such data to evolve as well. Compliance with any new or more stringent laws or regulations, or stricter interpretations of existing laws, could require additional expenditures by us or our suppliers, in which case, the costs of raw materials and component parts could increase. We may incur some of these costs directly and others may be passed on to us from our third-party suppliers.

Any failure to achieve our goals with respect to corporate citizenship and sustainability matters or a perception (whether or not valid) of our failure to act responsibly with respect to the environment or to adequately manage the political, legal and regulatory impacts of corporate citizenship or other sustainability matters could adversely affect our financial condition, results of operations, cash flows and reputation.

Product recalls or other product liability claims could materially and adversely affect our business, financial condition and results of operation.

Due to the highly regulated nature of our products, which are primarily designed for consumer use, we may be required to stop selling, return or recall products due to a variety of potential concerns including suspected or confirmed product contamination, adulteration, product mislabeling or misbranding, tampering, or other deficiencies. Product recalls or voluntary market withdrawals could result in significant losses due to their costs, the destruction of product inventory, and lost sales due to the unavailability of the product for a period of time. Adverse attention about these types of concerns, whether or not valid, may damage our reputation, discourage consumers from buying our products, or cause production and delivery disruptions that could negatively impact our sales and financial condition.

12

Table of Contents

We may also suffer losses if our products or operations violate applicable laws or regulations, or if our products are alleged to cause damage to property, injury, illness, or death. A significant product liability, legal judgment or a related regulatory enforcement action against us, or a significant product recall or voluntary withdrawal, may materially and adversely affect our business, financial condition and results of operation.

If the perception of our brands or organizational reputation are damaged, our consumers, distributors and retailers may react negatively, which could materially and adversely affect our business, financial condition and results of operations.

We believe we have built our reputation on the efficacy and safety of our brands. Any incident that erodes consumer affinity for our brands or our business operations could significantly reduce our value and damage our business. For example, negative third-party research or media reports on our product safety or efficacy, whether accurate or not, may adversely affect consumer perceptions, which could cause the value of our brands to suffer and adversely affect our business. We may also be adversely affected by news or other negative publicity, regardless of accuracy, regarding other aspects of our business, such as:

•     public health concerns, illness or safety;

•     the perception of our environmental stewardship and the effects our business has on the environment;

•     security breaches of confidential company, customer or employee information; or

•     employee related claims relating to alleged employment discrimination, health care and benefit issues.

As part of our marketing initiatives, we have contracted with certain public figures to market and endorse our products. While we maintain specific selection criteria and are diligent in our efforts to seek out public figures that resonate genuinely and effectively with our consumer audience, the individuals we choose to market and endorse our products may fall into negative favor with the general public. Because our consumers may associate the public figures that market and endorse our products with us, any negative publicity on behalf of such individuals may cause negative publicity about us and our products. This negative publicity could materially and adversely affect our brands and reputation and our revenue and profits.

Certain of our products may be purchased for use in new and emerging industries or segments and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative practices, enforcement approaches, judicial interpretations, and consumer perceptions.

We sell products, including hydroponic gardening products, that end users may purchase for use in new and emerging industries or segments, including the growing of cannabis, that may not grow or achieve market acceptance in a manner that we can predict. The demand for these products depends on the uncertain growth of these industries or segments. For example, our Hawthorne segment sales volume has decreased due to an oversupply of cannabis, which has led to a prolonged period of lower cannabis wholesale prices and reduced indoor and outdoor cannabis cultivation. The oversupply has been driven by increased licensing activity across the U.S. and significant capital investment in the cannabis production marketplace over the past several years, as well as inconsistent enforcement of regulations.

In addition, we sell products that end users may purchase for use in industries or segments, including the growing of cannabis, that are subject to varying, inconsistent, and rapidly changing laws, regulations, administrative practices, enforcement approaches, judicial interpretations, and consumer perceptions. For example, certain countries and 38 U.S. states have adopted frameworks that authorize, regulate, and tax the cultivation, processing, sale, and use of cannabis for medicinal and/or non-medicinal use, while the U.S. Controlled Substances Act and the laws of other U.S. states prohibit growing cannabis.

If we are unable to effectively execute our e-commerce business, our reputation and operating results may be harmed.

We sell certain of our products over the Internet through our online store and our retail customer’s e-commerce retail platforms. As consumers demonstrate greater reliance on e-commerce channels, the success of our business depends on our investment in e-commerce platforms, consumer preferences and buying trends relating to e-commerce, and our ability to both maintain the continuous operation of our online store and our fulfillment operations that support both our own and our retail customers’ e-commerce platforms. It is essential that these platforms provide a shopping experience that will generate orders and return visits to the respective platforms.

We are also vulnerable to certain additional risks and uncertainties associated with our e-commerce business, including: changes in required technology interfaces; website downtime and other technical failures; costs and technical issues associated with website software, systems and technology investments and upgrades; data and system security; system failures, disruptions and breaches and the costs to address and remedy such failures, disruptions or breaches; computer viruses; and changes in and compliance with applicable federal and state regulations. In addition, our efforts to remain competitive with technology trends, including the use of new or improved technology, creative user interfaces and other e-commerce marketing tools such as paid search and mobile applications, among others, may increase our costs and may not increase sales or attract consumers. Our failure to successfully respond to these risks and uncertainties might adversely affect the sales of our e-commerce business, as well as damage our reputation and brands.

13

Table of Contents

Additionally, the success of our e-commerce business and the satisfaction of our consumers depend on the timely receipt of our products by our consumers. The efficient delivery of our products to our consumers requires that our distribution centers have adequate capacity to support the current level of e-commerce operations and any anticipated increased levels that may occur as a result of the growth of our e-commerce business. If we encounter difficulties with our distribution centers, or if any distribution centers shut down for any reason, including as a result of pandemics, acts of war, terrorism, government shut downs, work stoppages and fire or other natural disasters, we could face inventory shortages that may result in out of stock conditions in our online store, incur significantly higher costs and longer lead times associated with distributing our products to our consumers and experience dissatisfaction from our consumers. Any of these issues could have a material adverse effect on our business and harm our reputation.

Our operations, financial condition or reputation may be impaired if our information or operational technology systems fail to perform adequately or if we are the subject of a data breach or cyber-attack.

We rely on information and operational technology systems to conduct business, including communicating with associates and our key retail customers, ordering and managing materials from suppliers, shipping products to retail customers and analyzing and reporting results of operations. While we have taken steps to ensure the security of our information and operational technology systems, including those of our customers, vendors, suppliers and other third-party service providers on whom we rely, our systems, as well the systems utilized by our customers, vendors, suppliers and other third-party service providers, have, in the past, been and may, in the future, be vulnerable to cyber threats such as malware, security breaches, phishing attacks, unauthorized activity, system failures, defects, unintentional or malicious actions of associates, contractors, and bad actors (e.g., cyber criminal groups, nation state actors and hacktivist organizations).

We have experienced and may continue to experience an increase in the number of such cyber threats. In addition, while we maintain cyber-security insurance, costs related to a cyber-attack may exceed the amount of insurance coverage or be excluded under the terms of our cyber-security insurance policy. As cyber-attacks increase in frequency and magnitude, we may be unable to obtain cyber-security insurance in amounts and on terms we view as appropriate for our operations.

If our information or operational technology systems are damaged or cease to function properly for an extended period of time, whether as a result of a significant cyber-incident or any other adverse event, our ability to operate or communicate internally as well as with our retail customers, vendors, suppliers and other parties critical to our business, could be significantly impaired, which may adversely impact our business.

Additionally, in the normal course of our business, we collect, store and transmit proprietary and confidential information regarding our customers, consumers, associates, suppliers and others, including personally identifiable information. We are required to comply with increasingly complex and changing data privacy and security laws and regulations, that apply to the collection, storage, use, transmission and protection of personal information and other consumer and employee data, including particularly the transfer of personal data between or among countries. High-profile security breaches of the information systems of a number of U.S. companies and/or government agencies may result in increased regulations and new security laws.

An operational failure or breach of security from increasingly sophisticated cyber-threats could lead to loss, misuse or unauthorized disclosure of this information about our associates or consumers, which may result in regulatory or other legal proceedings, and have a material adverse effect on our business and reputation. We may not have the resources or technical sophistication to anticipate or prevent rapidly-evolving types of cyber-attacks. Any such attacks or precautionary measures taken to prevent anticipated attacks may result in increasing costs, including costs for additional technologies, training and third-party consultants. The losses incurred from a cybersecurity-related event as well as the precautionary measures required to address this evolving risk may adversely impact our financial condition, results of operations, cash flows and reputation.

Our insurance coverage may not be sufficient to avoid or effectively mitigate the material impact on our financial position or results of operations resulting from claims or liabilities against us, and we may not be able to obtain appropriate insurance coverage in the future.

We maintain insurance coverage to manage our exposure to future claims and liabilities that may adversely impact our financial position or results of operations. The extent of our insurance program is under continuous review and coverages are modified as we deem necessary to mitigate current or emerging risks. Despite our program, it is possible that claims or liabilities against us may have a material adverse impact on our financial position or results of operations. In addition, we may not be able to obtain sufficient insurance coverage, when our existing insurance policies expire.

We maintain an insurance program that includes coverage to de-risk against claims associated with property damage, management liability, cargo liability, cyber threats, workers compensation and general liability losses. While we expect to be able to continue our insurance coverages, there can be no assurance that we will be able to procure insurance coverage, or that such policy limits will be adequate to cover any liability we may incur, or that our insurance premiums will continue to be available at a cost similar to our cost today. The volatility of the insurance and reinsurance markets are also subject to macroeconomic conditions and events that are outside of our control.

14

Table of Contents

Additionally, it is possible one or more of our insurers could specifically exclude from our policy certain chemicals used in our products. Consequently, we may have to cease use of those chemicals and/or be forced to substitute less effective or more expensive alternatives to continue manufacturing and/or distributing such goods. A substantial increase in liability exposure or the loss of customers or product offerings could each have a material adverse effect on our results of operations and financial condition.

Our international operations make us susceptible to the costs and risks associated with operating internationally.

We operate manufacturing, sales and service facilities outside of the United States, particularly in Canada, the Netherlands, Mexico and China. Accordingly, we are subject to risks associated with operating in foreign countries, including:

•fluctuations in currency exchange rates;

•limitations on the remittance of dividends and other payments by foreign subsidiaries;

•additional costs of compliance with local regulations;

•historically, in certain countries, higher rates of inflation than in the United States;

•changes in the economic conditions or consumer preferences or demand for our products in these markets;

•restrictive actions by multinational governing bodies, foreign governments or subdivisions thereof;

•changes in foreign labor laws and regulations affecting our ability to hire and retain associates;

•changes in U.S. and foreign laws regarding trade and investment, including the impact of tariffs;

•less robust protection of our intellectual property under foreign laws; and

•difficulty in obtaining distribution and support for our products, including the impact of shipping port delays.

In addition, our operations outside the United States are subject to the risk of new and different legal and regulatory requirements in local jurisdictions, potential difficulties in staffing and managing local operations and potentially adverse tax consequences. The costs associated with operating our continuing international business could adversely affect our results of operations, financial condition and cash flows in the future.

In the event the Third Restated Agreement for Monsanto’s consumer Roundup® products terminates or Monsanto’s consumer Roundup® business materially declines, we would lose a substantial source of future earnings and overhead expense absorption.

If we (i) become insolvent, (ii) commit a material breach, material fraud or material willful misconduct under the Third Restated Agreement, (iii) experience a change of control (subject to certain exceptions), or (iv) impermissibly assign our rights or delegate our obligations under the Third Restated Agreement, Monsanto may terminate the Third Restated Agreement without paying a termination fee to the Company, subject to certain terms and conditions as set forth therein. In addition, if Program EBIT (as defined in the Third Restated Agreement) falls below $50.0 million in any program year, Monsanto may terminate the Third Restated Agreement without paying a termination fee to the Company, subject to certain terms and conditions as set forth therein.

Monsanto may also terminate the Third Restated Agreement in the event of (a) a change of control of Monsanto or a sale of the Roundup® business effective at the end of the fifth full year after providing notice of termination, subject to certain terms and conditions as set forth in the applicable agreements, or (b) Monsanto’s decision to decommission the permits, licenses and registrations needed for, and the trademarks, trade names, packages, copyrights and designs used in, the sale of the Roundup® products in the lawn and garden market (a “Brand Decommissioning Event”), but, in each case, Monsanto would have to pay a termination fee to the Company.

If circumstances exist or otherwise develop that result in a material decline in Monsanto’s consumer Roundup® business, or in the event of Monsanto’s insolvency or bankruptcy, we would seek to mitigate the impact on us by exercising various rights and remedies under the Third Restated Agreement and applicable law. We cannot, however, provide any assurance that our exercise of such rights or remedies would produce the desired outcomes or that a material decline in Monsanto’s consumer Roundup® business would not have a material adverse effect on our business, financial condition or results of operations.

In the event that the Third Restated Agreement terminates or Monsanto’s consumer Roundup® business materially declines, we would lose all, or a substantial portion, of the significant source of earnings and overhead expense absorption the Third Restated Agreement provides.

For additional information regarding the Third Restated Agreement including certain of our rights and remedies under the Third Restated Agreement, see “NOTE 6. MARKETING AGREEMENT” of the Notes to Consolidated Financial Statements included in this Form 10-K.

15

Table of Contents

We may not be able to adequately protect our intellectual property and other proprietary rights that are material to our business.

Our ability to compete effectively depends in part on our rights to service marks, trademarks, trade names and other intellectual property rights we own or license, particularly our registered brand names and issued patents. Although we have a robust portfolio of registered trademarks, we have not sought to register each of our marks either in the United States or in every country in which such mark is used. Furthermore, because of the differences in foreign trademark, patent and other intellectual property or proprietary rights laws, we may not receive the same protection in other countries as we would in the United States with respect to the registered brand names and issued patents we hold. If we are unable to protect our intellectual property, proprietary information and/or brand names, we could suffer a material adverse effect on our business, financial condition and results of operations.

Litigation may be necessary to enforce our intellectual property rights and protect our proprietary information, or to defend against claims by third parties that our products or services infringe their intellectual property rights. Any litigation or claims brought by or against us could result in substantial costs and diversion of our resources. A successful claim of trademark, patent or other intellectual property infringement against us, or any other successful challenge to the use of our intellectual property, could subject us to damages or prevent us from providing certain products or services, or using certain of our recognized brand names, which could have a material adverse effect on our business, financial condition and results of operations.

Our success depends upon the retention and availability of key personnel and the effective succession of senior management.

Our success largely depends on the performance of our management team and other key personnel. Our future operations could be harmed if we are unable to attract and retain talented, highly qualified senior executives and other key personnel. In fiscal 2023 and fiscal 2024, we experienced management transitions involving our Chief Financial Officer, Chief Operating Officer, Chief Human Resources Officer and General Counsel. In addition, our current Chief Financial Officer will be departing the Company effective December 31, 2024. For additional information regarding this departure, see “ITEM 9B. OTHER INFORMATION” of this Form 10-K.

If we are unable to effectively provide for the succession of senior management, including our chief executive officer, our business, prospects, results of operations, financial condition and cash flows may be materially adversely affected.

Our workforce reductions may cause undesirable consequences and adversely affect our business and results of operations.

During fiscal 2024, fiscal 2023 and fiscal 2022, we undertook strategic reductions in our workforce as part of an on-going series of organizational changes and initiatives intended to create operational and management-level efficiencies. This workforce reduction may yield unintended consequences, such as attrition beyond our intended reduction in workforce and reduced employee morale, which may cause our associates who were not affected by the reduction in workforce to seek alternate employment. Associates whose positions were eliminated or those who determine to seek alternate employment may seek employment with our competitors.

We cannot provide assurance that we will not undertake additional workforce reductions or that we will be able to realize the cost savings and other anticipated benefits from our previous or any future workforce reduction plans. In addition, if we continue to reduce our workforce, it may adversely impact our ability to respond rapidly to any new product, growth or revenue opportunities and to execute our business plans. Additionally, reductions in workforce may make it more difficult to recruit and retain associates if they perceive uncertainty in employment. If we need to increase the size of our workforce in the future, we may encounter a competitive hiring market due to labor shortages, increased employee turnover, changes in the availability of workers and increased wage costs.

We are involved in a number of legal proceedings and, while we cannot predict the outcomes of such proceedings and other contingencies with certainty, some of these outcomes could adversely affect our business, financial condition, results of operations and cash flows.

We are involved in legal proceedings and are subject to investigations, inspections, audits, inquiries and similar actions by governmental authorities, arising in the course of our business (see the discussion in “ITEM 3. LEGAL PROCEEDINGS” of this Form 10-K). Legal proceedings, in general, can be expensive and disruptive. Some of these suits may purport or may be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts of damages, including punitive or exemplary damages, and may remain unresolved for several years. For example, product liability claims challenging the safety of our products or products we market on behalf of third parties may also result in a decline in sales for a particular product and could damage the reputation or the value of related brands, involve us in litigation and have a material adverse effect on our business.

16

Table of Contents

From time to time, we are also involved in legal proceedings involving contract, intellectual property and other matters including, for example, the securities litigation and shareholder derivative suits discussed in “ITEM 3. LEGAL PROCEEDINGS” of this Form 10-K. We cannot predict with certainty the outcomes of these legal proceedings and other contingencies, and the costs incurred in litigation can be substantial, regardless of the outcome. Substantial unanticipated verdicts, fines and rulings do sometimes occur. As a result, we could from time to time incur judgments, enter into settlements or revise our expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on our results of operations in the period in which the amounts are accrued and/or our cash flows in the period in which the amounts are paid. The outcome of some of these legal proceedings and other contingencies could require us to take, or refrain from taking, actions which could negatively affect our operations and, depending on the nature of the allegations, could negatively impact our reputation or the reputation of products we market on behalf of third parties. Additionally, defending against these legal proceedings may involve significant expense and diversion of management’s attention and resources.

Risks Related to Our M&A, Lending and Financing Activities

Our indebtedness could limit our flexibility and adversely affect our financial condition.

As of September 30, 2024, we had $2,242.8 million of debt and $1,167.0 million in available borrowings under our credit facility. Our inability to meet restrictive financial and non-financial covenants associated with that debt, or to generate sufficient cash flow to repay maturing debt, could adversely affect our financial condition. For example, our debt level could:

•make it more difficult for us to satisfy our obligations with respect to our indebtedness;

•make us more vulnerable to general adverse economic and industry conditions;

•require us to dedicate a substantial portion of cash flows from operating activities to payments on our indebtedness, which would reduce the cash flows available to fund working capital, capital expenditures, advertising, research and development efforts, pay dividends, repurchase our Common Shares and other general corporate activities;

•limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;

•limit our ability to borrow additional funds;

•expose us to risks inherent in interest rate fluctuations because some of our borrowings are at variable rates of interest, which could result in higher interest expense in the event of increases in interest rates; and

•place us at a competitive disadvantage compared to our competitors that have less debt.

Our ability to make payments on or to refinance our indebtedness, fund planned capital expenditures and acquisitions, pay dividends and repurchase our Common Shares will depend on our ability to generate cash in the future which, to some extent, is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control. We cannot provide any assurance that our business will generate sufficient cash flow from operating activities or that future borrowings will be available to us in amounts sufficient to enable us to pay our indebtedness or to fund our other liquidity needs.

Our credit facility and the indentures governing our 5.250% Senior Notes due 2026 (the “5.250% Senior Notes”), our 4.500% Senior Notes due 2029 (the “4.500% Senior Notes”), our 4.000% Senior Notes due 2031 (the “4.000% Senior Notes”) and our 4.375% Senior Notes due 2032 (the “4.375% Senior Notes” and, collectively with the 5.250% Senior Notes, the 4.500% Senior Notes and the 4.000% Senior Notes, the “Senior Notes”) contain restrictive covenants and cross-default provisions. For example, under our credit facility the maximum permitted leverage ratio is (i) 6.00 for the fourth quarter of fiscal 2024, (ii) 5.50 for the first quarter of fiscal 2025, (iii) 5.25 for the second quarter of fiscal 2025, (iv) 5.00 for the third quarter of fiscal 2025, (v) 4.75 for the fourth quarter of fiscal 2025 and (vi) 4.50 for the first quarter of fiscal 2026 and thereafter. Our leverage ratio was 4.86 at September 30, 2024. In addition, our credit facility contains a fixed charge coverage ratio covenant which sets the minimum permitted fixed charge coverage ratio at 1.00. Our fixed charge coverage ratio was 1.27 for the twelve months ended September 30, 2024. The Senior Notes contain an interest coverage ratio covenant which sets the minimum permitted interest coverage ratio at 2.00. Our interest coverage ratio was 3.57 for the twelve months ended September 30, 2024. A breach of any of these financial ratio covenants or other covenants could result in a default and/or a cross default under the credit facility and Senior Notes, as applicable. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, and could cease making further loans and institute foreclosure proceedings against our assets. We cannot provide any assurance that the holders of such indebtedness would waive a default or that we would have the resources to pay the accelerated indebtedness in full.

Subject to compliance with certain covenants under our credit facility and the indentures governing the Senior Notes, we may incur additional debt in the future. If we incur additional debt, the risks described above could intensify.

17

Table of Contents

Significant or prolonged periods of higher interest rates may have an adverse effect on our results of operations, financial condition and cash flows.

Interest rates have a direct impact on our business due to the amount of variable rate debt the Company utilizes in its operations. Prolonged periods of higher interest rates may have a negative impact on the Company’s results of operations, financial condition and cash flows. All of our debt under the sixth amended and restated credit agreement (the “Sixth A&R Credit Agreement”) bears interest at variable rates primarily derived from, as defined therein, the (i) the Alternate Base Rate, (ii) the Adjusted Term SOFR Rate or (iii) the Swingline Rate. In a rising interest rate environment, debt financing will become more expensive and may have higher transactional and servicing costs. For example, the weighted average interest rates on average borrowings under the Sixth A&R Credit Agreement, excluding the impact of interest rate swaps, were 9.1%, 7.6% and 2.8% for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Although the Company has taken steps to reduce our exposure to variable rate debt instruments, if interest rates remain relatively high or increase in the future, we could see increases in our borrowing costs which could have a material adverse effect on our results of operations, financial condition and cash flows.

Global economic and capital market conditions may limit our access to capital and/or increase the costs of such capital.

In the future, we may need new or additional financing to provide liquidity to conduct our operations, expand our business or refinance existing indebtedness. Any sustained weakness in general economic conditions and/or U.S. or global capital markets could adversely affect our ability to raise capital on favorable terms or at all. From time to time we have relied, and we may also rely in the future, on access to financial markets as a source of liquidity for working capital requirements, acquisitions and general corporate purposes. Our access to funds under our credit facility depends on the ability of the lenders that are parties to that facility to meet their funding commitments. Moreover, the obligations of the lenders under our credit facility are several and not joint and, as a result, a funding default by one lender does not need to be made up by the others. Longer term volatility in the capital and credit markets as a result of uncertainty, changing or increased regulation of financial institutions or reduced alternatives could adversely affect our access to the liquidity needed for our businesses in the longer term. Such disruptions could require us to take measures to conserve cash until the markets stabilize or until alternative credit arrangements or other funding for our business needs can be arranged.

Acquisitions, other strategic alliances and investments could result in operating difficulties, dilution, and other harmful consequences that may adversely impact our business and results of operations.

Acquisitions, strategic alliances and investments are an important element of our long-term corporate strategy and use of capital, and these transactions could be material to our financial condition and results of operations. We expect to continue to evaluate and enter into discussions regarding a wide array of potential strategic transactions. The process of integrating an acquired company, business, or product has created, and will continue to create, unforeseen operating difficulties and expenditures. The areas where we face risks include:

•Assumptions implicit to our acquisition strategy or valuations are not realized.

•Diversion of management time and focus from operating our business to acquisition integration challenges.

•Failure to successfully further develop the acquired business or product lines.

•Implementation or remediation of controls, procedures and policies at the acquired company.

•Integration of the acquired company’s accounting, human resources and other administrative systems, and coordination of product, engineering and sales and marketing functions.

•Transition of operations, users and customers onto our existing platforms.

•Reliance on the expertise of our strategic partners with respect to market development, sales, local regulatory compliance and other operational matters.

•Failure to obtain required approvals on a timely basis, if at all, from governmental authorities, or conditions placed upon approval, under competition and antitrust laws which could, among other things, delay or prevent us from completing a transaction, or otherwise restrict our ability to realize the expected financial or strategic goals of an acquisition.

•In the case of foreign acquisitions, the need to integrate operations across different cultures and languages and to address the particular economic, currency, political and regulatory risks associated with specific countries.

•Cultural challenges associated with integrating associates from the acquired company into our organization, and retention of associates from the businesses we acquire.

18

Table of Contents

•Strategic investments in which we have a minority ownership stake and that we do not control may from time to time have economic, business, or legal interests or goals that are inconsistent with our goals. As a result, business decisions or other actions or omissions of controlling owners, management, or other persons or entities who control companies in which we invest may adversely affect the value of our investment, result in litigation or regulatory action against us, or otherwise damage our reputation.

•Liability for or reputational harm from activities of the acquired company before the acquisition or from our strategic partners, including patent and trademark infringement claims, violations of laws, commercial disputes, tax liabilities and other known and unknown liabilities.

•Litigation or other claims in connection with the acquired company, including claims from terminated associates, customers, former shareholders or other third parties.

Our failure to address these risks or other problems encountered in connection with our past or future acquisitions and investments or strategic alliances could cause us to fail to realize the anticipated benefits of such acquisitions, investments or alliances, incur unanticipated liabilities, and harm our business generally.

Our acquisitions, strategic alliances and investments could also result in dilutive issuances of our equity securities, the incurrence of debt, contingent liabilities or amortization expenses, or impairment of goodwill and purchased long-lived assets, and restructuring charges, any of which could harm our financial condition or results of operations and cash flows. Also, the anticipated benefits of many of our acquisitions may not materialize.

Changes in credit ratings issued by nationally recognized statistical rating organizations (NRSROs) could adversely affect our cost of financing and the market price of our Senior Notes.

NRSROs rate the Senior Notes and the Company based on factors that include our operating results, actions that we take, their view of the general outlook for our industry and their view of the general outlook for the economy. Actions taken by the NRSROs can include maintaining, upgrading or downgrading the current rating or placing us on a watch list for possible future downgrading. Downgrading the credit rating of the Senior Notes or placing us on a watch list for possible future downgrading could increase our cost of financing, limit our access to the capital markets and have an adverse effect on the market price of the Senior Notes.

In August 2023, S&P Global Ratings lowered our issuer credit rating to B+ from BB- and lowered its rating on our Senior Notes to B- from B. Also in August 2023, Moody’s Investors Service lowered (i) our Corporate Family Rating to B1 from Ba3, (ii) our Probability of Default Rating to B1-PD from Ba3-PD and (iii) its rating on the Senior Notes to B2 from B1.

A failure to dispose of assets or businesses in a timely manner may cause the results of the Company to suffer.

We evaluate as necessary the potential disposition of assets and businesses that may no longer help meet our objectives. When we decide to sell assets or a business, we may encounter difficulty in finding buyers or alternative exit strategies on acceptable terms in a timely manner, which could delay the achievement of our strategic objectives. Alternatively, we may dispose of a business at a price or on terms that are less than we had anticipated. After reaching an agreement with a buyer for the disposition of a business, the pre-closing conditions must also be satisfied or waived, which may prevent us from completing the transaction. Dispositions may also involve continued financial involvement in the divested business, such as through continuing equity ownership, guarantees, indemnities or other financial obligations. Under these arrangements, performance by the divested businesses or other conditions outside our control could affect our future financial results.

Our lending activities may adversely impact our business and results of operations.

As part of our strategic initiatives, we have provided financing to certain strategic partners. Our exposure to credit losses on these financing balances and strategic investments will depend on the financial condition of these counterparties as well as legal, regulatory and macroeconomic factors beyond our control, such as deteriorating conditions in the world economy or in the industries served by the borrowers and federal legalization of the U.S. cannabis market. While we monitor our exposure, there can be no guarantee we will be able to successfully mitigate all of these risks. For example, during fiscal 2024 and fiscal 2023, the Company recorded non-cash, pre-tax other-than-temporary impairment charges related to its convertible debt investments of $64.6 million and $101.3 million, respectively. These or other credit losses, if significant, could have a material adverse effect on our business, financial condition, results of operations and cash flows.

19

Table of Contents

Our hedging arrangements expose us to certain counterparty risks.

In addition to commodity hedge agreements, we utilize interest rate swap agreements to manage the net interest rate risk inherent in our sources of borrowing as well as foreign currency forward contracts to manage the exchange rate risk associated with certain intercompany loans with foreign subsidiaries and other approved transactional currency exposures. Utilizing these hedge agreements exposes us to certain counterparty risks. The failure of one or more of the counterparties to fulfill their obligations under the hedge agreements, whether as a result of weakening financial stability or otherwise, could adversely affect our financial condition, results of operations or cash flows.

Our postretirement-related costs and funding requirements could increase as a result of volatility in the financial markets, changes in interest rates and actuarial assumptions.

We sponsor a number of defined benefit pension plans associated with our U.S. and former international businesses, as well as a postretirement medical plan in the United States for certain retired associates and their dependents. The performance of the financial markets and changes in interest rates impact the funded status of these plans and may cause volatility in our postretirement-related costs and future funding requirements. If the financial markets do not provide the expected long-term returns on invested assets, we could be required to make significant pension contributions. Additionally, changes in interest rates and legislation enacted by governmental authorities can impact the timing and amounts of contribution requirements.

We utilize third-party actuaries to evaluate assumptions used in determining projected benefit obligations and the fair value of plan assets for our pension and other postretirement benefit plans. In the event we determine that our assumptions should be revised, such as the discount rate or expected return on assets, our future pension and postretirement benefit expenses could increase or decrease. The assumptions we use may differ from actual results, which could have a significant impact on our pension and postretirement liabilities and related costs and funding requirements.

Risks Related to Regulation of Our Company

Compliance with environmental and other public health regulations or changes in such regulations or regulatory enforcement priorities could increase our costs of doing business or limit our ability to market all of our products.

Laws and regulations relating to environmental matters affect us in several ways. All pesticide products sold in the United States must comply with FIFRA and most must be registered with the U.S. EPA and similar state agencies. Our inability to obtain or maintain such registrations, or the cancellation of any such registration of our products, could have an adverse effect on our business, the severity of which would depend on a variety of factors, including the product(s) involved, whether another product could be substituted and whether our competitors were similarly affected. We attempt to anticipate regulatory developments and maintain registrations of, and access to, substitute active ingredients, but there can be no assurance that we will be able to avoid these risks. For example, there are indications that federal agencies in the U.S. may take more restrictive positions on pesticides. In addition, several provinces in Canada have adopted regulations that substantially restrict our ability to market and sell certain consumer pesticide products.

Under the Food Quality Protection Act, enacted by the U.S. Congress in 1996, food-use pesticides are evaluated to determine whether there is reasonable certainty that no harm will result from the cumulative effects of pesticide exposures. Under this Act, the U.S. EPA is evaluating the cumulative and aggregate risks from dietary and non-dietary exposures to pesticides. The pesticides in our products, certain of which may be also used on crops processed into various food products, are manufactured by independent third parties and continue to be evaluated by the U.S. EPA as part of this exposure risk assessment. The U.S. EPA or the third-party registrant may decide that a pesticide we use in our products will be limited or made unavailable to us. We cannot predict the outcome or the severity of the effect of these continuing evaluations.

In addition, the use of certain fertilizer and pesticide products (including pesticide products that contain glyphosate) is regulated by various environmental and public health agencies. These regulations may, among other things, limit or ban the use of certain ingredients contained in such products or require (i) that only certified or professional users apply the product, (ii) that certain products be used only on certain types of locations, (iii) users to post notices on properties to which products have been or will be applied, and/or (iv) notification to individuals in the vicinity that products will be applied in the future. Even if we are able to comply with all such regulations and obtain all necessary registrations and licenses, we cannot provide assurance that our products, particularly pesticide products, will not cause or be alleged to cause injury to the environment or to people under all circumstances, particularly when used improperly or contrary to instructions. The costs of compliance, remediation or products liability have adversely affected operating results in the past and could materially adversely affect future quarterly or annual operating results.

20

Table of Contents

Our products and operations may be subject to increased regulatory and environmental scrutiny in jurisdictions in which we do business. For example, we are subject to regulations relating to our harvesting of peat for our growing media business which has come under increasing regulatory and environmental scrutiny. In the United States, state regulations frequently require us to limit our harvesting and to restore the property to an agreed-upon condition. In some locations, we have been required to create water retention ponds to control the sediment content of discharged water. In Canada, our peat extraction efforts are also the subject of regulation.

In addition to the laws and regulations already described, various governmental agencies regulate the disposal, transport, handling and storage of waste, the remediation of contaminated sites, air and water discharges from our facilities, and workplace health and safety. Under certain environmental laws and regulations, we may be liable for the costs of investigation and remediation of the presence of certain regulated materials or damage to natural resources, at various properties, including current and former properties we have owned or operated, as well as offsite waste handling or disposal sites that we have used. Liability may be imposed upon us without regard to whether we knew of or caused the presence of such materials and, under certain circumstances, on a joint and several basis. There can be no assurances that the presence of such regulated materials at any such locations, or locations that we may acquire in the future, will not result in liability to us under such laws or regulations or expose us to third-party actions such as tort suits based on alleged conduct or environmental conditions.

In 2021, the Biden Administration announced a multi-agency plan to address PFAS contamination. Various federal agencies, including the U.S. EPA, have and are expected to continue to take actions to prevent the release of PFAS into the air, drinking systems, and food supply and to expand cleanup efforts to remediate the impacts of PFAS pollution. As part of this announcement, the U.S. EPA released its PFAS Strategic Roadmap: EPA’s Commitments to Action 2021-2024, which identifies timelines by which the U.S. EPA plans to take specific actions during the Biden Administration. For example, in August 2022, the U.S. EPA proposed to designate PFAS chemicals, PFOA and PFOS, as hazardous substances under CERCLA, which could have wide-ranging impact on companies across various industries. Until further detail is provided, including whether the rule is enacted as proposed, we cannot predict the outcome or the severity of the impact of these proposed actions. Further, many states have taken action to address PFAS concerns with actions ranging from appropriation legislation to fund scientific research, bans on certain categories of consumer products containing PFAS and/or broad prohibitions on PFAS across all products. Complicating this patchwork of state regulation is that jurisdictions may differ as to what they consider PFAS. It is possible, therefore, that some of these actions will have an impact – direct or indirect – on our business.

Many states are increasingly scrutinizing packaging, including seeking to reduce single use plastics and establish extended producer responsibility programs, which are designed to bolster the recycling industry by transferring the cost of packaging disposal to the manufacturers. Extended producer responsibility programs typically include targets and reporting responsibilities for, among other things, post-consumer recycling usage, compostable packaging, material reduction and refill strategies.

The adequacy of our current non-FIFRA compliance-related environmental accruals and future provisions depends upon our operating in substantial compliance with applicable environmental and public health laws and regulations, as well as the assumptions that we have both identified the significant sites that must be remediated and that there are no significant conditions of potential contamination that are unknown to us. A significant change in the facts and circumstances underlying these assumptions or in current enforcement policies or requirements, or a finding that we are not in substantial compliance with applicable environmental and public health laws and regulations, could have a material adverse effect on future environmental capital expenditures and other environmental expenses, as well as our financial condition, results of operations and cash flows.

Unanticipated changes in our tax provisions, the adoption of new tax legislation or exposure to additional tax liabilities could affect our profitability and cash flows.

We are subject to income and other taxes in the United States federal jurisdiction and various local, state and foreign jurisdictions. Our effective tax rate in the future could be adversely affected by changes to our operating structure, changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets (such as net operating losses and tax credits) and liabilities, changes in tax laws and the discovery of new information in the course of our tax return preparation process. In particular, the carrying value of deferred tax assets, which are predominantly related to our operations in the United States, is dependent on our ability to generate future taxable income of the appropriate character in the relevant jurisdiction.

21

Table of Contents

From time to time, tax proposals are introduced or considered by the U.S. Congress or the legislative bodies in local, state and foreign jurisdictions that could also affect our tax rate, the carrying value of our deferred tax assets, or our tax liabilities. Our tax liabilities are also affected by the amounts we charge for inventory, services, licenses, funding and other items in intercompany transactions. We are subject to ongoing tax audits in various jurisdictions. In connection with these audits (or future audits), tax authorities may disagree with our intercompany charges, cross-jurisdictional transfer pricing or other matters and assess additional taxes. We regularly assess the likely outcomes of our audits in order to determine the appropriateness of our tax provision. As a result, the ultimate resolution of our tax audits, changes in tax laws or tax rates, and the ability to utilize our deferred tax assets could materially affect our tax provision, net income and cash flows in future periods.

Risks Related to Our Common Shares

The Company’s decision to maintain, reduce or discontinue paying cash dividends to our shareholders or repurchasing our Common Shares could cause the market price for our Common Shares to decline.

Our payment of quarterly cash dividends on and repurchase of our Common Shares pursuant to a stock repurchase program are subject to, among other things, our financial position and results of operations, available cash and cash flow, capital requirements, credit facility provisions and other factors. Prior to fiscal 2022, we generally increased the cash dividends on our Common Shares as well as engaged in share repurchase activity. Since fiscal 2022, we have not changed the dividend amount nor have we engaged in share repurchase activity outside of our compensation programs. As of September 30, 2024, we do not have a board authorized share repurchase program.

We may maintain, or increase or decrease (including eliminating) the amount of cash dividends on, and increase or decrease the amount of repurchases of, our Common Shares in the future. Any decision by us regarding the payment of quarterly cash dividends or repurchases of our Common Shares could cause the market price of our Common Shares to decline. A failure to pay dividends, an inability to resume increases of our cash dividends or an inability to begin repurchasing Common Shares at historical levels could result in a lower market valuation of our Common Shares.

Hagedorn Partnership, L.P. beneficially owns approximately 24% of our Common Shares and can significantly influence decisions that require the approval of shareholders.

Hagedorn Partnership, L.P. beneficially owned approximately 24% of our outstanding Common Shares as of November 18, 2024. As a result, it has sufficient voting power to significantly influence the election of directors and the approval of other actions requiring the approval of our shareholders, including entering into certain business combination transactions. In addition, because of the percentage of ownership and voting concentration in Hagedorn Partnership, L.P., elections of our Board of Directors will generally be within the control of Hagedorn Partnership, L.P. While all of our shareholders are entitled to vote on matters submitted to our shareholders for approval, the concentration of our Common Shares and voting control presently lies with Hagedorn Partnership, L.P. As such, it would be difficult for shareholders to propose and have approved proposals not supported by Hagedorn Partnership, L.P. Hagedorn Partnership, L.P.’s interests could differ from, or conflict with, the interests of other shareholders.

ITEM 1B.    UNRESOLVED STAFF COMMENTS

None.

22

Table of Contents

ITEM 1C.    CYBERSECURITY

Risk Management and Strategy

Cybersecurity risk was identified as a significant enterprise risk based on the results of our most recent enterprise risk assessment. As a significant enterprise risk, management has worked to identify the underlying drivers of cybersecurity risk, identify the activities in place to manage it, and assess its residual risk level. We have developed and implemented comprehensive strategies and processes to assess, identify, manage and mitigate cybersecurity risks, aligning with the National Institute of Standards and Technology Cybersecurity Framework (“NIST-CSF”). These processes include:

•implementing security event monitoring, incident response processes, access management controls, vulnerability identification and remediation, third-party risk monitoring, and user awareness and training;

•providing regular security training and awareness content for all associates, with mandatory training for new hires;

•maintaining cybersecurity risk insurance to mitigate potential breach-related costs;

•engaging consultants to perform periodic external assessments using industry-recognized frameworks like NIST-CSF; and

•monitoring program maturity through periodic reviews against the Capability Maturity Model Integration framework.

Mitigating Risks Posed by Third Parties

Risk Assessments

We identify and categorize existing third-party service providers based on criticality to our operations and prioritize those that pose the highest risks. We leverage a third-party risk management solution to facilitate our risk assessment process for new third parties which includes interviews and questionnaires with internal business contacts and contacts from the third party to perform an inherent risk assessment. We determine applicable security controls based on the inherent risk level to drive the residual risk score to an acceptable level where possible. The goal of the assessment process is to evaluate the risks associated with each third party, including operational, financial, legal, and reputational risks.

Ongoing Monitoring

Based on the residual risk score of a third party, we conduct assessments on a periodic basis to help ensure that we maintain current, up-to-date information on our vendors. We leverage an external third-party monitoring service to conduct continuous monitoring of our critical vendors to provide additional visibility and response efforts and work directly with vendors to remediate identified vulnerabilities. Finally, we review contracts that outline risk management responsibilities, compliance requirements, data protection, and incident management protocols.

Incident Management

We have developed an incident response plan that includes a process for addressing issues arising from third-party relationships which includes communication channels for reporting and managing incidents involving third parties.

Documentation and Reporting

We maintain detailed records of our third-party assessments and any evidence or documentation that is provided during the assessment process. We regularly review and report on third-party risk management activities and any significant issues to senior management and/or our Audit Committee or Board of Directors.

External Resources; Associate Training and Awareness

We have developed a comprehensive information security protocol that relies on support from third-party experts and an internal training and awareness program aligned with industry standards and best practices.

Given the complex and evolving nature of cybersecurity threats, we engage third-party advisors and consultants to assist us in developing and maintaining effective cybersecurity risk management processes. Partnering with these third parties allows us to leverage specialized knowledge and insights, better ensuring our cybersecurity strategies and processes are well-designed and effective. For example, we work with third parties to regularly conduct simulated attack exercises to identify additional needs for training and overall program refinement.

Internally, our training and awareness program creates multi-layered defenses by empowering associates with knowledge and tools to recognize and respond to security risks. Through role-specific and comprehensive training, we seek to maintain a workforce that actively contributes to our cybersecurity goals. Key components of our training program include:

23

Table of Contents

•Onboarding Training — All new associates participate in an initial cybersecurity training module at onboarding. This training covers the Company’s security policies, data protection standards and foundational security practices helping to ensure that new hires are equipped to meet the Company’s expectations pertaining to its security protocols.

•Articles — We publish articles on our intranet site for all associates to easily access. These articles highlight emerging threats, industry trends, and actionable tips to help associates enhance their personal and professional security posture. We target critical topics such as ransomware, social engineering, data management, and the latest threats and best practices.

•Phishing Simulations — Our phishing awareness program includes continuous phishing simulations conducted on a routine basis. This program helps associates develop the skills to effectively identify and mitigate phishing attempts. Associates who fail a threshold number of simulations during a calendar year are required to undergo additional training.

•Cybersecurity Awareness Month Activities — We have implemented interactive, virtual and on-site awareness activities during Cybersecurity Awareness Month in October. These activities include phishing simulations, articles, lunch and learns, and gamification to serve as refreshers on critical security concepts and reinforce our commitment to maintaining a security-conscious culture.

Governance

Our Board of Directors has overall oversight responsibility for our risk management and has delegated oversight of cybersecurity risks to our Audit Committee, including overseeing the actions management has taken to identify, monitor, and control such exposure. Our Audit Committee reviews the measures implemented by the Company to identify and mitigate data protection and cybersecurity risks on a quarterly basis. As part of our continued investment in developing our overall enterprise risk management program, our Audit Committee receives reports and presentations from management which address a range of topics including recent developments, evolving standards, vulnerability assessments, third-party and independent reviews, the threat environment, and technological trends. Our Audit Committee reports to our Board of Directors at least annually on cybersecurity matters.

At the management level, our Chief Information Security Officer (“CISO”) leads the team responsible for implementing, monitoring, and maintaining information security, including data protection practices across our business. Our CISO receives reports on cybersecurity threats from both our internal personnel and external partners on a regular basis. Our Chief Operating Officer and Chief Administrative Officer receive regular reports from our CISO on the cyber program and measures implemented by the Company to identify and mitigate cybersecurity risks. Our CISO works closely with our Company’s legal team to ensure compliance with legal and regulatory cybersecurity requirements. Our CISO has over a decade of cybersecurity and risk management experience and holds CISA, CISM, and CISSP certifications as well as a bachelor’s degree in Business Information Systems.

Cybersecurity Threats and Incidents

To date, risks from cybersecurity threats, including as a result of previous cybersecurity incidents, have not materially affected us, including our business strategy, results of operations, or financial condition. During fiscal 2024, fiscal 2023 and fiscal 2022, the Company did not experience any cybersecurity threats or incidents that have materially affected or are reasonably likely to materially affect the Company or its business strategy, results of operations and/or financial condition. Despite our efforts, we cannot eliminate all risks from cybersecurity threats or incidents or provide assurances that we have not experienced undetected cybersecurity incidents. For additional details regarding the risks the Company faces from cybersecurity threats, see “ITEM 1A. RISK FACTORS — Risks Related to Our Business — Our operations, financial condition or reputation may be impaired if our information or operational technology systems fail to perform adequately or if we are the subject of a data breach or cyber-attack” in this Form 10-K.

24

Table of Contents

ITEM 2.    PROPERTIES

Our corporate headquarters is located in Marysville, Ohio, where we own approximately 729 acres of land. In addition, we own and lease numerous industrial, commercial and office properties located in North America, Europe and Asia that support the management, manufacturing, distribution and research and development of our products and services. We believe our properties are suitable and adequate to serve the needs of our business and that our leased properties are subject to appropriate lease agreements.

The following is a summary of owned and leased primary operating properties by country as of September 30, 2024:

Location	Owned	Leased
United States	352	553,4
Canada	10	13
Mexico	—	1
China	—	6
The Netherlands	—	3
Total	45	78

We own or lease 45 manufacturing properties, 16 distribution properties and 4 research and development properties in the United States. We own or lease 15 manufacturing properties, 1 distribution property and 1 research and development property in Canada, 2 manufacturing properties in the Netherlands and 1 research and development property in China. Most of the manufacturing properties, which include growing media properties and peat harvesting properties, have production lines, warehouses, offices and field processing areas.

2 Includes one manufacturing location that is not operational.

3 Includes one manufacturing location under development with operations scheduled to begin in fiscal 2025.

4 Includes ten distribution centers that are not operational. Disposition and sublease efforts are underway or in place.

25

Table of Contents

ITEM 3.    LEGAL PROCEEDINGS

As noted in the discussion in “ITEM 1. BUSINESS — Regulatory Considerations — Regulatory Matters” of this Form 10-K, we are involved in several pending environmental and regulatory matters. We believe that our assessment of contingencies is reasonable and that the related accruals, in the aggregate, are adequate; however, there can be no assurance that the final resolution of these matters will not have a material effect on our financial condition, results of operations or cash flows.

On June 6, 2024, a purported shareholder filed a lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03132) on behalf of a proposed class of purchasers of Common Shares between November 3, 2021, and August 1, 2023. On July 26, 2024, another purported shareholder filed a lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03766) on behalf of a proposed class of purchasers of Common Shares between June 2, 2021, and August 1, 2023. These lawsuits, which will likely be consolidated with any subsequently filed lawsuits alleging similar facts, assert claims under Section 10(b), Rule 10b-5 and Section 20(a) of the Securities Exchange Act against the Company and certain of its current and former officers based on alleged misstatements about the Company’s inventories, sales and business prospects. The actions seek, among other things, unspecified monetary damages, reasonable costs and expenses and equitable/injunctive or other relief as deemed appropriate by the Court. The Company believes that the claims asserted are without merit and intends to vigorously defend the actions.

On July 3, 2024, a purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03636), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On July 30, 2024, a second purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No.1:24-cv-00402), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On August 23, 2024, a third purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03880), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On September 9, 2024, a fourth purported shareholder filed a shareholder derivative lawsuit in the Union County (Ohio) Court of Common Pleas (Case No. 24CV0193), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On September 26, 2024, a fifth purported shareholder filed a shareholder derivative lawsuit in the Union County (Ohio) Court of Common Pleas (Case No. 24CV0203), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On November 19, 2024, a sixth purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-04180), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On November 22, 2024, a seventh purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-04190), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. The federal lawsuits will likely be consolidated with one another, along with any subsequently filed federal lawsuits alleging similar facts, and the state court lawsuits will likely be consolidated with one another, along with any subsequently filed state lawsuits alleging similar facts. All of the lawsuits include allegations that generally mirror those asserted in the securities lawsuits described above and assert claims for breaches of fiduciary duties and unjust enrichment, as well as abuse of control, gross mismanagement, and waste of corporate assets. The federal lawsuits also assert claims under Section 10(b), Rule 10b-5, Section 14(a), Rule 14a-9, and Section 20(a) of the Securities Exchange Act, and contribution under Sections 10(b) and 21D of the Securities Exchange Act. The actions seek a judgment in favor of the Company for damages in an unspecified amount, disgorgement, interest, and costs and expenses, including attorneys’ and experts’ fees.

The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. The Company has not recorded any accruals in its consolidated financial statements as the likelihood of a loss from these cases is not probable at this time. The Company does not believe a reasonably possible loss would be material to the Company’s financial condition, results of operations or cash flows. In addition, the Company does not believe the ultimate resolution of these cases will have a material adverse effect on the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows.

We are involved in other lawsuits and claims which arise in the normal course of our business including the initiation and defense of proceedings to protect intellectual property rights, advertising claims, securities matters and employment disputes. In our opinion, these claims individually and in the aggregate are not expected to have a material adverse effect on our financial condition, results of operations or cash flows.

26

Table of Contents

ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.

PART II

SUPPLEMENTAL ITEM. EXECUTIVE OFFICERS OF THE REGISTRANT

The executive officers of Scotts Miracle-Gro, their positions and, as of November 20, 2024, their ages and years with Scotts Miracle-Gro (and its predecessors) are set forth below. 

Name	Age	Position(s) Held	Years with Company
James Hagedorn	69	Chairman & Chief Executive Officer	37
Nathan E. Baxter	52	President & Chief Operating Officer	1
Matthew E. Garth	50	Executive Vice President, Chief Financial Officer & Chief Administrative Officer	2
Christopher J. Hagedorn	40	Executive Vice President & Chief of Staff	13
Dimiter Todorov	52	Executive Vice President, Chief Legal Officer & Corporate Secretary	16

Executive officers serve at the discretion of the Board of Directors of Scotts Miracle-Gro and pursuant to executive severance agreements or other arrangements. The business experience of each of the individuals listed above during at least the past five years is as follows:

Mr. Hagedorn was named Chairman of the Board of Scotts Miracle-Gro’s predecessor in January 2003 and Chief Executive Officer of Scotts Miracle-Gro’s predecessor in May 2001. Prior to these appointments, Mr. Hagedorn held several senior leadership positions at the Company including President from October 2023 until November 2024. Mr. Hagedorn serves on Scotts Miracle-Gro’s Board of Directors, a position he has held with Scotts Miracle-Gro (or its predecessor) since 1995. Mr. Hagedorn is the brother of Katherine Hagedorn Littlefield, a director of Scotts Miracle-Gro, and is the father of Christopher J. Hagedorn, an executive officer of the Company.

Mr. Baxter was named Executive Vice President & Chief Operating Officer of Scotts Miracle-Gro in August 2023 and President in November 2024. Prior to August 2023, Mr. Baxter served as Executive Vice President, Technology & Operations, a position he held since April 2023. Previously, Mr. Baxter served as President of Tokyo Electron U.S. Holdings, a semiconductor manufacturing equipment company. Mr. Baxter is a general partner of the Hagedorn Partnership, L.P., the largest shareholder of the Company.

Mr. Garth was named Executive Vice President, Chief Financial Officer & Chief Administrative Officer of Scotts Miracle-Gro in October 2023. Prior to this appointment, Mr. Garth served as Executive Vice President & Chief Financial Officer, a position he held since December 2022. Previously, Mr. Garth served as Senior Vice President, Finance and Treasury, and Chief Financial Officer for Mineral Technologies Inc., a specialty mineral company. Mr. Garth will be departing the Company effective December 31, 2024. For additional information regarding this departure, see “ITEM 9B. OTHER INFORMATION” of this Form 10-K.

Mr. C. Hagedorn was named Executive Vice President & Chief of Staff of Scotts Miracle-Gro in November 2024. Prior to this appointment, Mr. C. Hagedorn served as Division President of Scotts Miracle-Gro from January 2021 through November 2024. Previously, Mr. C. Hagedorn served as Senior Vice President & General Manager, Hawthorne, a position he held since January 2017. Mr. C. Hagedorn is the son of Mr. Hagedorn, the Chief Executive Officer, President & Chairman of the Board of Scotts Miracle-Gro.

Mr. Todorov was named Executive Vice President, Chief Legal Officer & Corporate Secretary in November 2024. Prior to this appointment, Mr. Todorov served as Executive Vice President, General Counsel, Corporate Secretary & Chief Ethics and Compliance Officer of Scotts Miracle-Gro, a position he held since October 2024, and Executive Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer, a position he held since December 2022. Previously, Mr. Todorov served as Vice President, Legal, a position he held since June 2015.

27

ITEM 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

The Common Shares trade on the New York Stock Exchange under the symbol “SMG.” The payment of future dividends, if any, on the Common Shares will be determined by the Board of Directors in light of conditions then existing, including the Company’s earnings, financial condition and capital requirements, restrictions in financing agreements, business conditions and other factors.

Amendment No. 2 to the Sixth A&R Credit Agreement (“Amendment No. 2”) limits the Company’s ability to declare or pay any discretionary dividends, distributions or other restricted payments to only the payment of (i) regularly scheduled cash dividends to holders of its Common Shares in an aggregate amount not to exceed $225.0 million per fiscal year and (ii) other dividends, distributions or restricted payments in an aggregate amount not to exceed $25.0 million.

On September 4, 2024, September 13, 2023 and December 14, 2022, Scotts Miracle-Gro issued 286,204, 373,831 and 388,878 Common Shares, respectively, having a contractual value of $20.0 million each, to a vendor who is an accredited investor as consideration for advertising services. The issuances of the Common Shares were exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2). Scotts Miracle-Gro issued the Common Shares in privately negotiated transactions, and such restricted shares were acquired for the recipient’s account for investment purposes.

As of November 18, 2024, there were approximately 226,000 shareholders, including holders of record and our estimate of beneficial holders.

The following table shows the purchases of Common Shares made by or on behalf of Scotts Miracle-Gro or any “affiliated purchaser” (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended) of Scotts Miracle-Gro for each of the three fiscal months in the quarter ended September 30, 2024:

Period	Total Number of Common Shares Purchased(1)	Average Price Paid per Common Share(2)		Total Number of Common Shares Purchased as Part of Publicly Announced Plans or Programs(3)	Approximate Dollar Value of Common Shares That May Yet Be Purchased Under the Plans or Programs(3)
June 30, 2024 through July 27, 2024	1,295	$	70.29	—	N/A
July 28, 2024 through August 24, 2024	—	$	—	—	N/A
August 25, 2024 through September 30, 2024	2,350	$	77.46	—	N/A
Total	3,645	$	74.91	—

(1)All of the Common Shares purchased during the fourth quarter of fiscal 2024 were purchased in open market transactions. The Common Shares purchased during the quarter consisted of 3,645 Common Shares purchased by the trustee of the rabbi trust established by the Company as permitted pursuant to the terms of The Scotts Company LLC Executive Retirement Plan.

(2)The average price paid per Common Share is calculated on a settlement basis and includes commissions.

(3)On February 6, 2020, the Company announced a repurchase program allowing for repurchases of up to $750.0 million of Common Shares from April 30, 2020 through March 25, 2023. The program expired on March 25, 2023 and, as of September 30, 2024, the Company does not have an active repurchase program.

28

Comparison of Cumulative Five-Year Total Return*

The following graph compares the yearly change in the cumulative total stockholder return on our Common Shares for the past five fiscal years with the cumulative total return of the Russell 2000 Index and the S&P 500 Household Products Index.

ITEM 6.    RESERVED

29

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

ITEM 7.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The purpose of this Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is to provide an understanding of our financial condition and results of operations by focusing on changes in certain key measures from year-to-year. This MD&A includes the following sections:

•Executive summary

•Results of operations

•Segment results

•Liquidity and capital resources

•Regulatory matters

•Critical accounting estimates

Executive Summary

Our operations are divided into three reportable segments: U.S. Consumer, Hawthorne and Other. U.S. Consumer consists of our consumer lawn and garden business in the United States. Hawthorne consists of our indoor and hydroponic gardening business. Other primarily consists of our consumer lawn and garden business in Canada. This division of reportable segments is consistent with how the segments report to and are managed by our chief operating decision maker. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the business segments. See “SEGMENT RESULTS” below for additional information regarding our evaluation of segment performance.

Through our U.S. Consumer and Other segments, we are the leading manufacturer and marketer of branded consumer lawn and garden products in North America. Our products are marketed under some of the most recognized brand names in the industry. Our key consumer lawn and garden brands include Scotts® Turf Builder® lawn fertilizer and Scotts® grass seed products; Miracle-Gro® soil, plant food and gardening products; Ortho® herbicide and pesticide products; and Tomcat® rodent control and animal repellent products. We are the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products within the United States and certain other specified countries. In addition, we have an equity interest in Bonnie Plants, LLC, a joint venture with AFC, focused on planting, growing, developing, distributing, marketing and selling live plants.

Through our Hawthorne segment, we are a leading provider of nutrients, lighting and other materials used for indoor and hydroponic gardening in North America. Our key brands include General Hydroponics®, Gavita®, Botanicare®, Agrolux®, Gro Pro®, Mother Earth®, Grower’s Edge®, HydroLogic Purification System® and CYCO®.

As a leading consumer branded lawn and garden company, our product development and marketing efforts are largely focused on providing innovative and differentiated products and continually increasing brand and product awareness to inspire consumers to create retail demand. We have implemented this model for a number of years by focusing on research and development and investing approximately 3-5% of our U.S. Consumer segment annual net sales in advertising to support and promote our consumer lawn and garden products and brands. We continually explore new and innovative ways to communicate with consumers. We believe that we receive a significant benefit from these expenditures and anticipate a similar commitment to research and development, advertising and marketing investments in the future, with the continuing objective of driving category growth and profitably maintaining and/or increasing market share.

Our consumer lawn and garden net sales in any one year are susceptible to weather conditions in the markets in which our products are sold. For instance, periods of abnormally wet or dry weather can adversely impact the sale of certain products, while increasing demand for other products. We believe that our diversified product line and our geographic diversification reduce this risk, although to a lesser extent in a year in which unfavorable weather is geographically widespread and extends across a significant portion of the lawn and garden season. We also believe that weather conditions in any one year, positive or negative, do not materially impact longer-term category growth trends.

30

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

Due to the seasonal nature of the consumer lawn and garden business, significant portions of our U.S. Consumer and Other segment net sales ship to our retail customers during our second and third fiscal quarters, as noted in the following table. Our annual net sales are further concentrated in the second and third fiscal quarters by retailers who rely on our ability to deliver products closer to when consumers buy our products. Our Hawthorne segment is also impacted by seasonal sales patterns for certain product categories due to the timing of growing patterns in North America during our second and third fiscal quarters, and the timing of certain controlled agricultural lighting project sales during our third and fourth fiscal quarters.

 

	Percent of Net Sales from Continuing  Operations by Quarter
	2024		2023		2022
First Quarter	11.6	%	14.8	%	14.4	%
Second Quarter	42.9	%	43.2	%	42.8	%
Third Quarter	33.8	%	31.5	%	30.2	%
Fourth Quarter	11.7	%	10.5	%	12.6	%

Management focuses on a variety of key indicators and operating metrics to monitor the financial condition and performance of the continuing operations of our business. These metrics include consumer purchases (point-of-sale data), market share, category growth, net sales (including unit volume, mix, pricing and foreign exchange movements), gross margins, advertising to net sales ratios, income (loss) from operations, net income (loss), earnings per share, earnings before interest, taxes, depreciation and amortization (“EBITDA”), leverage ratio, fixed charge coverage ratio and interest coverage ratio. We also focus on measures to optimize cash flow and return on invested capital, including the management of working capital and capital expenditures.

Recent Events

During fiscal 2022, we began implementing a series of Company-wide organizational changes and initiatives intended to create operational and management-level efficiencies. As part of this restructuring initiative, we reduced the size of our supply chain network, reduced staffing levels and implemented other cost-reduction initiatives. We also accelerated the reduction of certain Hawthorne inventory, primarily lighting, growing environments and hardware products, to reduce our on hand inventory to align with the reduced network capacity. These efforts have delivered run-rate annualized savings of more than $300.0, which has increased our gross margin rate and lowered SG&A. During fiscal 2024, we incurred costs of $83.5 in the “Cost of sales—impairment, restructuring and other” line and $6.0 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets, intangible assets, property, plant and equipment and software. Costs incurred from the inception of this restructuring initiative through September 30, 2024 were $383.5. Future costs associated with this restructuring initiative are not expected to be material.

During fiscal 2024, our Hawthorne segment continued to experience adverse financial results primarily due to decreased sales volume. The decrease in sales volume is attributable to an oversupply of cannabis, which has led to a prolonged period of lower cannabis wholesale prices and reduced indoor and outdoor cannabis cultivation. The oversupply has been driven by increased licensing activity across the U.S. and significant capital investment in the cannabis production marketplace over the past several years, as well as inconsistent enforcement of regulations. We expect that the oversupply of cannabis will continue to adversely impact our Hawthorne segment. If the oversupply of cannabis persists longer, or is more significant than we expect, our results of operations could be materially and adversely impacted for a longer period and to a greater extent than we currently anticipate.

During fiscal 2024, our Hawthorne segment announced a strategic partnership with BFG Supply (“BFG”), a leading national horticultural and agricultural product distributor, under which BFG will distribute Hawthorne’s proprietary Signature brand cultivation supplies and solutions. Our Hawthorne segment also announced it is discontinuing the distribution of other companies’ products and shifting its focus solely to marketing, innovating and supporting its portfolio of Signature brands, including General Hydroponics®, Gavita®, Botanicare®, Gro Pro®, Mother Earth®, Grower’s Edge®, HydroLogic Purification System® and CYCO®. We expect the discontinuation of sales of other companies’ products will decrease the sales volume of our Hawthorne segment in future periods, but will enable continued optimization of its operations and improvement of its profitability.

31

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

During fiscal 2024, we continued to experience the impacts of cost inflation and uncertain macroeconomic and geopolitical conditions (including the ongoing conflicts in Ukraine and the Middle East), resulting in persistently high manufacturing costs, elevated interest rates and volatile commodity costs. Higher costs over the past several years required us to implement significant price increases across our business in fiscal 2022 and fiscal 2023, and we implemented targeted price reductions on certain products during fiscal 2024. We expect inflationary headwinds, volatile commodity costs and elevated interest rates to continue. The impact that these trends will continue to have on our operational and financial performance will depend on future developments, including inflationary, macroeconomic and geopolitical conditions, and their potential impact on consumer behavior, which are difficult to predict.

During fiscal 2024, we recorded a non-cash, pre-tax other-than-temporary impairment charge of $64.6 related to our convertible debt investments in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. Refer to “NOTE 16. FAIR VALUE MEASUREMENTS” of the Notes to the Consolidated Financial Statements included in this Form 10-K for more information regarding convertible debt investments. In addition, we recorded pre-tax impairment charges of $61.9 associated with our investment in Bonnie Plants, LLC in the “Equity in loss of unconsolidated affiliates” line in the Consolidated Statements of Operations during fiscal 2024. Refer to “NOTE 8. INVESTMENT IN UNCONSOLIDATED AFFILIATES” of the Notes to the Consolidated Financial Statements included in this Form 10-K for more information regarding our investment in Bonnie Plants, LLC.

Results of Operations

The following table sets forth the components of earnings as a percentage of net sales:

	Year Ended September 30,
	2024		% of Net Sales		2023		% of Net Sales		2022		% of Net Sales
Net sales	$	3,552.7	100.0	%	$	3,551.3	100.0	%	$	3,924.1	100.0	%
Cost of sales	2,618.7		73.7		2,708.3		76.3		2,891.1		73.7
Cost of sales—impairment, restructuring and other	83.5		2.4		185.7		5.2		160.1		4.1
Gross margin	850.5		23.9		657.3		18.5		872.9		22.2
Operating expenses:
Selling, general and administrative	559.0		15.7		551.3		15.5		613.0		15.6
Impairment, restructuring and other	62.8		1.8		280.5		7.9		693.1		17.7
Other (income) expense, net	19.9		0.6		(0.1)		—		0.8		—
Income (loss) from operations	208.8		5.9		(174.4)		(4.9)		(434.0)		(11.1)
Equity in loss of unconsolidated affiliates	68.1		1.9		101.1		2.8		12.9		0.3
Interest expense	158.8		4.5		178.1		5.0		118.1		3.0
Other non-operating (income) expense, net	5.5		0.2		(0.3)		—		(6.9)		(0.2)
Loss before income taxes	(23.6)		(0.7)		(453.3)		(12.8)		(558.1)		(14.2)
Income tax expense (benefit)	11.3		0.3		(73.2)		(2.1)		(120.6)		(3.1)
Net loss	$	(34.9)	(1.0)	%	$	(380.1)	(10.7)	%	$	(437.5)	(11.1)	%

The sum of the components may not equal due to rounding.

Net Sales

Net sales for fiscal 2024 were $3,552.7 as compared to net sales of $3,551.3 for fiscal 2023. Net sales for fiscal 2023 decreased 9.5% from net sales of $3,924.1 for fiscal 2022. Factors contributing to the change in net sales are outlined in the following table:

	Year Ended September 30,
	2024		2023
Volume and mix	1.1	%	(14.3)	%
Foreign exchange rates	—		(0.4)
Pricing	(1.1)		5.0
Acquisitions	—		0.2
Change in net sales	—	%	(9.5)	%

32

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

Net sales for fiscal 2024 as compared to fiscal 2023 were primarily driven by the offsetting changes below:

•increased sales volume, comprised of the net impact of higher volume in our U.S. Consumer segment driven by mulch, soils and controls products, partially offset by lower volume in our Hawthorne segment driven by the discontinuation of sales of other companies’ products; and

•increased net sales associated with the Roundup® marketing agreement;

•offset by decreased pricing in our U.S. Consumer, Hawthorne and Other segments.

The decrease in net sales for fiscal 2023 as compared to fiscal 2022 was primarily driven by:

•decreased sales volume across all segments driven by growing environments, growing media, hardware, nutrients and lighting products in our Hawthorne segment; and lawn care, plant food and controls products in our U.S. Consumer segment; and

•the unfavorable impact of foreign exchange rates as a result of the strengthening of the U.S. dollar relative to the Canadian dollar;

•partially offset by increased pricing in our U.S. Consumer, Hawthorne and Other segments.

Cost of Sales

The following table shows the major components of cost of sales:

	Year Ended September 30,
	2024		2023		2022
Materials	$	1,401.7	$	1,524.1	$	1,616.7
Manufacturing labor and overhead	610.8		545.4		546.4
Distribution and warehousing	515.0		556.3		660.1
Costs associated with Roundup® marketing agreement	91.2		82.5		67.9
Cost of sales	2,618.7		2,708.3		2,891.1
Cost of sales—impairment, restructuring and other	83.5		185.7		160.1
	$	2,702.2	$	2,894.0	$	3,051.2

Factors contributing to the change in cost of sales are outlined in the following table:

	Year Ended September 30,
	2024		2023
Volume, mix and other	$	(71.4)	$	(299.7)
Material cost changes	(26.6)		112.7
Foreign exchange rates	(0.3)		(10.4)
Costs associated with Roundup® marketing agreement	8.7		14.6
	(89.6)		(182.8)
Impairment, restructuring and other	(102.2)		25.6
Change in cost of sales	$	(191.8)	$	(157.2)

The decrease in cost of sales for fiscal 2024 as compared to fiscal 2023 was primarily driven by: 

•lower warehousing and transportation costs included within “volume, mix and other” in our U.S. Consumer and Hawthorne segments;

•lower material costs in our U.S. Consumer segment;

•lower sales volume in our Hawthorne segment; and

•a decrease in impairment, restructuring and other charges;

•partially offset by higher sales volume in our U.S. Consumer segment;

•inventory write-down charges included within “volume, mix and other” associated with our U.S. Consumer segment; and

33

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

•an increase in costs associated with the Roundup® marketing agreement.

The decrease in cost of sales for fiscal 2023 as compared to fiscal 2022 was primarily driven by: 

•lower sales volume in our U.S. Consumer, Hawthorne and Other segments;

•lower warehousing costs included within “volume, mix and other” in our U.S. Consumer and Hawthorne segments; and

•the favorable impact of foreign exchange rates as a result of the strengthening of the U.S. dollar relative to the Canadian dollar;

•partially offset by higher material costs in our U.S. Consumer, Hawthorne and Other segments;

•higher manufacturing costs, primarily labor, included within “volume, mix and other” in our U.S. Consumer, Hawthorne and Other segments;

•inventory write-down charges included within “volume, mix and other” associated with our U.S. Consumer segment;

•an increase in costs associated with the Roundup® marketing agreement; and

•an increase in impairment, restructuring and other charges.

Gross Margin

As a percentage of net sales, our gross margin rate was 23.9%, 18.5% and 22.2% for fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Factors contributing to the change in gross margin rate are outlined in the following table:

	Year Ended September 30,
	2024		2023
Volume, mix and other	2.4	%	(4.0)	%
Material costs	0.7		(3.3)
Roundup® commissions and reimbursements	0.3		(0.3)
Pricing	(0.8)		5.0
	2.6		(2.6)
Impairment, restructuring and other	2.8		(1.1)
Change in gross margin rate	5.4	%	(3.7)	%

The increase in gross margin rate for fiscal 2024 as compared to fiscal 2023 was primarily driven by: 

•lower warehousing and transportation costs included within “volume, mix and other” in our U.S. Consumer and Hawthorne segments;

•favorable mix driven by lower sales in our Hawthorne segment relative to our U.S. Consumer segment;

•lower material costs in our U.S. Consumer segment; and

•a decrease in impairment, restructuring and other charges;

•partially offset by decreased pricing in our U.S. Consumer, Hawthorne and Other segments; and

•inventory write-down charges included within “volume, mix and other” associated with our U.S. Consumer segment.

The decrease in gross margin rate for fiscal 2023 as compared to fiscal 2022 was primarily driven by: 

•higher material costs in our U.S. Consumer, Hawthorne and Other segments;

•higher manufacturing costs, primarily labor, included within “volume, mix and other” in our U.S. Consumer, Hawthorne and Other segments;

•unfavorable leverage of fixed costs, included within “volume, mix and other,” driven by lower sales and production volume in our U.S. Consumer, Hawthorne and Other segments;

•inventory write-down charges included within “volume, mix and other” associated with our U.S. Consumer segment; and

34

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

•an increase in impairment, restructuring and other charges;

•partially offset by increased pricing in our U.S. Consumer, Hawthorne and Other segments; and

•lower warehousing costs included within “volume, mix and other” in our U.S. Consumer and Hawthorne segments.

Selling, General and Administrative Expenses

The following table sets forth the components of selling, general and administrative expenses (“SG&A”):

	Year Ended September 30,
	2024			2023			2022
Advertising	$	141.0		$	123.7		$	120.3
Advertising as a percentage of net sales	4.0		%	3.5		%	3.1		%
Share-based compensation	57.2			49.7			34.3
Research and development	34.6			35.7			45.3
Amortization of intangibles	13.9			22.6			31.0
Other selling, general and administrative	312.3			319.6			382.1
	$	559.0		$	551.3		$	613.0

SG&A increased $7.7, or 1.4%, during fiscal 2024 compared to fiscal 2023. Advertising expense increased $17.3, or 14.0%, in fiscal 2024 driven by increased media spending in our U.S. Consumer segment. Share-based compensation expense, which excludes certain advertising expenses paid for in Common Shares, increased $7.5, or 15.1%, due to a cumulative adjustment recognized during fiscal 2023 for certain performance-based award units to reflect management’s assessment of a lower probability of achievement of performance goals. Amortization expense decreased $8.7, or 38.5%, driven by the impairment of certain Hawthorne segment intangible assets during fiscal 2023. Other SG&A decreased by $7.3, or 2.3%, driven by reductions in staffing levels and other cost-reduction initiatives.

SG&A decreased $61.7, or 10.1%, during fiscal 2023 compared to fiscal 2022. Advertising expense increased $3.4, or 2.8%, in fiscal 2023 driven by increased media spending in our U.S. Consumer segment. Share-based compensation expense, which excludes certain advertising expenses paid for in Common Shares, increased $15.4, or 44.9%, driven by short-term variable incentive compensation that was provided to associates as share-based awards for fiscal 2023 in lieu of a cash-based program, partially offset by the recognition of a cumulative adjustment for certain performance-based award units to reflect management’s assessment of a lower probability of achievement of performance goals. Amortization expense decreased $8.4, or 27.1%, driven by the impairment of certain Hawthorne segment intangible assets during fiscal 2022 and fiscal 2023. Other SG&A and research and development costs decreased by a combined $72.1, or 16.9%, driven by reductions in staffing levels and other cost-reduction initiatives.

35

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

Impairment, Restructuring and Other

Activity described herein is classified within the “Cost of sales—impairment, restructuring and other” and “Impairment, restructuring and other” lines in the Consolidated Statements of Operations. The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:

	Year Ended September 30,
	2024		2023		2022
Cost of sales—impairment, restructuring and other:
Restructuring and other charges, net	$	72.9	$	148.5	$	143.6
Property, plant and equipment impairments	5.3		11.4		16.6
Right-of-use asset impairments	5.3		25.8		—
Operating expenses—impairment, restructuring and other:
Convertible debt other-than-temporary impairments	64.6		101.3		—
Goodwill and intangible asset impairments	2.5		127.9		668.3
Restructuring and other charges (recoveries), net	(4.3)		51.2		40.9
Gains on sale of property, plant and equipment	—		—		(16.2)
Total impairment, restructuring and other charges	$	146.3	$	466.1	$	853.2

During fiscal 2024 and fiscal 2023, we recorded non-cash, pre-tax other-than-temporary impairment charges related to our convertible debt investments of $64.6 and $101.3, respectively, in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. Refer to “NOTE 16. FAIR VALUE MEASUREMENTS” of the Notes to the Consolidated Financial Statements included in this Form 10-K for more information regarding convertible debt investments.

During fiscal 2024, we recorded a gain of $12.1 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with a payment received in resolution of a dispute with the former ownership group of a business that was acquired in fiscal 2022.

During fiscal 2022, we began implementing a series of Company-wide organizational changes and initiatives intended to create operational and management-level efficiencies. As part of this restructuring initiative, we reduced the size of our supply chain network, reduced staffing levels and implemented other cost-reduction initiatives. We also accelerated the reduction of certain Hawthorne inventory, primarily lighting, growing environments and hardware products, to reduce on hand inventory to align with the reduced network capacity. During fiscal 2024, we incurred costs of $89.4 associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets, intangible assets, property, plant and equipment and software. We incurred costs of $11.3 in our U.S. Consumer segment and $71.8 in our Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2024. We incurred costs of $1.5 in our U.S. Consumer segment, $1.0 in our Hawthorne segment, $1.1 in our Other segment and $2.4 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2024. During fiscal 2023, we incurred costs of $229.0 associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets and property, plant and equipment. We incurred costs of $16.3 in our U.S. Consumer segment and $168.5 in our Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2023. We incurred costs of $7.7 in our U.S. Consumer segment, $20.7 in our Hawthorne segment, $0.8 in our Other segment and $14.9 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2023. During fiscal 2022, we incurred costs of $65.2 associated with this restructuring initiative primarily related to employee termination benefits and impairment of property, plant and equipment. We incurred costs of $9.7 in our U.S. Consumer segment and $27.1 in our Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. We incurred costs of $11.9 in our U.S. Consumer segment, $8.1 in our Hawthorne segment, $0.7 in our Other segment and $7.7 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. Costs incurred since the inception of this restructuring initiative through September 30, 2024 were $58.3 for our U.S. Consumer segment, $297.2 for our Hawthorne segment, $2.9 for our Other segment and $25.1 at Corporate.

During fiscal 2023, we recorded non-cash, pre-tax goodwill and intangible asset impairment charges of $127.9 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, comprised of $117.7 of finite-lived intangible asset impairment charges associated with our Hawthorne segment and $10.3 of goodwill impairment charges associated with our Other segment.

36

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

During fiscal 2022, we recorded non-cash, pre-tax goodwill and intangible asset impairment charges of $632.4 as a result of interim impairment testing of our Hawthorne segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, comprised of $522.4 of goodwill impairment charges and $110.0 of finite-lived intangible asset impairment charges.

During fiscal 2022, we incurred inventory write-down charges of $120.9 in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations and finite-lived intangible asset impairment charges of $35.3 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with our decision to discontinue and exit the market for certain Hawthorne lighting products and brands.

During fiscal 2022, we recorded gains of $16.2 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with the sale of property, plant and equipment.

Other (Income) Expense, net

Other (income) expense is comprised of activities such as the discount on sales of accounts receivable under the Master Receivables Purchase Agreement, royalty income from the licensing of certain of our brand names and foreign exchange transaction gains and losses. Other (income) expense was $19.9, $(0.1) and $0.8 in fiscal 2024, fiscal 2023 and fiscal 2022, respectively. The increase in expense during fiscal 2024 was primarily due to the discount on sales of accounts receivable under the Master Receivables Purchase Agreement.

Income (Loss) from Operations

Income (loss) from operations was $208.8 in fiscal 2024 compared to $(174.4) in fiscal 2023. The increase was primarily driven by lower impairment, restructuring and other charges and a higher gross margin rate, partially offset by higher other expense and higher SG&A.

Loss from operations was $(174.4) in fiscal 2023 compared to $(434.0) in fiscal 2022. The decrease was driven by lower impairment, restructuring and other charges and lower SG&A, partially offset by lower net sales and a decrease in gross margin rate.

Equity in Loss of Unconsolidated Affiliates

Equity in loss of unconsolidated affiliates associated with Bonnie Plants, LLC was $68.1, $101.1 and $12.9 in fiscal 2024, fiscal 2023 and fiscal 2022, respectively. We recorded pre-tax impairment charges associated with our investment in Bonnie Plants, LLC of $61.9 and $94.7 during fiscal 2024 and fiscal 2023, respectively. Refer to “NOTE 8. INVESTMENT IN UNCONSOLIDATED AFFILIATES” of the Notes to the Consolidated Financial Statements included in this Form 10-K for more information regarding Bonnie Plants, LLC.

Interest Expense

Interest expense was $158.8 in fiscal 2024, a decrease of 10.8% compared to $178.1 in fiscal 2023. The decrease was driven by lower average borrowings of $554.8, partially offset by an increase in our weighted average interest rate, net of the impact of interest rate swaps, of 40 basis points. The decrease in average borrowings was driven by our focus on using available cash flow to reduce our debt as well as the impact of the expiration of the Receivables Facility and the execution of the Master Receivables Purchase Agreement. The increase in our weighted average interest rate was primarily driven by higher borrowing rates under the Sixth A&R Credit Agreement.

Interest expense was $178.1 in fiscal 2023, an increase of 50.8% compared to $118.1 in fiscal 2022. The increase was driven by an increase in our weighted average interest rate, net of the impact of interest rate swaps, of 180 basis points, primarily driven by higher borrowing rates under the Sixth A&R Credit Agreement. While we had net debt repayments of $353.6 during fiscal 2023, our seasonal borrowing and repayment pattern resulted in an average debt balance for fiscal 2023 that was consistent with fiscal 2022.

37

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

Income Tax Expense (Benefit)

A reconciliation of the federal corporate income tax rate and the effective tax rate on loss before income taxes is summarized below:

	Year Ended September 30,
	2024		2023		2022
Statutory income tax rate	21.0	%	21.0	%	21.0	%
Effect of foreign operations	(2.0)		0.2		(1.6)
State taxes, net of federal benefit	8.0		3.2		2.6
Effect of other permanent differences	(32.8)		(0.8)		2.8
Research and Experimentation and other federal tax credits	2.9		0.2		0.2
Effect of tax contingencies	3.7		0.1		(1.8)
Change in valuation allowances	(57.4)		(8.7)		(0.9)
Other	8.7		1.0		(0.7)
Effective income tax rate	(47.9)	%	16.2	%	21.6	%

For fiscal 2024, the impact on the effective tax rate of the items noted in the table above increased due to the decrease in loss before income taxes for fiscal 2024 as compared to fiscal 2023 and fiscal 2022. Deferred tax assets related to unrealized losses on convertible debt investments were $43.6 and $33.4 at September 30, 2024 and 2023, respectively. A full valuation allowance was recorded against these losses at September 30, 2024 and 2023 as we do not expect to utilize them prior to their expiration, and this impact is included in the “Change in valuation allowances” line in the table above.

Net Loss

Net loss was $34.9, or $0.61 per diluted share, in fiscal 2024 compared to $380.1, or $6.79 per diluted share, in fiscal 2023. The decrease was driven by lower impairment, restructuring and other charges, a higher gross margin rate, lower equity in loss of unconsolidated affiliates and lower interest expense, partially offset by higher other expense, higher income tax expense and higher SG&A.

Net loss was $380.1, or $6.79 per diluted share, in fiscal 2023 compared to $437.5, or $7.88 per diluted share, in fiscal 2022. The decrease was driven by lower impairment, restructuring and other charges, and lower SG&A, partially offset by lower net sales, a decrease in gross margin rate, higher equity in loss of unconsolidated affiliates, higher interest expense, lower other non-operating income and lower income tax benefit.

Diluted average common shares used in the diluted loss per common share calculation for fiscal 2024, fiscal 2023 and fiscal 2022 were 56.8 million, 56.0 million and 55.5 million, respectively, which excluded potential common shares of 0.9 million, 0.4 million and 0.6 million, respectively, because the effect of their inclusion would be anti-dilutive as we incurred a net loss for fiscal 2024, 2023 and 2022.

Segment Results

The performance of each reportable segment is evaluated based on several factors, including income (loss) before income taxes, amortization, impairment, restructuring and other charges (“Segment Profit (Loss)”), which is a non-GAAP financial measure. Senior management uses Segment Profit (Loss) to evaluate segment performance because they believe this measure is indicative of performance trends and the overall earnings potential of each segment.

The following table sets forth net sales by segment:

	Year Ended September 30,
	2024		2023		2022
U.S. Consumer	$	3,013.7	$	2,843.7	$	2,928.8
Hawthorne	294.7		467.3		716.2
Other	244.3		240.3		279.1
Consolidated	$	3,552.7	$	3,551.3	$	3,924.1

38

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

The following table sets forth Segment Profit (Loss) as well as a reconciliation to loss before income taxes, the most directly comparable measure prepared in accordance with U.S. generally accepted accounting principles (“GAAP”):

	Year Ended September 30,
	2024		2023		2022
U.S. Consumer	$	498.0	$	454.1	$	568.6
Hawthorne	(14.2)		(48.1)		(21.1)
Other	4.7		12.4		20.2
Total Segment Profit (Non-GAAP)	488.5		418.4		567.7
Corporate	(117.7)		(101.6)		(112.4)
Intangible asset amortization	(15.7)		(25.2)		(37.1)
Impairment, restructuring and other	(146.3)		(466.0)		(852.2)
Equity in loss of unconsolidated affiliates	(68.1)		(101.1)		(12.9)
Interest expense	(158.8)		(178.1)		(118.1)
Other non-operating income (expense), net	(5.5)		0.3		6.9
Loss before income taxes (GAAP)	$	(23.6)	$	(453.3)	$	(558.1)

U.S. Consumer

U.S. Consumer segment net sales were $3,013.7 in fiscal 2024, an increase of 6.0% from fiscal 2023 net sales of $2,843.7. The increase was driven by higher sales volume of 7.3%, partially offset by decreased pricing of 1.3%. The increase in sales volume for fiscal 2024 was driven by mulch, soils and controls products as well as increased net sales associated with the Roundup® marketing agreement.

U.S. Consumer Segment Profit was $498.0 in fiscal 2024, an increase of 9.7% from fiscal 2023 Segment Profit of $454.1. The increase for fiscal 2024 was primarily due to higher net sales and a higher gross margin rate, partially offset by higher SG&A driven by advertising expense and higher other expense driven by the discount on sales of accounts receivable.

U.S. Consumer segment net sales were $2,843.7 in fiscal 2023, a decrease of 2.9% from fiscal 2022 net sales of $2,928.8. The decrease was driven by lower sales volume of 8.3%, partially offset by increased pricing of 5.4%. The decrease in sales volume for fiscal 2023 was driven by lawn care, plant food and controls products.

U.S. Consumer Segment Profit was $454.1 in fiscal 2023, a decrease of 20.1% from fiscal 2022 Segment Profit of $568.6. The decrease for fiscal 2023 was primarily due to lower net sales and a lower gross margin rate, partially offset by lower SG&A.

Hawthorne

Hawthorne segment net sales were $294.7 in fiscal 2024, a decrease of 36.9% from fiscal 2023 net sales of $467.3. The decrease was driven by lower sales volume of 36.8% and decreased pricing of 0.5%, partially offset by favorable foreign exchange rates of 0.4%. The decrease in sales volume for fiscal 2024 was driven by all product categories and the impact of the discontinuation of sales of other companies’ products.

Hawthorne Segment Loss was $14.2 in fiscal 2024 compared to fiscal 2023 Segment Loss of $48.1. The improvement was driven by a higher gross margin rate and lower SG&A, partially offset by lower net sales.

Hawthorne segment net sales were $467.3 in fiscal 2023, a decrease of 34.8% from fiscal 2022 net sales of $716.2. The decrease was driven by lower sales volume of 38.1%, partially offset by increased pricing of 2.5% and acquisitions of 0.8%. The decrease in sales volume for fiscal 2023 was driven by growing environments, growing media, hardware, nutrients and lighting products.

Hawthorne Segment Loss was $48.1 in fiscal 2023 compared to fiscal 2022 Segment Loss of $21.1. The increase for fiscal 2023 was driven by lower net sales and a lower gross margin rate, partially offset by lower SG&A.

Other

Other segment net sales were $244.3 in fiscal 2024, an increase of 1.7% from fiscal 2023 net sales of $240.3. The increase was driven by higher sales volume of 3.5%, partially offset by decreased pricing of 1.0% and unfavorable foreign exchange rates of 0.8%.

Other Segment Profit was $4.7 in fiscal 2024, a decrease of 62.1% from fiscal 2023 Segment Profit of $12.4. The decrease was driven by a lower gross margin rate and higher SG&A, partially offset by higher net sales.

39

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

Other segment net sales were $240.3 in fiscal 2023, a decrease of 13.9% from fiscal 2022 net sales of $279.1. The decrease was driven by lower sales volume of 16.0% and unfavorable foreign exchange rates of 4.8%, partially offset by increased pricing of 6.9%.

Other Segment Profit was $12.4 in fiscal 2023, a decrease of 38.6% from fiscal 2022 Segment Profit of $20.2. The decrease was driven by lower net sales and a lower gross margin rate.

Corporate 

Corporate expenses were $117.7 in fiscal 2024, an increase of 15.8% from fiscal 2023 expenses of $101.6. The increase was primarily driven by higher share-based compensation expense due to the recognition of a cumulative adjustment in fiscal 2023 for certain performance-based award units to reflect management’s assessment of a lower probability of achievement of performance goals, partially offset by reductions in staffing levels and other cost-reduction initiatives.

Corporate expenses were $101.6 in fiscal 2023, a decrease of 9.6% from fiscal 2022 expenses of $112.4. The decrease was driven by lower share-based compensation expense due to the recognition of a cumulative adjustment for certain performance-based award units to reflect management’s assessment of a lower probability of achievement of performance goals, and reductions in staffing levels and other cost-reduction initiatives.

Liquidity and Capital Resources

The following table summarizes cash activities for the years ended September 30:

	2024		2023		2022
Net cash provided by (used in) operating activities	$	667.5	$	531.0	$	(129.0)
Net cash used in investing activities	(100.4)		(65.7)		(283.2)
Net cash (used in) provided by financing activities	(527.9)		(520.1)		255.3

Operating Activities

Cash provided by operating activities totaled $667.5 for fiscal 2024, an increase of $136.5 compared to $531.0 for fiscal 2023. This increase was driven by lower accounts receivable, higher gross margin, accounts payable timing, lower payments associated with restructuring activities and lower interest payments, partially offset by higher inventory production, higher payments to customers related to promotional programs and lower income tax refunds received. Lower accounts receivable is driven by the favorable impact of accounts receivable sold under the Master Receivables Purchase Agreement. Accounts payable timing is driven by the impact of extended payment terms with vendors for payments originally due in the final weeks of fiscal 2022 that were paid in the first quarter of fiscal 2023.

Cash provided by operating activities totaled $531.0 for fiscal 2023, an increase of $660.0 compared to cash used in operating activities of $129.0 for fiscal 2022. This increase was driven by a reduction in inventory, lower short-term variable cash incentive compensation payouts, higher income tax refunds and lower SG&A, partially offset by lower gross margin, higher interest payments, higher payments associated with restructuring activities and accounts payable timing. Accounts payable timing is driven by the unfavorable impact of extended payment terms with vendors for payments originally due in the final weeks of fiscal 2022 that were paid in the first quarter of fiscal 2023.

The seasonal nature of our North America consumer lawn and garden business generally requires cash to fund significant increases in inventories during the first half of the fiscal year. Receivables and payables also build substantially in our second quarter of the fiscal year in line with the timing of sales to support our retailers’ spring selling season.

Investing Activities

Cash used in investing activities totaled $100.4 for fiscal 2024, an increase of $34.7 compared to $65.7 for fiscal 2023. Cash used for investments in property, plant and equipment during fiscal 2024 and fiscal 2023 was $84.0 and $92.8, respectively. We also acquired an additional equity interest in Bonnie Plants, LLC for $21.4 and had other investing cash inflows of $2.6 during fiscal 2024.

Cash used in investing activities totaled $65.7 for fiscal 2023, a decrease of $217.5 compared to $283.2 for fiscal 2022. Cash used for investments in property, plant and equipment during fiscal 2023 was $92.8, a decrease from $113.5 in fiscal 2022 due to higher spending in fiscal 2022 on capital projects to expand network capacity. We also received proceeds of $37.0 during fiscal 2023 related to the payoff of seller financing that we provided in connection with a fiscal 2017 divestiture, and had other investing cash outflows of $12.4 primarily associated with currency forward contracts.

40

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

For the three fiscal years ended September 30, 2024, we allocated our capital spending as follows: 70% for maintenance of existing productive assets; 20% for cost savings projects, focused primarily on supply chain and information technology; and 10% for innovation and expansion. We expect fiscal 2025 capital expenditures to be approximately $100.0 and we expect to allocate approximately 60% to maintenance of existing productive assets, 30% to cost savings projects and 10% to innovation and expansion projects.

Financing Activities

Cash used in financing activities totaled $527.9 for fiscal 2024 compared to $520.1 for fiscal 2023. During fiscal 2024, we had net debt repayments of $391.0, paid dividends of $151.3 and repurchased Common Shares for $5.1 (which includes cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation). We also had other financing cash inflows of $15.7 during fiscal 2024 related to collections of previously sold accounts receivable not yet submitted to the buyer. Higher debt repayment is driven by our focus on using available cash flow to reduce our debt.

Cash used in financing activities totaled $520.1 for fiscal 2023 compared to cash provided by financing activities of $255.3 for fiscal 2022. During fiscal 2023, we had net debt repayments of $353.6, paid dividends of $149.1, paid financing and issuance fees of $6.4 and repurchased Common Shares for $9.3 (which includes cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation).

Accounts Receivable Sales

On October 27, 2023, we entered into the Master Receivables Purchase Agreement, under which we could sell up to $600.0 of available and eligible outstanding customer accounts receivable generated by sales to four specified customers. On September 1, 2024, we amended the Master Receivables Purchase Agreement to permit us to sell up to $750.0 of available and eligible outstanding customer accounts receivable generated by sales to five specified customers. The agreement is uncommitted and expires on September 1, 2025. The receivable sales are non-recourse to the Company, other than with respect to (i) repurchase obligations and indemnification obligations for any violations by the Company of its respective representations or obligations as seller or servicer and (ii) certain repurchase and payment obligations arising from any dilution of, or dispute with respect to, any purchased receivables that arise after the sale of such purchased receivables to the purchaser not contemplated in the applicable purchase price of such purchased receivable. The recourse obligations of the Company that may arise from time to time are supported by standby letters of credit of $75.0. Transactions under the Master Receivables Purchase Agreement are accounted for as sales of accounts receivable, and the receivables sold are removed from the Consolidated Balance Sheets at the time of the sales transaction. Proceeds received from the sales of accounts receivable are classified as operating cash flows and collections of previously sold accounts receivable not yet submitted to the buyer are classified as financing cash flows in the Consolidated Statements of Cash Flows. We record the discount on sales in the “Other (income) expense, net” line in the Consolidated Statements of Operations. At September 30, 2024, net receivables of $186.6 were derecognized. During fiscal 2024, proceeds from the sale of receivables under the Master Receivables Purchase Agreement totaled $1,938.6 and the total discount recorded on sales was $24.6.

Supplier Finance Program

We have an agreement to provide a supplier finance program which facilitates participating suppliers’ ability to finance our payment obligations with a designated third-party financial institution. Participating suppliers may, at their sole discretion, elect to finance our payment obligations prior to their scheduled due dates at a discounted price to the participating financial institution. Our obligations to our suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under this arrangement. The payment terms that we negotiate with our suppliers are consistent, regardless of whether a supplier participates in the program. Our current payment terms with a majority of our suppliers generally range from 30 to 60 days, which we deem to be commercially reasonable. Our outstanding payment obligations under our supplier finance program were $12.5 and $18.3 at September 30, 2024 and 2023, respectively, and are recorded within accounts payable in the Consolidated Balance Sheets. The associated payments were $245.5 and $185.3 for fiscal 2024 and fiscal 2023, respectively, and are classified as operating activities in the Consolidated Statements of Cash Flows.

Share Repurchases

On February 6, 2020, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $750.0 of Common Shares from April 30, 2020 through March 25, 2023. There were no share repurchases under this share repurchase authorization during fiscal 2023 through its expiration on March 25, 2023. During fiscal 2022, Scotts Miracle-Gro repurchased 1.1 million Common Shares under this share repurchase authorization for $175.0. Treasury share purchases also include cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation of $5.1, $9.3 and $82.9 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

41

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

Cash and Cash Equivalents

Our cash and cash equivalents were held in cash depository accounts with major financial institutions around the world or invested in high quality, short-term liquid investments having original maturities of three months or less. The cash and cash equivalents balances of $71.6 and $31.9 at September 30, 2024 and 2023, respectively, included $15.9 and $26.6, respectively, held by controlled foreign corporations. As of September 30, 2024, we maintain our assertion of indefinite reinvestment of the earnings of all material foreign subsidiaries.

Borrowing Agreements

Credit Facilities

Our primary sources of liquidity are cash generated by operations and borrowings under our credit facilities, which are guaranteed by substantially all of Scotts Miracle-Gro’s domestic subsidiaries. On April 8, 2022, we entered into the Sixth A&R Credit Agreement, providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2,500.0, comprised of a revolving credit facility of $1,500.0 and a term loan in the original principal amount of $1,000.0 (the “Sixth A&R Credit Facilities”). The Sixth A&R Credit Agreement will terminate on April 8, 2027. The Sixth A&R Credit Facilities are available for the issuance of letters of credit up to $100.0. The terms of the Sixth A&R Credit Agreement include customary representations and warranties, affirmative and negative covenants, financial covenants, and events of default.

Under the terms of the Sixth A&R Credit Agreement, loans bear interest, at our election, at a rate per annum equal to either (i) the Alternate Base Rate plus the Applicable Spread (each, as defined in the Sixth A&R Credit Agreement) or (ii) the Adjusted Term SOFR Rate for the Interest Period in effect for such borrowing plus the Applicable Spread (all as defined in the Sixth A&R Credit Agreement). Swingline Loans bear interest at the applicable Swingline Rate set forth in the Sixth A&R Credit Agreement. Interest rates for other select non-U.S. dollar borrowings, including borrowings denominated in euro, Pounds Sterling and Canadian dollars, are based on separate interest rate indices, as set forth in the Sixth A&R Credit Agreement.

On June 8, 2022, we entered into Amendment No. 1 to the Sixth A&R Credit Agreement (“Amendment No. 1”). Amendment No. 1 increased the maximum permitted leverage ratio for the quarterly leverage covenant until April 1, 2024. Amendment No. 1 also increased the interest rate applicable to borrowings under the revolving credit facility by 35 bps and the term loan facility by 50 bps, and increased the annual facility fee rate on the revolving credit facility by 15 bps, in each case, when our quarterly-tested leverage ratio exceeded 4.75.

On July 31, 2023, we entered into Amendment No. 2 to the Sixth A&R Credit Agreement. Amendment No. 2 (i) reduces the revolving loan commitments by $250.0; (ii) increases the maximum permitted leverage ratio for the quarterly leverage covenant until the earlier of (a) October 1, 2025 and (b) subject to certain conditions specified in Amendment No. 2, the termination by the Company of such adjustment (such period, the “Leverage Adjustment Period”); (iii) replaces the interest coverage covenant with a fixed charge coverage covenant; (iv) increases the interest rate applicable to borrowings under the revolving credit facility and the term loan facility by 25 bps for each existing pricing tier and adds a pricing tier applicable to periods when the leverage ratio exceeds 6.00; (v) limits the amount of certain incremental investments, loans and advances to $25.0 during the Leverage Adjustment Period; and (vi) adds our intellectual property (subject to certain exceptions) as collateral to secure our obligations under the Sixth A&R Credit Agreement. Additionally, Amendment No. 2 limits our ability to declare or pay any discretionary dividends, distributions or other restricted payments during the Leverage Adjustment Period to only the payment of (i) regularly scheduled cash dividends to holders of our Common Shares in an aggregate amount not to exceed $225.0 per fiscal year and (ii) other dividends, distributions or restricted payments in an aggregate amount not to exceed $25.0. Amendment No. 2 also subjects our ability to make certain investments to pro forma compliance with certain leverage levels specified in Amendment No. 2. Pursuant to Amendment No. 2, the Sixth A&R Credit Agreement is secured by (i) a perfected first priority security interest in all of the accounts receivable, inventory, equipment and intellectual property (subject to certain exceptions) of Scotts Miracle-Gro and certain of its domestic subsidiaries and (ii) the pledge of all of the capital stock of certain of Scotts Miracle-Gro’s domestic subsidiaries and a portion of the capital stock of certain of its foreign subsidiaries.

At September 30, 2024, we had letters of credit outstanding in the aggregate principal amount of $83.0, and had $1,167.0 of borrowing availability under the Sixth A&R Credit Agreement. The weighted average interest rates on average borrowings under the credit facilities, excluding the impact of interest rate swaps, were 9.1%, 7.6% and 2.8% for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

During fiscal 2024, we used available cash on hand to make repayments on the term loan of the Sixth A&R Credit Agreement in the amount of $250.0, which was applied to the outstanding principal amount.

42

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

The Sixth A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding our leverage ratio determined as of the end of each of our fiscal quarters calculated as average total indebtedness, divided by our earnings before interest, taxes, depreciation and amortization, as adjusted pursuant to the terms of Amendment No. 2 (“Adjusted EBITDA”). Pursuant to Amendment No. 2, the maximum permitted leverage ratio is (i) 6.00 for the fourth quarter of fiscal 2024, (ii) 5.50 for the first quarter of fiscal 2025, (iii) 5.25 for the second quarter of fiscal 2025, (iv) 5.00 for the third quarter of fiscal 2025, (v) 4.75 for the fourth quarter of fiscal 2025 and (vi) 4.50 for the first quarter of fiscal 2026 and thereafter. Our leverage ratio was 4.86 at September 30, 2024. Pursuant to Amendment No. 2, the Sixth A&R Credit Agreement also contains an affirmative covenant regarding our fixed charge coverage ratio determined as of the end of each of our fiscal quarters, calculated as Adjusted EBITDA minus capital expenditures and expense for taxes paid in cash, divided by the sum of interest expense plus restricted payments, as described in Amendment No. 2. The minimum required fixed charge coverage ratio is 1.00. Our fixed charge coverage ratio was 1.27 for the twelve months ended September 30, 2024.

As of September 30, 2024, we were in compliance with all applicable covenants in the agreements governing our debt. Based on our projections of financial performance for the twelve-month period subsequent to the date of the filing of this Form 10-K, we expect to remain in compliance with the financial covenants under the Sixth A&R Credit Agreement. However, our assessment of our ability to meet our future obligations is inherently subjective, judgment-based, and susceptible to change based on future events. A covenant violation may result in an event of default. Such a default would allow the lenders under the Sixth A&R Credit Agreement to accelerate the maturity of the indebtedness thereunder and would also implicate cross-default provisions under the Senior Notes and cause the Senior Notes to become due and payable at that time. As of September 30, 2024, our indebtedness under the Sixth A&R Credit Agreement and Senior Notes was $2,225.0. We do not have sufficient cash on hand or available liquidity that can be utilized to repay these outstanding amounts in the event of default.

As part of our contingency planning to address potential future circumstances that could result in noncompliance, we have contemplated alternative plans including additional restructuring activities to reduce operating expenses and certain cash management strategies that are within our control. Additionally, we have contemplated alternative plans that are subject to market conditions and not in our control, including, among others, discussions with our lenders to amend the terms of our financial covenants under the Sixth A&R Credit Agreement and generating cash by completing other financing transactions, which may include issuing equity. There is no assurance that we will be successful in implementing these alternative plans.

Senior Notes

On December 15, 2016, Scotts Miracle-Gro issued $250.0 aggregate principal amount of 5.250% Senior Notes due 2026. The 5.250% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with our existing and future unsecured senior debt. The 5.250% Senior Notes have interest payment dates of June 15 and December 15 of each year.

On October 22, 2019, Scotts Miracle-Gro issued $450.0 aggregate principal amount of 4.500% Senior Notes due 2029. The 4.500% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with our existing and future unsecured senior debt. The 4.500% Senior Notes have interest payment dates of April 15 and October 15 of each year.

On March 17, 2021, Scotts Miracle-Gro issued $500.0 aggregate principal amount of 4.000% Senior Notes due 2031. The 4.000% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with our existing and future unsecured senior debt. The 4.000% Senior Notes have interest payment dates of April 1 and October 1 of each year.

On August 13, 2021, Scotts Miracle-Gro issued $400.0 aggregate principal amount of 4.375% Senior Notes due 2032. The 4.375% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with our existing and future unsecured senior debt. The 4.375% Senior Notes have interest payment dates of February 1 and August 1 of each year.

Substantially all of Scotts Miracle-Gro’s directly and indirectly owned domestic subsidiaries serve as guarantors of the 5.250% Senior Notes, the 4.500% Senior Notes, the 4.000% Senior Notes and the 4.375% Senior Notes.

The Senior Notes contain an affirmative covenant regarding our interest coverage ratio determined as of the end of each of our fiscal quarters, calculated as Adjusted EBITDA divided by interest expense excluding costs related to refinancings. The minimum required interest coverage ratio is 2.00. Our interest coverage ratio was 3.57 for the twelve months ended September 30, 2024.

43

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

Receivables Facility

We also maintained a Master Repurchase Agreement (including the annexes thereto, the “Repurchase Agreement”) and a Master Framework Agreement, as amended (the “Framework Agreement” and, together with the Repurchase Agreement, the “Receivables Facility”) under which we could sell a portfolio of available and eligible outstanding customer accounts receivable to the purchasers subject to agreeing to repurchase the receivables on a weekly basis. The eligible accounts receivable consisted of accounts receivable generated by sales to three specified customers. The eligible amount of customer accounts receivables which could be sold under the Receivables Facility was $400.0. The Receivables Facility expired on August 18, 2023. The sale of receivables under the Receivables Facility was accounted for as short-term debt and we continued to carry the receivables on our Consolidated Balance Sheets, primarily as a result of our requirement to repurchase receivables sold.

Interest Rate Swap Agreements

We enter into interest rate swap agreements with major financial institutions that effectively convert a portion of our variable rate debt to a fixed rate. Interest payments made between the effective date and expiration date are hedged by the swap agreements. Swap agreements that were hedging interest payments as of September 30, 2024 and 2023 had a maximum total U.S. dollar equivalent notional amount of $450.0 and $600.0, respectively. During fiscal 2024, we terminated an interest rate swap agreement in exchange for a cash payment of $11.0. The notional amount, effective date, expiration date and rate of each of the swap agreements outstanding at September 30, 2024 are shown in the table below:

Notional Amount ($)		Effective Date (a)	Expiration Date	Fixed Rate
150		6/7/2023	4/7/2027	3.37	%
50		6/7/2023	4/7/2027	3.34	%
100	(b)	11/20/2023	3/22/2027	4.74	%
150	(b)	9/20/2024	9/20/2029	4.25	%

(a)The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b)Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

Availability and Use of Cash

We believe that our cash flows from operations and borrowings under our agreements described herein will be sufficient to meet debt service, capital expenditures and working capital needs for the foreseeable future. However, we cannot ensure that our business will generate sufficient cash flow from operations or that future borrowings will be available under our borrowing agreements in amounts sufficient to pay indebtedness or fund other liquidity needs. Actual results of operations will depend on numerous factors, many of which are beyond our control as further discussed in “ITEM 1A. RISK FACTORS — Risks Related to Our M&A, Lending and Financing Activities — Our indebtedness could limit our flexibility and adversely affect our financial condition” of this Form 10-K.

Financial Disclosures About Guarantors and Issuers of Guaranteed Securities

The 5.250% Senior Notes, 4.500% Senior Notes, 4.000% Senior Notes and 4.375% Senior Notes were issued by Scotts Miracle-Gro on December 15, 2016, October 22, 2019, March 17, 2021 and August 13, 2021, respectively. The Senior Notes are guaranteed by certain consolidated domestic subsidiaries of Scotts Miracle-Gro (collectively, the “Guarantors”) and, therefore, we report summarized financial information in accordance with SEC Regulation S-X, Rule 13-01, “Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.”

The guarantees are “full and unconditional,” as those terms are used in Regulation S-X, Rule 3-10(b)(3), except that a Guarantor’s guarantee will be released in certain circumstances set forth in the indentures governing the Senior Notes, such as: (i) upon any sale or other disposition of all or substantially all of the assets of the Guarantor (including by way of merger or consolidation) to any person other than Scotts Miracle-Gro or any “restricted subsidiary” under the applicable indenture; (ii) if the Guarantor merges with and into Scotts Miracle-Gro, with Scotts Miracle-Gro surviving such merger; (iii) if the Guarantor is designated an “unrestricted subsidiary” in accordance with the applicable indenture or otherwise ceases to be a “restricted subsidiary” (including by way of liquidation or dissolution) in a transaction permitted by such indenture; (iv) upon legal or covenant defeasance; (v) at the election of Scotts Miracle-Gro following the Guarantor’s release as a guarantor under the Sixth A&R Credit Agreement, except a release by or as a result of the repayment of the Sixth A&R Credit Agreement; or (vi) if the Guarantor ceases to be a “restricted subsidiary” and the Guarantor is not otherwise required to provide a guarantee of the Senior Notes pursuant to the applicable indenture.

44

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

Our foreign subsidiaries and certain of our domestic subsidiaries are not guarantors (collectively, the “Non-Guarantors”) of the Senior Notes. Payments on the Senior Notes are only required to be made by Scotts Miracle-Gro and the Guarantors. As a result, no payments are required to be made from the assets of the Non-Guarantors, unless those assets are transferred by dividend or otherwise to Scotts Miracle-Gro or a Guarantor. In the event of a bankruptcy, insolvency, liquidation or reorganization of any of the Non-Guarantors, holders of their indebtedness, including their trade creditors and other obligations, will be entitled to payment of their claims from the assets of the Non-Guarantors before any assets are made available for distribution to Scotts Miracle-Gro or the Guarantors. As a result, the Senior Notes are effectively subordinated to all the liabilities of the Non-Guarantors.

The guarantees may be subject to review under federal bankruptcy laws or relevant state fraudulent conveyance or fraudulent transfer laws. In certain circumstances, the court could void the guarantee, subordinate the amounts owing under the guarantee, or take other actions detrimental to the holders of the Senior Notes.

As a general matter, value is given for a transfer or an obligation if, in exchange for the transfer or obligation, property is transferred or a valid antecedent debt is satisfied. A court would likely find that a Guarantor did not receive reasonably equivalent value or fair consideration for its guarantee to the extent such Guarantor did not obtain a reasonably equivalent benefit from the issuance of the Senior Notes.

The measure of insolvency varies depending upon the law of the jurisdiction that is being applied. Regardless of the measure being applied, a court could determine that a Guarantor was insolvent on the date the guarantee was issued, so that payments to the holders of the Senior Notes would constitute a preference, fraudulent transfer or conveyances on other grounds. If a guarantee is voided as a fraudulent conveyance or is found to be unenforceable for any other reason, the holders of the Senior Notes will not have a claim against the Guarantor.

Each guarantee contains a provision intended to limit the Guarantor’s liability to the maximum amount that it could incur without causing the incurrence of obligations under its guarantee to be a fraudulent conveyance. However, there can be no assurance as to what standard a court will apply in making a determination of the maximum liability of each Guarantor. Moreover, this provision may not be effective to protect the guarantees from being voided under fraudulent conveyance laws. There is a possibility that the entire guarantee may be set aside, in which case the entire liability may be extinguished.

The following tables present summarized financial information on a combined basis for Scotts Miracle-Gro and the Guarantors. Transactions between Scotts Miracle-Gro and the Guarantors have been eliminated and the summarized financial information does not reflect investments of the Scotts Miracle-Gro and the Guarantors in the Non-Guarantor subsidiaries.

	September 30, 2024
Current assets	$	838.4
Non-current assets (a)	1,805.1
Current liabilities	667.3
Non-current liabilities	2,471.6

(a)Includes amounts due from Non-Guarantor subsidiaries of $49.5.

	Year Ended
	September 30, 2024
Net sales	$	3,248.6
Gross margin	809.5
Net loss (a)	(16.1)

(a)Includes intercompany income from Non-Guarantor subsidiaries of $12.5.

Judicial and Administrative Proceedings

We are party to various pending judicial and administrative proceedings arising in the ordinary course of business, including, among others, proceedings based on accidents or product liability claims and alleged violations of environmental laws. We have reviewed these pending judicial and administrative proceedings, including the probable outcomes, reasonably anticipated costs and expenses, and the availability and limits of our insurance coverage, and have established what we believe to be appropriate accruals. We believe that our assessment of contingencies is reasonable and that the related accruals, in the aggregate, are adequate; however, there can be no assurance that future quarterly or annual operating results will not be materially affected by these proceedings, whether as a result of adverse outcomes or as a result of significant defense costs.

45

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

Contractual Obligations

The following table summarizes our future cash outflows for contractual obligations as of September 30, 2024:

			Payments Due by Period
Contractual Cash Obligations	Total		Less Than 1 Year		1-3 Years		3-5 Years		More Than 5 Years
Debt obligations	$	2,225.0	$	50.0	$	825.0	$	—	$	1,350.0
Interest expense on debt obligations	501.0		112.7		194.8		121.7		71.8
Finance lease obligations	21.5		3.4		5.6		3.9		8.6
Operating lease obligations	340.9		89.8		122.7		65.9		62.5
Purchase obligations	681.2		310.9		272.7		63.9		33.7
Other, primarily retirement plan obligations	46.5		5.1		9.7		9.6		22.1
Total contractual cash obligations	$	3,816.1	$	571.9	$	1,430.5	$	265.0	$	1,548.7

We had long-term debt obligations and interest payments due primarily under the 5.250% Senior Notes, 4.500% Senior Notes, 4.000% Senior Notes, 4.375% Senior Notes and our credit facilities. Amounts in the table represent scheduled future maturities of debt principal for the periods indicated.

The interest payments for our credit facilities are based on outstanding borrowings as of September 30, 2024. Actual interest expense will likely be higher due to the seasonality of our business and associated higher average borrowings.

Purchase obligations primarily represent commitments for materials used in our manufacturing processes, including urea and packaging, as well as commitments for warehouse services, grass seed, marketing services and information technology services which comprise the unconditional purchase obligations disclosed in “NOTE 18. COMMITMENTS” of the Notes to Consolidated Financial Statements included in this Form 10-K.

Other obligations include actuarially determined retiree benefit payments and pension funding to comply with local funding requirements. Pension funding requirements are based on preliminary estimates using actuarial assumptions determined as of September 30, 2024. These amounts represent expected payments through 2034. Based on the accounting rules for defined benefit pension plans and retirement health care plans, the liabilities reflected in our Consolidated Balance Sheets differ from these expected future payments (see “NOTE 9. RETIREMENT PLANS” and “NOTE 10. ASSOCIATE MEDICAL BENEFITS” of the Notes to Consolidated Financial Statements included in this Form 10-K). The above table excludes liabilities for unrecognized tax benefits and insurance accruals as we are unable to estimate the timing of payments for these items.

Regulatory Matters

We are subject to local, state, federal and foreign environmental protection laws and regulations with respect to our business operations and believe we are operating in substantial compliance, or taking actions aimed at ensuring compliance with, such laws and regulations. We are involved in several legal actions with various governmental agencies related to environmental matters. While it is difficult to quantify the potential financial impact of actions involving these environmental matters, particularly remediation costs at waste disposal sites and future capital expenditures for environmental control equipment, in the opinion of management, the ultimate liability arising from such environmental matters, taking into account established accruals, is not expected to have a material effect on our financial condition, results of operations or cash flows. However, there can be no assurance that the resolution of these matters will not materially affect our future quarterly or annual results of operations, financial condition or cash flows. Additional information on environmental matters affecting us is provided in “ITEM 1. BUSINESS — Regulatory Considerations” and “ITEM 3. LEGAL PROCEEDINGS” of this Form 10-K.

Critical Accounting Estimates

Our audited consolidated financial statements have been prepared in accordance with GAAP. The preparation of financial statements and related disclosures in accordance with GAAP requires management to use judgment and make estimates that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. We evaluate our estimates on an ongoing basis. By their nature, these judgments are subject to uncertainty. We base our estimates on historical experience, current trends and other factors that we believe to be relevant under the circumstances at the time the estimate was made. Certain accounting estimates are particularly significant, including those related to revenue recognition and promotional allowances, income taxes and goodwill and indefinite-lived intangible assets.

46

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

We believe that our estimates, assumptions, and judgments are reasonable in that they were based on information available when the estimates, assumptions and judgments were made. However, because future events and their effects cannot be determined with certainty, actual results could differ materially from those implied by our assumptions and estimates.

The Audit Committee of the Board of Directors of Scotts Miracle-Gro reviews our critical accounting estimates on an ongoing basis, including those related to revenue recognition and promotional allowances, income taxes and goodwill and indefinite-lived intangible assets.

Revenue Recognition and Promotional Allowances

Our revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products. Product sales are recognized at a point in time when control of products transfers to customers and we have no further obligation to provide services related to such products. Sales are typically recognized when products are delivered to or picked up by the customer. We are generally the principal in a transaction and, therefore, primarily record revenue on a gross basis. Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns.

Our promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotional costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Consolidated Statements of Operations. We exclude from revenue any amounts collected from customers for sales or other taxes.

Income Taxes

Our annual effective tax rate is established based on our pre-tax income (loss), statutory tax rates and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. We record income tax liabilities utilizing known obligations and estimates of potential obligations. A deferred tax asset or liability is recognized whenever there are future tax effects from existing temporary differences and operating loss and tax credit carryforwards. Valuation allowances are used to reduce deferred tax assets to the balances that are more likely than not to be realized. In determining whether a valuation allowance is warranted, we take into account many factors, including the specific tax jurisdiction, both historical and projected future earnings, carryback and carryforward periods and tax planning strategies. Many of the judgments made in adjusting valuation allowances involve assumptions and estimates that are highly subjective. When we determine that deferred tax assets could be realized in greater or lesser amounts than recorded, the asset balance and Consolidated Statements of Operations reflect the change in the period such determination is made. Due to changes in facts and circumstances and the estimates and judgments involved in determining the proper valuation allowances, differences between actual future events and prior estimates and judgments could result in adjustments to these valuation allowances.

We also establish a liability for tax return positions in which there is uncertainty as to whether or not the position will ultimately be sustained. These uncertain tax positions are adjusted as a result of changes in factors such as tax legislation, interpretations of laws by courts, rulings by tax authorities, new audit developments, changes in estimates and the expiration of the statute of limitations. Amounts for uncertain tax positions are adjusted in quarters when new information becomes available or when positions are effectively settled. Many of the judgments made in adjusting uncertain tax positions involve assumptions and estimates regarding audit outcomes and the timing of audit settlements, which are often uncertain and subject to change.

Goodwill and Indefinite-Lived Intangible Assets

We have significant investments in intangible assets and goodwill. We perform our annual goodwill and indefinite-lived intangible asset testing as of the first day of our fiscal fourth quarter or more frequently if circumstances indicate potential impairment. In our evaluation of impairment for goodwill and indefinite-lived intangible assets, we perform either an initial qualitative or quantitative evaluation for each of our reporting units and indefinite-lived intangible assets. Factors considered in the qualitative test include operating results as well as new events and circumstances impacting the operations or cash flows of the reporting unit or indefinite-lived intangible assets. For the quantitative test, the review for impairment of goodwill and indefinite-lived intangible assets is based on an income-based approach, including the relief-from-royalty method for indefinite-lived trade names. If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the reporting unit or intangible asset exceeds its estimated fair value.

47

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

Under the income-based approach, we determine fair value using a discounted cash flow approach that requires significant judgment with respect to revenue and profitability growth rates, based upon annual budgets and longer-range strategic plans, and the selection of an appropriate discount rate. These budgets and plans are used for internal purposes and are also the basis for communication with outside parties about future business trends. Fair value estimates employed in our annual impairment review of indefinite-lived intangible assets and goodwill were determined using models involving several assumptions. Changes in our assumptions could materially impact our fair value estimates. Assumptions critical to our fair value estimates were: (i) discount rates; (ii) royalty rates used in our intangible asset valuations; (iii) projected future revenues and profitability; and (iv) projected long-term growth rates used in the derivation of terminal year values. These and other assumptions are impacted by economic conditions and expectations of management and may change in the future based on period specific facts and circumstances. While we believe the assumptions we used to estimate future cash flows are reasonable, there can be no assurance that the expected future cash flows will be realized. As a result, impairment charges that possibly would have been recognized in earlier periods may not be recognized until later periods if actual results deviate unfavorably from earlier estimates. The use of different assumptions would increase or decrease discounted cash flows or earnings projections and, therefore, could change impairment determinations.

At September 30, 2024, goodwill totaled $243.9, all of which was associated with our U.S. Consumer segment. Based on the results of the annual quantitative evaluation for fiscal 2024, the fair value of our U.S. Consumer segment reporting unit substantially exceeded its carrying value. A 100 basis point change in the discount rate would not have resulted in an impairment for this reporting unit.

At September 30, 2024, indefinite-lived intangible assets consisted of trade names of $168.2 and the Roundup® marketing agreement amendment of $155.7, all of which were associated with our U.S. Consumer segment. Based on the results of the annual quantitative evaluation for fiscal 2024, the fair values of our indefinite-lived intangible assets substantially exceeded their respective carrying values. A 100 basis point change in the discount rate would not have resulted in an impairment of any of our indefinite-lived intangible assets.

Other Significant Accounting Policies

Other significant accounting policies, primarily those with lower levels of uncertainty than those discussed above, are also critical to understanding the consolidated financial statements. The Notes to Consolidated Financial Statements included in this Form 10-K contain additional information related to our accounting policies, including recent accounting pronouncements, and should be read in conjunction with this discussion. 

48

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

ITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As part of our ongoing business, we are exposed to certain market risks, including fluctuations in interest rates, foreign currency exchange rates and commodity prices. Financial derivatives and other instruments are used to manage these risks. These instruments are not used for trading or speculative purposes.

Interest Rate Risk

The following table summarizes information about our debt instruments and derivative financial instruments that are sensitive to changes in interest rates as of September 30, 2024 and 2023. For debt instruments, the table presents principal cash flows and related weighted-average interest rates by expected maturity dates. For interest rate swap agreements, the table presents expected cash flows based on notional amounts and weighted-average interest rates by contractual maturity dates. We have outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a maximum total U.S. dollar equivalent notional amount of $450.0 and $600.0 at September 30, 2024 and 2023, respectively. Weighted-average variable rates are based on rates in effect at September 30, 2024 and 2023. Assuming average unhedged variable interest rate borrowing levels during fiscal 2024 of $575.0, a change in our variable interest rate of 100 basis points for a full twelve-month period would have an impact of $5.8 on interest expense.

	Expected Maturity Date (Fiscal Year)																		Total			Fair Value
2024	2025			2026			2027			2028			2029			After
Long-term debt:
Fixed rate debt	$	—		$	—		$	250.0		$	—		$	—		$	1,350.0		$	1,600.0		$	1,507.1
Average rate	—			—			5.3		%	—			—			4.3		%	4.4		%	—
Variable rate debt	$	50.0		$	50.0		$	525.0		$	—		$	—		$	—		$	625.0		$	625.0
Average rate	7.5		%	7.5		%	7.5		%	—			—			—			7.5		%	—
Interest rate derivatives:
Interest rate swaps	$	(1.0)		$	(1.0)		$	(1.1)		$	(0.7)		$	(0.6)		$	—		$	(4.4)		$	(4.4)
Average rate	3.7		%	3.7		%	3.9		%	4.2		%	4.2		%	—			3.9		%	—

	Expected Maturity Date (Fiscal Year)																	Total			Fair Value
2023	2024			2025			2026			2027			2028		After
Long-term debt:
Fixed rate debt	$	—		$	—		$	—		$	250.0		$	—	$	1,350.0		$	1,600.0		$	1,283.9
Average rate	—			—			—			5.3		%	—		4.3		%	4.4		%	—
Variable rate debt	$	50.0		$	50.0		$	50.0		$	863.3		$	—	$	—		$	1,013.3		$	1,013.3
Average rate	8.2		%	8.2		%	8.2		%	8.1		%	—		—			8.1		%	—
Interest rate derivatives:
Interest rate swaps	$	13.1		$	9.3		$	7.5		$	1.5		$	—	$	—		$	31.4		$	31.4
Average rate	1.6		%	2.1		%	2.3		%	3.4		%	—		—			2.1		%	—

Excluded from the information provided above are miscellaneous debt instruments of $0.0 and $0.4 and finance lease obligations of $17.8 and $16.9 at September 30, 2024 and 2023, respectively.

Other Market Risks

We are subject to market risk from fluctuations in foreign currency exchange rates and fluctuating prices of certain raw materials, including urea and other fertilizer inputs, resins, diesel, gasoline, natural gas, sphagnum peat, bark and grass seed. Refer to “NOTE 15.  DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES” of the Notes to Consolidated Financial Statements included in this Form 10-K for discussion of these market risks and the derivatives used to manage these risks.

49

THE SCOTTS MIRACLE-GRO COMPANY

(Dollars in millions, except per share data)

ITEM 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements and other information required by this Item are contained in the Consolidated Financial Statements, Notes to Consolidated Financial Statements and Schedules Supporting the Consolidated Financial Statements listed in the “Index to Consolidated Financial Statements and Financial Statement Schedules” on page 58 of this Form 10-K.

ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A.    CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

With the participation of the principal executive officer and the principal financial officer of The Scotts Miracle-Gro Company (the “Registrant”), the Registrant’s management has evaluated the effectiveness of the Registrant’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934), as of the end of the fiscal year covered by this Form 10-K. Based upon that evaluation, the Registrant’s principal executive officer and principal financial officer have concluded that the Registrant’s disclosure controls and procedures were effective as of the end of the fiscal year covered by this Form 10-K.

Management’s Annual Report on Internal Control Over Financial Reporting

The “Annual Report of Management on Internal Control Over Financial Reporting” required by Item 308(a) of SEC Regulation S-K is included on page 59 of this Form 10-K.

Attestation Report of Independent Registered Public Accounting Firm

The “Report of Independent Registered Public Accounting Firm” required by Item 308(b) of SEC Regulation S-K is included on page 60 of this Form 10-K.

Changes in Internal Control Over Financial Reporting

No changes in the Registrant’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) occurred during the Registrant’s fiscal quarter ended September 30, 2024, that have materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

50

ITEM 9B.    OTHER INFORMATION

On November 26, 2024, the Company, as part of a series of executive and senior leadership enhancements, announced that Nathan E. Baxter, currently Executive Vice President & Chief Operating Officer, has been named President and Chief Operating Officer. The position of President was previously held by James Hagedorn, the Company’s Chairman and Chief Executive Officer, who will continue in those roles.

In connection with his appointment to President, Mr. Baxter’s annual base salary was increased from $950,000 to $1,000,000. His target incentive percentage under The Scotts Company LLC Executive Incentive Plan was increased from 125% to 150%. Finally, Mr. Baxter’s annual target under the Company’s Long Term Incentive Plan will increase from $2,000,000 to $2,500,000.

The Company also announced that Matthew Garth, Executive Vice President, Chief Financial Officer & Chief Administrative Officer, will be departing the Company effective December 31, 2024 (the “Termination Date”).

In a corresponding move, Mark J. Scheiwer, currently Vice President and Treasurer, will assume the role of interim Chief Financial Officer & Chief Accounting Officer upon Mr. Garth’s departure. Mr. Scheiwer, 49, has been with the Company since 2011. His previous leadership roles at the Company include Vice President, Finance Lead – Hawthorne and Vice President, Corporate Controller.

In connection with his appointment to interim Chief Financial Officer & Chief Accounting Officer, Mr. Scheiwer will receive an annual base salary of $550,000, a target incentive percentage of 90% under The Scotts Company LLC Executive Incentive Plan and an annual target under the Company’s Long Term Incentive Plan of $600,000. In addition, Mr. Scheiwer will be a Tier 2 Participant under the Company’s Executive Severance Plan and will be entitled to purchase up to 25 hours on Company aircraft for personal use on an annual basis.

The Company is carrying out a search process to fill the Chief Financial Officer role on a permanent basis with the help of an executive search firm that is expected to consider internal and external candidates.

A copy of the Company’s news release announcing these changes is included as Exhibit 99.1 to this Annual Report on Form 10-K and is incorporated herein by reference.

In connection with Mr. Garth’s departure on the Termination Date, the Scotts Company LLC, a subsidiary of the Company (“Scotts LLC”), entered into a Separation Agreement and Release of All Claims (the “Separation Agreement”) with Mr. Garth on November 25, 2024. The Separation Agreement addresses the payments and benefits to which Mr. Garth is entitled in connection with his departure.

The Company will pay or make the following benefits available to Mr. Garth in connection with his departure that are generally consistent with the “Severance Benefits” under his Tier 1 Participation Agreement (the “Participation Agreement”) under the Company’s Executive Severance Plan pursuant to a termination without Cause: (a) pay equal to 24 months of salary, at Mr. Garth’s regular monthly base pay, payable in accordance with Scotts LLC’s standard payroll procedures; (b) in lieu of outplacement services, a lump sum payment of $30,000; (c) for a period of 24 months, a benefits offset payment in an amount equal to the excess of the COBRA premium charged by the Company to terminated employees over the premium Mr. Garth paid as an active employee; and (d) an amount equal to two times Mr. Garth’s Target Bonus Opportunity for the fiscal year ending September 30, 2025, 50% of which is payable on the first scheduled pay date following the first anniversary of Mr. Garth’s Termination Date and 50% of which is payable on the first scheduled pay date following the second anniversary of Mr. Garth’s Termination Date, subject to Mr. Garth’s continued compliance as of the payment date with all of his post-employment obligations to the Company.

In addition to the benefits Mr. Garth is entitled to receive pursuant to the Company’s Executive Severance Plan and his Participation Agreement as summarized above, the Compensation and Organization Committee has elected to provide partial vesting for certain equity-based awards to the extent of Mr. Garth’s service, as follows:

•The 28,599 non-qualified stock options granted to Mr. Garth on February 3, 2023, the 79,982 non-qualified stock options granted to Mr. Garth on November 16, 2023 and the 14,935 non-qualified stock options granted to Mr. Garth on February 16, 2024, all of which are unvested, will vest on a prorated basis on the Termination Date based on the number of days of active service between the grant date and the Termination Date over 1,097 days and will expire on the second anniversary of the Termination Date;

51

•The unvested 10,940 performance units and related dividend equivalents granted to Mr. Garth on February 3, 2023 will vest on a prorated basis on February 3, 2026 based on the number of days of active service between the grant date and the Termination Date over 1,097 days with the Company confirming that the performance criteria for this award having been satisfied as of the Termination Date; and

•The unvested 27,098 performance units and related dividend equivalents granted to Mr. Garth on February 16, 2024 will vest on a prorated basis on February 16, 2027, to the extent that the underlying performance criteria have been satisfied as of that date, based on the number of days of active service between the grant date and the Termination Date over 1,097 days.

Pursuant to the terms of the applicable award agreements entered into between the Company and Mr. Garth at the time of grant, the following equity-based awards will either naturally vest and settle or forfeit based on the applicable terms and conditions, without modification:

•The 13,580 restricted stock units and related dividend equivalents granted to Mr. Garth on December 1, 2022, will fully vest and settle on December 1, 2024, to the extent not previously settled; and

•The 42,017 unvested non-qualified stock options granted to Mr. Garth on November 8, 2024, will be cancelled as of the Termination Date.

All amounts payable to Mr. Garth under the Separation Agreement and the applicable award agreements will be subject to all applicable withholdings and deductions required by federal, state and local taxing authorities.

The payments and benefits described above are the only amounts to which Mr. Garth is entitled under the Separation Agreement (or any other agreement). He also remains entitled to any vested benefits he had as of his Termination Date under other benefit plans or programs maintained by the Company or its subsidiaries, including The Scotts Company LLC Retirement Savings Plan and The Scotts Company LLC Executive Retirement Plan.

The Separation Agreement, together with the Employee Confidentiality, Noncompetition, Nonsolicitation Agreement previously executed by Mr. Garth on April 12, 2023 which will continue in effect following his departure, also contains various restrictive covenants, including covenants relating to noncompetition, confidentiality, cooperation and nonsolicitation.

ITEM 9C.    DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable.

52

PART III

ITEM 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Directors, Executive Officers and Persons Nominated or Chosen to Become Directors or Executive Officers

The information required by Item 401 of SEC Regulation S-K concerning the directors of Scotts Miracle-Gro and the nominees for election or re-election as directors of Scotts Miracle-Gro at its Annual Meeting of Shareholders to be held on January 27, 2025 (the “2025 Annual Meeting”) is incorporated herein by reference from the disclosure which will be included under the caption “PROPOSAL NUMBER 1 — ELECTION OF DIRECTORS” in Scotts Miracle-Gro’s definitive Proxy Statement relating to the 2025 Annual Meeting (the “Proxy Statement”), which will be filed pursuant to SEC Regulation 14A not later than 120 days after the end of Scotts Miracle-Gro’s fiscal year ended September 30, 2024.

The information required by Item 401 of SEC Regulation S-K concerning the executive officers of Scotts Miracle-Gro is incorporated herein by reference from the disclosure included under the caption “SUPPLEMENTAL ITEM. EXECUTIVE OFFICERS OF THE REGISTRANT” in Part II of this Form 10-K.

Compliance with Section 16(a) of the Securities Exchange Act of 1934

The information required by Item 405 of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “DELINQUENT 16(a) REPORTS” in its Proxy Statement.

Procedures for Recommending Director Nominees

Information concerning the procedures by which shareholders of Scotts Miracle-Gro may recommend nominees to Scotts Miracle-Gro’s Board of Directors is incorporated herein by reference from the disclosures which will be included under the captions “CORPORATE GOVERNANCE — Nominations of Directors” and “MEETINGS AND COMMITTEES OF THE BOARD — Committees of the Board — Nominating and Governance Committee” in the Proxy Statement. These procedures have not materially changed from those described in Scotts Miracle-Gro’s definitive Proxy Statement for the 2024 Annual Meeting of Shareholders held on January 22, 2024.

Audit Committee

The information required by Items 407(d)(4) and 407(d)(5) of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “MEETINGS AND COMMITTEES OF THE BOARD — Committees of the Board” in the Proxy Statement.

Committee Charters; Code of Business Conduct & Ethics; Corporate Governance Guidelines

The Board of Directors of Scotts Miracle-Gro has adopted charters for each of the Audit Committee, the Nominating and Governance Committee, the Compensation and Organization Committee, the Innovation and Technology Committee and the Finance Committee, as well as Corporate Governance Guidelines, as contemplated by the applicable sections of the New York Stock Exchange Listed Company Manual.

In accordance with the requirements of Section 303A.10 of the New York Stock Exchange Listed Company Manual and Item 406 of SEC Regulation S-K, the Board of Directors of Scotts Miracle-Gro has adopted a Code of Business Conduct & Ethics covering the members of Scotts Miracle-Gro’s Board of Directors and associates of Scotts Miracle-Gro and its subsidiaries, including, without limitation, Scotts Miracle-Gro’s principal executive officer, principal financial officer and principal accounting officer. Scotts Miracle-Gro intends to disclose the following events, if they occur, on its Internet website located at http://investor.scotts.com within four business days following their occurrence: (A) the date and nature of any amendment to a provision of Scotts Miracle-Gro’s Code of Business Conduct & Ethics that (i) applies to Scotts Miracle-Gro’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, (ii) relates to any element of the code of ethics definition enumerated in Item 406(b) of SEC Regulation S-K, and (iii) is not a technical, administrative or other non-substantive amendment; and (B) a description of any waiver (including the nature of the waiver, the name of the person to whom the waiver was granted and the date of the waiver), including an implicit waiver, from a provision of the Code of Business Conduct & Ethics granted to Scotts Miracle-Gro’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, that relates to one or more of the elements of the code of ethics definition enumerated in Item 406(b) of SEC Regulation S-K. In addition, Scotts Miracle-Gro will disclose any waivers from the provisions of the Code of Business Conduct & Ethics granted to an executive officer or a director of Scotts Miracle-Gro on Scotts Miracle-Gro’s Internet website located at http://investor.scotts.com within four business days of the determination to grant any such waiver.

53

The text of Scotts Miracle-Gro’s Code of Business Conduct & Ethics, Scotts Miracle-Gro’s Corporate Governance Guidelines, the Audit Committee charter, the Nominating and Governance Committee charter, the Compensation and Organization Committee charter, the Innovation and Technology Committee charter and the Finance Committee charter are posted under the “Corporate Governance” link on Scotts Miracle-Gro’s Internet website located at http://investor.scotts.com. Interested persons and shareholders of Scotts Miracle-Gro may also obtain copies of each of these documents without charge by writing to The Scotts Miracle-Gro Company, Attention: Corporate Secretary, 14111 Scottslawn Road, Marysville, Ohio 43041.

ITEM 11.    EXECUTIVE COMPENSATION

The information required by Item 402 of SEC Regulation S-K is incorporated herein by reference from the disclosures which will be included under the captions “EXECUTIVE COMPENSATION,” “NON-EMPLOYEE DIRECTOR COMPENSATION,” “EXECUTIVE COMPENSATION TABLES,” “SEVERANCE AND CHANGE IN CONTROL (CIC) ARRANGEMENTS,” and “PAYMENTS ON TERMINATION OF EMPLOYMENT AND/OR CHANGE IN CONTROL” in the Proxy Statement.

The information required by Item 407(e)(4) of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “MEETINGS AND COMMITTEES OF THE BOARD — Compensation and Organization Committee Interlocks and Insider Participation” in the Proxy Statement.

The information required by Item 407(e)(5) of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “COMPENSATION COMMITTEE REPORT” in the Proxy Statement.

ITEM 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Ownership of Common Shares of Scotts Miracle-Gro

The information required by Item 403 of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT” in the Proxy Statement.

Equity Compensation Plan Information

The information required by Item 201(d) of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “EQUITY COMPENSATION PLAN INFORMATION” in the Proxy Statement.

ITEM 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Certain Relationships and Related Person Transactions

The information required by Item 404 of SEC Regulation S-K is incorporated herein by reference from the disclosures which will be included under the caption “CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS” in the Proxy Statement.

Director Independence

The information required by Item 407(a) of SEC Regulation S-K is incorporated herein by reference from the disclosures which will be included under the captions “CORPORATE GOVERNANCE — Director Independence” and “MEETINGS AND COMMITTEES OF THE BOARD” in the Proxy Statement.

ITEM 14.    PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by this Item 14 is incorporated herein by reference from the disclosures which will be included under the captions “AUDIT COMMITTEE MATTERS — Fees of the Independent Registered Public Accounting Firm” and “AUDIT COMMITTEE MATTERS — Pre-Approval of Services Performed by the Independent Registered Public Accounting Firm” in the Proxy Statement.

54

PART IV

ITEM 15.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a) LIST OF DOCUMENTS FILED AS PART OF THIS REPORT

1 and 2. Financial Statements and Financial Statement Schedules:

The response to this portion of Item 15 is submitted as a separate section of this Form 10-K. Reference is made to the “Index to Consolidated Financial Statements and Financial Statement Schedules” on page 58 of this Form 10-K.

(b) EXHIBITS

The exhibits listed on the “Index to Exhibits” beginning on page 111 of this Form 10-K are filed or furnished with this Form 10-K or incorporated herein by reference as noted in the “Index to Exhibits.”

(c) FINANCIAL STATEMENT SCHEDULES

The financial statement schedule filed with this Form 10-K is submitted in a separate section hereof. For a description of such financial statement schedules, see “Index to Consolidated Financial Statements and Financial Statement Schedules” on page 58 of this Form 10-K.

ITEM 16.    FORM 10-K SUMMARY

None.

55

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

THE SCOTTS MIRACLE-GRO COMPANY
By:	/s/    JAMES HAGEDORN
	James Hagedorn, Chairman and Chief Executive Officer

Dated: November 26, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

Signature	Title	Date
/s/   MATTHEW E. GARTH	Executive Vice President, Chief Financial Officer & Chief Administrative Officer	November 26, 2024
Matthew E. Garth	(Principal Financial Officer and Principal Accounting Officer)
/s/   JAMES HAGEDORN	Chairman and Chief Executive Officer	November 26, 2024
James Hagedorn	(Principal Executive Officer)
/s/   EDITH AVILES*	Director	November 26, 2024
Edith Aviles
/s/ ROBERTO CANDELINO*	Director	November 26, 2024
Roberto Candelino
/s/   DAVID C. EVANS*	Director	November 26, 2024
David C. Evans
/s/   ADAM HANFT*	Director	November 26, 2024
Adam Hanft
/s/   STEPHEN L. JOHNSON*	Director	November 26, 2024
Stephen L. Johnson
/s/   THOMAS N. KELLY JR.*	Director	November 26, 2024
Thomas N. Kelly Jr.
/s/   MARK D. KINGDON*	Director	November 26, 2024
Mark D. Kingdon
/s/   KATHERINE HAGEDORN LITTLEFIELD*	Director	November 26, 2024
Katherine Hagedorn Littlefield

56

Signature	Title	Date
/s/ BRIAN E. SANDOVAL*	Director	November 26, 2024
Brian E. Sandoval
/s/   PETER E. SHUMLIN*	Director	November 26, 2024
Peter E. Shumlin
/s/   JOHN R. VINES*	Director	November 26, 2024
John R. Vines

 

* The undersigned, by signing his name hereto, does hereby sign this Report on behalf of each of the directors of the Registrant identified above pursuant to Powers of Attorney executed by the directors identified above, which Powers of Attorney are filed with this Report as exhibits.

     

By:	/s/   MATTHEW E. GARTH
	Matthew E. Garth, Attorney-in-Fact

57

THE SCOTTS MIRACLE-GRO COMPANY

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

AND FINANCIAL STATEMENT SCHEDULES

 

	Page
Consolidated Financial Statements of The Scotts Miracle-Gro Company and Subsidiaries:
Annual Report of Management on Internal Control Over Financial Reporting	59
Reports of Independent Registered Public Accounting Firm (PCAOB ID: 34)	60
Consolidated Statements of Operations for the fiscal years ended September 30, 2024, 2023 and 2022	64
Consolidated Statements of Comprehensive Income (Loss) for the fiscal years ended September 30, 2024, 2023 and 2022	65
Consolidated Statements of Cash Flows for the fiscal years ended September 30, 2024, 2023 and 2022	66
Consolidated Balance Sheets at September 30, 2024 and 2023	67
Consolidated Statements of Shareholders’ Equity (Deficit) for the fiscal years ended September 30, 2024, 2023 and 2022	68
Notes to Consolidated Financial Statements	69
Schedules Supporting the Consolidated Financial Statements:
Schedule II—Valuation and Qualifying Accounts for the fiscal years ended September 30, 2024, 2023 and 2022	110

All other financial statement schedules for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are omitted because they are not required or are not applicable, or the required information has been presented in the Consolidated Financial Statements or Notes thereto.

58

ANNUAL REPORT OF MANAGEMENT ON INTERNAL

CONTROL OVER FINANCIAL REPORTING

Management is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of The Scotts Miracle-Gro Company and our consolidated subsidiaries; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of The Scotts Miracle-Gro Company and our consolidated subsidiaries are being made only in accordance with authorizations of management and directors of The Scotts Miracle-Gro Company and our consolidated subsidiaries, as appropriate; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the assets of The Scotts Miracle-Gro Company and our consolidated subsidiaries that could have a material effect on our consolidated financial statements.

Management, with the participation of our principal executive officer and principal financial officer, assessed the effectiveness of our internal control over financial reporting as of September 30, 2024, the end of our fiscal year. Management based its assessment on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management’s assessment included evaluation of such elements as the design and operating effectiveness of key financial reporting controls, process documentation, accounting policies and our overall control environment. This assessment is supported by testing and monitoring performed under the direction of management.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluations of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Accordingly, even an effective system of internal control over financial reporting will provide only reasonable assurance with respect to financial statement preparation.

Based on our assessment, management has concluded that our internal control over financial reporting was effective as of September 30, 2024, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with accounting principles generally accepted in the United States of America. We reviewed the results of management’s assessment with the Audit Committee of the Board of Directors of The Scotts Miracle-Gro Company.

Our independent registered public accounting firm, Deloitte & Touche LLP, independently audited our internal control over financial reporting as of September 30, 2024 and has issued their attestation report which appears herein.

/s/    JAMES HAGEDORN		/s/    MATTHEW E. GARTH
James Hagedorn		Matthew E. Garth
Chairman & Chief Executive Officer		Executive Vice President, Chief Financial Officer & Chief Administrative Officer
Dated:	November 26, 2024	Dated:	November 26, 2024

59

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholders and the Board of Directors of The Scotts Miracle-Gro Company

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of The Scotts Miracle‐Gro Company and subsidiaries (the “Company”) as of September 30, 2024 and 2023, the related consolidated statements of operations, comprehensive income (loss), shareholders’ equity (deficit), and cash flows, for each of the three years in the period ended September 30, 2024, and the related notes and the schedules listed in the Index at Item 15 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of September 30, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended September 30, 2024, in conformity with accounting principles generally accepted in the United States of America.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of September 30, 2024, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated November 26, 2024, expressed an unqualified opinion on the Company’s internal control over financial reporting.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

60

Investment in Unconsolidated Affiliates — Refer to Notes 1 and 8 to the financial statements.

Critical Audit Matter Description

The Company’s equity method investment in Bonnie Plants, LLC (“Bonnie Investment”) is recorded in the “Investment in unconsolidated affiliates” line in the Consolidated Balance Sheets. During the year ended September 30, 2024, the Company recorded pre-tax impairment charges of $61.9 million associated with this investment in the “Equity in loss of unconsolidated affiliates” line in the Consolidated Statements of Operations. The impairment charges were driven by revisions to the Company’s internal forecasts for Bonnie Plants, LLC in response to decreased sales volume and inflationary cost pressures. The estimated fair value of the Bonnie Investment was based upon an equal weighting of the income-based and market-based approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to the forecasted operating performance of the Bonnie Investment. The fair value estimate utilizes significant unobservable inputs and thus represents a Level 3 fair value measurement.

Evaluating the indicators of potential other-than-temporary impairment and calculating an other-than-temporary impairment involves significant and complex management judgment. Therefore, a high degree of auditor judgment and an increased extent of effort was required when performing audit procedures to evaluate the conclusions reached around whether these impairment indicators resulted in an other-than-temporary impairment and the appropriateness of management’s assumptions used in the calculation of the other-than-temporary impairment charge, including the need to involve fair value specialists.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to management’s assessment of identified impairment indicators, the conclusions reached around whether these impairment indicators resulted in an other-than-temporary impairment, and the determination of the fair value of the investment, included the following, among others:

•We tested the effectiveness of controls over management’s other-than-temporary impairment evaluation of the Bonnie Investment, and controls over management’s determination of various critical assumptions used to determine the estimated fair value of the investment, such as the controls related to the development of revenue and EBITDA forecasts, valuation multiples, long-term growth rate, discount for lack of marketability, the selection of an appropriate discount rate, and the guideline public companies.

•We performed inquiries with relevant members of management to obtain an understanding of their current and expected performance for the investment, including their understanding of any operational and strategic changes, corroborated by inspection of the investee’s internal communications to its board of directors.

•We evaluated management’s impairment analysis by assessing whether certain indicators were present and whether those indicators implied an other-than-temporary loss of value.

•We evaluated the sensitivity of various key assumptions used in the valuation, such as the revenue growth rate, EBITDA margin, revenue and EBITDA multiples, long-term growth rate, discount for lack of marketability, and the discount rate, including the company specific risk premium.

•We evaluated the reasonableness of the assumptions within the valuation analysis by:

•Evaluating the reasonableness of management’s forecasts by comparing the forecasts to (1) historical results, (2) the investee’s internal communications to management and its board of directors, and (3) forecasted information included in industry reports and companies in its peer group.

•Evaluating the impact of changes in management’s assumptions from prior estimates of fair value.

61

•With the assistance of our fair value specialists, we evaluated the reasonableness of the valuation methodology and valuation assumptions by:

•Testing the source information and verifying the mathematical accuracy of the calculations.

•Developing a range of independent estimates for significant assumptions, such as, the long-term growth rate, discount for lack of marketability, and the discount rate, which considers the company specific risk premium, and comparing those to the assumptions selected by management.

•Evaluating the selected revenue and EBITDA multiples, including testing the underlying source information and mathematical accuracy of the calculations, and comparing the multiples selected by management to its guideline companies.

•We tested the mathematical accuracy of the overall valuation analysis and the resulting estimated fair value of the investment, in comparison to the investment’s carrying value, to calculate the resulting impairment.

/s/ DELOITTE & TOUCHE LLP

Columbus, Ohio

November 26, 2024

We have served as the Company’s auditor since 2005.

62

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholders and the Board of Directors of The Scotts Miracle-Gro Company

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of The Scotts Miracle-Gro Company and subsidiaries (the “Company”) as of September 30, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 30, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended September 30, 2024, of the Company and our report dated November 26, 2024, expressed an unqualified opinion on those financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Annual Report of Management on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ DELOITTE & TOUCHE LLP

Columbus, Ohio

November 26, 2024

63

THE SCOTTS MIRACLE-GRO COMPANY

Consolidated Statements of Operations

(In millions, except per share data)

 

	Year Ended September 30,
	2024		2023		2022
Net sales	$	3,552.7	$	3,551.3	$	3,924.1
Cost of sales	2,618.7		2,708.3		2,891.1
Cost of sales—impairment, restructuring and other	83.5		185.7		160.1
Gross margin	850.5		657.3		872.9
Operating expenses:
Selling, general and administrative	559.0		551.3		613.0
Impairment, restructuring and other	62.8		280.5		693.1
Other (income) expense, net	19.9		(0.1)		0.8
Income (loss) from operations	208.8		(174.4)		(434.0)
Equity in loss of unconsolidated affiliates	68.1		101.1		12.9
Interest expense	158.8		178.1		118.1
Other non-operating (income) expense, net	5.5		(0.3)		(6.9)
Loss before income taxes	(23.6)		(453.3)		(558.1)
Income tax expense (benefit)	11.3		(73.2)		(120.6)
Net loss	$	(34.9)	$	(380.1)	$	(437.5)
Basic net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)
Diluted net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)

See Notes to Consolidated Financial Statements.

64

THE SCOTTS MIRACLE-GRO COMPANY

Consolidated Statements of Comprehensive Income (Loss)

(In millions)

	Year Ended September 30,
	2024		2023		2022
Net loss	$	(34.9)	$	(380.1)	$	(437.5)
Other comprehensive income (loss):
Net foreign currency translation adjustment	0.6		7.0		(27.2)
Net unrealized gain (loss) on derivative instruments, net of tax	(7.9)		4.2		29.9
Reclassification of net unrealized gain on derivative instruments to net loss, net of tax	(7.3)		(17.4)		(6.8)
Net unrealized loss on securities, net of tax	(40.4)		(34.9)		(77.4)
Reclassification of net unrealized loss on securities to net loss, net of tax	64.6		76.0		—
Net unrealized loss in pension and other post-retirement benefits, net of tax	(2.1)		(1.8)		(5.4)
Pension and other post-retirement benefit adjustments, net of tax	(2.0)		(1.3)		8.7
Total other comprehensive income (loss)	5.5		31.8		(78.2)
Comprehensive loss	$	(29.4)	$	(348.3)	$	(515.7)

See Notes to Consolidated Financial Statements.

65

THE SCOTTS MIRACLE-GRO COMPANY

Consolidated Statements of Cash Flows

(In millions)

	Year Ended September 30,
	2024		2023		2022
OPERATING ACTIVITIES
Net loss	$	(34.9)	$	(380.1)	$	(437.5)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Impairment, restructuring and other	84.3		288.6		666.8
Share-based compensation expense	80.4		68.9		34.3
Depreciation	64.9		67.3		68.1
Amortization	15.7		25.2		37.1
Deferred taxes	9.3		(58.7)		(182.8)
Equity in loss of unconsolidated affiliates	68.1		101.1		12.9
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	128.2		77.7		102.8
Inventories	293.8		450.5		(203.8)
Prepaid and other current assets	10.2		18.6		(3.3)
Accounts payable	(1.6)		(153.6)		(171.2)
Other current liabilities	(45.4)		52.0		(68.4)
Other non-current items	(6.2)		(30.7)		20.1
Other, net	0.7		4.2		(4.1)
Net cash provided by (used in) operating activities	667.5		531.0		(129.0)
INVESTING ACTIVITIES
Proceeds from sale of long-lived assets	2.4		2.5		63.3
Investments in property, plant and equipment	(84.0)		(92.8)		(113.5)
Proceeds from loans receivable	—		37.0		—
Investments in unconsolidated affiliates	(21.4)		—		—
Payment for acquisitions, net of cash acquired	—		—		(237.3)
Purchase of convertible debt investments	—		—		(25.0)
Other investing, net	2.6		(12.4)		29.3
Net cash used in investing activities	(100.4)		(65.7)		(283.2)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans	648.5		1,336.2		3,617.4
Repayments under revolving and bank lines of credit and term loans	(1,039.5)		(1,689.8)		(2,937.3)
Financing and issuance fees	—		(6.4)		(9.6)
Dividends paid	(151.3)		(149.1)		(166.2)
Purchase of Common Shares	(5.1)		(9.3)		(257.9)
Cash received from exercise of stock options	3.8		2.3		3.3
Other financing, net	15.7		(4.0)		5.6
Net cash (used in) provided by financing activities	(527.9)		(520.1)		255.3
Effect of exchange rate changes on cash	0.5		(0.1)		(0.4)
Net increase (decrease) in cash and cash equivalents	39.7		(54.9)		(157.3)
Cash and cash equivalents at beginning of year	31.9		86.8		244.1
Cash and cash equivalents at end of year	$	71.6	$	31.9	$	86.8

See Notes to Consolidated Financial Statements.

66

THE SCOTTS MIRACLE-GRO COMPANY

Consolidated Balance Sheets

(In millions, except per share data)

 

	September 30,
	2024		2023
ASSETS
Current assets:
Cash and cash equivalents	$	71.6	$	31.9
Accounts receivable, less allowances of $9.6 in 2024 and $15.1 in 2023	176.8		304.2
Inventories	587.5		880.3
Prepaid and other current assets	144.5		181.4
Total current assets	980.4		1,397.8
Investment in unconsolidated affiliates	45.2		91.9
Property, plant and equipment, net	609.5		610.3
Goodwill	243.9		243.9
Intangible assets, net	418.8		436.7
Other assets	574.1		633.1
Total assets	$	2,871.9	$	3,413.7
LIABILITIES AND EQUITY (DEFICIT)
Current liabilities:
Current portion of debt	$	52.6	$	52.3
Accounts payable	254.7		271.2
Other current liabilities	443.0		450.2
Total current liabilities	750.3		773.7
Long-term debt	2,174.2		2,557.4
Other liabilities	338.0		349.9
Total liabilities	3,262.5		3,681.0
Commitments and contingencies (Notes 17, 18 and 19)
Equity (deficit):
Common shares and capital in excess of $0.01 stated value per share; shares outstanding of 57.1 and 56.5, respectively	362.0		353.1
Retained earnings	303.8		490.9
Treasury shares, at cost; 11.0 and 11.6 shares, respectively	(949.1)		(998.5)
Accumulated other comprehensive loss	(107.3)		(112.8)
Total equity (deficit)	(390.6)		(267.3)
Total liabilities and equity (deficit)	$	2,871.9	$	3,413.7

See Notes to Consolidated Financial Statements.

67

THE SCOTTS MIRACLE-GRO COMPANY

Consolidated Statements of Shareholders’ Equity (Deficit)

(In millions, except per share data)

	Common Shares			Capital in Excess of Stated Value		Retained Earnings		Treasury Shares			Accumulated Other Comprehensive Income (Loss)		Total Equity (Deficit)
	Shares	Amount						Shares	Amount
Balance at September 30, 2021	68.1	$	0.3	$	476.7	$	1,605.1	12.6	$	(1,002.4)	$	(66.4)	$	1,013.3
Net income (loss)	—	—		—		(437.5)		—	—		—		(437.5)
Other comprehensive income (loss)	—	—		—		—		—	—		(78.2)		(78.2)
Share-based compensation	—	—		30.3		—		—	—		—		30.3
Dividends declared ($2.64 per share)	—	—		—		(147.5)		—	—		—		(147.5)
Treasury share purchases	—	—		—		—		1.7	(257.9)		—		(257.9)
Treasury share issuances	—	—		(143.3)		—		(1.5)	168.4		—		25.1
Balance at September 30, 2022	68.1	0.3		363.7		1,020.1		12.8	(1,091.8)		(144.6)		147.7
Net income (loss)	—	—		—		(380.1)		—	—		—		(380.1)
Other comprehensive income (loss)	—	—		—		—		—	—		31.8		31.8
Share-based compensation	—	—		68.1		—		—	—		—		68.1
Dividends declared ($2.64 per share)	—	—		—		(149.1)		—	—		—		(149.1)
Treasury share purchases	—	—		—		—		0.1	(9.3)		—		(9.3)
Treasury share issuances	—	—		(78.9)		—		(1.3)	102.6		—		23.7
Balance at September 30, 2023	68.1	0.3		352.8		490.9		11.6	(998.5)		(112.8)		(267.3)
Net income (loss)	—	—		—		(34.9)		—	—		—		(34.9)
Other comprehensive income (loss)	—	—		—		—		—	—		5.5		5.5
Share-based compensation	—	—		38.9		—		—	—		—		38.9
Dividends declared ($2.64 per share)	—	—		—		(152.2)		—	—		—		(152.2)
Treasury share purchases	—	—		—		—		0.1	(5.1)		—		(5.1)
Treasury share issuances	—	—		(30.0)		—		(0.7)	54.5		—		24.5
Balance at September 30, 2024	68.1	$	0.3	$	361.7	$	303.8	11.0	$	(949.1)	$	(107.3)	$	(390.6)

The sum of the components may not equal due to rounding.

See Notes to Consolidated Financial Statements.

68

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Dollars in millions, except per share data)

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor and hydroponic gardening. The Company’s products are sold in North America, Europe and Asia.

The Company’s North America consumer lawn and garden business is highly seasonal, with approximately 75% of its annual net sales occurring in the second and third fiscal quarters. The Company’s Hawthorne segment is also impacted by seasonal sales patterns for certain product categories due to the timing of growing patterns in North America during the second and third fiscal quarters, and the timing of certain controlled agricultural lighting project sales during the third and fourth fiscal quarters.

Organization and Basis of Presentation

The Company’s consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.

Advertising

Advertising costs incurred during the year are expensed to interim periods in relation to revenues. Advertising costs, except for external production costs, are generally expensed within the fiscal year in which such costs are incurred. External production costs for advertising programs are deferred until the period in which the advertising is first aired, and deferrals of these costs were not material at September 30, 2024 and 2023. On September 4, 2024, the Company issued 0.3 million restricted shares to a vendor in exchange for advertising services that will be performed during fiscal 2025. As of September 30, 2024, deferred advertising costs associated with the issuance of these restricted shares were $20.0. Advertising expenses were $141.0, $123.7 and $120.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Research and Development

Costs associated with research and development are generally charged to expense as incurred. Expenses for fiscal 2024, fiscal 2023 and fiscal 2022 were $34.6, $35.7 and $45.3, respectively, including product registration costs of $9.0, $12.4 and $13.0, respectively.

Environmental Costs

The Company recognizes environmental liabilities when conditions requiring remediation are probable and the amounts can be reasonably estimated. Expenditures which extend the life of the related property or mitigate or prevent future environmental contamination are capitalized. Environmental liabilities are not discounted or reduced for possible recoveries from insurance carriers.

Earnings per Common Share

Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding each period. Diluted income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus all dilutive potential common shares (stock options, restricted stock units, deferred stock units and performance-based award units) outstanding each period.

69

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Share-Based Compensation Awards

Scotts Miracle-Gro grants share-based awards annually to officers and certain other associates and to the non-employee directors of Scotts Miracle-Gro. The share-based awards have consisted of stock options, restricted stock units, deferred stock units and performance-based award units. Performance-based award units are subject to performance and service conditions, and certain awards contain a market condition based on the Company’s total shareholder return relative to a Company selected peer group. All of these share-based awards have been made under plans approved by the shareholders. The fair value of awards is expensed over the requisite service period which is typically the vesting period, generally three years for awards granted to officers and other associates and one year for awards granted to non-employee directors.

For restricted stock units, deferred stock units and performance-based award units that do not contain a market condition, the fair value of each award is estimated on the grant date based on the current market price of the Common Shares. For performance-based award units that contain a market condition, the fair value of each award is estimated using a Monte Carlo simulation model. Expected market price volatility is based on historical volatility specific to the Common Shares. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The grant date fair value of stock option awards is estimated using a binomial model. Expected market price volatility is based on implied volatilities from traded options on Common Shares and historical volatility specific to the Common Shares. Historical data, including demographic factors impacting historical exercise behavior, is used to estimate stock option exercises and employee terminations within the valuation model. The risk-free rate for periods within the contractual life of the stock option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected life of stock options is based on historical experience and expectations for grants outstanding.

Vesting of performance-based award units depends on service and achievement of specified performance targets. Based on the extent to which the targets are achieved, vested shares may range from 0% to 325% of the target award amount. For performance-based award units that do not contain a market condition, the total amount of compensation expense recognized reflects management’s assessment of the probability that performance goals will be achieved. A cumulative adjustment is recognized to compensation expense in the current period to reflect any changes in the probability of achievement of performance goals. For performance-based award units that contain a market condition, compensation expense is recognized regardless of the extent to which the targets are achieved.

Restricted stock units, deferred stock units and performance-based award units receive dividend equivalents equal to the cash dividends earned during the vesting period that are only paid out upon vesting. Share-based award units are generally forfeited if a holder terminates employment or service with the Company prior to the vesting date, except in cases where associates are eligible for accelerated vesting based on having satisfied retirement requirements relating to age and years of service. The Company estimates that 15% of its share-based awards will be forfeited based on an analysis of historical trends. The Company evaluates the estimated forfeiture rate on an annual basis and makes adjustments as appropriate. Stock options have exercise prices equal to the market price of the underlying Common Shares on the grant date and a term of 10 years. If available, Scotts Miracle-Gro typically uses treasury shares, or if not available, newly-issued Common Shares, to settle vested share-based awards. The Company classifies share-based compensation expense within cost of sales or selling, general and administrative expenses to correspond with the same line item as cash compensation paid to associates. Cash flows resulting from tax deductions in excess of the cumulative compensation cost recognized for share-based awards (excess tax benefits) are classified as operating cash inflows.

Cash and Cash Equivalents

Cash and cash equivalents are held in cash depository accounts with major financial institutions around the world or invested in high quality, short-term liquid investments. The Company considers all highly liquid financial instruments with original maturities of three months or less to be cash equivalents. The Company maintains cash deposits in banks which from time to time exceed the amount of deposit insurance available. Management periodically assesses the financial condition of the Company’s banks and believes that the risk of any potential credit loss is minimal.

Accounts Receivable and Allowances

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Allowances for doubtful accounts reflect the Company’s estimate of amounts in its existing accounts receivable that may not be collected due to customer claims or customer inability or unwillingness to pay. The allowance is determined based on a combination of factors, including the Company’s ongoing risk assessment regarding the credit worthiness of its customers, historical collection experience and length of time the receivables are past due. Account balances are charged off against the allowance when the Company believes it is probable the receivable will not be recovered.

70

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

On October 27, 2023, the Company entered into the Master Receivables Purchase Agreement, under which the Company could sell up to $600.0 of available and eligible outstanding customer accounts receivable generated by sales to four specified customers. On September 1, 2024, the Company amended the Master Receivables Purchase Agreement to permit the Company to sell up to $750.0 of available and eligible outstanding customer accounts receivable generated by sales to five specified customers. The agreement is uncommitted and expires on September 1, 2025. The receivable sales are non-recourse to the Company, other than with respect to (i) repurchase obligations and indemnification obligations for any violations by the Company of its respective representations or obligations as seller or servicer and (ii) certain repurchase and payment obligations arising from any dilution of, or dispute with respect to, any purchased receivables that arise after the sale of such purchased receivables to the purchaser not contemplated in the applicable purchase price of such purchased receivable. The recourse obligations of the Company that may arise from time to time are supported by standby letters of credit of $75.0. Transactions under the Master Receivables Purchase Agreement are accounted for as sales of accounts receivable, and the receivables sold are removed from the Consolidated Balance Sheets at the time of the sales transaction. Proceeds received from the sales of accounts receivable are classified as operating cash flows and collections of previously sold accounts receivable not yet submitted to the buyer are classified as financing cash flows in the Consolidated Statements of Cash Flows. The Company records the discount on sales in the “Other (income) expense, net” line in the Consolidated Statements of Operations. At September 30, 2024, net receivables of $186.6 were derecognized. During fiscal 2024, proceeds from the sale of receivables under the Master Receivables Purchase Agreement totaled $1,938.6 and the total discount recorded on sales was $24.6.

Inventories

Inventories are stated at the lower of cost or net realizable value and include the cost of raw materials, labor, manufacturing overhead and freight and inbound handling costs incurred to pre-position goods in the Company’s warehouse network. The Company makes provisions for obsolete or slow-moving inventories as necessary to properly reflect inventory at the lower of cost or net realizable value. Inventories are valued using the first in, first out method.

Investment in Unconsolidated Affiliates

Non-marketable equity investments in which the Company has the ability to exercise significant influence, but does not control, are accounted for using the equity method of accounting, with the Company’s proportionate share of the earnings and losses of these entities reflected in the Consolidated Statements of Operations. The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may be impaired. If a decline in the value of an equity method investment is determined to be other than temporary, an impairment loss is recognized in earnings for the amount by which the carrying amount of the investment exceeds its estimated fair value.

Long-Lived Assets

Property, plant and equipment are stated at cost. Interest capitalized in property, plant and equipment amounted to $1.1, $2.1 and $2.2 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Expenditures for maintenance and repairs are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost of the asset and the related accumulated depreciation are removed from the accounts with the resulting gain or loss being reflected in income (loss) from operations.

Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows: 

Land improvements	10 – 25 years
Buildings	10 – 40 years
Machinery and equipment	3 – 15 years
Furniture and fixtures	6 – 10 years
Software	3 – 8 years

71

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Intangible assets subject to amortization include technology, patents, customer relationships, non-compete agreements and certain trade names. These intangible assets are amortized over their estimated useful economic lives, which typically range from 3 to 25 years. The Company’s fixed assets and intangible assets subject to amortization are required to be tested for recoverability whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group would be compared to the asset group carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.

The Company had non-cash investing activities of $16.3, $32.1 and $33.3 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively, representing unpaid liabilities to acquire property, plant and equipment.

Internal Use Software

The Company capitalizes certain qualifying costs incurred in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest and payroll and payroll-related costs for associates during the application development stage. Internal and external costs incurred during the preliminary project stage and post implementation-operation stage, mainly training and maintenance costs, are expensed as incurred. Once the application is substantially complete and ready for its intended use, qualifying costs are amortized on a straight-line basis over the software’s estimated useful life. Capitalized internal use software is included in the “Property, plant and equipment, net” line in the Consolidated Balance Sheets. Capitalized software as a service is included in the “Prepaid and other current assets” line in the Consolidated Balance Sheets and is amortized using the straight-line method over the term of the hosting arrangement which typically ranges from 3 to 8 years.

Goodwill and Indefinite-lived Intangible Assets

Goodwill and indefinite-lived intangible assets are not subject to amortization. These assets are reviewed for impairment by applying a fair-value based test on an annual basis as of the first day of the Company’s fiscal fourth quarter or more frequently if circumstances indicate impairment may have occurred. With respect to goodwill, the Company performs either a qualitative or quantitative evaluation for each of its reporting units. Factors considered in the qualitative test include reporting unit specific operating results as well as new events and circumstances impacting the operations or cash flows of the reporting units. For the quantitative test, the Company assesses goodwill for impairment by comparing the carrying value of its reporting units to their respective fair values. A reporting unit is defined as an operating segment or one level below an operating segment. The Company determines the fair value of its reporting units using an income-based approach incorporating assumptions it believes market participants would utilize. The income-based approach utilizes discounted cash flows that depend upon internally-developed forecasts based on annual budgets and longer-range strategic plans. The Company uses discount rates that are commensurate with the risks and uncertainties inherent in the respective reporting units and in the internally-developed forecasts. To further substantiate fair value, the Company compares the aggregate fair value of the reporting units to the Company’s total market capitalization.

With respect to indefinite-lived intangible assets, the Company performs either a qualitative or quantitative evaluation for each asset. Factors considered in the qualitative test include asset specific operating results as well as new events and circumstances impacting the cash flows of the assets. For the quantitative test, the fair value of the Company’s indefinite-lived intangible assets is determined using an income-based approach utilizing discounted cash flows and incorporating assumptions the Company believes market participants would utilize. For trade names, fair value is determined using a relief-from-royalty methodology similar to that employed when the associated businesses were acquired but using updated estimates of sales, cash flow and profitability.

If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the reporting unit or intangible asset exceeds its estimated fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.

72

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Investments in Securities

Convertible debt investments are classified as “available for sale,” are reported at fair value and are presented in the “Other assets” line in the Consolidated Balance Sheets. If the fair value of an available for sale investment is less than its amortized cost basis at the balance sheet date, the impairment is either temporary or other-than-temporary. If a decline in fair value is considered to be temporary at the balance sheet date, unrealized gains and losses are included in accumulated other comprehensive loss (“AOCL”) in the Consolidated Balance Sheets. If management intends to sell the security or if it is more likely than not that the Company will have to sell the security, an other-than-temporary impairment is considered to have occurred and an amount equal to the difference between the investment’s amortized cost basis and its fair value at the balance sheet date will be charged to earnings. If a decline in fair value is considered to be other-than-temporary at the balance sheet date and management can assert that it does not intend to sell the security and it is not more likely than not that it will have to sell the security before recovering its amortized cost basis (net of allowance), an allowance for credit losses (impairment), including any write-off of accrued interest receivable, is charged to earnings. This impairment allowance is separated into two components: (i) the amount related to credit losses (recorded in earnings) and (ii) the amount related to all other factors (recorded in other comprehensive income / loss). Interest income is recorded on an accrual basis and is classified in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations.

Supplier Finance Program

The Company has an agreement to provide a supplier finance program which facilitates participating suppliers’ ability to finance payment obligations of the Company with a designated third-party financial institution. Participating suppliers may, at their sole discretion, elect to finance payment obligations of the Company prior to their scheduled due dates at a discounted price to the participating financial institution. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under this arrangement. The payment terms that the Company negotiates with its suppliers are consistent, regardless of whether a supplier participates in the program. The Company’s current payment terms with a majority of its suppliers generally range from 30 to 60 days, which the Company deems to be commercially reasonable. The Company’s outstanding payment obligations under its supplier finance program were $12.5 and $18.3 at September 30, 2024 and 2023, respectively, and are recorded within accounts payable in the Consolidated Balance Sheets. The associated payments were $245.5 and $185.3 for fiscal 2024 and fiscal 2023, respectively, and are classified as operating activities in the Consolidated Statements of Cash Flows.

Insurance and Self-Insurance

The Company maintains insurance for certain risks, including property damage, management liability, cargo liability, cyber threats, workers compensation and general liability losses, and is self-insured for employee-related health care benefits up to a specified level for individual claims. The Company accrues for the expected costs associated with these risks by considering historical claims experience, demographic factors, severity factors and other relevant information. Costs are recognized in the period the claim is incurred, and accruals include an actuarially determined estimate of claims incurred but not yet reported.

Income Taxes

The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax bases. Management reviews the Company’s deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change.

The Company establishes a liability for tax return positions in which there is uncertainty as to whether or not the position will ultimately be sustained. Amounts for uncertain tax positions are adjusted in quarters when new information becomes available or when positions are effectively settled. The Company recognizes interest expense and penalties related to these unrecognized tax benefits within income tax expense. GAAP provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits of the position. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

73

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

U.S. income tax expense and foreign withholding taxes are provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.

Translation of Foreign Currencies

The functional currency for each Scotts Miracle-Gro subsidiary is generally its local currency. Assets and liabilities of these subsidiaries are translated at the exchange rate in effect at each fiscal year-end. Income and expense accounts are translated at the average rate of exchange prevailing during the year. Translation gains and losses arising from the use of differing exchange rates from period to period are included in AOCL within shareholders’ equity (deficit). Foreign exchange transaction gains and losses are included in the determination of net income and classified as “Other (income) expense, net” in the Consolidated Statements of Operations. The Company recognized foreign exchange transaction (gains) losses of $(0.4), $1.3 and $1.3 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Derivative Instruments

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. A variety of financial instruments, including forwards, futures and swap contracts, are used to manage these exposures. These financial instruments are recognized at fair value in the Consolidated Balance Sheets, and all changes in fair value are recognized in net income (loss) or shareholders’ equity (deficit) through AOCL. The Company’s objective in managing these exposures is to better control these elements of cost and mitigate the earnings and cash flow volatility associated with changes in the applicable rates and prices.

The Company has established policies and procedures that encompass risk-management philosophy and objectives, guidelines for derivative instrument usage, counterparty credit approval, and the monitoring and reporting of derivative activity. The Company does not enter into derivative instruments for the purpose of speculation.

The Company formally designates and documents instruments at inception that qualify for hedge accounting of underlying exposures in accordance with GAAP. The Company formally assesses, both at inception and at least quarterly, whether the financial instruments used in hedging transactions are effective at offsetting changes in cash flows of the related underlying exposure. Fluctuations in the value of these instruments generally are offset by changes in the expected cash flows of the underlying exposures being hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument. The Company designates certain commodity hedges as cash flow hedges of forecasted purchases of commodities and interest rate swap agreements as cash flow hedges of interest payments on variable rate borrowings. Changes in the fair value of derivative contracts that qualify for hedge accounting are recorded in AOCL. For commodity hedges, realized gains or losses remain as a component of AOCL until the related inventory is sold. Cash flows associated with commodity and interest rate swap hedges are classified as operating activities in the Consolidated Statements of Cash Flows.

Leases

The Company determines whether an arrangement contains a lease at inception by determining if the contract conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration and other facts and circumstances. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets are calculated based on the lease liability adjusted for any lease payments paid to the lessor at or before the commencement date and initial direct costs incurred by the Company and exclude any lease incentives received from the lessor. Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. The lease term may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date based on the lease term. The Company considers its credit rating and the current economic environment in determining this collateralized rate. Variable lease payments are the portion of lease payments that are not fixed over the lease term. Variable lease payments are expensed as incurred and include certain non-lease components, such as maintenance and other services provided by the lessor, and other charges included in the lease, as applicable. The Company elected to exclude short-term leases, defined as leases with initial terms of 12 months or less, from its Consolidated Balance Sheets.

74

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Statements of Cash Flows

Supplemental cash flow information was as follows:

	Year Ended September 30,
	2024		2023		2022
Interest paid	$	157.7	$	173.5	$	112.5
Income taxes paid (refunded), net	9.4		(18.2)		27.2

During fiscal 2024, the Company acquired an additional equity interest in Bonnie Plants, LLC for $21.4, which was classified as an investing activity in the Consolidated Statements of Cash Flows. During fiscal 2023, the Company received proceeds of $37.0 related to the payoff of seller financing that the Company provided in connection with a fiscal 2017 divestiture, which was classified as an investing activity in the Consolidated Statements of Cash Flows. During fiscal 2022, the Company made an additional investment in RIV Capital Inc. (“RIV Capital”) in the form of a $25.0 convertible note, which was classified as an investing activity in the Consolidated Statements of Cash Flows. The Company received (paid) cash of $2.6, $(12.4) and $29.3 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively, primarily associated with currency forward contracts, which was classified as an investing activity in the “Other investing, net” line in the Consolidated Statements of Cash Flows. Cash flow from operating activities in fiscal 2022 was favorably impacted by extended payment terms with vendors for payments originally due in the final weeks of fiscal 2022 that were paid in the first quarter of fiscal 2023.

The Company uses the “cumulative earnings” approach for determining cash flow presentation of distributions from unconsolidated affiliates. Distributions received are included in the Consolidated Statements of Cash Flows as operating activities, unless the cumulative distributions exceed the portion of the cumulative equity in the net earnings of the unconsolidated affiliate, in which case the excess distributions are deemed to be returns of the investment and are classified as investing activities in the Consolidated Statements of Cash Flows.

RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS

In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-04, “Liabilities — Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” This ASU requires disclosure of the key terms of outstanding supplier finance programs and a roll-forward of the related obligations. ASU No. 2022-04 is effective for fiscal years beginning after December 15, 2022, except for the amendment on roll-forward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted the ASU as of October 1, 2023. The adoption relates to disclosures only and does not have any impact on the Company’s consolidated financial position, results of operations or cash flows.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU requires enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker that are included within each reported measure of segment profit or loss, and also requires all annual disclosures currently required by Topic 280 to be included in interim periods. ASU No. 2023-07 is to be applied retrospectively for all periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU primarily requires enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative and qualitative disclosures regarding income taxes paid. ASU No. 2023-09 is to be applied prospectively, with the option to apply the standard retrospectively, effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

In November 2024, the FASB issued ASU No. 2024-03, “Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” This ASU requires disaggregated disclosures on an annual and interim basis, in the notes to the financial statements, of certain categories of expenses that are included in expense line items on the face of the statement of operations. ASU No. 2024-03 is to be applied prospectively, with the option to apply the standard retrospectively, effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

75

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

NOTE 2. REVENUE RECOGNITION

Nature of Goods and Services

The Company’s revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers. In addition to product sales, the Company acts as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, and performs certain other services under ancillary agreements with Monsanto. Refer to “NOTE 20. SEGMENT INFORMATION” for disaggregated revenue information and “NOTE 6. MARKETING AGREEMENT” for revenue information related to the Monsanto agreements.

Identification and Satisfaction of Performance Obligations

The Company recognizes product sales at a point in time when it transfers control of products to customers and has no further obligation to provide services related to such products. Control is the ability of customers to direct the “use of” and “obtain” the benefit from the Company’s products. In evaluating the timing of the transfer of control of products to customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are typically recognized when products are delivered to or picked up by the customer. The Company is generally the principal in a transaction and, therefore, primarily records revenue on a gross basis. When the Company is a principal in a transaction, it has determined that it controls the ability to direct the use of the product prior to transfer to a customer, is primarily responsible for fulfilling the promise to provide the product or service to the customer, has discretion in establishing prices, and ultimately controls the transfer of the product or services provided to the customer.

Under the terms of the Third Restated Agreement, pursuant to which the Company serves as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The Third Restated Agreement also requires the Company to make annual payments to Monsanto as a contribution against the overall expenses of its consumer Roundup® business. The gross commission earned under the Third Restated Agreement and the contribution payments to Monsanto are included in the “Net sales” line in the Consolidated Statements of Operations. The Company performs other services, including conversion services, pursuant to ancillary agreements with Monsanto. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross margin dollars or net income.

Transactional Price and Promotional Allowances

Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that the Company expects to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns. Commission income related to the Monsanto agreements is recognized over the program year as the services are performed based upon the commission income formula in the agreements.

The Company’s promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotional costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Accruals for expected payouts under these programs are included in the “Other current liabilities” line in the Consolidated Balance Sheets. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Consolidated Statements of Operations. The Company excludes from revenue any amounts collected from customers for sales or other taxes.

76

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

NOTE 3.  IMPAIRMENT, RESTRUCTURING AND OTHER

Activity described herein is classified within the “Cost of sales—impairment, restructuring and other” and “Impairment, restructuring and other” lines in the Consolidated Statements of Operations. The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:

	Year Ended September 30,
	2024		2023		2022
Cost of sales—impairment, restructuring and other:
Restructuring and other charges, net	$	72.9	$	148.5	$	143.6
Property, plant and equipment impairments	5.3		11.4		16.6
Right-of-use asset impairments	5.3		25.8		—
Operating expenses—impairment, restructuring and other:
Convertible debt other-than-temporary impairments	64.6		101.3		—
Goodwill and intangible asset impairments	2.5		127.9		668.3
Restructuring and other charges (recoveries), net	(4.3)		51.2		40.9
Gains on sale of property, plant and equipment	—		—		(16.2)
Total impairment, restructuring and other charges	$	146.3	$	466.1	$	853.2

The following table summarizes the activity related to liabilities associated with restructuring activities for each of the periods presented:

	Year Ended September 30,
	2024		2023		2022
Amounts accrued at beginning of year	$	40.5	$	31.5	$	1.9
Restructuring charges	11.8		55.6		47.1
Payments	(33.4)		(46.6)		(17.5)
Amounts accrued at end of year	$	18.9	$	40.5	$	31.5

As of September 30, 2024, restructuring accruals include $5.7 that is classified as long-term.

During fiscal 2024 and fiscal 2023, the Company recorded non-cash, pre-tax other-than-temporary impairment charges related to its convertible debt investments of $64.6 and $101.3, respectively, in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. Refer to “NOTE 16. FAIR VALUE MEASUREMENTS” for more information regarding convertible debt investments.

During fiscal 2024, the Company recorded a gain of $12.1 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with a payment received in resolution of a dispute with the former ownership group of a business that was acquired in fiscal 2022.

During fiscal 2022, the Company began implementing a series of Company-wide organizational changes and initiatives intended to create operational and management-level efficiencies. As part of this restructuring initiative, the Company reduced the size of its supply chain network, reduced staffing levels and implemented other cost-reduction initiatives. The Company also accelerated the reduction of certain Hawthorne inventory, primarily lighting, growing environments and hardware products, to reduce on hand inventory to align with the reduced network capacity. During fiscal 2024, the Company incurred costs of $89.4 associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets, intangible assets, property, plant and equipment and software. The Company incurred costs of $11.3 in its U.S. Consumer segment and $71.8 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2024. The Company incurred costs of $1.5 in its U.S. Consumer segment, $1.0 in its Hawthorne segment, $1.1 in its Other segment and $2.4 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2024. During fiscal 2023, the Company incurred costs of $229.0 associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets and property, plant and equipment. The Company incurred costs of $16.3 in its U.S. Consumer segment and $168.5 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2023. The Company incurred costs of $7.7 in its U.S. Consumer segment, $20.7 in its Hawthorne segment, $0.8 in its Other segment and $14.9 at Corporate in the “Impairment, restructuring and other”

77

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

line in the Consolidated Statements of Operations during fiscal 2023. During fiscal 2022, the Company incurred costs of $65.2 associated with this restructuring initiative primarily related to employee termination benefits and impairment of property, plant and equipment. The Company incurred costs of $9.7 in its U.S. Consumer segment and $27.1 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. The Company incurred costs of $11.9 in its U.S. Consumer segment, $8.1 in its Hawthorne segment, $0.7 in its Other segment and $7.7 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. Costs incurred since the inception of this restructuring initiative through September 30, 2024 were $58.3 for the U.S. Consumer segment, $297.2 for the Hawthorne segment, $2.9 for the Other segment and $25.1 at Corporate.

During fiscal 2023, the Company recorded non-cash, pre-tax goodwill and intangible asset impairment charges of $127.9 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, comprised of $117.7 of finite-lived intangible asset impairment charges associated with the Hawthorne segment and $10.3 of goodwill impairment charges associated with the Other segment.

During fiscal 2022, the Company recorded non-cash, pre-tax goodwill and intangible asset impairment charges of $632.4 as a result of interim impairment testing of its Hawthorne segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, comprised of $522.4 of goodwill impairment charges and $110.0 of finite-lived intangible asset impairment charges.

During fiscal 2022, the Company incurred inventory write-down charges of $120.9 in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations and finite-lived intangible asset impairment charges of $35.3 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with its decision to discontinue and exit the market for certain Hawthorne lighting products and brands.

During fiscal 2022, the Company recorded gains of $16.2 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with the sale of property, plant and equipment.

NOTE 4.  GOODWILL AND INTANGIBLE ASSETS, NET

The following table displays a rollforward of the carrying amount of goodwill by reportable segment:

	U.S. Consumer		Hawthorne		Other		Total
Goodwill	$	245.7	$	617.0	$	10.1	$	872.8
Accumulated impairment losses	(1.8)		(617.0)		—		(618.8)
Balance at September 30, 2022	243.9		—		10.1		254.0
Foreign currency translation	—		—		0.2		0.2
Impairment	—		—		(10.3)		(10.3)
Goodwill	245.7		617.0		10.3		873.0
Accumulated impairment losses	(1.8)		(617.0)		(10.3)		(629.1)
Balance at September 30, 2023	243.9		—		—		243.9
Goodwill	245.7		617.0		10.3		873.0
Accumulated impairment losses	(1.8)		(617.0)		(10.3)		(629.1)
Balance at September 30, 2024	$	243.9	$	—	$	—	$	243.9

78

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

The following table presents intangible assets, net of accumulated amortization and impairment charges:

	September 30, 2024						September 30, 2023
	Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount
Finite-lived intangible assets:
Trade names	$	325.8	$	(272.8)	$	53.0	$	322.4	$	(260.7)	$	61.7
Customer relationships	253.1		(223.9)		29.2		251.5		(216.1)		35.4
Technology	50.2		(45.5)		4.7		50.1		(44.5)		5.6
Other	35.0		(27.0)		8.0		34.9		(24.8)		10.1
Total finite-lived intangible assets, net					94.9						112.8
Indefinite-lived intangible assets:
Indefinite-lived trade names					168.2						168.2
Roundup® marketing agreement amendment					155.7						155.7
Total indefinite-lived intangible assets					323.9						323.9
Total intangible assets, net					$	418.8					$	436.7

During fiscal 2023, the Company identified circumstances that indicated the carrying amounts of Hawthorne’s long-lived assets, including trade names and customer relationships, may not be recoverable. Accordingly, the Company performed a recoverability test for long-lived assets during the fourth quarter of fiscal 2023. The Company concluded that the carrying value of these long-lived assets exceeded their estimated fair value and recorded non-cash, pre-tax impairment charges of $72.0 related to trade names and $45.7 related to customer relationships during the fourth quarter of fiscal 2023 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The fair values of long-lived assets were determined using income-based approaches, including the relief-from-royalty method for trade names, that include market participant expectations of cash flows that the assets will generate over the remaining useful life discounted to present value using an appropriate discount rate. These fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.

The Company performed annual goodwill impairment testing as of the first day of its fourth quarter of fiscal 2023. This test resulted in a non-cash, pre-tax goodwill impairment charge of $10.3 related to the Other segment, which was recorded during the fourth quarter of fiscal 2023 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The carrying value of goodwill of the Other segment reporting unit after recognizing the impairment is zero. The estimated fair value of the Other segment reporting unit was based upon an equal weighting of the income-based and market-based approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to the operating performance of the reporting unit. The fair value estimate utilizes significant unobservable inputs and thus represents a Level 3 fair value measurement.

Total amortization expense was $15.7, $25.2 and $37.1 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Amortization expense is estimated to be as follows for the years ending September 30:

2025	$	12.6
2026	11.5
2027	10.7
2028	9.1
2029	6.9

79

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

NOTE 5.  DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS

The following presents detail regarding certain financial statement accounts:

	September 30,
	2024		2023
INVENTORIES:
Raw materials	$	256.8	$	272.5
Finished goods	246.6		506.2
Work-in-progress	84.1		101.6
	$	587.5	$	880.3
PROPERTY, PLANT AND EQUIPMENT, NET:
Machinery and equipment	$	683.6	$	651.7
Buildings	305.8		277.1
Land and improvements	152.9		149.0
Software	107.2		109.9
Construction in progress	78.7		104.6
Furniture and fixtures	62.6		62.3
Finance leases	24.1		21.1
	1,414.9		1,375.7
Less: accumulated depreciation	(805.4)		(765.4)
	$	609.5	$	610.3
OTHER ASSETS:
Operating lease right-of-use assets	$	265.4	$	262.6
Net deferred tax assets	191.3		189.8
Accrued pension, postretirement and executive retirement assets	62.7		64.1
Convertible debt investments	45.8		85.8
Other	8.9		30.8
	$	574.1	$	633.1

	September 30,
	2024		2023
OTHER CURRENT LIABILITIES:
Advertising and promotional accruals	$	131.2	$	143.0
Current operating lease liabilities	75.3		76.4
Payroll and other compensation accruals	72.0		51.2
Accrued interest	29.4		31.9
Accrued taxes	16.7		28.5
Other	118.4		119.2
	$	443.0	$	450.2
OTHER NON-CURRENT LIABILITIES:
Non-current operating lease liabilities	$	215.8	$	220.1
Accrued pension, postretirement and executive retirement liabilities	73.0		76.7
Net deferred tax liabilities	7.0		1.1
Other	42.2		52.0
	$	338.0	$	349.9

80

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

NOTE 6.  MARKETING AGREEMENT

The Scotts Company LLC (“Scotts LLC”) is the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries. The annual commission payable under the Third Restated Agreement is equal to 50% of the actual earnings before interest and income taxes of Monsanto’s consumer Roundup® business for each program year in the markets covered by the Third Restated Agreement (“Program EBIT”). The Third Restated Agreement also requires the Company to make annual payments of $18.0 to Monsanto as a contribution against the overall expenses of its consumer Roundup® business, subject to reduction pursuant to the Third Restated Agreement for any program year in which the Program EBIT does not equal or exceed $36.0.

Unless Monsanto terminates the Third Restated Agreement due to an event of default by the Company, termination rights under the Third Restated Agreement include the following:

•The Company may terminate the Third Restated Agreement upon the insolvency or bankruptcy of Monsanto;

•Monsanto may terminate the Third Restated Agreement in the event that Monsanto decides to decommission the permits, licenses and registrations needed for, and the trademarks, trade names, packages, copyrights and designs used in, the sale of the Roundup® products in the lawn and garden market (a “Brand Decommissioning Termination”); and

•Each party may terminate the Third Restated Agreement if Program EBIT falls below $50.0 and, in such case, no termination fee would be payable to either party.

The termination fee structure requires Monsanto to pay a termination fee to the Company in an amount equal to (i) $375.0 upon a Brand Decommissioning Termination, and (ii) the greater of $175.0 or four times an amount equal to the average of the Program EBIT for the three program years before the year of termination, minus $186.4, if Monsanto or its successor terminates the Third Restated Agreement as a result of a Roundup Sale or Change of Control of Monsanto (each, as defined in the Third Restated Agreement).

The elements of the net commission and reimbursements earned under the Third Restated Agreement and included in the “Net sales” line in the Consolidated Statements of Operations are as follows:

	Year Ended September 30
	2024		2023		2022
Gross commission	$	90.8	$	75.7	$	83.4
Contribution expenses	(18.0)		(18.0)		(18.0)
Net commission	72.8		57.7		65.4
Reimbursements associated with Roundup® marketing agreement	91.2		82.5		67.9
Total net sales associated with Roundup® marketing agreement	$	164.0	$	140.2	$	133.3

NOTE 7.  ACQUISITIONS AND INVESTMENTS

CYCO

On April 28, 2022, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of S.J. Enterprises PTY LTD, d.b.a. CYCO (“CYCO”), an Australia-based provider of premium nutrients, additives and growing media products for indoor growing sold mostly in the United States, for an estimated purchase price of $37.3. The purchase price includes contingent consideration, a non-cash investing activity, with an initial fair value of $3.1 and a maximum payout of $10.0, which is based on the achievement of certain performance metrics through December 31, 2024 and is not expected to be paid. Prior to the transaction, the Company served as the exclusive distributor of CYCO’s products in the United States. The valuation of the acquired assets included (i) $1.3 of inventory, (ii) $10.5 of finite-lived identifiable intangible assets and (iii) $25.6 of tax-deductible goodwill. Identifiable intangible assets included trade names, customer relationships and non-compete agreements with initial useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate.

81

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Luxx Lighting

On December 30, 2021, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of Luxx Lighting, Inc., a provider of lighting products for indoor growing. The purchase price was $213.2, a portion of which was paid by the issuance of 0.1 million Common Shares, a non-cash investing and financing activity, with a fair value of $21.0 based on the share price at the time of payment. The valuation of the acquired assets included (i) $32.8 of inventory and accounts receivable, (ii) $5.7 of other current assets, (iii) $24.2 of current liabilities, (iv) $47.3 of finite-lived identifiable intangible assets and (v) $151.6 of tax-deductible goodwill. Identifiable intangible assets included trade names, customer relationships and non-compete agreements with initial useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. During the fourth quarter of fiscal 2022, the Company decided it would discontinue and exit the market for certain Hawthorne lighting products and brands, including Luxx Lighting, Inc. Refer to “NOTE 3. IMPAIRMENT, RESTRUCTURING AND OTHER” for more information.

True Liberty Bags

On December 23, 2021, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of True Liberty Bags, a leading provider of liners and storage solutions to dry and cure plant products, for $10.1. The valuation of the acquired assets included (i) $1.1 of inventory, (ii) $5.8 of finite-lived identifiable intangible assets and (iii) $3.2 of tax-deductible goodwill. Identifiable intangible assets included trade names and customer relationships with initial useful lives of 15 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate.

NOTE 8. INVESTMENT IN UNCONSOLIDATED AFFILIATES

The Company holds a 50% equity interest in Bonnie Plants, LLC, a joint venture with AFC focused on planting, growing, developing, distributing, marketing and selling live plants. During the three months ended December 31, 2022, the Company and AFC amended the joint venture agreement to allow AFC to make an additional equity contribution to Bonnie Plants, LLC, and, as a result of this contribution by AFC, the Company’s equity interest in Bonnie Plants, LLC was reduced to 45%. On November 7, 2023, the Company purchased an additional 5% equity interest in Bonnie Plants, LLC from AFC for $21.4, which restored its total equity interest back to 50%. The Company’s interest is accounted for using the equity method of accounting, with the Company’s proportionate share of Bonnie Plants, LLC earnings reflected in the Consolidated Statements of Operations.

The Company recorded equity in loss of unconsolidated affiliates associated with Bonnie Plants, LLC of $68.1, $101.1 and $12.9 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. The Company recorded pre-tax impairment charges associated with its investment in Bonnie Plants, LLC of $61.9 and $94.7 in the “Equity in loss of unconsolidated affiliates” line in the Consolidated Statements of Operations during fiscal 2024 and fiscal 2023, respectively. The impairment charges were driven by revisions to the Company’s internal forecasts for Bonnie Plants, LLC in response to decreased sales volume and inflationary cost pressures. The estimated fair value of Bonnie Plants, LLC was based upon an equal weighting of the income-based and market-based approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to the operating performance of the investment. The fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.

As a result of the impairment charges recorded by the Company during fiscal 2024 and fiscal 2023, the carrying value of the Company’s equity method investment is lower than its interest in Bonnie Plants, LLC’s underlying net assets as of September 30, 2024. Of this basis difference, the majority relates to goodwill and indefinite-lived intangible assets recorded by Bonnie Plants, LLC, which are not amortized. The remaining amount relates to long-lived assets, including finite-lived intangible assets, and will be amortized over the remaining useful life of the long-lived assets.

82

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

NOTE 9.  RETIREMENT PLANS

The Company sponsors a defined contribution 401(k) plan for substantially all U.S. associates. The Company matches 200% of associates’ initial 3% contribution and 50% of their remaining contribution up to 6%. The Company may make additional discretionary profit sharing matching contributions to eligible associates on their initial 4% contribution. The Company recorded expenses of $23.7, $24.1 and $28.3 associated with the plan in fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

The Company sponsors two defined benefit pension plans for certain U.S. associates and three defined benefit pension plans associated with the former businesses in the United Kingdom and Germany. Benefits under these plans have been frozen and closed to new associates since 1997 for the U.S. plans, 2010 for the United Kingdom plans and 2017 for the Germany plan. The benefits under the plans are based on years of service and compensation levels. The Company’s funding policy for the defined benefit pension plans, consistent with statutory requirements and tax considerations, is based on actuarial computations using the Projected Unit Credit method.

During fiscal 2023 and 2021, the defined benefit pension plans associated with the former business in the United Kingdom entered into buy-in insurance policies in exchange for premium payments of $76.3 and $67.7, respectively, which are subject to adjustment as a result of subsequent data cleansing activities. Under the terms of these buy-in insurance policies, the respective insurers are liable to pay the benefits to the plans, but the plans still retain full legal responsibility to pay benefits to plan participants using the insurance payments. The buy-in policies will be treated as assets of the plans going forward until such time as the buy-in policies are converted to buy-out policies, which is when individual insurance policies will be assigned to each plan participant and the plans will no longer have legal responsibility to pay the benefits to the plan participants.

The following tables present information about benefit obligations, plan assets, annual expense, assumptions and other information about the Company’s defined benefit pension plans. The defined benefit pension plans are valued using a September 30 measurement date.

	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2024		2023		2024		2023
Change in projected benefit obligation:
Benefit obligation at beginning of year	$	71.8	$	77.7	$	108.5	$	109.2
Interest cost	3.7		3.6		5.9		6.2
Actuarial (gain) loss	5.5		(2.5)		5.1		(11.0)
Benefits paid	(6.8)		(6.9)		(6.6)		(5.9)
Foreign currency translation	—		—		10.3		10.0
Projected benefit obligation (“PBO”) at end of year	$	74.2	$	71.8	$	123.2	$	108.5
Accumulated benefit obligation (“ABO”) at end of year	$	74.2	$	71.8	$	123.2	$	108.5
Change in plan assets:
Fair value of plan assets at beginning of year	$	54.1	$	59.1	$	124.8	$	128.9
Actual return on plan assets	7.1		1.7		10.0		(11.5)
Employer contribution	2.9		0.2		0.9		1.2
Benefits paid	(6.8)		(6.9)		(6.6)		(5.9)
Foreign currency translation	—		—		12.3		12.1
Fair value of plan assets at end of year	$	57.3	$	54.1	$	141.4	$	124.8
Overfunded (underfunded) status at end of year	$	(16.9)	$	(17.7)	$	18.2	$	16.3

83

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2024		2023		2024		2023
Information for pension plans with an ABO in excess of plan assets:
Accumulated benefit obligation	$	74.2	$	71.8	$	12.0	$	11.5
Fair value of plan assets	57.3		54.1		—		—
Information for pension plans with a PBO in excess of plan assets:
Projected benefit obligation	$	74.2	$	71.8	$	12.0	$	11.5
Fair value of plan assets	57.3		54.1		—		—
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	$	—	$	—	$	30.2	$	27.8
Current liabilities	(0.2)		(0.2)		(0.9)		(0.9)
Non-current liabilities	(16.7)		(17.5)		(11.1)		(10.6)
Total amount accrued	$	(16.9)	$	(17.7)	$	18.2	$	16.3
Amounts recognized in AOCL consist of:
Actuarial loss	$	34.1	$	35.2	$	64.1	$	60.0
Prior service cost	—		—		2.3		2.1
Total amount recognized	$	34.1	$	35.2	$	66.4	$	62.1

	U.S. Defined Benefit Pension Plans						International Defined Benefit Pension Plans
	2024			2023			2024			2023
Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	$	(0.5)		$	1.8		$	(0.7)		$	(6.0)
Reclassification to net earnings	1.7			1.8			2.3			2.0
Foreign currency translation	—			—			(5.9)			(4.8)
Total change in other comprehensive loss	$	1.2		$	3.6		$	(4.3)		$	(8.8)
Weighted average assumptions used in development of projected benefit obligation:
Discount rate	4.62		%	5.54		%	4.86		%	5.38		%

 

	U.S. Defined Benefit Pension Plans									International Defined Benefit Pension Plans
	2024			2023			2022			2024			2023			2022
Components of net periodic benefit cost (income):
Interest cost	$	3.7		$	3.6		$	1.7		$	5.9		$	6.2		$	3.0
Expected return on plan assets	(2.2)			(2.5)			(2.8)			(5.7)			(5.5)			(5.1)
Net amortization	1.7			1.8			1.7			2.3			2.0			1.3
Net periodic benefit cost (income)	$	3.2		$	2.9		$	0.6		$	2.5		$	2.7		$	(0.8)
Weighted average assumptions used in development of net periodic benefit cost (income):
Weighted average discount rate - interest cost	5.46		%	4.87		%	1.74		%	5.38		%	5.29		%	1.64		%
Expected return on plan assets	4.25		%	4.50		%	3.50		%	4.42		%	3.91		%	2.37		%

84

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Investment Strategy

Target allocation percentages among various asset classes are maintained based on an individual investment policy established for each of the various pension plans. Asset allocations are designed to achieve long-term objectives of return while mitigating against downside risk considering expected cash requirements necessary to fund benefit payments. However, the Company cannot predict future investment returns and therefore cannot determine whether future pension plan funding requirements could materially and adversely affect its financial condition, results of operations or cash flows.

Basis for Long-Term Rate of Return on Asset Assumptions

The Company’s expected long-term rate of return on asset assumptions are derived from studies conducted by third parties. The studies include a review of anticipated future long-term performance of individual asset classes and consideration of the appropriate asset allocation strategy given the anticipated requirements of the plans to determine the average rate of earnings expected. While the studies give appropriate consideration to recent fund performance and historical returns, the assumptions primarily represent expectations about future rates of return over the long term.

	U.S. Defined Benefit Pension Plans			International Defined Benefit Pension Plans
Other information:
Plan asset allocations:
Target for September 30, 2025:
Equity securities	19		%	—		%
Debt securities	76		%	—		%
Real estate securities	3		%	—		%
Cash and cash equivalents	2		%	15		%
Insurance contracts	—		%	85		%
September 30, 2024
Equity securities	19		%	—		%
Debt securities	74		%	—		%
Real estate securities	2		%	—		%
Cash and cash equivalents	5		%	15		%
Insurance contracts	—		%	85		%
September 30, 2023
Equity securities	18		%	—		%
Debt securities	75		%	5		%
Real estate securities	3		%	—		%
Cash and cash equivalents	4		%	11		%
Insurance contracts	—		%	84		%
Expected company contributions in fiscal 2025	$	2.7		$	0.9
Expected future benefit payments:
2025	$	7.5		$	7.3
2026	7.0			7.4
2027	6.9			7.4
2028	6.7			7.6
2029	6.5			7.8
2030 – 2034	28.4			40.5

85

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

The following tables set forth the fair value of the Company’s pension plan assets, segregated by level within the fair value hierarchy:

	Fair Value Hierarchy Level	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
		2024		2023		2024		2023
Cash and cash equivalents	Level 1	$	2.6	$	2.2	$	21.9	$	14.0
Insurance contracts	Level 3	—		—		119.5		104.3
Total assets in the fair value hierarchy		$	2.6	$	2.2	$	141.4	$	118.3
Common collective trusts measured at net asset value
Real estate		$	1.4	$	1.8	$	—	$	—
Equities		10.9		10.0		—		—
Fixed income		42.4		40.1		—		6.5
Total common collective trusts measured at net asset value		54.7		51.9		—		6.5
Total assets at fair value		$	57.3	$	54.1	$	141.4	$	124.8

The carrying value of cash equivalents approximated their aggregate fair value as of September 30, 2024 and 2023. The valuation of the buy-in insurance policies was calculated on an insurer pricing basis updated for changes in market implied insurance pricing, market rates, and inflation, and was estimated using unobservable inputs. Common collective trusts are not publicly traded and were valued at a net asset value unit price determined by the portfolio’s sponsor based on the fair value of underlying assets held by the common collective trust on September 30, 2024 and 2023. The common collective trusts hold underlying investments that have prices derived from quoted prices in active markets. The underlying assets are principally marketable equity and fixed income securities.

86

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

NOTE 10.  ASSOCIATE MEDICAL BENEFITS

The Company provides comprehensive major medical benefits to its associates. The Company is self-insured for certain health benefits up to $1.0 per occurrence per individual. The cost of such benefits is recognized as expense in the period the claim is incurred and was $42.5, $40.1 and $46.6 in fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

The Company also provides comprehensive major medical benefits to certain retired associates and their dependents. Substantially all of the Company’s domestic associates who were hired before January 1, 1998 become eligible for these benefits if they retire at age 55 or older with more than ten years of service. The retiree medical plan requires certain minimum contributions from retired associates and includes provisions to limit the overall cost increases the Company is required to cover. The Company funds its portion of retiree medical benefits as claims are paid.

The following tables set forth information about the retiree medical plan for domestic associates. The retiree medical plan is valued using a September 30 measurement date.

	2024		2023
Change in Accumulated Plan Benefit Obligation (“APBO”):
Benefit obligation at beginning of year	$	13.3	$	15.7
Service cost	0.1		0.1
Interest cost	0.8		0.8
Plan participants’ contributions	0.3		0.4
Actuarial (gain) loss	1.5		(2.2)
Benefits paid	(2.2)		(1.5)
Benefit obligation at end of year	$	13.8	$	13.3
Change in plan assets:
Fair value of plan assets at beginning of year	$	—	$	—
Employer contribution	1.9		1.1
Plan participants’ contributions	0.3		0.4
Gross benefits paid	(2.2)		(1.5)
Fair value of plan assets at end of year	$	—	$	—
Unfunded status at end of year	$	(13.8)	$	(13.3)

	2024			2023
Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities	$	(1.3)		$	(1.4)
Non-current liabilities	(12.5)			(11.9)
Total amount accrued	$	(13.8)		$	(13.3)
Amounts recognized in accumulated other comprehensive (income) loss consist of:
Actuarial gain	$	(1.3)		$	(3.4)
Total accumulated other comprehensive income	$	(1.3)		$	(3.4)
Total change in other comprehensive income attributable to:
Gain (loss) during the period	$	(1.5)		$	2.2
Reclassification to net earnings	(0.6)			(0.2)
Total change in other comprehensive income	$	(2.1)		$	2.0
Discount rate used in development of APBO	4.86		%	5.98		%

Net periodic benefit cost (income) was $0.3, $0.7 and $(0.2) during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. For measurement as of September 30, 2024, management has assumed that health care costs will increase at an annual rate of 6.50%, and thereafter decrease to an ultimate trend rate of 4.50% in 2033.

87

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

The following benefit payments under the plan are expected to be paid by the Company and the retirees for the fiscal years indicated:

	Gross Benefit Payments		Retiree Contributions		Net Company Payments
2025	$	1.6	$	(0.3)	$	1.3
2026	1.8		(0.4)		1.3
2027	1.9		(0.6)		1.4
2028	2.0		(0.7)		1.3
2029	2.1		(0.7)		1.3
2030 – 2034	9.5		(3.7)		5.7

NOTE 11.  DEBT

The components of debt are as follows:

	September 30,
	2024		2023
Credit Facilities:
Revolving loans	$	—	$	88.3
Term loans	625.0		925.0
Senior Notes due 2031 – 4.000%	500.0		500.0
Senior Notes due 2032 – 4.375%	400.0		400.0
Senior Notes due 2029 – 4.500%	450.0		450.0
Senior Notes due 2026 – 5.250%	250.0		250.0
Finance lease obligations	17.8		16.9
Other	—		0.4
Total debt	2,242.8		2,630.6
Less current portions	52.6		52.3
Less unamortized debt issuance costs	16.0		20.9
Long-term debt	$	2,174.2	$	2,557.4

The Company’s aggregate scheduled maturities of debt by fiscal year, excluding finance lease obligations, are as follows:

2025	$	50.0
2026	50.0
2027	775.0
2028	—
2029	—
Thereafter	1,350.0
	$	2,225.0

Credit Facilities

On April 8, 2022, the Company entered into the Sixth A&R Credit Agreement, providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2,500.0, comprised of a revolving credit facility of $1,500.0 and a term loan in the original principal amount of $1,000.0. The Sixth A&R Credit Agreement will terminate on April 8, 2027. The Sixth A&R Credit Facilities are available for the issuance of letters of credit up to $100.0. The terms of the Sixth A&R Credit Agreement include customary representations and warranties, affirmative and negative covenants, financial covenants, and events of default.

88

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Under the terms of the Sixth A&R Credit Agreement, loans bear interest, at the Company’s election, at a rate per annum equal to either (i) the Alternate Base Rate plus the Applicable Spread (each, as defined in the Sixth A&R Credit Agreement) or (ii) the Adjusted Term SOFR Rate for the Interest Period in effect for such borrowing plus the Applicable Spread (all as defined in the Sixth A&R Credit Agreement). Swingline Loans bear interest at the applicable Swingline Rate set forth in the Sixth A&R Credit Agreement. Interest rates for other select non-U.S. dollar borrowings, including borrowings denominated in euro, Pounds Sterling and Canadian dollars, are based on separate interest rate indices, as set forth in the Sixth A&R Credit Agreement.

On June 8, 2022, the Company entered into Amendment No. 1 to the Sixth A&R Credit Agreement. Amendment No. 1 increased the maximum permitted leverage ratio for the quarterly leverage covenant until April 1, 2024. Amendment No. 1 also increased the interest rate applicable to borrowings under the revolving credit facility by 35 bps and the term loan facility by 50 bps, and increased the annual facility fee rate on the revolving credit facility by 15 bps, in each case, when the Company’s quarterly-tested leverage ratio exceeded 4.75.

On July 31, 2023, the Company entered into Amendment No. 2 to the Sixth A&R Credit Agreement. Amendment No. 2 (i) reduces the revolving loan commitments by $250.0; (ii) increases the maximum permitted leverage ratio for the quarterly leverage covenant during the Leverage Adjustment Period; (iii) replaces the interest coverage covenant with a fixed charge coverage covenant; (iv) increases the interest rate applicable to borrowings under the revolving credit facility and the term loan facility by 25 bps for each existing pricing tier and adds a pricing tier applicable to periods when the leverage ratio exceeds 6.00; (v) limits the amount of certain incremental investments, loans and advances to $25.0 during the Leverage Adjustment Period; and (vi) adds the Company’s intellectual property (subject to certain exceptions) as collateral to secure its obligations under the Sixth A&R Credit Agreement. Additionally, Amendment No. 2 limits the Company’s ability to declare or pay any discretionary dividends, distributions or other restricted payments during the Leverage Adjustment Period to only the payment of (i) regularly scheduled cash dividends to holders of its Common Shares in an aggregate amount not to exceed $225.0 per fiscal year and (ii) other dividends, distributions or restricted payments in an aggregate amount not to exceed $25.0. Amendment No. 2 also subjects the Company’s ability to make certain investments to pro forma compliance with certain leverage levels specified in Amendment No. 2. Pursuant to Amendment No. 2, the Sixth A&R Credit Agreement is secured by (i) a perfected first priority security interest in all of the accounts receivable, inventory, equipment and intellectual property (subject to certain exceptions) of Scotts Miracle-Gro and certain of its domestic subsidiaries and (ii) the pledge of all of the capital stock of certain of Scotts Miracle-Gro’s domestic subsidiaries and a portion of the capital stock of certain of its foreign subsidiaries.

At September 30, 2024, the Company had letters of credit outstanding in the aggregate principal amount of $83.0, and had $1,167.0 of borrowing availability under the Sixth A&R Credit Agreement. The weighted average interest rates on average borrowings under the credit facilities, excluding the impact of interest rate swaps, were 9.1%, 7.6% and 2.8% for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

During fiscal 2024, the Company used available cash on hand to make repayments on the term loan of the Sixth A&R Credit Agreement in the amount of $250.0, which was applied to the outstanding principal amount.

The Sixth A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio determined as of the end of each of its fiscal quarters calculated as average total indebtedness, divided by the Company’s Adjusted EBITDA. Pursuant to Amendment No. 2, the maximum permitted leverage ratio is (i) 6.00 for the fourth quarter of fiscal 2024, (ii) 5.50 for the first quarter of fiscal 2025, (iii) 5.25 for the second quarter of fiscal 2025, (iv) 5.00 for the third quarter of fiscal 2025, (v) 4.75 for the fourth quarter of fiscal 2025 and (vi) 4.50 for the first quarter of fiscal 2026 and thereafter. The Company’s leverage ratio was 4.86 at September 30, 2024. Pursuant to Amendment No. 2, the Sixth A&R Credit Agreement also contains an affirmative covenant regarding the Company’s fixed charge coverage ratio determined as of the end of each of its fiscal quarters, calculated as Adjusted EBITDA minus capital expenditures and expense for taxes paid in cash, divided by the sum of interest expense plus restricted payments, as described in Amendment No. 2. The minimum required fixed charge coverage ratio is 1.00. The Company’s fixed charge coverage ratio was 1.27 for the twelve months ended September 30, 2024.

89

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

As of September 30, 2024, the Company was in compliance with all applicable covenants in the agreements governing its debt. Based on the Company’s projections of its financial performance for the twelve-month period subsequent to the date of the filing of this Form 10-K, the Company expects to remain in compliance with the financial covenants under the Sixth A&R Credit Agreement. However, the Company’s assessment of its ability to meet its future obligations is inherently subjective, judgment-based, and susceptible to change based on future events. A covenant violation may result in an event of default. Such a default would allow the lenders under the Sixth A&R Credit Agreement to accelerate the maturity of the indebtedness thereunder and would also implicate cross-default provisions under the Senior Notes, and cause the Senior Notes to become due and payable at that time. As of September 30, 2024, the Company’s indebtedness under the Sixth A&R Credit Agreement and Senior Notes was $2,225.0. The Company does not have sufficient cash on hand or available liquidity that can be utilized to repay these outstanding amounts in the event of default.

As part of its contingency planning to address potential future circumstances that could result in noncompliance, the Company has contemplated alternative plans including additional restructuring activities to reduce operating expenses and certain cash management strategies that are within the Company’s control. Additionally, the Company has contemplated alternative plans that are subject to market conditions and not in the Company’s control, including, among others, discussions with its lenders to amend the terms of its financial covenants under the Sixth A&R Credit Agreement and generating cash by completing other financing transactions, which may include issuing equity. There is no assurance that the Company will be successful in implementing these alternative plans.

Senior Notes

On December 15, 2016, Scotts Miracle-Gro issued $250.0 aggregate principal amount of 5.250% Senior Notes due 2026. The 5.250% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 5.250% Senior Notes have interest payment dates of June 15 and December 15 of each year.

On October 22, 2019, Scotts Miracle-Gro issued $450.0 aggregate principal amount of 4.500% Senior Notes due 2029. The 4.500% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.500% Senior Notes have interest payment dates of April 15 and October 15 of each year.

On March 17, 2021, Scotts Miracle-Gro issued $500.0 aggregate principal amount of 4.000% Senior Notes due 2031. The 4.000% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.000% Senior Notes have interest payment dates of April 1 and October 1 of each year.

On August 13, 2021, Scotts Miracle-Gro issued $400.0 aggregate principal amount of 4.375% Senior Notes due 2032. The 4.375% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.375% Senior Notes have interest payment dates of February 1 and August 1 of each year.

Substantially all of Scotts Miracle-Gro’s directly and indirectly owned domestic subsidiaries serve as guarantors of the 5.250% Senior Notes, the 4.500% Senior Notes, the 4.000% Senior Notes and the 4.375% Senior Notes.

The Senior Notes contain an affirmative covenant regarding the Company’s interest coverage ratio determined as of the end of each of its fiscal quarters, calculated as Adjusted EBITDA divided by interest expense excluding costs related to refinancings. The minimum required interest coverage ratio is 2.00. The Company’s interest coverage ratio was 3.57 for the twelve months ended September 30, 2024.

Receivables Facility

On April 7, 2017, the Company entered into the Receivables Facility, under which the Company could sell a portfolio of available and eligible outstanding customer accounts receivable to the purchasers subject to agreeing to repurchase the receivables on a weekly basis. The eligible accounts receivable consisted of accounts receivable generated by sales to three specified customers. The eligible amount of customer accounts receivables which could be sold under the Receivables Facility was $400.0. The Receivables Facility expired on August 18, 2023. The sale of receivables under the Receivables Facility was accounted for as short-term debt and the Company continued to carry the receivables on its Consolidated Balance Sheets, primarily as a result of its requirement to repurchase receivables sold.

90

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Interest Rate Swap Agreements

The Company enters into interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest payments made between the effective date and expiration date are hedged by the swap agreements. Swap agreements that were hedging interest payments as of September 30, 2024 and 2023 had a maximum total U.S. dollar equivalent notional amount of $450.0 and $600.0, respectively. During fiscal 2024, the Company terminated an interest rate swap agreement in exchange for a cash payment of $11.0. The notional amount, effective date, expiration date and rate of each of the swap agreements outstanding at September 30, 2024 are shown in the table below:

Notional Amount ($)		Effective Date (a)	Expiration Date	Fixed Rate
150		6/7/2023	4/7/2027	3.37	%
50		6/7/2023	4/7/2027	3.34	%
100	(b)	11/20/2023	3/22/2027	4.74	%
150	(b)	9/20/2024	9/20/2029	4.25	%

(a)The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b)Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

Weighted Average Interest Rate

The weighted average interest rates on the Company’s debt, including the impact of interest rate swaps, were 5.8%, 5.4% and 3.6% for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

NOTE 12.  EQUITY (DEFICIT)

Authorized and issued shares consisted of the following (in millions):

	September 30,
	2024	2023
Preferred shares, no par value:
Authorized	0.2 shares	0.2 shares
Issued	0.0 shares	0.0 shares
Common shares, no par value, $0.01 stated value per share:
Authorized	100.0 shares	100.0 shares
Issued	68.1 shares	68.1 shares

In fiscal 1995, The Scotts Company merged with Stern’s Miracle-Gro Products, Inc. (“Miracle-Gro”). At September 30, 2024, the former shareholders of Miracle-Gro, including the Hagedorn Partnership, L.P., owned approximately 24% of Scotts Miracle-Gro’s outstanding Common Shares and, therefore, have the ability to significantly influence the election of directors and other actions requiring the approval of Scotts Miracle-Gro’s shareholders.

Under the terms of the merger agreement with Miracle-Gro, the former shareholders of Miracle-Gro may not collectively acquire, directly or indirectly, beneficial ownership of Voting Stock (as that term is defined in the Miracle-Gro merger agreement) representing more than 49% of the total voting power of the outstanding Voting Stock, except pursuant to a tender offer for 100% of that total voting power, which tender offer is made at a price per share which is not less than the market price per share on the last trading day before the announcement of the tender offer and is conditioned upon the receipt of at least 50% of the Voting Stock beneficially owned by shareholders of Scotts Miracle-Gro other than the former shareholders of Miracle-Gro and their affiliates and associates.

91

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Accumulated Other Comprehensive Loss

Changes in AOCL by component were as follows for the fiscal years ended September 30:

	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Loss On Securities		Pension and Other Post- Retirement Benefit Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance at September 30, 2021	$	(1.7)	$	10.2	$	(2.3)	$	(72.5)	$	(66.4)
Other comprehensive income (loss) before reclassifications	(27.2)		40.1		(102.0)		(7.3)		(96.4)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.1)		—		11.7		2.6
Income tax benefit (expense)	—		(7.9)		24.6		(1.1)		15.6
Net current period other comprehensive income (loss)	(27.2)		23.1		(77.4)		3.3		(78.2)
Balance at September 30, 2022	(28.9)		33.3		(79.7)		(69.3)		(144.6)
Other comprehensive income (loss) before reclassifications	7.0		5.6		(34.9)		(2.5)		(24.8)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(23.3)		101.3		(1.6)		76.4
Income tax benefit (expense)	—		4.5		(25.3)		1.0		(19.8)
Net current period other comprehensive income (loss)	7.0		(13.2)		41.1		(3.1)		31.8
Balance at September 30, 2023	(21.9)		20.1		(38.6)		(72.4)		(112.8)
Other comprehensive income (loss) before reclassifications	0.6		(10.6)		(40.4)		(2.8)		(53.2)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.7)		64.6		(2.7)		52.2
Income tax benefit (expense)	—		5.1		—		1.4		6.5
Net current period other comprehensive income (loss)	0.6		(15.2)		24.2		(4.1)		5.5
Balance at September 30, 2024	$	(21.3)	$	4.9	$	(14.4)	$	(76.5)	$	(107.3)

The sum of the components may not equal due to rounding.

Share Repurchases

On February 6, 2020, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $750.0 of Common Shares from April 30, 2020 through March 25, 2023. There were no share repurchases under this share repurchase authorization during fiscal 2023 through its expiration on March 25, 2023. During fiscal 2022, Scotts Miracle-Gro repurchased 1.1 million Common Shares under this share repurchase authorization for $175.0. Treasury share purchases also include cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation of $5.1, $9.3 and $82.9 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

92

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Share-Based Awards

In January 2024, the shareholders of Scotts Miracle-Gro approved an amendment and restatement of The Scotts Miracle-Gro Company Long-Term Incentive Plan. As of September 30, 2024, the Company is authorized under this plan to grant up to approximately 7.9 million Common Shares, which includes an estimate of the number of Common Shares subject to outstanding awards under the plan that terminate, expire, or are cancelled, forfeited, exchanged, or surrendered without having been exercised, vested, or paid. At September 30, 2024, approximately 3.6 million Common Shares were not subject to outstanding awards and were available to underlie the grant of new share-based awards. Common Shares held in treasury totaling 0.3 million, 0.4 million and 0.9 million were reissued in support of share-based compensation awards under this plan and employee purchases under the employee stock purchase plan during fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Subsequent to September 30, 2024, the Company awarded stock options representing 0.3 million Common Shares to associates with an estimated grant date fair value of $9.8.

Total share-based compensation was as follows for each of the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Share-based compensation	$	79.8	$	68.1	$	30.3
Related tax benefit recognized	14.8		15.6		4.9

Excess tax benefit (tax deficiency) related to share-based compensation was $(3.0), $(1.5) and $14.8 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Stock Options

Stock option activity was as follows:

	No. of   Options	Wtd. Avg. Exercise Price		Wtd Avg Remaining Life	Aggregate Intrinsic Value
Awards outstanding at September 30, 2023	1,191,183	$	76.64	6.6 years
Granted	1,356,698	53.75
Exercised	(35,027)	58.52
Forfeited	(135,182)	55.69
Awards outstanding at September 30, 2024	2,377,672	65.03		7.5 years	$	71.4
Exercisable	493,832	108.97		2.6 years	8.9

The weighted average fair value per share of each option granted during fiscal 2024 and fiscal 2023 was $15.25 and $14.25, respectively. There were no options granted during fiscal 2022. The total intrinsic value of options exercised during fiscal 2024 was $0.6. There were no options exercised during fiscal 2023 or fiscal 2022. As of September 30, 2024, there was $9.4 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options that is expected to be recognized over a weighted-average period of 2.0 years. Cash received from the exercise of stock options, including amounts received from employee purchases under the employee stock purchase plan, was $3.8, $2.3 and $3.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

The weighted average assumptions used in the estimation of fair value for awards granted in fiscal 2024 are as follows:

Expected volatility	38.8	%
Risk-free interest rate	4.7	%
Expected dividend yield	4.1	%
Expected life	6.1 years

93

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Restricted share-based awards

Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:

	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at September 30, 2023	611,838	$	89.10
Granted	363,264	55.12
Vested	(77,826)	182.87
Forfeited	(130,892)	59.40
Awards outstanding at September 30, 2024	766,384	68.54

The weighted-average grant-date fair value of restricted stock-based awards granted during fiscal 2024, fiscal 2023 and fiscal 2022 was $55.12, $59.48 and $109.10 per share, respectively. As of September 30, 2024, there was $9.9 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted stock-based awards that is expected to be recognized over a weighted-average period of 1.7 years. The total fair value of restricted stock units and deferred stock units vested during fiscal 2024, fiscal 2023 and fiscal 2022 was $4.6, $11.2 and $28.2, respectively.

Performance-based awards

Performance-based award activity was as follows (based on target award amounts):

	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at September 30, 2023	544,790	$	76.85
Granted	240,677	74.57
Vested (a)	(181,791)	59.88
Forfeited	(194,246)	65.89
Awards outstanding at September 30, 2024	409,430	86.61

(a)Vested at a weighted average of 100% of the target performance share units granted.

The weighted-average grant-date fair value of performance-based award units granted during fiscal 2024, fiscal 2023 and fiscal 2022 was $74.57, $66.00 and $132.74 per share, respectively. As of September 30, 2024, there was $7.6 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based award units that is expected to be recognized over a weighted-average period of 2.1 years. The total fair value of performance-based award unit vested during fiscal 2024, fiscal 2023 and fiscal 2022 was $10.6, $17.4 and $182.5, respectively.

During fiscal 2024, the Company granted performance-based award units with a three-year vesting period that include a performance target based on the Company’s total shareholder return relative to a Company selected peer group, among other financial targets. Details of the assumptions used in the estimation of fair value for these awards are as follows:

Expected volatility	36.6	%
Risk-free interest rate	4.5	%

94

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

For fiscal 2024, the Company is granting short-term equity incentive compensation awards to certain associates in the form of performance-based award units in lieu of cash-based annual incentive awards. Subsequent to September 30, 2024, awards representing 0.3 million Common Shares were granted and vested on the incentive payout date. The number of performance-based award units that the Company ultimately issued to participating associates was based on the incentive payout amount determined for each employee that was then converted into a variable number of performance-based award units based on the fair value of the Common Shares on the grant date. The awards were classified as liability awards and, as of September 30, 2024, the Company had accrued $20.2 in the “Other current liabilities” line in the Consolidated Balance Sheets and there was $0.0 unrecognized pre-tax compensation cost associated with these awards. The units associated with these awards are excluded from the table above.

Restricted shares issued to vendor

During fiscal 2024 and fiscal 2023, the Company issued 0.3 million and 0.8 million restricted shares, respectively, with a weighted-average grant date fair value of $69.88 and $52.44 per share, respectively, out of its treasury shares to a vendor in exchange for advertising services. As of September 30, 2024, there was $20.0 of total unrecognized pre-tax compensation cost related to these restricted shares that is expected to be recognized during fiscal 2025, when the services are performed.

NOTE 13.  EARNINGS PER COMMON SHARE

The following table presents information necessary to calculate basic and diluted net loss per Common Share for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Net loss	$	(34.9)	$	(380.1)	$	(437.5)
Basic net loss per common share:
Weighted-average common shares outstanding during the period	56.8		56.0		55.5
Basic net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)
Diluted net loss per common share:
Weighted-average common shares outstanding during the period	56.8		56.0		55.5
Dilutive potential common shares	—		—		—
Weighted-average number of common shares outstanding and dilutive potential common shares	56.8		56.0		55.5
Diluted net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)
Antidilutive stock options outstanding	0.4		0.4		0.2

Diluted average common shares used in the diluted loss per common share calculation for fiscal 2024, fiscal 2023 and fiscal 2022 were 56.8 million, 56.0 million and 55.5 million, respectively, which excluded potential common shares of 0.9 million, 0.4 million and 0.6 million, respectively, because the effect of their inclusion would be anti-dilutive as the Company incurred a net loss for fiscal 2024, 2023 and 2022.

95

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

NOTE 14.  INCOME TAXES

The provision (benefit) for income taxes consisted of the following:

	Year Ended September 30,
	2024		2023		2022
Current:
Federal	$	2.4	$	3.7	$	22.8
State	2.5		0.6		9.3
Foreign	(5.3)		1.6		8.7
Total current	(0.4)		5.9		40.8
Deferred:
Federal	11.6		(62.1)		(125.5)
State	(3.8)		(5.2)		(23.3)
Foreign	3.9		(11.8)		(12.6)
Total deferred	11.7		(79.1)		(161.4)
Income tax expense (benefit)	$	11.3	$	(73.2)	$	(120.6)

The domestic and foreign components of loss before income taxes were as follows:

	Year Ended September 30,
	2024		2023		2022
Domestic	$	(10.8)	$	(376.2)	$	(427.3)
Foreign	(12.8)		(77.1)		(130.8)
Loss before income taxes	$	(23.6)	$	(453.3)	$	(558.1)

A reconciliation of the federal corporate income tax rate and the effective tax rate on loss before income taxes is summarized below:

	Year Ended September 30,
	2024		2023		2022
Statutory income tax rate	21.0	%	21.0	%	21.0	%
Effect of foreign operations	(2.0)		0.2		(1.6)
State taxes, net of federal benefit	8.0		3.2		2.6
Effect of other permanent differences	(32.8)		(0.8)		2.8
Research and Experimentation and other federal tax credits	2.9		0.2		0.2
Effect of tax contingencies	3.7		0.1		(1.8)
Change in valuation allowances	(57.4)		(8.7)		(0.9)
Other	8.7		1.0		(0.7)
Effective income tax rate	(47.9)	%	16.2	%	21.6	%

96

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the deferred income tax assets and liabilities were as follows:

	September 30,
	2024		2023
DEFERRED TAX ASSETS
Lease liabilities	$	67.6	$	70.0
Intangible assets	62.2		79.2
Net operating loss carryovers	56.4		67.3
Interest limitation carryforward	55.9		35.9
Convertible debt investments	43.6		33.4
Accrued liabilities	43.2		48.7
Outside basis difference in equity investments	23.1		10.4
Inventories	16.1		26.1
Foreign tax credit carryovers	15.2		16.3
Other	22.4		23.8
Gross deferred tax assets	405.7		411.1
Valuation allowance	(96.5)		(87.7)
Total deferred tax assets	309.2		323.4
DEFERRED TAX LIABILITIES
Lease right-of-use assets	(62.0)		(62.1)
Property, plant and equipment	(58.5)		(62.7)
Other	(4.4)		(9.9)
Total deferred tax liabilities	(124.9)		(134.7)
Net deferred tax asset	$	184.3	$	188.7

At September 30, 2024 and 2023, after netting by taxing jurisdiction, net deferred tax assets of $191.3 and $189.8, respectively, were recorded in the “Other assets” line in the Consolidated Balance Sheets, and net deferred tax liabilities of $7.0 and $1.1, respectively, were recorded in the “Other liabilities” line in the Consolidated Balance Sheets.

GAAP requires that a valuation allowance be recorded against a deferred tax asset if it is more likely than not that the tax benefit associated with the asset will not be realized in the future. As shown in the table above, valuation allowances were recorded against $96.5 and $87.7 of deferred tax assets as of September 30, 2024 and 2023, respectively. Most of these valuation allowances relate to losses on convertible debt investments, credits, and net operating losses (“NOLs”), as explained further below.

Deferred tax assets related to unrealized losses on convertible debt investments were $43.6 and $33.4 at September 30, 2024 and 2023, respectively. A full valuation allowance was recorded against these losses at September 30, 2024 and 2023 as the Company does not expect to utilize them prior to their expiration.

Deferred tax assets related to foreign tax credits were $15.2 and $16.3 at September 30, 2024 and 2023, respectively. A full valuation allowance was recorded against these credits as of September 30, 2024 and 2023 as the Company does not expect to utilize them prior to their expiration. Tax benefits associated with state tax credits will also expire if not utilized and amounted to $1.0 and $1.4 at September 30, 2024 and 2023, respectively. A valuation allowance in the amount of $0.8 and $1.3 was recorded at September 30, 2024 and 2023, respectively, related to state credits the Company does not expect to utilize.

Deferred tax assets related to certain federal NOLs subject to limitation under IRC §382 from current and prior ownership changes were $9.9 and $10.5 at September 30, 2024 and 2023, respectively. These NOLs will be subject to expiration gradually from fiscal year end 2024 through fiscal year end 2032. The Company determined that a portion of these deferred tax assets will expire unutilized due to the closing of statutes of limitation and has recorded a valuation allowance of $9.7 and $10.2 at September 30, 2024 and 2023, respectively. The Company had deferred tax assets related to federal NOLs not subject to limitation of $20.6 at September 30, 2024, which can be utilized to reduce future years’ tax liabilities.

97

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Deferred tax assets related to foreign NOLs of certain controlled foreign corporations were $6.8 and $8.3 as of September 30, 2024 and 2023, respectively. Due to a history of losses, a valuation allowance of $4.6 and $6.4 has been recorded against these deferred tax assets as of September 30, 2024 and 2023, respectively. A valuation allowance has also been recorded against deferred tax assets related to other foreign items of $13.0 and $11.0 at September 30, 2024 and 2023, respectively.

Deferred tax assets related to state NOLs were $19.1 and $15.2 as of September 30, 2024 and 2023, respectively, with carryforward periods ranging from 5 to unlimited years. Any losses not utilized within a specific state’s carryforward period will expire. A valuation allowance was recorded against $7.0 and $6.9 of these deferred tax assets as of September 30, 2024 and 2023, respectively, for state NOLs that the Company does not expect to realize within their respective carryforward periods. A valuation allowance has also been recorded against deferred tax assets related to other state items of $2.6 and $2.2 at September 30, 2024 and 2023, respectively.

As of September 30, 2024, the Company maintains its assertions of indefinite reinvestment of the earnings of all material foreign subsidiaries.

The Company had $25.7, $34.6 and $35.8 of gross unrecognized tax benefits related to uncertain tax positions at September 30, 2024, 2023 and 2022, respectively. Included in the September 30, 2024, 2023 and 2022 balances were $23.1, $31.1 and $31.5, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate.

A reconciliation of the unrecognized tax benefits is as follows:

	Year Ended September 30,
	2024		2023		2022
Balance at beginning of year	$	34.6	$	35.8	$	24.1
Additions for tax positions of the current year	0.2		0.2		11.3
Additions for tax positions of prior years	0.1		3.8		2.2
Reductions for tax positions of prior years	(3.7)		(0.2)		(2.5)
Settlements with tax authorities	(0.7)		(0.1)		1.3
Expiration of statutes of limitation	(4.8)		(4.9)		(0.6)
Balance at end of year	$	25.7	$	34.6	$	35.8

The Company continues to recognize accrued interest and penalties related to unrecognized tax benefits as a component of the provision for income taxes. As of September 30, 2024, 2023 and 2022, the Company had $5.8, $3.9 and $3.2, respectively, accrued for the payment of interest that, if recognized, would impact the effective tax rate. The Company had $1.1, $1.3 and $1.6 accrued for the payment of penalties as of September 30, 2024, 2023 and 2022, respectively.

Scotts Miracle-Gro or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. Subject to the following exceptions, the Company is no longer subject to examination by these tax authorities for fiscal years prior to 2021. There are currently no ongoing audits with respect to the U.S. federal jurisdiction. With respect to the foreign jurisdictions, a Canadian audit covering fiscal years 2020 through 2021 is in process. The Company is currently under examination by certain U.S. state and local tax authorities covering various periods from fiscal years 2018 through 2023. In addition to the aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.

The Company currently anticipates that few of its open and active audits will be resolved within the next twelve months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although the outcomes of such examinations and the timing of any payments required upon the conclusion of such examinations are subject to significant uncertainty, the Company does not anticipate that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows.

98

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

NOTE 15.  DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.

Exchange Rate Risk Management

The Company uses currency forward contracts to manage the exchange rate risk associated with intercompany loans and certain other balances denominated in foreign currencies. Currency forward contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. The notional amount of outstanding currency forward contracts was $148.4 and $123.1 at September 30, 2024 and 2023, respectively. Contracts outstanding at September 30, 2024 will mature over the next fiscal quarter.

Interest Rate Risk Management

The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Swap agreements that were hedging interest payments as of September 30, 2024 and 2023 had a maximum total U.S. dollar equivalent notional amount of $450.0 and $600.0, respectively. Refer to “NOTE 11. DEBT” for the terms of the swap agreements outstanding at September 30, 2024. Included in the AOCL balance at September 30, 2024 was a gain of $4.7 related to interest rate swap agreements that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.

Commodity Price Risk Management

The Company enters into hedging arrangements designed to fix the price of a portion of its projected future urea and diesel requirements. Commodity contracts are valued using observable commodity exchange prices in active markets. Included in the AOCL balance at September 30, 2024 was a gain of $0.7 related to commodity hedges that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.

The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:

	September 30,
	2024	2023
Commodity
Urea	51,000 tons	52,500 tons
Diesel	1,092,000 gallons	1,974,000 gallons
Heating Oil	42,000 gallons	966,000 gallons

99

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Fair Values of Derivative Instruments

The fair values of the Company’s derivative instruments, which represent Level 2 fair value measurements, were as follows:

		Assets / (Liabilities)
		2024		2023
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value
Interest rate swap agreements	Prepaid and other current assets	$	0.9	$	16.7
	Other assets	—		14.7
	Other current liabilities	(0.2)		—
	Other liabilities	(5.1)		—
Commodity hedging instruments	Prepaid and other current assets	0.8		2.3
Total derivatives designated as hedging instruments		$	(3.6)	$	33.7
Derivatives Not Designated as Hedging Instruments	Balance Sheet Location
Currency forward contracts	Prepaid and other current assets	$	0.1	$	5.6
	Other current liabilities	(4.0)		—
Commodity hedging instruments	Prepaid and other current assets	—		0.9
Total derivatives not designated as hedging instruments		(3.9)		6.5
Total derivatives		$	(7.5)	$	40.2

The effect of derivative instruments on AOCL, net of tax, and the Consolidated Statements of Operations for the years ended September 30 was as follows:

 

	Amount of Gain / (Loss) Recognized in AOCL
Derivatives in Cash Flow Hedging Relationships	2024		2023
Interest rate swap agreements	$	(7.1)	$	11.3
Commodity hedging instruments	(0.8)		(7.1)
Total	$	(7.9)	$	4.2

 

	Reclassified from AOCL into	Amount of Gain / (Loss)
Derivatives in Cash Flow Hedging Relationships	Statement of Operations	2024		2023
Interest rate swap agreements	Interest expense	$	11.7	$	11.5
Commodity hedging instruments	Cost of sales	(4.4)		5.9
Total		$	7.3	$	17.4

 

	Recognized in	Amount of Gain / (Loss)
Derivatives Not Designated as Hedging Instruments	Statement of Operations	2024		2023
Currency forward contracts	Other income / expense, net	$	(9.6)	$	(14.7)
Commodity hedging instruments	Cost of sales	(2.0)		1.2
Total		$	(11.6)	$	(13.5)

100

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

NOTE 16.  FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following describes the valuation methodologies used for financial assets and liabilities measured or disclosed at fair value on a recurring basis, as well as the general classification within the valuation hierarchy.

Cash Equivalents

Cash equivalents consist of highly liquid financial instruments with original maturities of three months or less. The carrying value of these cash equivalents approximates fair value due to their short-term maturities.

Other

Investment securities in non-qualified retirement plan assets are valued using observable market prices in active markets.

The fair values of convertible debt investments are determined using scenario-based internally developed valuation models that consider a probability-weighted assessment of possible future cash flows related to the debt component and the conversion component of the instruments, discounted to present value using an appropriate discount rate. The probability of amendments to federal laws in the United States to allow for the general cultivation, distribution, and possession of cannabis, and the impact of such amendments on the value of the underlying investments are important assumptions in the fair value estimates. The valuation models and related assumptions require significant judgment. These and other assumptions are impacted by economic conditions and expectations of management and may change in the future based on period specific facts and circumstances.

Debt Instruments

Debt instruments are recorded at cost. The interest rate on borrowings under the Sixth A&R Credit Agreement fluctuates in accordance with the terms of the Sixth A&R Credit Agreement and thus the carrying value is a reasonable estimate of fair value. The fair values of the 4.000% Senior Notes, 4.375% Senior Notes, 4.500% Senior Notes and 5.250% Senior Notes are determined based on quoted market prices.

101

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required:

		2024				2023
	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Cash equivalents	Level 1	$	51.2	$	51.2	$	1.2	$	1.2
Other
Investment securities in non-qualified retirement plan assets	Level 1	32.4		32.4		36.3		36.3
Convertible debt investments	Level 3	45.8		45.8		85.8		85.8
Liabilities
Debt instruments
Credit facilities – revolving loans	Level 2	—		—		88.3		88.3
Credit facilities – term loans	Level 2	625.0		625.0		925.0		925.0
Senior Notes due 2031 – 4.000%	Level 2	500.0		456.3		500.0		380.0
Senior Notes due 2032 – 4.375%	Level 2	400.0		370.0		400.0		304.0
Senior Notes due 2029 – 4.500%	Level 2	450.0		432.0		450.0		366.8
Senior Notes due 2026 – 5.250%	Level 2	250.0		248.8		250.0		233.1
Other debt	Level 2	—		—		0.4		0.4

Changes in the balance of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3.

	Year Ended September 30,
	2024		2023
Fair value at beginning of year	$	85.8	$	117.0
Total realized / unrealized gains (losses) included in net earnings	(64.2)		(97.6)
Total realized / unrealized gains / losses included in / reclassified from OCI	24.2		66.4
Fair value at end of year	$	45.8	$	85.8

Convertible debt investments include, among other minority non-equity investments, convertible notes issued to The Hawthorne Collective, Inc. (“THC”), a wholly-owned subsidiary of the Company, by RIV Capital (CSE: RIV) (OTC: CNPOF). Assuming full conversion of the RIV Capital convertible notes, THC would be entitled to receive approximately 123.0 million common shares of RIV Capital, representing approximately 47% of RIV Capital’s outstanding shares as of September 30, 2024. The RIV Capital convertible notes are convertible into common shares of RIV Capital either (i) at the election of THC or (ii) at the election of RIV Capital after the date on which federal laws in the United States are amended to allow for the general cultivation, distribution, and possession of cannabis. In connection with issuance of the RIV Capital convertible notes, the Company entered into an investor rights agreement with RIV Capital providing for, among other things, customary registration rights, participation rights, as well as certain standstill and transfer restrictions. In addition, THC is entitled to designate three nominees to the RIV Capital board of directors for so long as the board is comprised of seven directors, and will be entitled to designate four nominees to the RIV Capital board of directors if the size of the board is increased to nine directors. The Company or THC will not have control of or an active day-to-day role in any entity in which THC has a convertible debt investment. The convertible notes include restrictions that the funds received from the Company will be used for general corporate and other lawful purposes, which could include acquisitions, and that the funds will not be used in connection with or for any cannabis or cannabis-related operations in the U.S. unless and until such operations comply with all applicable U.S. federal laws.

During fiscal 2023, the Company recognized a non-cash, pre-tax other-than-temporary impairment charge related to its convertible debt investments of $101.3 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. This charge was driven by revisions to the Company’s internal forecasts of cash flows expected to be collected from its convertible debt investments resulting from the accumulation of adverse conditions impacting the cannabis market, including both federal and state level regulatory considerations and persistent industry oversupply conditions.

102

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

On May 30, 2024, RIV Capital and Cansortium Inc. (“Cansortium”) (CSE: TIUM.U) (OTCQB: CNTMF) announced they have entered into a definitive agreement pursuant to which Cansortium will acquire all of the issued and outstanding common shares of RIV Capital in exchange for Cansortium shares (the “Transaction”). The closing of the Transaction is subject to various conditions, including shareholder and court approvals, the receipt of all required regulatory approvals, and the exchange of THC’s existing convertible debt investment in RIV Capital for a new class of non-voting exchangeable shares of Cansortium. These exchangeable shares would be convertible, at THC’s discretion, into approximately 23% of the common shares of Cansortium on a pro forma basis as of the closing of the Transaction. During the fourth quarter of fiscal 2024, the shareholders of RIV Capital and Cansortium voted in favor of the resolutions associated with the Transaction. At September 30, 2024, the Company concluded it had the intent to exchange its RIV Capital convertible notes for non-voting exchangeable shares of Cansortium in connection with the Transaction, and remeasured the investment at the fair value of the non-voting exchangeable shares that the Company expects to receive. This resulted in the recognition of a non-cash, pre-tax other-than-temporary impairment charge of $64.6 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. In addition, the previously recorded allowance for credit losses associated with the RIV Capital convertible notes of $99.4 was written off and the amortized cost basis was written down to the investment’s fair value.

The amortized cost basis of convertible debt investments was $62.1 and $225.8 at September 30, 2024 and 2023, respectively. At September 30, 2024 and 2023, gross unrealized losses on convertible debt investments were $16.4 and $140.0, respectively, and there were no gross unrealized gains. These investments have been in a continuous unrealized loss position for greater than 12 months as of September 30, 2024. The allowance for expected credit losses was $1.9 and $101.3 at September 30, 2024 and 2023, respectively. At September 30, 2024, the period until scheduled maturity of the Company’s convertible debt investments was between 2.9 and 5.0 years.

Credit losses on convertible debt investments are measured based on the present value of expected future cash flows compared to amortized cost. Impairment losses are recognized through an allowance and recoveries of previously impaired amounts are recorded as an immediate reversal of all or a portion of the allowance. In addition, the allowance for expected credit losses cannot cause the amortized cost net of the allowance to be below fair value. A progression of the allowance for expected credit losses on convertible debt investments is shown below:

	Year Ended September 30,
	2024		2023
Balance at beginning of year	$	101.3	$	—
Provision for expected credit losses on securities with no previous allowance	—		101.3
Reductions for securities intended to be sold / exchanged	(99.4)		—
Balance at end of year	$	1.9	$	101.3

NOTE 17.  LEASES

The Company leases certain property and equipment from third parties under various non-cancelable lease agreements, including industrial, commercial and office properties and equipment that support the management, manufacturing, distribution and research and development of products marketed and sold by the Company. The lease agreements generally require that the Company pay taxes, insurance and maintenance expenses related to the leased assets. At September 30, 2024, the Company had entered into operating leases that were yet to commence with a combined total expected lease liability of $29.6. From time to time, the Company will sublease portions of its facilities, resulting in sublease income. Sublease income and the related cash flows were not material to the consolidated financial statements for fiscal 2024.

The Company leases certain vehicles (primarily cars and light trucks) under agreements that are cancellable after the first year, but typically continue on a month-to-month basis until canceled by the Company. The vehicle leases and certain other non-cancelable operating leases contain residual value guarantees that create a contingent obligation on the part of the Company to compensate the lessor if the leased asset cannot be sold for an amount in excess of a specified minimum value at the conclusion of the lease term. If all such vehicle leases had been canceled as of September 30, 2024, the Company’s residual value guarantee would have approximated $6.3.

103

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Supplemental balance sheet information related to the Company’s leases was as follows:

	Balance Sheet Location	September 30, 2024		September 30, 2023
Operating leases:
Right-of-use assets	Other assets	$	265.4	$	262.6
Current lease liabilities	Other current liabilities	75.3		76.4
Non-current lease liabilities	Other liabilities	215.8		220.1
Total operating lease liabilities		$	291.1	$	296.5
Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	15.2	$	14.5
Current lease liabilities	Current portion of debt	2.6		1.9
Non-current lease liabilities	Long-term debt	15.2		15.0
Total finance lease liabilities		$	17.8	$	16.9

Components of lease cost were as follows:

	Year Ended September 30,
	2024		2023		2022
Operating lease cost (a)	$	85.8	$	92.3	$	86.7
Variable lease cost	30.3		28.6		35.9
Finance lease cost
Amortization of right-of-use assets	2.6		3.0		6.4
Interest on lease liabilities	0.8		0.8		1.2
Total finance lease cost	$	3.4	$	3.8	$	7.6

(a)Operating lease cost includes amortization of right-of-use assets of $70.4, $81.0 and $75.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Short-term lease expense is excluded from operating lease cost and was $6.1, $6.6 and $19.1 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:

	Year Ended September 30,
	2024		2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net	$	99.2	$	93.0	$	83.9
Operating cash flows from finance leases	0.8		0.8		1.2
Financing cash flows from finance leases	2.3		2.7		5.9
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	77.0	$	90.4	$	71.9
Finance leases	3.4		—		1.5

104

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:

	September 30, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	5.2		5.4
Finance leases	8.1		9.5
Weighted-average discount rate:
Operating leases	5.9	%	5.2	%
Finance leases	4.7	%	4.4	%

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2024 were as follows:

Year	Operating Leases		Finance Leases
2025	$	89.8	$	3.4
2026	73.5		3.0
2027	49.2		2.6
2028	38.8		2.2
2029	27.1		1.7
Thereafter	62.5		8.6
Total lease payments	340.9		21.5
Less: Imputed interest	(49.8)		(3.7)
Total lease liabilities	$	291.1	$	17.8

NOTE 18.  COMMITMENTS

At September 30, 2024, the Company had the following unconditional purchase obligations by purchase date that have not been recognized in the Consolidated Balance Sheet:

 

2025	$	310.9
2026	193.5
2027	79.2
2028	39.3
2029	24.6
Thereafter	33.7
	$	681.2

Purchase obligations primarily represent commitments for materials used in the Company’s manufacturing processes, including urea and packaging, as well as commitments for warehouse services, grass seed, marketing services and information technology services.

NOTE 19.  CONTINGENCIES

Management regularly evaluates the Company’s contingencies, including various judicial and administrative proceedings and claims arising in the ordinary course of business, including product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals are adequate, both individually and in the aggregate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows.

105

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

Regulatory Matters

At September 30, 2024, the Company had recorded liabilities of $2.6 for environmental actions, the majority of which are for site remediation. The Company believes that the amounts accrued are adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.

Other

The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. The Company has not recorded any accruals in its consolidated financial statements as the likelihood of a loss from these cases is not probable at this time. The Company does not believe a reasonably possible loss would be material to the Company’s financial condition, results of operations or cash flows. In addition, the Company does not believe the ultimate resolution of these cases will have a material adverse effect on the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows.

On June 6, 2024, a purported shareholder filed a lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03132) on behalf of a proposed class of purchasers of Common Shares between November 3, 2021, and August 1, 2023. On July 26, 2024, another purported shareholder filed a lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03766) on behalf of a proposed class of purchasers of Common Shares between June 2, 2021, and August 1, 2023. These lawsuits, which will likely be consolidated with any subsequently filed lawsuits alleging similar facts, assert claims under Section 10(b), Rule 10b-5 and Section 20(a) of the Securities Exchange Act against the Company and certain of its current and former officers based on alleged misstatements about the Company’s inventories, sales and business prospects. The actions seek, among other things, unspecified monetary damages, reasonable costs and expenses and equitable/injunctive or other relief as deemed appropriate by the Court. The Company believes that the claims asserted are without merit and intends to vigorously defend the actions.

On July 3, 2024, a purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03636), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On July 30, 2024, a second purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No.1:24-cv-00402), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On August 23, 2024, a third purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03880), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On September 9, 2024, a fourth purported shareholder filed a shareholder derivative lawsuit in the Union County (Ohio) Court of Common Pleas (Case No. 24CV0193), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On September 26, 2024, a fifth purported shareholder filed a shareholder derivative lawsuit in the Union County (Ohio) Court of Common Pleas (Case No. 24CV0203), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On November 19, 2024, a sixth purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-04180), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On November 22, 2024, a seventh purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-04190), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. The federal lawsuits will likely be consolidated with one another, along with any subsequently filed federal lawsuits alleging similar facts, and the state court lawsuits will likely be consolidated with one another, along with any subsequently filed state lawsuits alleging similar facts. All of the lawsuits include allegations that generally mirror those asserted in the securities lawsuits described above and assert claims for breaches of fiduciary duties and unjust enrichment, as well as abuse of control, gross mismanagement, and waste of corporate assets. The federal lawsuits also assert claims under Section 10(b), Rule 10b-5, Section 14(a), Rule 14a-9, and Section 20(a) of the Securities Exchange Act, and contribution under Sections 10(b) and 21D of the Securities Exchange Act. The actions seek a judgment in favor of the Company for damages in an unspecified amount, disgorgement, interest, and costs and expenses, including attorneys’ and experts’ fees.

106

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to have a material effect on the Company’s financial condition, results of operations or cash flows.

NOTE 20.  SEGMENT INFORMATION

The Company divides its operations into three reportable segments: U.S. Consumer, Hawthorne and Other. U.S. Consumer consists of the Company’s consumer lawn and garden business in the United States. Hawthorne consists of the Company’s indoor and hydroponic gardening business. Other primarily consists of the Company’s consumer lawn and garden business in Canada. This identification of reportable segments is consistent with how the segments report to and are managed by the chief operating decision maker of the Company. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the reportable business segments.

The performance of each reportable segment is evaluated based on several factors, including income (loss) before income taxes, amortization, impairment, restructuring and other charges (“Segment Profit (Loss)”). Senior management uses Segment Profit (Loss) to evaluate segment performance because the Company believes this measure is indicative of performance trends and the overall earnings potential of each segment.

The following tables present financial information for the Company’s reportable segments for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Net Sales:
U.S. Consumer	$	3,013.7	$	2,843.7	$	2,928.8
Hawthorne	294.7		467.3		716.2
Other	244.3		240.3		279.1
Consolidated	$	3,552.7	$	3,551.3	$	3,924.1
Segment Profit (Loss):
U.S. Consumer	$	498.0	$	454.1	$	568.6
Hawthorne	(14.2)		(48.1)		(21.1)
Other	4.7		12.4		20.2
Total Segment Profit	488.5		418.4		567.7
Corporate	(117.7)		(101.6)		(112.4)
Intangible asset amortization	(15.7)		(25.2)		(37.1)
Impairment, restructuring and other	(146.3)		(466.0)		(852.2)
Equity in loss of unconsolidated affiliates	(68.1)		(101.1)		(12.9)
Interest expense	(158.8)		(178.1)		(118.1)
Other non-operating income (expense), net	(5.5)		0.3		6.9
Loss before income taxes	$	(23.6)	$	(453.3)	$	(558.1)
Depreciation and amortization:
U.S. Consumer	$	56.2	$	58.2	$	55.8
Hawthorne	16.7		25.8		34.8
Other	5.9		5.6		7.0
Corporate	1.8		2.9		7.6
	$	80.6	$	92.5	$	105.2
Capital expenditures:
U.S. Consumer	$	81.5	$	79.6	$	97.4
Hawthorne	—		8.5		12.4
Other	2.5		4.7		3.7
	$	84.0	$	92.8	$	113.5

107

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

	September 30,
	2024		2023
Total assets:
U.S. Consumer	$	2,022.7	$	2,296.2
Hawthorne	387.3		581.6
Other	189.3		189.8
Corporate	272.6		346.1
Consolidated	$	2,871.9	$	3,413.7

The following table presents net sales by product category for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
U.S. Consumer:
Growing media and mulch	$	1,310.6	$	1,223.7	$	1,192.6
Lawn care	929.6		897.4		973.6
Controls	414.6		362.9		382.2
Roundup® marketing agreement	162.4		138.7		132.3
Other, primarily gardening	196.5		221.0		248.1
Hawthorne:
Lighting	108.2		165.9		200.0
Nutrients	87.2		105.3		148.0
Growing media	37.3		67.5		119.0
Growing environment	27.7		72.5		143.7
Other, primarily hardware	34.3		56.1		105.5
Other:
Growing media	91.3		93.0		96.6
Lawn care	80.2		75.8		92.9
Other, primarily gardening and controls	72.8		71.5		89.6
Total net sales	$	3,552.7	$	3,551.3	$	3,924.1

The Company’s two largest customers accounted for the following percentages of net sales for the fiscal years ended September 30: 

	Percentage of Net Sales
	2024		2023		2022
The Home Depot	30	%	29	%	28	%
Lowe’s	18	%	18	%	15	%

Accounts receivable for these two largest customers as a percentage of consolidated accounts receivable were 18% and 41% as of September 30, 2024 and 2023, respectively. The decrease was due to the impact of accounts receivable sold under the Master Receivables Purchase Agreement.

108

Table of Contents THE SCOTTS MIRACLE-GRO COMPANY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) (Dollars in millions, except per share data)

The following table presents net sales by geographic area for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Net sales:
United States	$	3,247.8	$	3,209.5	$	3,554.6
International	304.9		341.8		369.5
	$	3,552.7	$	3,551.3	$	3,924.1

Other than the United States, no other country accounted for more than 10% of the Company’s net sales for any period presented above.

The following table presents long-lived assets (property, plant and equipment and finite-lived intangibles) by geographic area: 

	September 30,
	2024		2023
Long-lived assets:
United States	$	630.5	$	644.4
International	73.9		78.7
	$	704.4	$	723.1

NOTE 21.  SUBSEQUENT EVENT

On November 26, 2024, the Company announced that Matthew Garth, Executive Vice President, Chief Financial Officer & Chief Administrative Officer, will be departing the Company effective December 31, 2024 (the “Termination Date”). In connection with Mr. Garth’s departure on the Termination Date, the Company entered into a Separation Agreement and Release of All Claims (the “Separation Agreement”) with Mr. Garth on November 25, 2024. The Separation Agreement addresses the payments and benefits to which Mr. Garth is entitled in connection with his departure. The Company will pay or make the following benefits available to Mr. Garth in connection with his departure: (a) pay equal to 24 months of salary, at Mr. Garth’s regular monthly base pay, payable in accordance with the Company’s standard payroll procedures; (b) in lieu of outplacement services, a lump sum payment of $0.03; (c) for a period of 24 months, a benefits offset payment in an amount equal to the excess of the COBRA premium charged by the Company to terminated employees over the premium Mr. Garth paid as an active employee; and (d) an amount equal to two times Mr. Garth’s target bonus opportunity for the fiscal year ending September 30, 2025, 50% of which is payable on the first scheduled pay date following the first anniversary of Mr. Garth’s Termination Date and 50% of which is payable on the first scheduled pay date following the second anniversary of Mr. Garth’s Termination Date, subject to Mr. Garth’s continued compliance as of the payment date with all of his post-employment obligations to the Company. Additionally, Mr. Garth will fully and partially vest in certain equity-based awards upon his departure from the Company. The Company will record charges associated with these payments and benefits during fiscal 2025.

109

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2024

Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Additions Other		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for expected credit losses	$	116.4	$	—	$	3.7	$	(108.6)	$	11.5
Income tax valuation allowance	87.7		3.6		13.7		(8.5)		96.5

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2023

Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Additions Other		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for expected credit losses	$	14.4	$	—	$	109.6	$	(7.6)	$	116.4
Income tax valuation allowance	40.7		9.5		37.8		(0.3)		87.7

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2022

Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Additions Other		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for expected credit losses	$	16.8	$	—	$	5.8	$	(8.2)	$	14.4
Income tax valuation allowance	32.3		—		9.0		(0.6)		40.7

110

The Scotts Miracle-Gro Company

Index to Exhibits

		Incorporated by Reference
Exhibit No.	Description	Form	Exhibit	Filing Date	Filed Herewith
3.1(a)	Initial Articles of Incorporation of The Scotts Miracle-Gro Company filed on November 22, 2004	8-K	3.1	March 24, 2005
3.1(b)	Certificate of Amendment by Shareholders to Articles of Incorporation of The Scotts Miracle-Gro Company filed on March 18, 2005	8-K	3.2	March 24, 2005
3.2	Code of Regulations of The Scotts Miracle-Gro Company	8-K	3.3	March 24, 2005
4.1(a)	Indenture, dated as of December 15, 2016, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	8-K	4.1	December 16, 2016
4.1(b)	First Supplemental Indenture, dated July 17, 2018, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	10-Q	10.4	August 8, 2018
4.1(c)	Second Supplemental Indenture, dated March 24, 2020, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	10-Q	4.2	May 6, 2020
4.1(d)	Third Supplemental Indenture, dated March 29, 2021, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	10-Q	4.2	May 12, 2021
4.1(e)	Fourth Supplemental Indenture, dated June 24, 2021, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	10-Q	4.1	August 11, 2021
4.1(f)	Form of 5.250% Senior Notes due 2026 (included in Exhibit 4.1)	8-K	4.2	December 16, 2016
4.2(a)	Indenture, dated as of October 22, 2019, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	8-K	4.1	October 28, 2019
4.2(b)	First Supplemental Indenture, dated March 24, 2020, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	10-Q	4.1	May 6, 2020
4.2(c)	Second Supplemental Indenture, dated March 29, 2021, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	10-Q	4.3	May 12, 2021
4.2(d)	Third Supplemental Indenture, dated June 24, 2021, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	10-Q	4.2	August 11, 2021
4.2(e)	Form of 4.500% Senior Notes due 2029 (included in Exhibit 4.1)	8-K	4.2	October 28, 2019
4.3(a)	Indenture, dated as of March 17, 2021, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	8-K	4.1	March 17, 2021
4.3(b)	First Supplemental Indenture, dated as of June 24, 2021, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	10-Q	4.3	August 11, 2021
4.3(c)	Form of 4.000% Senior Notes due 2031 (included in Exhibit 4.1)	8-K	4.2	March 17, 2021
4.4(a)	Indenture, dated as of August 13, 2021, by and among The Scotts Miracle-Gro Company, the Guarantors (as defined therein) and U.S. Bank National Association, as trustee	8-K	4.1	August 13, 2021
4.4(b)	Form of 4.375% Senior Notes due 2032 (included in Exhibit 4.1)	8-K	4.2	August 13, 2021
4.5	Agreement to furnish copies of instruments and agreements defining rights of holders of long-term debt				X
4.6	Description of Capital Stock				X

111

		Incorporated by Reference
Exhibit No.	Description	Form	Exhibit	Filing Date	Filed Herewith
10.1(a)(i)	Sixth Amended and Restated Credit Agreement, dated as of April 8, 2022, by and among The Scotts Miracle-Gro Company, as a Borrower; the Subsidiary Borrowers (as defined therein); JPMorgan Chase Bank, N.A., as Administrative Agent; Wells Fargo Bank, National Association, Mizuho Bank, Ltd. and Bank of America, N.A., as Co-Syndication Agents; CoBank, ACB, Fifth Third Bank, National Association, Coöperatieve Rabobank U.A., New York Branch, Sumitomo Mitsui Banking Corporation, TD Bank N.A. and Truist Bank, as Co-Documentation Agents; and the several other banks and other financial institutions from time to time parties thereto	8-K	10.1	April 14, 2022
10.1(a)(ii)	Amendment No. 1, dated June 8, 2022, to Sixth Amended and Restated Credit Agreement, dated as of April 8, 2022, by and among The Scotts Miracle-Gro Company, as a Borrower; the Subsidiary Borrowers (as defined therein); JPMorgan Chase Bank, N.A., as Administrative Agent; Wells Fargo Bank, National Association, Mizuho Bank, Ltd. and Bank of America, N.A., as Co-Syndication Agents; CoBank, ACB, Fifth Third Bank, National Association, Coöperatieve Rabobank U.A., New York Branch, Sumitomo Mitsui Banking Corporation, TD Bank N.A. and Truist Bank, as Co-Documentation Agents; and the several other banks and other financial institutions from time to time parties thereto	8-K	10.1	June 8, 2022
10.1(a)(iii)	Amendment No. 2, dated July 31, 2023, to Sixth Amended and Restated Credit Agreement, dated as of April 8, 2022, by and among The Scotts Miracle-Gro Company, as a Borrower; the Subsidiary Borrowers (as defined therein); JPMorgan Chase Bank, N.A., as Administrative Agent; Wells Fargo Bank, National Association, Mizuho Bank, Ltd. and Bank of America, N.A., as Co-Syndication Agents; CoBank, ACB, Fifth Third Bank, National Association, Coöperatieve Rabobank U.A., New York Branch, Sumitomo Mitsui Banking Corporation, TD Bank N.A. and Truist Bank, as Co-Documentation Agents; and the several other banks and other financial institutions from time to time parties thereto	10-K	10.1(a)(iii)	November 22, 2023
10.1(a)(iv)	Amendment No. 3, dated June 11, 2024, to Sixth Amended and Restated Credit Agreement, dated as of April 8, 2022, by and among The Scotts Miracle-Gro Company, The Scotts Company LLC, Scotts Canada Ltd., as Borrowers, the other Loan Parties party thereto, the Lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent	10-Q	10	August 7, 2024
10.1(b)(i)	Sixth Amended and Restated Guarantee and Collateral Agreement, dated as of April 8, 2022, made by The Scotts Miracle-Gro Company, each domestic Subsidiary Borrower under the Sixth Amended and Restated Credit Agreement, and certain of its and their domestic subsidiaries, in favor of JPMorgan Chase Bank, N.A., as Administrative Agent	8-K	10.2	April 14, 2022
10.1(b)(ii)	Amendment No. 1, dated July 31, 2023, to Sixth Amended and Restated Guarantee and Collateral Agreement, dated as of April 8, 2022, made by The Scotts Miracle-Gro Company, each domestic Subsidiary Borrower under the Sixth Amended and Restated Credit Agreement, and certain of its and their domestic subsidiaries, in favor of JPMorgan Chase Bank, N.A., as Administrative Agent	10-K	10.1(b)(ii)	November 22, 2023
10.2(a)†	The Scotts Miracle-Gro Company Long-Term Incentive Plan (reflects amendment and restatement of plan formerly known as The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan) [January 17, 2013 through January 26, 2017]	8-K	10.1	January 24, 2013
10.2(b)†	Form of Standard Nonqualified Stock Option Award Agreement for Employees used to evidence grants made under The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 17, 2013 through January 26, 2017]	10-Q	10.7	May 7, 2015
10.3(a)†	The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 27, 2017 through January 23, 2022]	8-K	10.1	January 30, 2017

112

		Incorporated by Reference
Exhibit No.	Description	Form	Exhibit	Filing Date	Filed Herewith
10.3(b)†	Form of Standard Nonqualified Stock Option Award Agreement for Employees used to evidence grants which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 27, 2017 through January 23, 2022]	10-K	10.3(c)	November 22, 2023
10.4(a)†	The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 24, 2022 through January 22, 2023]	8-K	10.1	January 27, 2022
10.4(b)†	Form of Standard Performance Unit Award Agreement for Employees used to evidence grants which may be made under The Scotts Miracle-Gro Long-Term Incentive Plan [January 24, 2022 through January 22, 2023]	10-K	10.4(b)	November 28, 2022
10.4(c)†	Form of Standard Restricted Stock Unit Award Agreement for Employees used to evidence grants which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 24, 2022 through January 22, 2023]	10-K	10.4(c)	November 22, 2023
10.4(d)†	Form of Standard Nonqualified Stock Option Award Agreement for Employees used to evidence grants which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 24, 2022 through January 22, 2023]	10-K	10.4(d)	November 22, 2023
10.4(e)†	Form of Deferred Stock Unit Award Agreement for Non-Employee Directors Retainer Deferrals (with Related Dividend Equivalents) used to evidence grants which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 24, 2022 through January 22, 2023]	10-K	10.4(e)	November 22, 2023
10.4(f)†	Form of Standard Restricted Stock Unit Award Agreement for Non-Employee Directors (with Related Dividend Equivalents) used to evidence grants which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 24, 2022 through January 22, 2023]	10-K	10.4(f)	November 22, 2023
10.5(a)†	The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 23, 2023 through January 21, 2024]	8-K	10.1	January 27, 2023
10.5(b)†	Form of Special Restricted Stock Unit Award Agreement for Non-Employee Directors (with Related Dividend Equivalents) used to evidence grants which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 23, 2023 through January 21, 2024]	8-K	10.2	January 27, 2023
10.5(c)†	Form of Standard Restricted Stock Unit Award Agreement for Non-Employee Directors (with Related Dividend Equivalents) used to evidence grants which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 23, 2023 through January 21, 2024]	10-K	10.5(c)	November 22, 2023
10.5(d)†	Form of Standard Performance Unit Award Agreement for Employees used to evidence grants which may be made under The Scotts Miracle-Gro Long-Term Incentive Plan [January 23, 2023 through January 21, 2024]	8-K	10.1	February 1, 2023
10.5(e)†	Form of Standard Nonqualified Stock Option Award Agreement for Employees used to evidence grants which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan [January 23, 2023 through January 21, 2024]	10-K	10.5(e)	November 22, 2023
10.6(a)†	The Scotts Miracle-Gro Company Long-Term Incentive Plan (effective as of January 22, 2024)	8-K	10.1	January 24, 2024
10.6(b)†	Form of Standard Restricted Stock Unit Award Agreement for Non-Employee Directors (with Related Dividend Equivalents) which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan	8-K	10.2	January 24, 2024
10.6(c)†	Form of Deferred Stock Unit Award Agreement for Non-Employee Directors (with Related Dividend Equivalents) which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan	8-K	10.3	January 24, 2024
10.6(d)†	Form of Standard Nonqualified Stock Option Award Agreement for Employees used to evidence grants which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan	10-Q	10.8	February 7, 2024

113

		Incorporated by Reference
Exhibit No.	Description	Form	Exhibit	Filing Date	Filed Herewith
10.6(e)†	Form of Standard Restricted Stock Unit Award Agreement for Employees used to evidence grants which may be made under The Scotts Miracle-Gro Company Long-Term Incentive Plan	10-Q	10.9	February 7, 2024
10.6(f)†	Form of Fiscal Year 2024 Incentive RSU Award Agreement	8-K	10.1	November 5, 2024
10.6(g)†	Form of Performance Unit Award Agreement which may be made under The Scotts Miracle-Gro Long-Term Incentive Plan	10-Q	10.10	February 7, 2024
10.6(h)†	Form of Performance Unit / Cash Unit Award Agreement for Employees which may be made under The Scotts Miracle-Gro Long-Term Incentive Plan	8-K	10.1	February 15, 2024
10.7(a)†	The Scotts Company LLC Amended and Restated Executive Incentive Plan (effective as of October 1, 2019)	10-Q	10	August 5, 2020
10.7(b)†	Form of Employee Confidentiality, Noncompetition, Nonsolicitation Agreement for employees participating in The Scotts Company LLC Executive/Management Incentive Plan (now known as The Scotts Company LLC Amended and Restated Executive Incentive Plan)	10-Q	10.1	August 10, 2006
10.8†	The Scotts Company LLC Executive Retirement Plan, as Amended and Restated as of January 1, 2015 (executed December 31, 2014)	10-Q	10.2	February 5, 2015
10.9(a)†	Employee Confidentiality, Noncompetition, Nonsolicitation Agreement, dated as of December 12, 2013, by and between The Scotts Company LLC, all companies controlled by, controlling or under common control with The Scotts Company LLC, and James Hagedorn	8-K	10.2	December 17, 2013
10.9(b)†	Executive Severance Agreement, dated as of December 11, 2013, by and between The Scotts Company LLC and James Hagedorn	8-K	10.1	December 17, 2013
10.10†	Summary of Compensation for Nonemployee Directors of The Scotts Miracle-Gro Company (effective as of January 22, 2024)				X
10.11(a)†	The Scotts Company LLC Executive Severance Plan, adopted on April 25, 2017	10-Q	10.9	May 10, 2017
10.11(b)†	Form of Tier 1 Participation Agreement under The Scotts Company LLC Executive Severance Plan	10-Q	10.10	May 10, 2017
10.12	Third Amended and Restated Exclusive Agency and Marketing Agreement, entered into on July 29, 2019 and effective as of August 1, 2019, between Monsanto Company and The Scotts Company LLC	8-K	10.2	July 31, 2019
10.13†	Form of Aircraft Time Sharing Agreement for Executive Officers	10-Q	10.4	May 11, 2016
10.14†	Separation Agreement and Release of All Claims, effective as of October 4, 2022, by and between The Scotts Company LLC and Cory J. Miller	8-K	10.1	October 4, 2022
10.15†	Separation Agreement and Release of All Claims, entered into on October 6, 2023, by and between The Scotts Company LLC and Michael C. Lukemire	8-K	10.1	October 10, 2023
10.16(a)†	Retention Agreement, dated August 20, 2018, by and between The Scotts Company LLC and Denise S. Stump	8-K	10.3	August 24, 2018
10.16(b)†	Separation Agreement and Release of All Claims, entered into on November 12, 2023, by and between The Scotts Company LLC and Denise S. Stump	8-K	10.1	November 16, 2023
10.17(a)(i)	Master Receivables Purchase Agreement, dated October 27, 2023, by and among The Scotts Company LLC, The Scotts Miracle-Gro Company and JPMorgan Chase Bank, N.A.	8-K	10.1	November 1, 2023
10.17(a)(ii)	Performance Undertaking, dated October 27, 2023, by The Scotts Miracle-Gro Company in favor of JP Morgan Chase Bank, N.A.	8-K	10.2	November 1, 2023
10.17(b)(i)	First Amendment to Master Receivables Purchase Agreement, dated September 1, 2024, by and between The Scotts Miracle-Gro Company to JPMorgan Chase Bank, N.A.	8-K	10.2	September 4, 2024

114

		Incorporated by Reference
Exhibit No.	Description	Form	Exhibit	Filing Date	Filed Herewith
10.17(b)(ii)	Facility Extension Request Letter, dated September 1, 2024, from The Scotts Miracle-Gro Company to JPMorgan Chase Bank, N.A.	8-K	10.1	September 4, 2024
19	Insider Trading Policy of The Scotts Miracle-Gro Company & Subsidiaries				X
21	Subsidiaries of The Scotts Miracle-Gro Company				X
22	Guarantor Subsidiaries				X
23	Consent of Independent Registered Public Accounting Firm — Deloitte & Touche LLP				X
24	Powers of Attorney of Executive Officers and Directors of The Scotts Miracle-Gro Company				X
31.1	Rule 13a-14(a)/15d-14(a) Certifications (Principal Executive Officer)				X
31.2	Rule 13a-14(a)/15d-14(a) Certifications (Principal Financial Officer)				X
32	Section 1350 Certifications (Principal Executive Officer and Principal Financial Officer)				X
97	Executive Officer Clawback Policy				X
99.1	News release issued by The Scotts Miracle-Gro Company on November 26, 2024				X
101.SCH	XBRL Taxonomy Extension Schema				X
101.CAL	XBRL Taxonomy Extension Calculation Linkbase				X
101.DEF	XBRL Taxonomy Extension Definition Linkbase				X
101.LAB	XBRL Taxonomy Extension Label Linkbase				X
101.PRE	XBRL Taxonomy Extension Presentation Linkbase				X
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)				X

†  Management contract, compensatory plan or arrangement.

115

EX-4.5

Exhibit 4.5

November 26, 2024

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Re:    The Scotts Miracle-Gro Company – Annual Report on Form 10-K for the fiscal year ended September 30, 2024

Ladies and Gentlemen:

    The Scotts Miracle-Gro Company, an Ohio corporation (“Scotts Miracle-Gro”), is today filing its Annual Report on Form 10-K for the fiscal year ended September 30, 2024 (the “Form 10-K”).

Neither Scotts Miracle-Gro nor any of its consolidated subsidiaries has outstanding any instrument or agreement with respect to its long-term debt, other than those filed or incorporated by reference as an exhibit to the Form 10-K, under which the total amount of long-term debt authorized exceeds ten percent (10%) of the total assets of Scotts Miracle-Gro and its subsidiaries on a consolidated basis. In accordance with the provisions of Item 601(b)(4)(iii) of SEC Regulation S-K, Scotts Miracle-Gro hereby agrees to furnish to the SEC, upon request, a copy of each such instrument or agreement defining the rights of holders of long-term debt of Scotts Miracle-Gro or the rights of holders of long-term debt of one of Scotts Miracle-Gro’s consolidated subsidiaries, in each case which is not being filed or incorporated by reference as an exhibit to the Form 10-K.

Very truly yours,

THE SCOTTS MIRACLE-GRO COMPANY

/s/ MATTHEW E. GARTH

Matthew E. Garth

Executive Vice President, Chief Financial Officer & Chief Administrative Officer

14111 Scottslawn Road Marysville, OH 43041 937-644-0011

www.scotts.com

EX-4.6

Exhibit 4.6

DESCRIPTION OF CAPITAL STOCK

As of September 30, 2024, The Scotts Miracle-Gro Company (“Scotts,” the “Company,” “we,” “us” or “our”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common shares, without par value (our “common shares”).

The following summary describes the material features of our common shares and our preferred shares, without par value (our “preferred shares”). This summary does not describe every aspect of our common shares or preferred shares and is subject to, and qualified in its entirety by reference to, all the provisions of our amended articles of incorporation and code of regulations, each of which is filed as an exhibit to this Annual Report on Form 10-K, and the applicable provisions of Ohio law.

Authorized Capital Stock

Under our amended articles of incorporation, we have the authority to issue up to an aggregate amount of 100,000,000 common shares and 195,000 preferred shares. As of September 30, 2024, there were 57,115,475 common shares issued and outstanding and no preferred shares issued and outstanding.

Common Shares

Holders of our common shares are entitled to:

•one vote for each share held;

•receive dividends when and if declared by our board of directors from funds legally available therefor, subject to the rights of holders of our preferred shares, if any, and any restrictions contained in our long-term indebtedness; and

•share ratably in our net assets, legally available to our shareholders in the event of our liquidation, dissolution or winding up, after provision for distribution to the holders of any preferred shares and to the payment in full of all amounts required to be paid to creditors or provision for such payment.

Holders of our common shares have no preemptive, subscription, redemption, conversion or cumulative voting rights. All of our outstanding common shares are fully paid and non-assessable. Our amended articles of incorporation contain no restrictions on the alienability of our common shares.

Our common shares are listed on the New York Stock Exchange (“NYSE”) under the symbol “SMG.”

Preferred Shares

Under our amended articles of incorporation, our board of directors is authorized to issue, without any further vote or action by our shareholders, subject to certain limitations prescribed by Ohio law and the rules and regulations of the NYSE, up to an aggregate of 195,000 preferred shares in one or more series. Our board of directors is also authorized to fix or change the rights, preferences and limitations of each series, including the division of such shares into series and the designation and authorized number of each series, dividend and distribution rights, liquidation rights, preferences and price, redemption rights and price, sinking fund requirements, voting rights, preemptive rights, conversion rights and restrictions on issuance of shares. Absent a determination by the board of directors to establish different voting rights, holders of preferred shares are entitled to one vote per share on matters to be voted upon by the holders of common shares and preferred shares voting together as a single class. Ohio law also entitles the holders of preferred shares to exercise a class vote on certain matters.

Our board of directors may authorize the issuance of preferred shares with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common shares. The issuance of preferred shares could have the effect of decreasing the market price of our common shares. The issuance of preferred shares also could have the effect of delaying, deterring or preventing a change in control of us without further action by our shareholders.

Anti-Takeover Effects of Amended Articles of Incorporation, Code of Regulations and Ohio Law

Certain provisions in our amended articles of incorporation and code of regulations and the Ohio Revised Code could discourage potential takeover attempts and make attempts by shareholders to change management more difficult. These provisions could adversely affect the market price of our shares. A description of these provisions is set forth below.

Classified Board of Directors

Our board of directors is divided into three classes, with three-year staggered terms. This classification system increases the difficulty of replacing a majority of the directors at any one time and may tend to discourage a third party from making a tender offer or otherwise attempting to gain control of us. It also may maintain the incumbency of our board of directors. Under the Ohio General Corporation Law, our shareholders may not remove any directors on our classified board of directors without cause.

Supermajority Voting Provisions

Under the Ohio General Corporation Law, in the case of most mergers, sales of all or substantially all the assets of a corporation and amendments to a corporation’s articles of incorporation, the affirmative vote of two-thirds of the voting power of the corporation is required unless the corporation’s articles of incorporation provide for a lower amount not less than a majority. Our amended articles of incorporation change the default voting requirement provided by the Ohio General Corporation Law to a majority of the voting power, except that the affirmative vote of two-thirds of our voting power is required with respect to any of the following:

•proposed amendments to the supermajority voting provision in our amended articles of incorporation;

•an agreement of merger or consolidation providing for the proposed merger or consolidation of us with or into one or more other corporations and requiring shareholder approval;

•a proposed combination or majority share acquisition involving the issuance of our shares and requiring shareholder approval;

•a proposal to sell, exchange, transfer or otherwise dispose of all, or substantially all, of our assets, with or without goodwill; and

•a proposed dissolution of us.

Limited Shareholder Action by Written Consent

The Ohio General Corporation Law requires that an action by written consent of the shareholders in lieu of a meeting be unanimous, except that the code of regulations may be amended by an action by written consent of holders of shares entitling them to exercise two-thirds of the voting power of the corporation or, if the articles of incorporation or code of regulations otherwise provide, such greater or lesser amount, but not less than a majority. This provision may have the effect of delaying, deferring or preventing a tender offer or takeover attempt that a shareholder might consider to be in its best interest.

Control Share Acquisition Act

The Ohio General Corporation Law provides that certain notice and informational filings, and special shareholder meeting and voting procedures, must occur prior to any person’s acquisition of an issuer’s shares that would entitle the acquirer to exercise or direct the voting power of the issuer in the election of directors within any of the following ranges:

•one-fifth or more but less than one-third of such voting power;    

•one-third or more but less than a majority of such voting power; and

•a majority or more of such voting power.

This provision, which is known as the Control Share Acquisition Act, does not apply to a corporation if its articles of incorporation or code of regulations so provide. We have not opted out of the application of the Control Share Acquisition Act.

Merger Moratorium Statute

Chapter 1704 of the Ohio Revised Code, known as the Merger Moratorium Statute, prohibits specified business combinations and other transactions (including mergers, consolidations, asset sales, loans, disproportionate distributions of property and disproportionate issuances or transfers of shares or rights to acquire shares) between an Ohio corporation and an “Interested Shareholder” (as such term is defined in Section 1704.01 of the Ohio Revised Code) for a period of three years after a person becomes an Interested Shareholder, unless, prior to such date, the directors approved either the business combination or other transaction or approved the acquisition that caused the person to become an Interested Shareholder. Under the Merger Moratorium Statute, an Interested Shareholder generally includes any beneficial owner of shares of an Ohio corporation who, alone or with others, may exercise or direct the exercise of at least 10% of the voting power of the corporation in the election of directors.

Following the three-year moratorium period, the corporation may engage in the covered transaction with the Interested Shareholder only if:

•the transaction receives the approval of the holders of shares entitling them to exercise at least two-thirds of the voting power of the corporation in the election of directors (or a different proportion specified in the corporation’s articles of incorporation), including at least a majority of the voting shares held by persons other than an Interested Shareholder; or

•the remaining shareholders receive an amount for their shares equal to the higher of the highest amount paid in the past by the Interested Shareholder for the corporation’s shares or the amount that would be due to the shareholders if the corporation were to dissolve.

The Merger Moratorium Statute does not apply to a corporation if its articles of incorporation or code of regulations so provide. We have not opted out of the application of the Merger Moratorium Statute.

EX-10.10

Exhibit 10.10

Summary of Compensation for Nonemployee Directors of

The Scotts Miracle-Gro Company

Effective as of January 22, 2024

_____________________________________

At the meeting of the Board of Directors (the “Board”) of The Scotts Miracle-Gro Company (the “Company”) held on January 22, 2024, the Board approved the recommendations of the Nominating and Governance Committee of the Board (the “Committee”) with respect to compensation for the calendar year for nonemployee members of the Board (“Nonemployee Directors”) and the Lead Independent Director of the Company. The compensation approved by the Board is described below.

Annual Cash Retainer; Reimbursement of Expenses

Each of the Nonemployee Directors is normally paid an annual cash retainer in the amount of $115,000 that is paid in quarterly increments of $28,750 in February, April, July and October. However, for calendar 2024, the Nonemployee Directors have the option to elect, in advance, to defer 100% of their quarterly cash retainers, in exchange for fully-vested deferred stock units that will settle on or after January 31, 2027, at the election of the Nonemployee Director. As an inducement for the Nonemployee Directors to defer all of their cash compensation in calendar 2024, the deferred quarterly cash retainer amount of $28,750 was enhanced by 15% each quarter prior to converting the cash to deferred stock units. Nonemployee Directors receive reimbursement of all reasonable travel and other expenses associated with attending Board and Board committee meetings.

Restricted Stock Units

Shortly following each of the Company’s annual meetings: (a) each Nonemployee Director will be granted restricted stock units having a grant date value of $210,000, with no additional restricted stock units awarded for serving as Board committee chairs or members; and (b) the Lead Independent Director will be granted additional restricted stock units having a grant date value of $50,000. The number of restricted stock units (and related dividend equivalents) granted to each Nonemployee Director will be calculated by dividing the aggregate value of restricted stock units to be granted to such Nonemployee Director by the closing price of the Company’s common shares on the grant date and rounding any resulting fractional restricted stock unit up to the next whole restricted stock unit.

The restricted stock units (and related dividend equivalents) will be granted under The Scotts Miracle-Gro Company Long-Term Incentive Plan (Effective as of January 22, 2024) (the “2024 Plan”). Each whole restricted stock unit represents the right to receive one full common share of the Company at the time and in the manner described in the Restricted Stock Unit Award Agreement for Nonemployee Directors (with Related Dividend Equivalents) evidencing the award. Each dividend equivalent represents the right to receive additional restricted stock units (rounded to the nearest whole restricted stock unit) in respect of dividends that are declared and paid during the period beginning on the grant date and ending on the settlement date with respect to the common shares of the Company represented by the related restricted stock units.

The restricted stock units, including any restricted stock units received in respect of dividend equivalents on or prior to the vesting date, will generally become 100% vested on the first anniversary of the grant date (the “Vesting Date”). Any restricted stock units received in respect of dividend equivalents

following the vesting date will be 100% vested on the date they are credited to the Nonemployee Director. If a Nonemployee Director ceases to be a member of the Board as a result of their death or becoming totally disabled, then all of the Nonemployee Director’s restricted stock units (and related dividend equivalents) will become 100% vested as of the date the Nonemployee Director’s service on the Board terminates. If a Nonemployee Director ceases to be a member of the Board prior to the Vesting Date for any reason other than a change in control of the Company (except as provided above for death or disability), the Nonemployee Director’s restricted stock units (and related dividend equivalents) will be immediately forfeited.

Subject to the terms of the 2024 Plan and the applicable restricted stock unit award agreement, vested restricted stock units (and related dividend equivalents) will be settled in a lump sum as soon as administratively practicable following the earliest to occur of (a) termination, (b) death, (c) disability, or (d) the third anniversary of the grant date; unless the Nonemployee Director elected, in advance, to defer settlement of the restricted stock units to a later date. Whole restricted stock units (and related dividend equivalents) will be settled in full common shares of the Company and any fractional restricted stock units will be settled in cash, determined based on the fair market value of a common share of the Company on the settlement date.

If there is a Change in Control (as defined in the 2024 Plan), each Nonemployee Director’s restricted stock units (and related dividend equivalents) will become 100% vested on the date of the Change in Control and will be settled within 30-days of the Change in Control.

For more information about the restricted stock units (and related dividend equivalents) granted to the Nonemployee Directors, please refer to: (a) the Form of Deferred Stock Unit Award Agreement for Nonemployee Director Retainer Deferral (with Related Dividend Equivalents) that is included as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed January 24, 2024; (b) the Form of Standard Restricted Stock Unit Award Agreement for Nonemployee Directors (with Related Dividend Equivalents) that is included as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed January 24, 2024; and (c) the 2024 Plan that is included as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed January 24, 2024.

EX-19

Exhibit 19

THE SCOTTS MIRACLE-GRO COMPANY & SUBSIDIARIES

CORPORATE POLICY W-LG-1             INSIDER TRADING POLICY

To:	All Scotts Associates                     Date: April 22, 2024
From:	Matthew E. Garth, Executive Vice President, Chief Financial Officer & Chief Administrative Officer Dimiter Todorov, Executive Vice President, General Counsel, Secretary and Chief Compliance Officer

ScottsMiracle-Gro’s Principle

The Scotts Miracle-Gro Company is committed to full compliance with the U.S. Federal and State securities laws and regulations. The securities laws dealing with trading in securities are intended to ensure the maintenance of fair and honest stock markets. Conduct that violates the securities laws can subject individuals, as well as the Company, to civil and criminal penalties and is contrary to the values of the Company and its subsidiaries.

GENERAL POLICY

In the course of business operations, associates and members of the Board of Directors of the Company (“Directors”) may become aware of material, non-public “inside” information about the Company or about another public company, whether favorable or unfavorable. It is particularly important that all associates and Directors (and others who may become involved in these matters such as consultants and independent contractors) recognize the sensitivity of confidential business information and conduct themselves accordingly. The misuse of material, non-public information can have serious, undesirable consequences. In the case of trading in securities based on inside information or providing such information to other persons who may trade on the basis of that information, such consequences may include termination of employment, other adverse employment consequences, and criminal and civil penalties.

COVERAGE

Unlawful insider trading occurs when a person uses material non-public information obtained through their employment or other involvement with the Company to make decisions to purchase, sell or otherwise engage in transactions in that Company’s securities or to provide that information to others outside the Company. The prohibitions against insider trading apply to trading or otherwise transacting in the Company’s securities, tipping and making recommendations to engage in

transactions by virtually any person, including all persons associated with the Company, if the information involved is “material” and “non-public.” These terms are defined below.

This Policy applies to: (1) all Directors; (2) all associates of the Company and the Company’s direct and indirect subsidiaries (wherever located); (3) all Family Members (as defined below) of Directors and associates; (4) all corporations, partnerships, trusts or other entities controlled by any of the above persons (or controlled by a group comprising two or more of any of the above persons); and (5) any other person or entity as designated from time to time by the General Counsel. This Policy shall continue to apply to a Director or associate, such individual’s Family Members and all corporations, partnerships, trusts or other entities controlled by such individual even after such Director’s or associate’s separation from service to the Company. If a Director or associate is in possession of material nonpublic information when his or her service terminates, that individual, such individual’s Family Members and all corporations, partnerships, trusts or other entities controlled by such individual may not trade in Company securities until that information has become public or is no longer material. The pre-clearance procedures specified for Designated Persons (as described below) will cease to apply to transactions in Company securities upon the expiration of any blackout period applicable at the time of the separation of such Director’s or associate’s service as a Director or associate of the Company.

This Policy does not apply to a partnership of which any of the persons identified in clauses (1), (2) or (3) is a non-controlling general or limited partner, it being understood that transactions in Company securities by such partnership that are for the account of such non-controlling general or limited partner identified in clauses (1), (2) or (3) shall be deemed for purposes of this Policy to be transactions directly by that person (and not the partnership) and as such covered by this Policy.

The term “Family Members” includes (1) a person’s family members who share the same address as, or who are financially dependent upon, that person; (2) any unrelated person who shares the same address as the person (other than employees or tenants); and (3) any family members who do not live with the covered person but whose transactions in the Company’s securities are directed by the covered person or subject to that person’s influence or control. You are responsible for the transactions of your Family Members and, therefore, should make them aware of the need to confer with you before they trade in Company securities, and you should treat all such transactions for the purposes of this Policy and applicable securities laws as if the transactions were for your own account. This Policy does not, however, apply to personal securities transactions by Family Members where the purchase or sale decision is made by a third party not controlled by, influenced by or related to you or your Family Members (e.g., transactions pursuant to a trading plan compliant with Rule 10b5-1 or a trust operated and controlled by a third party not controlled by, influenced or related to you or your Family Members).

In all cases, the duty to comply or cause compliance with this Policy resides in the Director or associate.

2

SPECIFIC GUIDANCE

• Materiality/Confidentiality and When Information is Considered Public

1. All material, non-public information about the Company, whether favorable or unfavorable, is to be kept confidential until publicly disclosed by the Company. Similarly, all material, non-public information about other companies with which the Company does business, whether favorable or unfavorable, is to be kept confidential until publicly disclosed.

2. In general, information is considered material if a “reasonable” person would attach importance to the information in determining whether to purchase or sell a company’s securities. Any information that could be expected to affect the Company’s stock price, whether positive or negative, should be considered material. There is no bright-line standard for assessing materiality; rather, materiality is based on an assessment of all of the facts and circumstances, and is often evaluated by enforcement authorities with the benefit of hindsight. Without attempting to list all types of material information, such information includes:

a.Company earnings, possible dividend increases or decreases, and other financial information;

b.Significant positive or negative variances to plan in consumer purchase activity, as measured by retailer point of sale, in peak lawn and garden season months;

c.Any technological or similar “break through” which, when made public, could affect a company’s stock price;

d.The fact that an acquisition candidate of material importance or a material divestiture is being evaluated or considered, that discussions or negotiations are in progress, and any information relating to such matters;

e.Changes in senior management; and

f.Entry into, or termination of, a significant contract.

3. Confidential information concerning such matters is to be restricted to those associates and agents who have a “need to know” for the proper performance of their respective functions.

4. Management and each associate should exercise due care in protecting the confidentiality of such matters. In particular,

a.casual conversations in public areas are to be avoided; and

b.files containing material, non-public information should be stored in “secured” places.

3

5. Information that has not been disclosed to the public is generally considered to be non-public information. In order to establish that information has been disclosed to the public, it may be necessary to demonstrate that the information has been widely disseminated. Once information has been widely disseminated to the public, it is still necessary to afford the investing public with sufficient time to absorb the information. As a general rule, information should not be considered fully absorbed by the marketplace until one complete trading day has concluded after the information is released. If the information is released once a trading day has commenced, the information is not considered absorbed until the conclusion of the next trading day.

A “trading day” is any day on which the New York Stock Exchange is open for trading.

    • Restrictions on Trading in Securities

1. Trading in Company Securities. No person subject to this Policy may buy, sell or make bona fide gifts of securities of the Company while aware of material, non-public or “inside” information concerning the Company. Designated Persons are subject to additional procedures specified below. It is the responsibility of each person subject to this policy to determine whether they are aware of material, non-public or “inside” information concerning the Company and, if so, to abstain from trading in Company securities.

2. Trading in the Securities of Other Companies. No person subject to this Policy who knows of a possible acquisition should make any trades in the securities of the acquisition candidate regardless of whether the acquisition is considered material to The Scotts Miracle-Gro Company or its subsidiaries. Similarly, no person subject to this Policy who becomes aware of material, non-public information relating to another company with which the Company transacts business or competes should make any trades in the securities of such company.

3. Prohibition on Short Sales. No person subject to this Policy may engage in short sales of Company securities. A short sale is the sale of a security that the seller does not own at the time of the trade; the sale is often accomplished using a security borrowed from a broker, and the seller is required to purchase the security at some time in the future to “cover” the sale.

4. Prohibition on Options Transactions. No person subject to this Policy may engage in transactions in puts, calls or other derivatives that relate to or involve Company securities. A put or call option gives the holder of the option the right to sell (put) or purchase (call) securities within a certain time period at a specified price. Such transactions are, in effect, bets on the short-term movement of the Company’s stock and, therefore, create the appearance that trading is based on non-public information.

5. Prohibition on Hedging Company Securities. Certain transactions, such as forward sale or purchase contracts, equity swaps, collars and exchange funds, allow an individual to hedge against decreases in the market value of Company securities held by or granted to such individual. These transactions allow the individual to continue to own the covered securities, but without the full risks and rewards of ownership. When that occurs, the individual may no longer have the same objectives as the Company’s other shareholders. Accordingly, persons subject to this Policy are prohibited from engaging in hedging transactions involving Company securities.

4

6. Prohibition on Tipping. Communication of “inside” information to another person who may trade or advise others to trade on the basis of the information is considered “tipping.” Tipping is illegal and could subject both the tipper and the tippee to severe civil and criminal penalties, as well as termination of employment by the Company.

7. Exceptions. These trading restrictions do not apply to:

    (a) Stock Option Exercises and Restricted Stock Awards. Exercises of stock options or other equity awards or the surrender or withholding of shares to the Company in payment of the exercise price or in satisfaction of any tax withholding obligations, in each case in a manner permitted by the applicable equity award agreement; provided, however, that the securities so acquired may not be sold (either outright or in connection with a “cashless” exercise transaction through a broker) other than to the Company as provided in clause (d) of this Section 5 while the associate or Director is aware of material, non-public information or, if the associate or Director is a Designated Person, while the trading window is closed;

    (b) 401(k) Plan or DSPP. Acquisitions or dispositions of Company stock under the Company’s 401(k) plan, the Company’s Discounted Stock Purchase Plan (“DSPP”) or other individual account plan which, subject to clause (c), are made pursuant to standing instructions not entered into or modified while the associate or Director is aware of material, non-public information or, if the associate or Director is a Designated Person, while the trading window is closed. This exception does not apply, however, to certain elections you may make under the 401(k) plan or DSPP, including, as applicable: (i) an election to increase or decrease the percentage of your elective deferrals that will be allocated to the Company stock fund; (ii) an election to initiate, increase or decrease contributions with respect to the DSPP; (iii) an election to make an intra-plan transfer of an existing account balance into or out of the Company stock fund; (iv) an election to borrow money against your 401(k) plan account if the loan will result in a liquidation of some or all of your Company stock fund balance; and (v) an election to pre-pay a plan loan if the pre-payment will result in allocation of loan proceeds to the Company stock fund;

    (c) Other Purchases from or Sales to the Company. Other purchases of securities from the Company or sales of securities to the Company; and

    (d) Rule 10b5-1 Trading Plans. Purchases or sales made pursuant to a binding contract, written plan or specific instruction (as discussed in more detail below, a “trading plan”) which is adopted and operated in compliance with Rule 10b5-1 and this Policy. This exception applies only to Section 1. Trading in Company Securities. All restrictions set forth in Sections 2 through 6 above shall apply.

    • Determination of Materiality

Determining what information about the Company or any other company is material may be difficult. If there is any doubt or the question is close, then the answer should be not to trade while aware of such information. If an associate has a question, he or she should raise it with the Chief Financial Officer or the General Counsel.

5

    • Penalties

Persons who trade in a company’s securities while aware of inside information are subject to severe sanctions, including (i) termination or suspension of employment by the Company, (ii) ineligibility for future participation in the Company’s equity incentive programs, (iii) compensation freezing, (iv) disgorgement of gains or avoided losses from transactions that violate this Policy, (v) reimbursement of the Company’s costs in responding to a violation of this Policy, as well as (vi) civil and criminal penalties, which could include monetary fines, liability for damages and prison time.

    • Additional Restrictions and Procedures for Designated Persons

1. Designated Persons. “Designated Persons” are persons that are otherwise covered by this Policy as set forth in “Coverage” above but who also come within one of the following four categories: (a) all Directors and executive officers of the Company (the “Section 16 Insiders”); (b) any associate of the Company who is specifically notified that he or she is a Designated Person; (c) Family Members of Section 16 Insiders or Family Members of specifically notified associates as specified in clause (b); and (d) all corporations, partnerships, trusts or other entities controlled by any of the above persons.

2. Pre-clearance of Trades. To help prevent inadvertent violations of this Policy and to avoid even the appearance of improper transactions, the Company has implemented the following procedures for pre-clearance of all trades (including gifts) in the securities of The Scotts Miracle-Gro Company by Designated Persons.

A Designated Person wishing to trade in Company securities must first notify the General Counsel’s office when they or any Family Member plans to enter into a transaction in the securities of The Scotts Miracle-Gro Company. This notification must be in writing (including by e-mail) and should include the identity of the Designated Person, the type of transaction (for example, an open market purchase, a privately negotiated sale, an option exercise, a gift, etc.), the date or proposed date of the transaction and the number of options or shares involved. In addition, the Designated Person must execute a certification (in the form attached as Exhibit A) that he or she is not aware of material, non-public information about the Company. The Chief Financial Officer and the General Counsel shall have sole discretion to decide whether to permit the contemplated transaction. (The General Counsel shall have sole discretion to decide whether to permit transactions by the Chief Financial Officer or his or her Family Members, and the Chief Financial Officer shall have sole discretion to decide whether to permit transactions by the General Counsel or his or her Family Members.) All trades that are pre-cleared must be effected within five business days of receipt of the pre-clearance unless a specific exception has been granted by the General Counsel and Chief Financial Officer. A pre-cleared trade (or any portion of a pre-cleared trade) that has not been effected during the five business day period must be pre-cleared again prior to execution. If a Designated Person becomes aware of material, non-public information following receipt of pre-clearance but before the trade is executed, the Designated Person must not complete the trade.

3. Trading Window. As a general rule, transactions by Designated Persons in the securities of The Scotts Miracle-Gro Company will be permitted only when the trading window is “open.” The open window period typically begins one full trading day following the public announcement by the Company of its quarterly earnings. The open window period typically ends on the day that is two

6

calendar weeks prior to the end of each fiscal quarter, except for the third fiscal quarter, where the open window period will end after two weeks. The Company may from time to time close the trading window when it would otherwise be open in view of significant events or developments involving the Company. As a convenience, Designated Persons will be sent notices pertaining to the opening and closing of the trading window.

4. Pre-clearance of 10b5-1 Trading Plans. Rule 10b5-1 under the Exchange Act provides an affirmative defense against an allegation of insider trading. In order to be eligible to rely on this defense, a Designated Person must enter into a Rule 10b5-1 plan for transactions in securities of The Scotts Miracle-Gro Company that satisfies certain requirements specified in the Rule (including cooling-off periods). If the plan meets the requirements of Rule 10b5-1, a Designated Person may purchase or sell securities of The Scotts Miracle-Gro Company pursuant to the plan without regard to certain insider trading restrictions. In general, a Rule 10b5-1 Plan must be entered into at a time when the person entering into the plan is not aware of material nonpublic information. Once the Rule 10b5-1 Plan is adopted, the person must not exercise any influence over the amount of securities to be traded, the price at which they are to be traded or the date of the trade. For example, if a Designated Person implements a written trading plan (at a time when he or she was not aware of material, non-public information) specifying that he or she will sell 1,000 shares of common stock of the Company on the first day of each month following the end of the applicable cooling-off period, a sale pursuant to that plan would not subject the Designated Person to insider trading liability even if he or she was aware of material, non-public information at the time the sale took place.

Trading plans complying with Rule 10b5-1 have the obvious advantage of protecting against insider trading liability. However, they also require advance commitments regarding the amounts, prices and timing of purchases and sales under those plans and contracts, and thus limit flexibility and discretion with respect to such transactions to some degree. Accordingly, while some Designated Persons may find such trading plans attractive, they may not be suitable for all Designated Persons. It is the Company’s policy that any Designated Person wishing to adopt a new Rule 10b5-1 trading plan or amend an existing Rule 10b5-1 trading plan submit the trading plan in advance for review and written approval by the General Counsel and/or the Chief Financial Officer.

The General Counsel and Chief Financial Officer will approve a trading plan or trading plan amendment only if the trading plan (1) is in writing; (2) is submitted to the Company for review by the General Counsel and/or Chief Financial Officer prior to its adoption; and (3) is to be adopted while the Designated Person is not aware of material, non-public information and when the trading window is open.

While the Company encourages Designated Persons to use trading plans as appropriate, the Company’s expectation is that the Designated Person will adhere to the terms of the trading plan and not seek to terminate the trading plan before its natural conclusion. While the Company will not permit amendments to a trading plan, it will consider requests for early termination of a trading plan on a case-by-case basis. The Company expects that a Designated Person who successfully terminates a trading plan early will not seek to enter into a new trading plan for a period of at least six months following the early termination of that trading plan. Further, if the Company, in its sole discretion, determines that a Designated Person has engaged in a pattern of early termination of trading plans, the Company may decline to pre-approve future requests for trading plans by the Designated Person.

7

5. Post Transaction Notification. Section 16 Insiders must notify the General Counsel promptly following, and in no event more than one business day after, any trades (including gifts) in the securities of The Scotts Miracle-Gro Company to facilitate compliance with the reporting requirements of Section 16(a) of the Securities Exchange Act of 1934 (and the rules promulgated thereunder).

All questions about this policy should be directed to the Office of the General Counsel or Office of the Chief Financial Officer.

8

Exhibit A

PRE-CLEARANCE CERTIFICATION

I certify that I have read and I am familiar with the Insider Trading Policy of The Scotts Miracle-Gro Company & Subsidiaries (the “Company”).

Based on my review of the Company’s Insider Trading Policy, I believe the proposed purchase or sale of securities of the Company, or adoption of a Rule 10b5-1 plan regarding a future purchase or sale of securities of the Company, for which I am seeking pre-clearance is being completed in accordance with the Company’s Insider Trading Policy.

Further, by signing this certification, I represent to the Company that to the best of my knowledge I am not currently aware of any material, non-public or “inside” information about the Company.

I agree that if I become aware of any material, non-public or “inside” information about the Company at any time after pre-clearance has been granted but before the purchase, sale or adoption of a 10b5-1 plan, or if I am not sure whether such information is material, I will immediately stop the execution of such purchase or sale or adoption of a 10b5-1 plan and contact the General Counsel or Chief Financial Officer of the Company. However, once the purchase or sale has taken place, or once the adoption of a 10b5-1 plan has become effective, I need not take any further action.

Finally, I understand that early termination of a 10b5-1 plan exposes me to external regulatory risks as well as internal Company actions intended to discourage such activity.

Print Name ________________________

Signature __________________________

Date ______________________________

9

EX-21

Exhibit 21

DIRECT AND INDIRECT SUBSIDIARIES OF

THE SCOTTS MIRACLE-GRO COMPANY

Directly owned subsidiaries, as of September 30, 2024, are located at the left margin, each subsidiary tier thereunder is indented. Subsidiaries are listed under the names of their respective parent entities. Unless otherwise noted, the subsidiaries are wholly-owned.

NAME	JURISDICTION OF FORMATION
1868 Ventures LLC	Ohio
Swiss Farms Products, Inc.	Delaware
GenSource, Inc.	Ohio
OMS Investments, Inc.	Delaware
Scotts Temecula Operations, LLC	Delaware
Sanford Scientific, Inc.	New York
Scotts Global Services, Inc.	Ohio
Scotts Live Goods Holdings, Inc.	Ohio
Bonnie Plants, LLC1	Delaware
Scotts Manufacturing Company	Delaware
Miracle-Gro Lawn Products, Inc.	New York
Scotts Oregon Research Station LLC	Ohio
Scotts Products Co.	Ohio
Scotts Servicios, S.A. de C.V.2	Mexico
Miracle-Gro Tecnologia & Servicios, S de R.L.2	Mexico
Scotts Professional Products Co.	Ohio
Scotts Servicios, S.A. de C.V.22	Mexico
Miracle-Gro Tecnologia & Servicios, S de R.L.2	Mexico
SMG Growing Media, Inc.	Ohio
AeroGrow International, Inc.	Nevada
Hyponex Corporation	Delaware
Rod McLellan Company	California
The Hawthorne Gardening Company	Delaware
Hawthorne Hydroponics LLC	Delaware
Hawthorne Gardening B.V.	Netherlands
Gavita International B.V.	Netherlands
Agrolux Canada Limited	Canada
Hawthorne Canada Limited	Canada
HGCI, Inc.	Nevada

________________________

1 Scotts Live Goods Holdings, Inc.’s ownership is 50.0%.

2 Scotts Professional Products Co. owns 50% and Scotts Products Co. owns 50.0%.

SMGM LLC	Ohio
Scotts-Sierra Investments LLC	Delaware
Scotts Sierra (China) Co., Ltd.	China
Scotts Canada Ltd.	Canada
Laketon Peat Moss Inc.3	Canada
Scotts de Mexico SA de CV4	Mexico
SMG Germany GmbH	Germany
SMG Gardening (UK) Limited	United Kingdom
The Hawthorne Collective, Inc.	Ohio
The Scotts Company LLC	Ohio
The Scotts Miracle-Gro Foundation5	Ohio

________________________

3 Scotts Canada Ltd.'s ownership is 50.0%.

4 The Scotts Company LLC owns 0.5% and Scotts-Sierra Investments LLC owns the remaining 99.5%.

5 The Scotts Miracle-Gro Foundation is a 501(c)(3) corporation.

EX-22

Exhibit 22

LIST OF GUARANTOR SUBSIDIARIES

The following subsidiaries of The Scotts Miracle-Gro Company (the "Company") were, as of September 30, 2024, guarantors of the Company's 5.250% Senior Notes due 2026, 4.500% Senior Notes due 2029, 4.000% Senior Notes due 2031 and 4.375% Senior Notes due 2032:

NAME OF GUARANTOR SUBSIDIARY	JURISDICTION OF FORMATION
1868 Ventures LLC	Ohio
AeroGrow International, Inc.	Nevada
GenSource, Inc.	Ohio
Hawthorne Hydroponics LLC	Delaware
HGCI, Inc.	Nevada
Hyponex Corporation	Delaware
Miracle-Gro Lawn Products, Inc.	New York
OMS Investments, Inc.	Delaware
Rod McLellan Company	California
Sanford Scientific, Inc.	New York
Scotts Live Goods Holdings, Inc.	Ohio
Scotts Manufacturing Company	Delaware
Scotts Products Co.	Ohio
Scotts Professional Products Co.	Ohio
Scotts-Sierra Investments LLC	Delaware
Scotts Temecula Operations, LLC	Delaware
SMG Growing Media, Inc.	Ohio
SMGM LLC	Ohio
Swiss Farms Products, Inc.	Delaware
The Hawthorne Collective, Inc.	Ohio
The Hawthorne Gardening Company	Delaware
The Scotts Company LLC	Ohio

EX-23

Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-153925, 333-154364, 333-186187, 333-215774, 333-222840, 333-262303, 333-269360 and 333-276673 on Form S-8 and Registration Statement No. 333-261488 on Form S-3 of our reports dated November 26, 2024, relating to the consolidated financial statements of The Scotts Miracle-Gro Company and subsidiaries (the “Company”) and the effectiveness of the Company's internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the fiscal year ended September 30, 2024.

/s/ DELOITTE & TOUCHE LLP

Columbus, Ohio

November 26, 2024

EX-24

Exhibit 24

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ EDITH AVILES

Edith Aviles

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ ROBERTO CANDELINO

Roberto Candelino

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ DAVID C. EVANS

David C. Evans    

POWER OF ATTORNEY

    The undersigned officer and director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ JAMES HAGEDORN

James Hagedorn

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ ADAM HANFT

Adam Hanft

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ STEPHEN L. JOHNSON

Stephen L. Johnson

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ THOMAS N. KELLY JR.

Thomas N. Kelly Jr.

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ MARK D. KINGDON

Mark D. Kingdon

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ KATHERINE HAGEDORN LITTLEFIELD

Katherine Hagedorn Littlefield

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ BRIAN E. SANDOVAL

Brian E. Sandoval

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ PETER E. SHUMLIN

Peter E. Shumlin

POWER OF ATTORNEY

    The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn, Matthew E. Garth and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ JOHN R. VINES

John R. Vines

POWER OF ATTORNEY

    The undersigned officer of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2024, hereby constitutes and appoints James Hagedorn and Dimiter Todorov, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 26, 2024.

/s/ MATTHEW E. GARTH

Matthew E. Garth

EX-31.1

Exhibit 31.1

Rule 13a-14(a)/15d-14(a) Certifications

(Principal Executive Officer)

CERTIFICATIONS

I, James Hagedorn, certify that:

1.I have reviewed this Annual Report on Form 10-K of The Scotts Miracle-Gro Company for the fiscal year ended September 30, 2024;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 26, 2024	By:	/s/ JAMES HAGEDORN
		Printed Name: James Hagedorn
		Title: Chairman & Chief Executive Officer

EX-31.2

Exhibit 31.2

Rule 13a-14(a)/15d-14(a) Certifications

(Principal Financial Officer)

CERTIFICATIONS

I, Matthew E. Garth, certify that:

1.I have reviewed this Annual Report on Form 10-K of The Scotts Miracle-Gro Company for the fiscal year ended September 30, 2024;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 26, 2024	By:	/s/ MATTHEW E. GARTH
		Printed Name: Matthew E. Garth
		Title: Executive Vice President, Chief Financial Officer & Chief Administrative Officer

EX-32

Exhibit 32

SECTION 1350 CERTIFICATIONS*

In connection with the Annual Report on Form 10-K of The Scotts Miracle-Gro Company (the “Company”) for the fiscal year ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned James Hagedorn, Chairman & Chief Executive Officer of the Company, and Matthew E. Garth, Executive Vice President, Chief Financial Officer & Chief Administrative Officer of the Company, certify, pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of their knowledge:

1)    The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

2)    The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company and its subsidiaries.

/s/ JAMES HAGEDORN	/s/ MATTHEW E. GARTH
Printed Name: James Hagedorn	Printed Name: Matthew E. Garth
Title: Chairman & Chief Executive Officer	Title: Executive Vice President, Chief Financial Officer & Chief Administrative Officer
November 26, 2024	November 26, 2024

* THESE CERTIFICATIONS ARE BEING FURNISHED AS REQUIRED BY RULE 13a-14(b) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (THE “EXCHANGE ACT”) AND SECTION 1350 OF CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE, AND SHALL NOT BE DEEMED “FILED” FOR PURPOSES OF SECTION 18 OF THE EXCHANGE ACT OR OTHERWISE SUBJECT TO THE LIABILITY OF THAT SECTION. THESE CERTIFICATIONS SHALL NOT BE DEEMED TO BE INCORPORATED BY REFERENCE INTO ANY FILING UNDER THE SECURITIES ACT OF 1933 OR THE EXCHANGE ACT, EXCEPT TO THE EXTENT THAT THE COMPANY SPECIFICALLY INCORPORATES THESE CERTIFICATIONS BY REFERENCE.

EX-97

Exhibit 97

THE SCOTTS MIRACLE-GRO COMPANY & SUBSIDIARIES

EXECUTIVE OFFICER CLAWBACK POLICY

GENERAL POLICY:

Executive Officer Clawback Policy. Effective 10/02/2023 (the “Effective Date”). This policy supersedes and replaces in its entirety the Executive Compensation Recovery Policy that was effective as of September 22, 2010.

1.    ADMINISTRATION AND APPLICATION. This Executive Officer Clawback Policy (this “Policy”) shall be administered and interpreted by the Compensation and Organization Committee (the “Committee”) of the Board of Directors (the “Board”) of The Scotts Miracle-Gro Company (and together with its affiliates, the “Company”). This Policy provides for the recovery of Erroneously Awarded Compensation from Executive Officers in the event of an Accounting Restatement. This Policy is intended to comply with, and shall be interpreted consistent with, Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 promulgated under the Exchange Act (“Rule 10D-1”) and Section 303A.14 of the New York Stock Exchange (“NYSE”) Listed Company Manual (the “Listing Rule”). Unless otherwise defined in this Policy, capitalized terms used in this Policy have the meanings given to them in Section 2

SPECIFIC GUIDANCE:

2.    DEFINITIONS. For purposes of this Policy, the following capitalized terms have the meanings set forth below.

A.“Accounting Restatement” means an accounting restatement of the Company’s financial statements due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

B.“Accounting Restatement Date” means the earlier to occur of: (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement; and (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement.

C.“Clawback Period” means, with respect to any Accounting Restatement, the three completed fiscal years of the Company immediately preceding the Accounting

1

Restatement Date and any transition period (that results from a change in the Company’s fiscal year) of less than nine months within or immediately following those three completed fiscal years.

D.“Code” means the Internal Revenue Code of 1986, as amended.

E.“Erroneously Awarded Compensation” means, in the event of an Accounting Restatement, the amount of Incentive-Based Compensation received by an Executive Officer during the Clawback Period that exceeds the amount of Incentive-Based Compensation that otherwise would have been received by such Executive Officer had the Incentive-Based Compensation been determined based on the restated amounts in such Accounting Restatement. The amount of Erroneously Awarded Compensation shall be computed without regard to any taxes paid by the relevant Executive Officer (including any taxes withheld by the Company from the Incentive-Based Compensation paid to such Executive Officer). For Incentive-Based Compensation based on (or derived from) stock price or total stockholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement: (i) the Committee must determine the amount of Erroneously Awarded Compensation related to such Incentive-Based Compensation by making a reasonable estimate of the effect of the Accounting Restatement on the stock price or total stockholder return upon which the Incentive-Based Compensation was received; and (ii) the Company must maintain documentation of the determination of that reasonable estimate and provide such documentation to NYSE.

F.“Executive Officer” means each individual who is currently or was previously designated as an “officer” of the Company as defined in Rule 16a-1(f) under the Exchange Act. For the avoidance of doubt, the identification of an executive officer for purposes of this Policy shall include each executive officer who is or was identified pursuant to Item 401(b) of Regulation S-K, as well as the principal financial officer and principal accounting officer (or, if there is no principal accounting officer, the controller).

G.“Financial Reporting Measure” means any measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measure that is derived wholly or in part from such measure. A Financial Reporting Measure is not required to be presented within the Company’s financial statements or included in a filing with the SEC to qualify as a Financial Reporting Measure. For purposes of this Policy, Financial Reporting Measure includes, but is not limited to, stock price and total stockholder return.

H.“Incentive-Based Compensation” means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure.

2

I.“SEC” means the U.S. Securities and Exchange Commission.

3.    APPLICATION. This Policy applies to all Incentive-Based Compensation received by a person: (a) after beginning service as an Executive Officer; (b) who served as an Executive Officer at any time during the performance period for such Incentive-Based Compensation; (c) while the Company had a class of securities listed on a national securities exchange or a national securities association; and (d) during the Clawback Period. For purposes of this Policy, Incentive-Based Compensation is considered “received” in the Company’s fiscal period during which the relevant Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of such Incentive-Based Compensation occurs after the end of that period. For the avoidance of doubt, the terms of this Policy apply to any Incentive-Based Compensation received by Executive Officers on or after the Effective Date even if such Incentive-Based Compensation was approved, awarded, granted or paid to Executive Officers before the Effective Date.

4.    RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION. In the event of an Accounting Restatement, the Company shall reasonably promptly determine and recover the amount of any Erroneously Awarded Compensation received by any Executive Officer, as determined pursuant to this Policy. The Committee shall determine, in its sole and absolute discretion, the timing and method for recovering Erroneously Awarded Compensation, to the extent permitted under the Listing Rule and in compliance with (or pursuant to an exemption from the application of) Section 409A of the Code, which may include without limitation (a) seeking reimbursement of all or part of any cash or equity-based award, (b) cancelling prior cash or equity-based awards, (c) canceling or offsetting against any future payable or planned compensation (including, without limitation, base salary or cash or equity-based awards), (d) forfeiture of deferred compensation and (e) any other method authorized by applicable law or contract.

A.The Company’s recovery obligation pursuant to this Section 4 shall not apply if any of the following conditions are met and the Committee determines that such recovery would be impracticable:

i.The direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on expense of enforcement, the Company must make a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) to recover, and provide that documentation to NYSE;

ii.Recovery would violate home country law where that law was adopted prior to November 28, 2022. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on violation of home country law, the Company must obtain an opinion of home country counsel, acceptable to NYSE, that

3

recovery would result in such a violation, and provide a copy of the opinion to NYSE; or

iii.Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the registrant, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Code and regulations thereunder.

5.    MEANS OF COLLECTING RECOVERY. Recovery may be obtained, without limitation, by reducing future payments or by seeking repayment or return of prior awards to the Executive Officer. All actions by the Company to recover Incentive Based Compensation shall be taken in accordance with applicable law. Any right of recovery or recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company under applicable law, rule or regulation or pursuant to the terms of any similar policy in any employment agreement, award agreement or similar agreement and any other legal remedies available to the Company. Nothing contained in this Policy, and no recovery or recoupment as contemplated by this Policy, shall limit any claims, damages or other legal remedies the Company may have against an Executive Officer arising out of or resulting from any actions or omissions by the Executive Officer.

6.    INDEMNIFICATION PROHIBITION. The Company is prohibited from (a) indemnifying any Executive Officer against the loss of any Erroneously Awarded Compensation and (b) paying, or reimbursing any Executive Officer for, the cost of any insurance to cover any such loss.

7.    NOTICE. The Company shall take all appropriate steps to inform its Executive Officers of this Policy so that it is enforceable to the fullest extent legally permissible. These steps may include, without limitation, incorporating the terms of this Policy into the terms of any incentive plan or incentive award agreement applicable to Executive Officers and requiring an Executive Officer to acknowledge and agree that any employment agreement, award agreement or other agreement entered into or provided to such Executive Officer shall be subject to the terms of this Policy; provided, however, that the Company’s failure to do so shall not serve as a waiver of the Company’s rights or such Executive Officer’s obligations under this Policy with respect to any such employment agreement, award agreement or other agreement. In addition, the Company shall file all disclosures with respect to this Policy in accordance with the requirements of the federal securities laws, including disclosures required by applicable SEC filings.

8.    COORDINATION WITH LAW. The Committee is authorized to make all determinations under this Policy to the extent permitted by the Listing Rule and in compliance with Section 409A of the Code. In the event that any provision of this Policy is inconsistent with applicable laws, rules or regulations, including SEC rules or the rules of any national securities exchange or a national securities association on which the Company’s securities are listed, the Committee shall administer this Policy to comply with such laws, rules or regulations. All determinations made by the Committee pursuant

4

to this Policy will be final and binding on all persons, including the Company and its shareholders and Executive Officers, and need not be uniform with respect to each individual subject to the Policy.

9.    AMENDMENT; TERMINATION. The Committee may amend this Policy from time to time in its sole and absolute discretion and shall amend this Policy as it deems necessary to comply with applicable laws, rules or regulations, including SEC rules or the rules of any national securities exchange or a national securities association on which the Company’s securities are listed. The Committee may terminate this Policy at any time. Notwithstanding anything to the contrary, no amendment or termination of this Policy shall adversely affect in any material way any Incentive-Based Compensation approved, granted, awarded, earned or paid to an Executive Officer prior to the effective date of such amendment or termination, except solely to the extent such amendment or termination is required by applicable laws, rules or regulations, including SEC rules or the rules of any national securities exchange or a national securities association on which the Company’s securities are listed.

10.    SUCCESSORS. This Policy is binding and enforceable against all Executive Officers and their beneficiaries, heirs, executors, administrators or other legal representatives.

5

EX-99.1

Exhibit 99.1

The Scotts Miracle-Gro Company

ScottsMiracle-Gro Announces Executive Team Changes

Two key executives elevated to advance next phase of growth strategy;

CFO to depart December 31; Transition plan in place

MARYSVILLE, Ohio, November 26, 2024 – The Scotts Miracle-Gro Company (NYSE: SMG), the world’s largest marketer of branded consumer lawn and garden as well as a leader in indoor and hydroponic growing products, today announced expanded responsibilities for two executive team members along with a transition plan for the chief financial officer.

Chief Operating Officer Nate Baxter has been named president and COO with responsibilities for executing Company strategies and overseeing brands, sales, supply chain, marketing, R&D and information technology. Chris Hagedorn, division president leading wholly-owned Hawthorne Gardening Company subsidiary, has been named executive vice president and chief of staff to Chairman and CEO Jim Hagedorn with responsibilities for Company strategy and corporate affairs, including corporate communications and government relations, as well as oversight of the Hawthorne business. The chief of staff position is new on the executive team.

Matt Garth will depart as chief financial officer on December 31, 2024. Mark Scheiwer, who has served as VP and treasurer since December 2022, will become interim CFO and chief accounting officer on January 1, 2025. Garth, who also was chief administrative officer, will help facilitate a seamless transition during the time leading up to January 1. Scheiwer has more than 13 years of experience in a wide range of finance leadership roles at ScottsMiracle-Gro. The Company will conduct a search for a permanent CFO with the assistance of an executive search firm that is expected to consider internal and external candidates.

“We’re in the next phase of our transformation to build upon the meaningful gains we’ve made to strengthen our world-class, market-leading consumer franchise and strategically shift our Hawthorne subsidiary,” said Jim Hagedorn. “We’re poised to drive further expansion in the consumer segment while maintaining our focus on deleveraging and optimizing the balance sheet. The profitability potential of Hawthorne will continue to improve as we execute its turnaround.

“Nate and Chris are strong and trusted partners who complement one another well. Nate has established a track record of operational efficiency and discipline to capture new areas of value creation and has fostered cross-functional collaboration. Chris is a strategic thinker with proven management expertise and deep knowledge of our Company and the industries in which we compete. Together, they add to a resilient and powerful leadership team and bring extensive experience and capabilities to drive improved performance on many fronts as we advance our three-year growth plan.”

Nate Baxter and Chris Hagedorn Details

Baxter joined ScottsMiracle-Gro in April 2023 as executive vice president of technology and operations with a reputation of leading organizations to deliver results. He was named COO in September 2023. Previously, he was president of TEL U.S., a Tokyo Electron Ltd. subsidiary that manufactures semiconductor and flat-panel manufacturing equipment and worked with Intel Corporation in technology, supply chain, strategy and management.

Chris Hagedorn joined the Company in 2011 with previous experience at a New York strategy, marketing and communications agency. During his tenure with the Company, he served in positions with increasing responsibility. In addition to the Hawthorne business reporting to him, he oversees the wholly-owned Hawthorne Collective established in 2021 to strategically invest in emerging areas of the legal cannabis industry.

CFO Transition

Garth joined ScottsMiracle-Gro as CFO two years ago when the Company was in the midst of stabilizing the organization and executing the Project Springboard cost-cutting initiative.

Exhibit 99.1

“Matt joined us at a critical time, providing much-needed guidance and a steady hand to get us to the next phase in our journey,” Jim Hagedorn said. “We appreciate his dedication and contributions. Under his leadership, the Company has delivered on many key financial priorities. Matt has been a valued partner to me, and I know he will succeed in his future endeavors.”

Garth’s planned departure did not result from any disagreement with the Company or any matter relating to the Company’s financial reporting, policies or practices.

Garth said, “ScottsMiracle-Gro is well positioned for growth, as illustrated by the progress against our financial goals. I look forward to collaborating with the entire team to help ensure the Company sustains this momentum. While I appreciate the opportunities afforded me, I am looking forward to taking my career to the next level, enabling me to use my experience and expertise to drive growth and value for another industry-leading company.”

Scheiwer, a CPA, joined the Company in September 2011 and has held financial roles with increasing responsibility, such as corporate controller, operations finance, enterprise risk management, treasury and tax. As treasurer, he has maintained strong relationships with financial institutions, auditors and investors on behalf of the Company. He previously held a senior audit position with Ernst & Young on large SEC engagements with experience in dispositions, acquisitions, SEC and financial reporting, debt and equity offerings and restructurings.

“Mark brings significant experience to the interim CFO position that is grounded in the many roles he has held throughout his more than 13 years with our Company,” Jim Hagedorn said. “He provided stability during our most challenging financial times through his strong leadership and by successfully managing critically important external relationships. I’m confident in his ability to ensure a smooth and seamless transition.”

To further augment the Company’s financial capabilities, Stefan Selig will serve as a senior advisor to the executive team on strategic and financial matters. Selig, the former U.S. Undersecretary of Commerce, is a highly accomplished finance leader and board director with a reputation of being a trusted counselor to leading companies and investors.

Additionally, the Company is reaffirming the fiscal 2025 guidance that was provided during its fiscal 2024 year-end earnings call on November 6.

About ScottsMiracle-Gro

With approximately $3.6 billion in sales, the Company is the world’s largest marketer of branded consumer products for lawn and garden care. The Company’s brands are among the most recognized in the industry. The Company’s Scotts®, Miracle-Gro®, and Ortho® brands are market-leading in their categories. The Company’s wholly-owned subsidiary, The Hawthorne Gardening Company, is a leading provider of nutrients, lighting, and other materials used in the indoor and hydroponic growing segment. For additional information, visit us at www.scottsmiraclegro.com.

For investor inquiries:

Aimee DeLuca

Sr. Vice President, Investor Relations

aimee.deluca@scotts.com

(937) 578-5621

For media inquiries:

Tom Matthews

Chief Communications Officer

tom.matthews@scotts.com

(937) 644-7044

XML

Cover - USD ($)

12 Months Ended

Sep. 30, 2024

Nov. 18, 2024

Mar. 28, 2024

Cover [Abstract]

Document Type

10-K

Document Annual Report

true

Document Period End Date

Sep. 30, 2024

Current Fiscal Year End Date

--09-30

Document Transition Report

false

Entity File Number

001-11593

Entity Registrant Name

Scotts Miracle-Gro Co

Entity Incorporation, State or Country Code

OH

Entity Tax Identification Number

31-1414921

Entity Address, Address Line One

14111 Scottslawn Road,

Entity Address, City or Town

Marysville,

Entity Address, State or Province

OH

Entity Address, Postal Zip Code

43041

City Area Code

937

Local Phone Number

644-0011

Title of 12(b) Security

Common Shares, $0.01 stated value

Trading Symbol

SMG

Security Exchange Name

NYSE

Entity Well-known Seasoned Issuer

Yes

Entity Voluntary Filers

No

Entity Current Reporting Status

Yes

Entity Interactive Data Current

Yes

Entity Filer Category

Large Accelerated Filer

Entity Small Business

false

Entity Emerging Growth Company

false

ICFR Auditor Attestation Flag

true

Document Financial Statement Error Correction [Flag]

false

Entity Shell Company

false

Entity Public Float

$ 3,178,556,405

Entity Common Stock, Shares Outstanding

57,406,064

Documents Incorporated by Reference

Portions of the definitive Proxy Statement for the registrant’s 2025 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended September 30, 2024.

Entity Central Index Key

0000825542

Document Fiscal Year Focus

2024

Document Fiscal Period Focus

FY

Amendment Flag

false

XML

Audit Information	12 Months Ended
	Sep. 30, 2024
Audit Information [Abstract]
Auditor Firm ID	34
Auditor Location	Columbus, Ohio
Auditor Name	DELOITTE & TOUCHE LLP

XML

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net sales	$ 3,552.7	$ 3,551.3	$ 3,924.1
Cost of sales	2,618.7	2,708.3	2,891.1
Cost of sales—impairment, restructuring and other	83.5	185.7	160.1
Gross margin	850.5	657.3	872.9
Operating expenses:
Selling, general and administrative	559.0	551.3	613.0
Impairment, restructuring and other	62.8	280.5	693.1
Other (income) expense, net	19.9	(0.1)	0.8
Income (loss) from operations	208.8	(174.4)	(434.0)
Equity in loss of unconsolidated affiliates	68.1	101.1	12.9
Interest expense	158.8	178.1	118.1
Other non-operating (income) expense, net	5.5	(0.3)	(6.9)
Loss before income taxes	(23.6)	(453.3)	(558.1)
Income tax expense (benefit)	11.3	(73.2)	(120.6)
Net income (loss)	$ (34.9)	$ (380.1)	$ (437.5)
Basic net loss per common share
Basic net income (loss) per common share (USD per share)	$ (0.61)	$ (6.79)	$ (7.88)
Diluted net loss per common share
Diluted net income (loss) per common share (USD per share)	$ (0.61)	$ (6.79)	$ (7.88)

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (34.9)	$ (380.1)	$ (437.5)
Other comprehensive income (loss):
Net foreign currency translation adjustment	0.6	7.0	(27.2)
Net unrealized gain (loss) on derivative instruments, net of tax	(7.9)	4.2	29.9
Reclassification of net unrealized gain on derivative instruments to net loss, net of tax	(7.3)	(17.4)	(6.8)
Net unrealized loss on securities, net of tax	(40.4)	(34.9)	(77.4)
Reclassification of net unrealized loss on securities to net loss, net of tax	64.6	76.0	0.0
Net unrealized loss in pension and other post-retirement benefits, net of tax	(2.1)	(1.8)	(5.4)
Pension and other post-retirement benefit adjustments, net of tax	(2.0)	(1.3)	8.7
Total other comprehensive income (loss)	5.5	31.8	(78.2)
Comprehensive loss	$ (29.4)	$ (348.3)	$ (515.7)

XML

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES
Net income (loss)	$ (34.9)	$ (380.1)	$ (437.5)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Impairment, restructuring and other	84.3	288.6	666.8
Share-based compensation expense	80.4	68.9	34.3
Depreciation	64.9	67.3	68.1
Amortization	15.7	25.2	37.1
Deferred taxes	9.3	(58.7)	(182.8)
Equity in loss of unconsolidated affiliates	68.1	101.1	12.9
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	128.2	77.7	102.8
Inventories	293.8	450.5	(203.8)
Prepaid and other current assets	10.2	18.6	(3.3)
Accounts payable	(1.6)	(153.6)	(171.2)
Other current liabilities	(45.4)	52.0	(68.4)
Other non-current items	(6.2)	(30.7)	20.1
Other, net	0.7	4.2	(4.1)
Net cash provided by (used in) operating activities	667.5	531.0	(129.0)
INVESTING ACTIVITIES
Proceeds from sale of long-lived assets	2.4	2.5	63.3
Investments in property, plant and equipment	(84.0)	(92.8)	(113.5)
Proceeds from loans receivable	0.0	37.0	0.0
Investments in unconsolidated affiliates	(21.4)	0.0	0.0
Payment for acquisitions, net of cash acquired	0.0	0.0	(237.3)
Purchase of convertible debt investments	0.0	0.0	(25.0)
Other investing, net	2.6	(12.4)	29.3
Net cash used in investing activities	(100.4)	(65.7)	(283.2)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans	648.5	1,336.2	3,617.4
Repayments under revolving and bank lines of credit and term loans	(1,039.5)	(1,689.8)	(2,937.3)
Financing and issuance fees	0.0	(6.4)	(9.6)
Dividends paid	(151.3)	(149.1)	(166.2)
Purchase of Common Shares	(5.1)	(9.3)	(257.9)
Cash received from exercise of stock options	3.8	2.3	3.3
Other financing, net	15.7	(4.0)	5.6
Net cash (used in) provided by financing activities	(527.9)	(520.1)	255.3
Effect of exchange rate changes on cash	0.5	(0.1)	(0.4)
Net increase (decrease) in cash and cash equivalents	39.7	(54.9)	(157.3)
Cash and cash equivalents at beginning of year	31.9	86.8	244.1
Cash and cash equivalents at end of year	$ 71.6	$ 31.9	$ 86.8

XML

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 71.6	$ 31.9
Accounts receivable, less allowances of $9.6 in 2024 and $15.1 in 2023	176.8	304.2
Inventories	587.5	880.3
Prepaid and other current assets	144.5	181.4
Total current assets	980.4	1,397.8
Investment in unconsolidated affiliates	45.2	91.9
Property, plant and equipment, net	609.5	610.3
Goodwill	243.9	243.9
Intangible assets, net	418.8	436.7
Other assets	574.1	633.1
Total assets	2,871.9	3,413.7
Current liabilities:
Current portion of debt	52.6	52.3
Accounts payable	254.7	271.2
Other current liabilities	443.0	450.2
Total current liabilities	750.3	773.7
Long-term debt	2,174.2	2,557.4
Other liabilities	338.0	349.9
Total liabilities	3,262.5	3,681.0
Commitments and contingencies (Notes 17, 18 and 19)
Equity (deficit):
Common shares and capital in excess of $0.01 stated value per share; shares outstanding of 57.1 and 56.5, respectively	362.0	353.1
Retained earnings	303.8	490.9
Treasury shares, at cost; 11.0 and 11.6 shares, respectively	(949.1)	(998.5)
Accumulated other comprehensive loss	(107.3)	(112.8)
Total equity (deficit)	(390.6)	(267.3)
Total liabilities and equity (deficit)	$ 2,871.9	$ 3,413.7

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 9.6	$ 15.1
Common shares, stated value per share (USD per share)	$ 0.01	$ 0.01
Common shares outstanding (in shares)	57.1	56.5
Treasury shares, at cost (in shares)	11.0	11.6

XML

Consolidated Statements of Shareholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Shares	Capital in Excess of Stated Value	Retained Earnings	Treasury Shares	Accumulated Other Comprehensive Income (Loss)
Equity beginning balance (in shares) at Sep. 30, 2021		68.1
Equity beginning balance at Sep. 30, 2021		$ 0.3	$ 476.7	$ 1,605.1	$ (1,002.4)	$ (66.4)
Treasury shares, beginning balance (in shares) at Sep. 30, 2021					12.6
Total equity, beginning balance at Sep. 30, 2021	$ 1,013.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(437.5)			(437.5)
Other comprehensive income (loss)	(78.2)					(78.2)
Share-based compensation	30.3		30.3
Dividends declared	(147.5)			(147.5)
Treasury share purchases (in shares)					1.7
Treasury share purchases	(257.9)				$ (257.9)
Treasury share issuances (in shares)					(1.5)
Treasury share issuances	25.1		(143.3)		$ 168.4
Equity ending balance (in shares) at Sep. 30, 2022		68.1
Equity ending balance at Sep. 30, 2022		$ 0.3	363.7	1,020.1	$ (1,091.8)	(144.6)
Treasury shares, ending balance (in shares) at Sep. 30, 2022					12.8
Total equity, ending balance at Sep. 30, 2022	147.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(380.1)			(380.1)
Other comprehensive income (loss)	31.8					31.8
Share-based compensation	68.1		68.1
Dividends declared	(149.1)			(149.1)
Treasury share purchases (in shares)					0.1
Treasury share purchases	(9.3)				$ (9.3)
Treasury share issuances (in shares)					(1.3)
Treasury share issuances	23.7		(78.9)		$ 102.6
Equity ending balance (in shares) at Sep. 30, 2023		68.1
Equity ending balance at Sep. 30, 2023		$ 0.3	352.8	490.9	$ (998.5)	(112.8)
Treasury shares, ending balance (in shares) at Sep. 30, 2023					11.6
Total equity, ending balance at Sep. 30, 2023	(267.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(34.9)			(34.9)
Other comprehensive income (loss)	5.5					5.5
Share-based compensation	38.9		38.9
Dividends declared	(152.2)			(152.2)
Treasury share purchases (in shares)					0.1
Treasury share purchases	(5.1)				$ (5.1)
Treasury share issuances (in shares)					(0.7)
Treasury share issuances	24.5		(30.0)		$ 54.5
Equity ending balance (in shares) at Sep. 30, 2024		68.1
Equity ending balance at Sep. 30, 2024		$ 0.3	$ 361.7	$ 303.8	$ (949.1)	$ (107.3)
Treasury shares, ending balance (in shares) at Sep. 30, 2024					11.0
Total equity, ending balance at Sep. 30, 2024	$ (390.6)

XML

Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared (USD per share)	$ 2.64	$ 2.64	$ 2.64

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor and hydroponic gardening. The Company’s products are sold in North America, Europe and Asia.

The Company’s North America consumer lawn and garden business is highly seasonal, with approximately 75% of its annual net sales occurring in the second and third fiscal quarters. The Company’s Hawthorne segment is also impacted by seasonal sales patterns for certain product categories due to the timing of growing patterns in North America during the second and third fiscal quarters, and the timing of certain controlled agricultural lighting project sales during the third and fourth fiscal quarters.

Organization and Basis of Presentation

The Company’s consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.

Advertising

Advertising costs incurred during the year are expensed to interim periods in relation to revenues. Advertising costs, except for external production costs, are generally expensed within the fiscal year in which such costs are incurred. External production costs for advertising programs are deferred until the period in which the advertising is first aired, and deferrals of these costs were not material at September 30, 2024 and 2023. On September 4, 2024, the Company issued 0.3 million restricted shares to a vendor in exchange for advertising services that will be performed during fiscal 2025. As of September 30, 2024, deferred advertising costs associated with the issuance of these restricted shares were $20.0. Advertising expenses were $141.0, $123.7 and $120.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Research and Development

Costs associated with research and development are generally charged to expense as incurred. Expenses for fiscal 2024, fiscal 2023 and fiscal 2022 were $34.6, $35.7 and $45.3, respectively, including product registration costs of $9.0, $12.4 and $13.0, respectively.

Environmental Costs

The Company recognizes environmental liabilities when conditions requiring remediation are probable and the amounts can be reasonably estimated. Expenditures which extend the life of the related property or mitigate or prevent future environmental contamination are capitalized. Environmental liabilities are not discounted or reduced for possible recoveries from insurance carriers.

Earnings per Common Share

Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding each period. Diluted income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus all dilutive potential common shares (stock options, restricted stock units, deferred stock units and performance-based award units) outstanding each period.

Share-Based Compensation Awards

Scotts Miracle-Gro grants share-based awards annually to officers and certain other associates and to the non-employee directors of Scotts Miracle-Gro. The share-based awards have consisted of stock options, restricted stock units, deferred stock units and performance-based award units. Performance-based award units are subject to performance and service conditions, and certain awards contain a market condition based on the Company’s total shareholder return relative to a Company selected peer group. All of these share-based awards have been made under plans approved by the shareholders. The fair value of awards is expensed over the requisite service period which is typically the vesting period, generally three years for awards granted to officers and other associates and one year for awards granted to non-employee directors.

For restricted stock units, deferred stock units and performance-based award units that do not contain a market condition, the fair value of each award is estimated on the grant date based on the current market price of the Common Shares. For performance-based award units that contain a market condition, the fair value of each award is estimated using a Monte Carlo simulation model. Expected market price volatility is based on historical volatility specific to the Common Shares. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The grant date fair value of stock option awards is estimated using a binomial model. Expected market price volatility is based on implied volatilities from traded options on Common Shares and historical volatility specific to the Common Shares. Historical data, including demographic factors impacting historical exercise behavior, is used to estimate stock option exercises and employee terminations within the valuation model. The risk-free rate for periods within the contractual life of the stock option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected life of stock options is based on historical experience and expectations for grants outstanding.

Vesting of performance-based award units depends on service and achievement of specified performance targets. Based on the extent to which the targets are achieved, vested shares may range from 0% to 325% of the target award amount. For performance-based award units that do not contain a market condition, the total amount of compensation expense recognized reflects management’s assessment of the probability that performance goals will be achieved. A cumulative adjustment is recognized to compensation expense in the current period to reflect any changes in the probability of achievement of performance goals. For performance-based award units that contain a market condition, compensation expense is recognized regardless of the extent to which the targets are achieved.

Restricted stock units, deferred stock units and performance-based award units receive dividend equivalents equal to the cash dividends earned during the vesting period that are only paid out upon vesting. Share-based award units are generally forfeited if a holder terminates employment or service with the Company prior to the vesting date, except in cases where associates are eligible for accelerated vesting based on having satisfied retirement requirements relating to age and years of service. The Company estimates that 15% of its share-based awards will be forfeited based on an analysis of historical trends. The Company evaluates the estimated forfeiture rate on an annual basis and makes adjustments as appropriate. Stock options have exercise prices equal to the market price of the underlying Common Shares on the grant date and a term of 10 years. If available, Scotts Miracle-Gro typically uses treasury shares, or if not available, newly-issued Common Shares, to settle vested share-based awards. The Company classifies share-based compensation expense within cost of sales or selling, general and administrative expenses to correspond with the same line item as cash compensation paid to associates. Cash flows resulting from tax deductions in excess of the cumulative compensation cost recognized for share-based awards (excess tax benefits) are classified as operating cash inflows.

Cash and Cash Equivalents

Cash and cash equivalents are held in cash depository accounts with major financial institutions around the world or invested in high quality, short-term liquid investments. The Company considers all highly liquid financial instruments with original maturities of three months or less to be cash equivalents. The Company maintains cash deposits in banks which from time to time exceed the amount of deposit insurance available. Management periodically assesses the financial condition of the Company’s banks and believes that the risk of any potential credit loss is minimal.

Accounts Receivable and Allowances

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Allowances for doubtful accounts reflect the Company’s estimate of amounts in its existing accounts receivable that may not be collected due to customer claims or customer inability or unwillingness to pay. The allowance is determined based on a combination of factors, including the Company’s ongoing risk assessment regarding the credit worthiness of its customers, historical collection experience and length of time the receivables are past due. Account balances are charged off against the allowance when the Company believes it is probable the receivable will not be recovered.

On October 27, 2023, the Company entered into the Master Receivables Purchase Agreement, under which the Company could sell up to $600.0 of available and eligible outstanding customer accounts receivable generated by sales to four specified customers. On September 1, 2024, the Company amended the Master Receivables Purchase Agreement to permit the Company to sell up to $750.0 of available and eligible outstanding customer accounts receivable generated by sales to five specified customers. The agreement is uncommitted and expires on September 1, 2025. The receivable sales are non-recourse to the Company, other than with respect to (i) repurchase obligations and indemnification obligations for any violations by the Company of its respective representations or obligations as seller or servicer and (ii) certain repurchase and payment obligations arising from any dilution of, or dispute with respect to, any purchased receivables that arise after the sale of such purchased receivables to the purchaser not contemplated in the applicable purchase price of such purchased receivable. The recourse obligations of the Company that may arise from time to time are supported by standby letters of credit of $75.0. Transactions under the Master Receivables Purchase Agreement are accounted for as sales of accounts receivable, and the receivables sold are removed from the Consolidated Balance Sheets at the time of the sales transaction. Proceeds received from the sales of accounts receivable are classified as operating cash flows and collections of previously sold accounts receivable not yet submitted to the buyer are classified as financing cash flows in the Consolidated Statements of Cash Flows. The Company records the discount on sales in the “Other (income) expense, net” line in the Consolidated Statements of Operations. At September 30, 2024, net receivables of $186.6 were derecognized. During fiscal 2024, proceeds from the sale of receivables under the Master Receivables Purchase Agreement totaled $1,938.6 and the total discount recorded on sales was $24.6.

Inventories

Inventories are stated at the lower of cost or net realizable value and include the cost of raw materials, labor, manufacturing overhead and freight and inbound handling costs incurred to pre-position goods in the Company’s warehouse network. The Company makes provisions for obsolete or slow-moving inventories as necessary to properly reflect inventory at the lower of cost or net realizable value. Inventories are valued using the first in, first out method.

Investment in Unconsolidated Affiliates

Non-marketable equity investments in which the Company has the ability to exercise significant influence, but does not control, are accounted for using the equity method of accounting, with the Company’s proportionate share of the earnings and losses of these entities reflected in the Consolidated Statements of Operations. The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may be impaired. If a decline in the value of an equity method investment is determined to be other than temporary, an impairment loss is recognized in earnings for the amount by which the carrying amount of the investment exceeds its estimated fair value.

Long-Lived Assets

Property, plant and equipment are stated at cost. Interest capitalized in property, plant and equipment amounted to $1.1, $2.1 and $2.2 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Expenditures for maintenance and repairs are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost of the asset and the related accumulated depreciation are removed from the accounts with the resulting gain or loss being reflected in income (loss) from operations.

Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows: 

Land improvements	10 – 25 years
Buildings	10 – 40 years
Machinery and equipment	3 – 15 years
Furniture and fixtures	6 – 10 years
Software	3 – 8 years

Intangible assets subject to amortization include technology, patents, customer relationships, non-compete agreements and certain trade names. These intangible assets are amortized over their estimated useful economic lives, which typically range from 3 to 25 years. The Company’s fixed assets and intangible assets subject to amortization are required to be tested for recoverability whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group would be compared to the asset group carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.

The Company had non-cash investing activities of $16.3, $32.1 and $33.3 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively, representing unpaid liabilities to acquire property, plant and equipment.

Internal Use Software

The Company capitalizes certain qualifying costs incurred in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest and payroll and payroll-related costs for associates during the application development stage. Internal and external costs incurred during the preliminary project stage and post implementation-operation stage, mainly training and maintenance costs, are expensed as incurred. Once the application is substantially complete and ready for its intended use, qualifying costs are amortized on a straight-line basis over the software’s estimated useful life. Capitalized internal use software is included in the “Property, plant and equipment, net” line in the Consolidated Balance Sheets. Capitalized software as a service is included in the “Prepaid and other current assets” line in the Consolidated Balance Sheets and is amortized using the straight-line method over the term of the hosting arrangement which typically ranges from 3 to 8 years.

Goodwill and Indefinite-lived Intangible Assets

Goodwill and indefinite-lived intangible assets are not subject to amortization. These assets are reviewed for impairment by applying a fair-value based test on an annual basis as of the first day of the Company’s fiscal fourth quarter or more frequently if circumstances indicate impairment may have occurred. With respect to goodwill, the Company performs either a qualitative or quantitative evaluation for each of its reporting units. Factors considered in the qualitative test include reporting unit specific operating results as well as new events and circumstances impacting the operations or cash flows of the reporting units. For the quantitative test, the Company assesses goodwill for impairment by comparing the carrying value of its reporting units to their respective fair values. A reporting unit is defined as an operating segment or one level below an operating segment. The Company determines the fair value of its reporting units using an income-based approach incorporating assumptions it believes market participants would utilize. The income-based approach utilizes discounted cash flows that depend upon internally-developed forecasts based on annual budgets and longer-range strategic plans. The Company uses discount rates that are commensurate with the risks and uncertainties inherent in the respective reporting units and in the internally-developed forecasts. To further substantiate fair value, the Company compares the aggregate fair value of the reporting units to the Company’s total market capitalization.

With respect to indefinite-lived intangible assets, the Company performs either a qualitative or quantitative evaluation for each asset. Factors considered in the qualitative test include asset specific operating results as well as new events and circumstances impacting the cash flows of the assets. For the quantitative test, the fair value of the Company’s indefinite-lived intangible assets is determined using an income-based approach utilizing discounted cash flows and incorporating assumptions the Company believes market participants would utilize. For trade names, fair value is determined using a relief-from-royalty methodology similar to that employed when the associated businesses were acquired but using updated estimates of sales, cash flow and profitability.

If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the reporting unit or intangible asset exceeds its estimated fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.

Investments in Securities

Convertible debt investments are classified as “available for sale,” are reported at fair value and are presented in the “Other assets” line in the Consolidated Balance Sheets. If the fair value of an available for sale investment is less than its amortized cost basis at the balance sheet date, the impairment is either temporary or other-than-temporary. If a decline in fair value is considered to be temporary at the balance sheet date, unrealized gains and losses are included in accumulated other comprehensive loss (“AOCL”) in the Consolidated Balance Sheets. If management intends to sell the security or if it is more likely than not that the Company will have to sell the security, an other-than-temporary impairment is considered to have occurred and an amount equal to the difference between the investment’s amortized cost basis and its fair value at the balance sheet date will be charged to earnings. If a decline in fair value is considered to be other-than-temporary at the balance sheet date and management can assert that it does not intend to sell the security and it is not more likely than not that it will have to sell the security before recovering its amortized cost basis (net of allowance), an allowance for credit losses (impairment), including any write-off of accrued interest receivable, is charged to earnings. This impairment allowance is separated into two components: (i) the amount related to credit losses (recorded in earnings) and (ii) the amount related to all other factors (recorded in other comprehensive income / loss). Interest income is recorded on an accrual basis and is classified in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations.

Supplier Finance Program

The Company has an agreement to provide a supplier finance program which facilitates participating suppliers’ ability to finance payment obligations of the Company with a designated third-party financial institution. Participating suppliers may, at their sole discretion, elect to finance payment obligations of the Company prior to their scheduled due dates at a discounted price to the participating financial institution. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under this arrangement. The payment terms that the Company negotiates with its suppliers are consistent, regardless of whether a supplier participates in the program. The Company’s current payment terms with a majority of its suppliers generally range from 30 to 60 days, which the Company deems to be commercially reasonable. The Company’s outstanding payment obligations under its supplier finance program were $12.5 and $18.3 at September 30, 2024 and 2023, respectively, and are recorded within accounts payable in the Consolidated Balance Sheets. The associated payments were $245.5 and $185.3 for fiscal 2024 and fiscal 2023, respectively, and are classified as operating activities in the Consolidated Statements of Cash Flows.

Insurance and Self-Insurance

The Company maintains insurance for certain risks, including property damage, management liability, cargo liability, cyber threats, workers compensation and general liability losses, and is self-insured for employee-related health care benefits up to a specified level for individual claims. The Company accrues for the expected costs associated with these risks by considering historical claims experience, demographic factors, severity factors and other relevant information. Costs are recognized in the period the claim is incurred, and accruals include an actuarially determined estimate of claims incurred but not yet reported.

Income Taxes

The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax bases. Management reviews the Company’s deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change.

The Company establishes a liability for tax return positions in which there is uncertainty as to whether or not the position will ultimately be sustained. Amounts for uncertain tax positions are adjusted in quarters when new information becomes available or when positions are effectively settled. The Company recognizes interest expense and penalties related to these unrecognized tax benefits within income tax expense. GAAP provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits of the position. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

U.S. income tax expense and foreign withholding taxes are provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.

Translation of Foreign Currencies

The functional currency for each Scotts Miracle-Gro subsidiary is generally its local currency. Assets and liabilities of these subsidiaries are translated at the exchange rate in effect at each fiscal year-end. Income and expense accounts are translated at the average rate of exchange prevailing during the year. Translation gains and losses arising from the use of differing exchange rates from period to period are included in AOCL within shareholders’ equity (deficit). Foreign exchange transaction gains and losses are included in the determination of net income and classified as “Other (income) expense, net” in the Consolidated Statements of Operations. The Company recognized foreign exchange transaction (gains) losses of $(0.4), $1.3 and $1.3 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Derivative Instruments

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. A variety of financial instruments, including forwards, futures and swap contracts, are used to manage these exposures. These financial instruments are recognized at fair value in the Consolidated Balance Sheets, and all changes in fair value are recognized in net income (loss) or shareholders’ equity (deficit) through AOCL. The Company’s objective in managing these exposures is to better control these elements of cost and mitigate the earnings and cash flow volatility associated with changes in the applicable rates and prices.

The Company has established policies and procedures that encompass risk-management philosophy and objectives, guidelines for derivative instrument usage, counterparty credit approval, and the monitoring and reporting of derivative activity. The Company does not enter into derivative instruments for the purpose of speculation.

The Company formally designates and documents instruments at inception that qualify for hedge accounting of underlying exposures in accordance with GAAP. The Company formally assesses, both at inception and at least quarterly, whether the financial instruments used in hedging transactions are effective at offsetting changes in cash flows of the related underlying exposure. Fluctuations in the value of these instruments generally are offset by changes in the expected cash flows of the underlying exposures being hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument. The Company designates certain commodity hedges as cash flow hedges of forecasted purchases of commodities and interest rate swap agreements as cash flow hedges of interest payments on variable rate borrowings. Changes in the fair value of derivative contracts that qualify for hedge accounting are recorded in AOCL. For commodity hedges, realized gains or losses remain as a component of AOCL until the related inventory is sold. Cash flows associated with commodity and interest rate swap hedges are classified as operating activities in the Consolidated Statements of Cash Flows.

Leases

The Company determines whether an arrangement contains a lease at inception by determining if the contract conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration and other facts and circumstances. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets are calculated based on the lease liability adjusted for any lease payments paid to the lessor at or before the commencement date and initial direct costs incurred by the Company and exclude any lease incentives received from the lessor. Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. The lease term may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date based on the lease term. The Company considers its credit rating and the current economic environment in determining this collateralized rate. Variable lease payments are the portion of lease payments that are not fixed over the lease term. Variable lease payments are expensed as incurred and include certain non-lease components, such as maintenance and other services provided by the lessor, and other charges included in the lease, as applicable. The Company elected to exclude short-term leases, defined as leases with initial terms of 12 months or less, from its Consolidated Balance Sheets.

Statements of Cash Flows

Supplemental cash flow information was as follows:

	Year Ended September 30,
	2024		2023		2022
Interest paid	$	157.7	$	173.5	$	112.5
Income taxes paid (refunded), net	9.4		(18.2)		27.2

During fiscal 2024, the Company acquired an additional equity interest in Bonnie Plants, LLC for $21.4, which was classified as an investing activity in the Consolidated Statements of Cash Flows. During fiscal 2023, the Company received proceeds of $37.0 related to the payoff of seller financing that the Company provided in connection with a fiscal 2017 divestiture, which was classified as an investing activity in the Consolidated Statements of Cash Flows. During fiscal 2022, the Company made an additional investment in RIV Capital Inc. (“RIV Capital”) in the form of a $25.0 convertible note, which was classified as an investing activity in the Consolidated Statements of Cash Flows. The Company received (paid) cash of $2.6, $(12.4) and $29.3 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively, primarily associated with currency forward contracts, which was classified as an investing activity in the “Other investing, net” line in the Consolidated Statements of Cash Flows. Cash flow from operating activities in fiscal 2022 was favorably impacted by extended payment terms with vendors for payments originally due in the final weeks of fiscal 2022 that were paid in the first quarter of fiscal 2023.

The Company uses the “cumulative earnings” approach for determining cash flow presentation of distributions from unconsolidated affiliates. Distributions received are included in the Consolidated Statements of Cash Flows as operating activities, unless the cumulative distributions exceed the portion of the cumulative equity in the net earnings of the unconsolidated affiliate, in which case the excess distributions are deemed to be returns of the investment and are classified as investing activities in the Consolidated Statements of Cash Flows.

RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS

In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-04, “Liabilities — Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” This ASU requires disclosure of the key terms of outstanding supplier finance programs and a roll-forward of the related obligations. ASU No. 2022-04 is effective for fiscal years beginning after December 15, 2022, except for the amendment on roll-forward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted the ASU as of October 1, 2023. The adoption relates to disclosures only and does not have any impact on the Company’s consolidated financial position, results of operations or cash flows.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU requires enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker that are included within each reported measure of segment profit or loss, and also requires all annual disclosures currently required by Topic 280 to be included in interim periods. ASU No. 2023-07 is to be applied retrospectively for all periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU primarily requires enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative and qualitative disclosures regarding income taxes paid. ASU No. 2023-09 is to be applied prospectively, with the option to apply the standard retrospectively, effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

In November 2024, the FASB issued ASU No. 2024-03, “Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” This ASU requires disaggregated disclosures on an annual and interim basis, in the notes to the financial statements, of certain categories of expenses that are included in expense line items on the face of the statement of operations. ASU No. 2024-03 is to be applied prospectively, with the option to apply the standard retrospectively, effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

XML

REVENUE RECOGNITION

12 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

REVENUE RECOGNITION

REVENUE RECOGNITION

Nature of Goods and Services

The Company’s revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers. In addition to product sales, the Company acts as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, and performs certain other services under ancillary agreements with Monsanto. Refer to “NOTE 20. SEGMENT INFORMATION” for disaggregated revenue information and “NOTE 6. MARKETING AGREEMENT” for revenue information related to the Monsanto agreements.

Identification and Satisfaction of Performance Obligations

The Company recognizes product sales at a point in time when it transfers control of products to customers and has no further obligation to provide services related to such products. Control is the ability of customers to direct the “use of” and “obtain” the benefit from the Company’s products. In evaluating the timing of the transfer of control of products to customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are typically recognized when products are delivered to or picked up by the customer. The Company is generally the principal in a transaction and, therefore, primarily records revenue on a gross basis. When the Company is a principal in a transaction, it has determined that it controls the ability to direct the use of the product prior to transfer to a customer, is primarily responsible for fulfilling the promise to provide the product or service to the customer, has discretion in establishing prices, and ultimately controls the transfer of the product or services provided to the customer.

Under the terms of the Third Restated Agreement, pursuant to which the Company serves as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The Third Restated Agreement also requires the Company to make annual payments to Monsanto as a contribution against the overall expenses of its consumer Roundup® business. The gross commission earned under the Third Restated Agreement and the contribution payments to Monsanto are included in the “Net sales” line in the Consolidated Statements of Operations. The Company performs other services, including conversion services, pursuant to ancillary agreements with Monsanto. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross margin dollars or net income.

Transactional Price and Promotional Allowances

Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that the Company expects to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns. Commission income related to the Monsanto agreements is recognized over the program year as the services are performed based upon the commission income formula in the agreements.

The Company’s promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotional costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Accruals for expected payouts under these programs are included in the “Other current liabilities” line in the Consolidated Balance Sheets. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Consolidated Statements of Operations. The Company excludes from revenue any amounts collected from customers for sales or other taxes.

XML

IMPAIRMENT, RESTRUCTURING AND OTHER

12 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

IMPAIRMENT, RESTRUCTURING AND OTHER

IMPAIRMENT, RESTRUCTURING AND OTHER

Activity described herein is classified within the “Cost of sales—impairment, restructuring and other” and “Impairment, restructuring and other” lines in the Consolidated Statements of Operations. The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:

	Year Ended September 30,
	2024		2023		2022
Cost of sales—impairment, restructuring and other:
Restructuring and other charges, net	$	72.9	$	148.5	$	143.6
Property, plant and equipment impairments	5.3		11.4		16.6
Right-of-use asset impairments	5.3		25.8		—
Operating expenses—impairment, restructuring and other:
Convertible debt other-than-temporary impairments	64.6		101.3		—
Goodwill and intangible asset impairments	2.5		127.9		668.3
Restructuring and other charges (recoveries), net	(4.3)		51.2		40.9
Gains on sale of property, plant and equipment	—		—		(16.2)
Total impairment, restructuring and other charges	$	146.3	$	466.1	$	853.2

The following table summarizes the activity related to liabilities associated with restructuring activities for each of the periods presented:

	Year Ended September 30,
	2024		2023		2022
Amounts accrued at beginning of year	$	40.5	$	31.5	$	1.9
Restructuring charges	11.8		55.6		47.1
Payments	(33.4)		(46.6)		(17.5)
Amounts accrued at end of year	$	18.9	$	40.5	$	31.5

As of September 30, 2024, restructuring accruals include $5.7 that is classified as long-term.

During fiscal 2024 and fiscal 2023, the Company recorded non-cash, pre-tax other-than-temporary impairment charges related to its convertible debt investments of $64.6 and $101.3, respectively, in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. Refer to “NOTE 16. FAIR VALUE MEASUREMENTS” for more information regarding convertible debt investments.

During fiscal 2024, the Company recorded a gain of $12.1 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with a payment received in resolution of a dispute with the former ownership group of a business that was acquired in fiscal 2022.

During fiscal 2022, the Company began implementing a series of Company-wide organizational changes and initiatives intended to create operational and management-level efficiencies. As part of this restructuring initiative, the Company reduced the size of its supply chain network, reduced staffing levels and implemented other cost-reduction initiatives. The Company also accelerated the reduction of certain Hawthorne inventory, primarily lighting, growing environments and hardware products, to reduce on hand inventory to align with the reduced network capacity. During fiscal 2024, the Company incurred costs of $89.4 associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets, intangible assets, property, plant and equipment and software. The Company incurred costs of $11.3 in its U.S. Consumer segment and $71.8 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2024. The Company incurred costs of $1.5 in its U.S. Consumer segment, $1.0 in its Hawthorne segment, $1.1 in its Other segment and $2.4 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2024. During fiscal 2023, the Company incurred costs of $229.0 associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets and property, plant and equipment. The Company incurred costs of $16.3 in its U.S. Consumer segment and $168.5 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2023. The Company incurred costs of $7.7 in its U.S. Consumer segment, $20.7 in its Hawthorne segment, $0.8 in its Other segment and $14.9 at Corporate in the “Impairment, restructuring and other”

line in the Consolidated Statements of Operations during fiscal 2023. During fiscal 2022, the Company incurred costs of $65.2 associated with this restructuring initiative primarily related to employee termination benefits and impairment of property, plant and equipment. The Company incurred costs of $9.7 in its U.S. Consumer segment and $27.1 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. The Company incurred costs of $11.9 in its U.S. Consumer segment, $8.1 in its Hawthorne segment, $0.7 in its Other segment and $7.7 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. Costs incurred since the inception of this restructuring initiative through September 30, 2024 were $58.3 for the U.S. Consumer segment, $297.2 for the Hawthorne segment, $2.9 for the Other segment and $25.1 at Corporate.

During fiscal 2023, the Company recorded non-cash, pre-tax goodwill and intangible asset impairment charges of $127.9 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, comprised of $117.7 of finite-lived intangible asset impairment charges associated with the Hawthorne segment and $10.3 of goodwill impairment charges associated with the Other segment.

During fiscal 2022, the Company recorded non-cash, pre-tax goodwill and intangible asset impairment charges of $632.4 as a result of interim impairment testing of its Hawthorne segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, comprised of $522.4 of goodwill impairment charges and $110.0 of finite-lived intangible asset impairment charges.

During fiscal 2022, the Company incurred inventory write-down charges of $120.9 in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations and finite-lived intangible asset impairment charges of $35.3 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with its decision to discontinue and exit the market for certain Hawthorne lighting products and brands.

During fiscal 2022, the Company recorded gains of $16.2 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with the sale of property, plant and equipment.

XML

GOODWILL AND INTANGIBLE ASSETS, NET

12 Months Ended

Sep. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS, NET

GOODWILL AND INTANGIBLE ASSETS, NET

The following table displays a rollforward of the carrying amount of goodwill by reportable segment:

	U.S. Consumer		Hawthorne		Other		Total
Goodwill	$	245.7	$	617.0	$	10.1	$	872.8
Accumulated impairment losses	(1.8)		(617.0)		—		(618.8)
Balance at September 30, 2022	243.9		—		10.1		254.0
Foreign currency translation	—		—		0.2		0.2
Impairment	—		—		(10.3)		(10.3)
Goodwill	245.7		617.0		10.3		873.0
Accumulated impairment losses	(1.8)		(617.0)		(10.3)		(629.1)
Balance at September 30, 2023	243.9		—		—		243.9
Goodwill	245.7		617.0		10.3		873.0
Accumulated impairment losses	(1.8)		(617.0)		(10.3)		(629.1)
Balance at September 30, 2024	$	243.9	$	—	$	—	$	243.9

The following table presents intangible assets, net of accumulated amortization and impairment charges:

	September 30, 2024						September 30, 2023
	Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount
Finite-lived intangible assets:
Trade names	$	325.8	$	(272.8)	$	53.0	$	322.4	$	(260.7)	$	61.7
Customer relationships	253.1		(223.9)		29.2		251.5		(216.1)		35.4
Technology	50.2		(45.5)		4.7		50.1		(44.5)		5.6
Other	35.0		(27.0)		8.0		34.9		(24.8)		10.1
Total finite-lived intangible assets, net					94.9						112.8
Indefinite-lived intangible assets:
Indefinite-lived trade names					168.2						168.2
Roundup® marketing agreement amendment					155.7						155.7
Total indefinite-lived intangible assets					323.9						323.9
Total intangible assets, net					$	418.8					$	436.7

During fiscal 2023, the Company identified circumstances that indicated the carrying amounts of Hawthorne’s long-lived assets, including trade names and customer relationships, may not be recoverable. Accordingly, the Company performed a recoverability test for long-lived assets during the fourth quarter of fiscal 2023. The Company concluded that the carrying value of these long-lived assets exceeded their estimated fair value and recorded non-cash, pre-tax impairment charges of $72.0 related to trade names and $45.7 related to customer relationships during the fourth quarter of fiscal 2023 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The fair values of long-lived assets were determined using income-based approaches, including the relief-from-royalty method for trade names, that include market participant expectations of cash flows that the assets will generate over the remaining useful life discounted to present value using an appropriate discount rate. These fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.

The Company performed annual goodwill impairment testing as of the first day of its fourth quarter of fiscal 2023. This test resulted in a non-cash, pre-tax goodwill impairment charge of $10.3 related to the Other segment, which was recorded during the fourth quarter of fiscal 2023 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The carrying value of goodwill of the Other segment reporting unit after recognizing the impairment is zero. The estimated fair value of the Other segment reporting unit was based upon an equal weighting of the income-based and market-based approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to the operating performance of the reporting unit. The fair value estimate utilizes significant unobservable inputs and thus represents a Level 3 fair value measurement.

Total amortization expense was $15.7, $25.2 and $37.1 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Amortization expense is estimated to be as follows for the years ending September 30:

2025	$	12.6
2026	11.5
2027	10.7
2028	9.1
2029	6.9

XML

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS

12 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS

The following presents detail regarding certain financial statement accounts:

	September 30,
	2024		2023
INVENTORIES:
Raw materials	$	256.8	$	272.5
Finished goods	246.6		506.2
Work-in-progress	84.1		101.6
	$	587.5	$	880.3
PROPERTY, PLANT AND EQUIPMENT, NET:
Machinery and equipment	$	683.6	$	651.7
Buildings	305.8		277.1
Land and improvements	152.9		149.0
Software	107.2		109.9
Construction in progress	78.7		104.6
Furniture and fixtures	62.6		62.3
Finance leases	24.1		21.1
	1,414.9		1,375.7
Less: accumulated depreciation	(805.4)		(765.4)
	$	609.5	$	610.3
OTHER ASSETS:
Operating lease right-of-use assets	$	265.4	$	262.6
Net deferred tax assets	191.3		189.8
Accrued pension, postretirement and executive retirement assets	62.7		64.1
Convertible debt investments	45.8		85.8
Other	8.9		30.8
	$	574.1	$	633.1

	September 30,
	2024		2023
OTHER CURRENT LIABILITIES:
Advertising and promotional accruals	$	131.2	$	143.0
Current operating lease liabilities	75.3		76.4
Payroll and other compensation accruals	72.0		51.2
Accrued interest	29.4		31.9
Accrued taxes	16.7		28.5
Other	118.4		119.2
	$	443.0	$	450.2
OTHER NON-CURRENT LIABILITIES:
Non-current operating lease liabilities	$	215.8	$	220.1
Accrued pension, postretirement and executive retirement liabilities	73.0		76.7
Net deferred tax liabilities	7.0		1.1
Other	42.2		52.0
	$	338.0	$	349.9

XML

MARKETING AGREEMENT

12 Months Ended

Sep. 30, 2024

Marketing Agreement [Abstract]

MARKETING AGREEMENT

MARKETING AGREEMENT

The Scotts Company LLC (“Scotts LLC”) is the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries. The annual commission payable under the Third Restated Agreement is equal to 50% of the actual earnings before interest and income taxes of Monsanto’s consumer Roundup® business for each program year in the markets covered by the Third Restated Agreement (“Program EBIT”). The Third Restated Agreement also requires the Company to make annual payments of $18.0 to Monsanto as a contribution against the overall expenses of its consumer Roundup® business, subject to reduction pursuant to the Third Restated Agreement for any program year in which the Program EBIT does not equal or exceed $36.0.

Unless Monsanto terminates the Third Restated Agreement due to an event of default by the Company, termination rights under the Third Restated Agreement include the following:

•The Company may terminate the Third Restated Agreement upon the insolvency or bankruptcy of Monsanto;

•Monsanto may terminate the Third Restated Agreement in the event that Monsanto decides to decommission the permits, licenses and registrations needed for, and the trademarks, trade names, packages, copyrights and designs used in, the sale of the Roundup® products in the lawn and garden market (a “Brand Decommissioning Termination”); and

•Each party may terminate the Third Restated Agreement if Program EBIT falls below $50.0 and, in such case, no termination fee would be payable to either party.

The termination fee structure requires Monsanto to pay a termination fee to the Company in an amount equal to (i) $375.0 upon a Brand Decommissioning Termination, and (ii) the greater of $175.0 or four times an amount equal to the average of the Program EBIT for the three program years before the year of termination, minus $186.4, if Monsanto or its successor terminates the Third Restated Agreement as a result of a Roundup Sale or Change of Control of Monsanto (each, as defined in the Third Restated Agreement).

The elements of the net commission and reimbursements earned under the Third Restated Agreement and included in the “Net sales” line in the Consolidated Statements of Operations are as follows:

	Year Ended September 30
	2024		2023		2022
Gross commission	$	90.8	$	75.7	$	83.4
Contribution expenses	(18.0)		(18.0)		(18.0)
Net commission	72.8		57.7		65.4
Reimbursements associated with Roundup® marketing agreement	91.2		82.5		67.9
Total net sales associated with Roundup® marketing agreement	$	164.0	$	140.2	$	133.3

XML

ACQUISITIONS AND INVESTMENTS

12 Months Ended

Sep. 30, 2024

Business Combinations [Abstract]

ACQUISITIONS AND INVESTMENTS

ACQUISITIONS AND INVESTMENTS

CYCO

On April 28, 2022, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of S.J. Enterprises PTY LTD, d.b.a. CYCO (“CYCO”), an Australia-based provider of premium nutrients, additives and growing media products for indoor growing sold mostly in the United States, for an estimated purchase price of $37.3. The purchase price includes contingent consideration, a non-cash investing activity, with an initial fair value of $3.1 and a maximum payout of $10.0, which is based on the achievement of certain performance metrics through December 31, 2024 and is not expected to be paid. Prior to the transaction, the Company served as the exclusive distributor of CYCO’s products in the United States. The valuation of the acquired assets included (i) $1.3 of inventory, (ii) $10.5 of finite-lived identifiable intangible assets and (iii) $25.6 of tax-deductible goodwill. Identifiable intangible assets included trade names, customer relationships and non-compete agreements with initial useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate.

Luxx Lighting

On December 30, 2021, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of Luxx Lighting, Inc., a provider of lighting products for indoor growing. The purchase price was $213.2, a portion of which was paid by the issuance of 0.1 million Common Shares, a non-cash investing and financing activity, with a fair value of $21.0 based on the share price at the time of payment. The valuation of the acquired assets included (i) $32.8 of inventory and accounts receivable, (ii) $5.7 of other current assets, (iii) $24.2 of current liabilities, (iv) $47.3 of finite-lived identifiable intangible assets and (v) $151.6 of tax-deductible goodwill. Identifiable intangible assets included trade names, customer relationships and non-compete agreements with initial useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. During the fourth quarter of fiscal 2022, the Company decided it would discontinue and exit the market for certain Hawthorne lighting products and brands, including Luxx Lighting, Inc. Refer to “NOTE 3. IMPAIRMENT, RESTRUCTURING AND OTHER” for more information.

True Liberty Bags

On December 23, 2021, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of True Liberty Bags, a leading provider of liners and storage solutions to dry and cure plant products, for $10.1. The valuation of the acquired assets included (i) $1.1 of inventory, (ii) $5.8 of finite-lived identifiable intangible assets and (iii) $3.2 of tax-deductible goodwill. Identifiable intangible assets included trade names and customer relationships with initial useful lives of 15 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate.

XML

INVESTMENT IN UNCONSOLIDATED AFFILIATES

12 Months Ended

Sep. 30, 2024

Equity Method Investments and Joint Ventures [Abstract]

INVESTMENT IN UNCONSOLIDATED AFFILIATES

INVESTMENT IN UNCONSOLIDATED AFFILIATES

The Company holds a 50% equity interest in Bonnie Plants, LLC, a joint venture with AFC focused on planting, growing, developing, distributing, marketing and selling live plants. During the three months ended December 31, 2022, the Company and AFC amended the joint venture agreement to allow AFC to make an additional equity contribution to Bonnie Plants, LLC, and, as a result of this contribution by AFC, the Company’s equity interest in Bonnie Plants, LLC was reduced to 45%. On November 7, 2023, the Company purchased an additional 5% equity interest in Bonnie Plants, LLC from AFC for $21.4, which restored its total equity interest back to 50%. The Company’s interest is accounted for using the equity method of accounting, with the Company’s proportionate share of Bonnie Plants, LLC earnings reflected in the Consolidated Statements of Operations.

The Company recorded equity in loss of unconsolidated affiliates associated with Bonnie Plants, LLC of $68.1, $101.1 and $12.9 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. The Company recorded pre-tax impairment charges associated with its investment in Bonnie Plants, LLC of $61.9 and $94.7 in the “Equity in loss of unconsolidated affiliates” line in the Consolidated Statements of Operations during fiscal 2024 and fiscal 2023, respectively. The impairment charges were driven by revisions to the Company’s internal forecasts for Bonnie Plants, LLC in response to decreased sales volume and inflationary cost pressures. The estimated fair value of Bonnie Plants, LLC was based upon an equal weighting of the income-based and market-based approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to the operating performance of the investment. The fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.

As a result of the impairment charges recorded by the Company during fiscal 2024 and fiscal 2023, the carrying value of the Company’s equity method investment is lower than its interest in Bonnie Plants, LLC’s underlying net assets as of September 30, 2024. Of this basis difference, the majority relates to goodwill and indefinite-lived intangible assets recorded by Bonnie Plants, LLC, which are not amortized. The remaining amount relates to long-lived assets, including finite-lived intangible assets, and will be amortized over the remaining useful life of the long-lived assets.

XML

RETIREMENT PLANS

12 Months Ended

Sep. 30, 2024

Retirement Benefits [Abstract]

RETIREMENT PLANS

RETIREMENT PLANS

The Company sponsors a defined contribution 401(k) plan for substantially all U.S. associates. The Company matches 200% of associates’ initial 3% contribution and 50% of their remaining contribution up to 6%. The Company may make additional discretionary profit sharing matching contributions to eligible associates on their initial 4% contribution. The Company recorded expenses of $23.7, $24.1 and $28.3 associated with the plan in fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

The Company sponsors two defined benefit pension plans for certain U.S. associates and three defined benefit pension plans associated with the former businesses in the United Kingdom and Germany. Benefits under these plans have been frozen and closed to new associates since 1997 for the U.S. plans, 2010 for the United Kingdom plans and 2017 for the Germany plan. The benefits under the plans are based on years of service and compensation levels. The Company’s funding policy for the defined benefit pension plans, consistent with statutory requirements and tax considerations, is based on actuarial computations using the Projected Unit Credit method.

During fiscal 2023 and 2021, the defined benefit pension plans associated with the former business in the United Kingdom entered into buy-in insurance policies in exchange for premium payments of $76.3 and $67.7, respectively, which are subject to adjustment as a result of subsequent data cleansing activities. Under the terms of these buy-in insurance policies, the respective insurers are liable to pay the benefits to the plans, but the plans still retain full legal responsibility to pay benefits to plan participants using the insurance payments. The buy-in policies will be treated as assets of the plans going forward until such time as the buy-in policies are converted to buy-out policies, which is when individual insurance policies will be assigned to each plan participant and the plans will no longer have legal responsibility to pay the benefits to the plan participants.

The following tables present information about benefit obligations, plan assets, annual expense, assumptions and other information about the Company’s defined benefit pension plans. The defined benefit pension plans are valued using a September 30 measurement date.

	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2024		2023		2024		2023
Change in projected benefit obligation:
Benefit obligation at beginning of year	$	71.8	$	77.7	$	108.5	$	109.2
Interest cost	3.7		3.6		5.9		6.2
Actuarial (gain) loss	5.5		(2.5)		5.1		(11.0)
Benefits paid	(6.8)		(6.9)		(6.6)		(5.9)
Foreign currency translation	—		—		10.3		10.0
Projected benefit obligation (“PBO”) at end of year	$	74.2	$	71.8	$	123.2	$	108.5
Accumulated benefit obligation (“ABO”) at end of year	$	74.2	$	71.8	$	123.2	$	108.5
Change in plan assets:
Fair value of plan assets at beginning of year	$	54.1	$	59.1	$	124.8	$	128.9
Actual return on plan assets	7.1		1.7		10.0		(11.5)
Employer contribution	2.9		0.2		0.9		1.2
Benefits paid	(6.8)		(6.9)		(6.6)		(5.9)
Foreign currency translation	—		—		12.3		12.1
Fair value of plan assets at end of year	$	57.3	$	54.1	$	141.4	$	124.8
Overfunded (underfunded) status at end of year	$	(16.9)	$	(17.7)	$	18.2	$	16.3

	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2024		2023		2024		2023
Information for pension plans with an ABO in excess of plan assets:
Accumulated benefit obligation	$	74.2	$	71.8	$	12.0	$	11.5
Fair value of plan assets	57.3		54.1		—		—
Information for pension plans with a PBO in excess of plan assets:
Projected benefit obligation	$	74.2	$	71.8	$	12.0	$	11.5
Fair value of plan assets	57.3		54.1		—		—
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	$	—	$	—	$	30.2	$	27.8
Current liabilities	(0.2)		(0.2)		(0.9)		(0.9)
Non-current liabilities	(16.7)		(17.5)		(11.1)		(10.6)
Total amount accrued	$	(16.9)	$	(17.7)	$	18.2	$	16.3
Amounts recognized in AOCL consist of:
Actuarial loss	$	34.1	$	35.2	$	64.1	$	60.0
Prior service cost	—		—		2.3		2.1
Total amount recognized	$	34.1	$	35.2	$	66.4	$	62.1

	U.S. Defined Benefit Pension Plans						International Defined Benefit Pension Plans
	2024			2023			2024			2023
Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	$	(0.5)		$	1.8		$	(0.7)		$	(6.0)
Reclassification to net earnings	1.7			1.8			2.3			2.0
Foreign currency translation	—			—			(5.9)			(4.8)
Total change in other comprehensive loss	$	1.2		$	3.6		$	(4.3)		$	(8.8)
Weighted average assumptions used in development of projected benefit obligation:
Discount rate	4.62		%	5.54		%	4.86		%	5.38		%

 

	U.S. Defined Benefit Pension Plans									International Defined Benefit Pension Plans
	2024			2023			2022			2024			2023			2022
Components of net periodic benefit cost (income):
Interest cost	$	3.7		$	3.6		$	1.7		$	5.9		$	6.2		$	3.0
Expected return on plan assets	(2.2)			(2.5)			(2.8)			(5.7)			(5.5)			(5.1)
Net amortization	1.7			1.8			1.7			2.3			2.0			1.3
Net periodic benefit cost (income)	$	3.2		$	2.9		$	0.6		$	2.5		$	2.7		$	(0.8)
Weighted average assumptions used in development of net periodic benefit cost (income):
Weighted average discount rate - interest cost	5.46		%	4.87		%	1.74		%	5.38		%	5.29		%	1.64		%
Expected return on plan assets	4.25		%	4.50		%	3.50		%	4.42		%	3.91		%	2.37		%

Investment Strategy

Target allocation percentages among various asset classes are maintained based on an individual investment policy established for each of the various pension plans. Asset allocations are designed to achieve long-term objectives of return while mitigating against downside risk considering expected cash requirements necessary to fund benefit payments. However, the Company cannot predict future investment returns and therefore cannot determine whether future pension plan funding requirements could materially and adversely affect its financial condition, results of operations or cash flows.

Basis for Long-Term Rate of Return on Asset Assumptions

The Company’s expected long-term rate of return on asset assumptions are derived from studies conducted by third parties. The studies include a review of anticipated future long-term performance of individual asset classes and consideration of the appropriate asset allocation strategy given the anticipated requirements of the plans to determine the average rate of earnings expected. While the studies give appropriate consideration to recent fund performance and historical returns, the assumptions primarily represent expectations about future rates of return over the long term.

	U.S. Defined Benefit Pension Plans			International Defined Benefit Pension Plans
Other information:
Plan asset allocations:
Target for September 30, 2025:
Equity securities	19		%	—		%
Debt securities	76		%	—		%
Real estate securities	3		%	—		%
Cash and cash equivalents	2		%	15		%
Insurance contracts	—		%	85		%
September 30, 2024
Equity securities	19		%	—		%
Debt securities	74		%	—		%
Real estate securities	2		%	—		%
Cash and cash equivalents	5		%	15		%
Insurance contracts	—		%	85		%
September 30, 2023
Equity securities	18		%	—		%
Debt securities	75		%	5		%
Real estate securities	3		%	—		%
Cash and cash equivalents	4		%	11		%
Insurance contracts	—		%	84		%
Expected company contributions in fiscal 2025	$	2.7		$	0.9
Expected future benefit payments:
2025	$	7.5		$	7.3
2026	7.0			7.4
2027	6.9			7.4
2028	6.7			7.6
2029	6.5			7.8
2030 – 2034	28.4			40.5

The following tables set forth the fair value of the Company’s pension plan assets, segregated by level within the fair value hierarchy:

	Fair Value Hierarchy Level	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
		2024		2023		2024		2023
Cash and cash equivalents	Level 1	$	2.6	$	2.2	$	21.9	$	14.0
Insurance contracts	Level 3	—		—		119.5		104.3
Total assets in the fair value hierarchy		$	2.6	$	2.2	$	141.4	$	118.3
Common collective trusts measured at net asset value
Real estate		$	1.4	$	1.8	$	—	$	—
Equities		10.9		10.0		—		—
Fixed income		42.4		40.1		—		6.5
Total common collective trusts measured at net asset value		54.7		51.9		—		6.5
Total assets at fair value		$	57.3	$	54.1	$	141.4	$	124.8

The carrying value of cash equivalents approximated their aggregate fair value as of September 30, 2024 and 2023. The valuation of the buy-in insurance policies was calculated on an insurer pricing basis updated for changes in market implied insurance pricing, market rates, and inflation, and was estimated using unobservable inputs. Common collective trusts are not publicly traded and were valued at a net asset value unit price determined by the portfolio’s sponsor based on the fair value of underlying assets held by the common collective trust on September 30, 2024 and 2023. The common collective trusts hold underlying investments that have prices derived from quoted prices in active markets. The underlying assets are principally marketable equity and fixed income securities.

XML

ASSOCIATE MEDICAL BENEFITS

12 Months Ended

Sep. 30, 2024

Defined Benefit Plan, Postretirement Medical Plan with Prescription Drug Benefits [Abstract]

ASSOCIATE MEDICAL BENEFITS

ASSOCIATE MEDICAL BENEFITS

The Company provides comprehensive major medical benefits to its associates. The Company is self-insured for certain health benefits up to $1.0 per occurrence per individual. The cost of such benefits is recognized as expense in the period the claim is incurred and was $42.5, $40.1 and $46.6 in fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

The Company also provides comprehensive major medical benefits to certain retired associates and their dependents. Substantially all of the Company’s domestic associates who were hired before January 1, 1998 become eligible for these benefits if they retire at age 55 or older with more than ten years of service. The retiree medical plan requires certain minimum contributions from retired associates and includes provisions to limit the overall cost increases the Company is required to cover. The Company funds its portion of retiree medical benefits as claims are paid.

The following tables set forth information about the retiree medical plan for domestic associates. The retiree medical plan is valued using a September 30 measurement date.

	2024		2023
Change in Accumulated Plan Benefit Obligation (“APBO”):
Benefit obligation at beginning of year	$	13.3	$	15.7
Service cost	0.1		0.1
Interest cost	0.8		0.8
Plan participants’ contributions	0.3		0.4
Actuarial (gain) loss	1.5		(2.2)
Benefits paid	(2.2)		(1.5)
Benefit obligation at end of year	$	13.8	$	13.3
Change in plan assets:
Fair value of plan assets at beginning of year	$	—	$	—
Employer contribution	1.9		1.1
Plan participants’ contributions	0.3		0.4
Gross benefits paid	(2.2)		(1.5)
Fair value of plan assets at end of year	$	—	$	—
Unfunded status at end of year	$	(13.8)	$	(13.3)

	2024			2023
Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities	$	(1.3)		$	(1.4)
Non-current liabilities	(12.5)			(11.9)
Total amount accrued	$	(13.8)		$	(13.3)
Amounts recognized in accumulated other comprehensive (income) loss consist of:
Actuarial gain	$	(1.3)		$	(3.4)
Total accumulated other comprehensive income	$	(1.3)		$	(3.4)
Total change in other comprehensive income attributable to:
Gain (loss) during the period	$	(1.5)		$	2.2
Reclassification to net earnings	(0.6)			(0.2)
Total change in other comprehensive income	$	(2.1)		$	2.0
Discount rate used in development of APBO	4.86		%	5.98		%

Net periodic benefit cost (income) was $0.3, $0.7 and $(0.2) during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. For measurement as of September 30, 2024, management has assumed that health care costs will increase at an annual rate of 6.50%, and thereafter decrease to an ultimate trend rate of 4.50% in 2033.

The following benefit payments under the plan are expected to be paid by the Company and the retirees for the fiscal years indicated:

	Gross Benefit Payments		Retiree Contributions		Net Company Payments
2025	$	1.6	$	(0.3)	$	1.3
2026	1.8		(0.4)		1.3
2027	1.9		(0.6)		1.4
2028	2.0		(0.7)		1.3
2029	2.1		(0.7)		1.3
2030 – 2034	9.5		(3.7)		5.7

XML

DEBT

12 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

DEBT

DEBT

The components of debt are as follows:

	September 30,
	2024		2023
Credit Facilities:
Revolving loans	$	—	$	88.3
Term loans	625.0		925.0
Senior Notes due 2031 – 4.000%	500.0		500.0
Senior Notes due 2032 – 4.375%	400.0		400.0
Senior Notes due 2029 – 4.500%	450.0		450.0
Senior Notes due 2026 – 5.250%	250.0		250.0
Finance lease obligations	17.8		16.9
Other	—		0.4
Total debt	2,242.8		2,630.6
Less current portions	52.6		52.3
Less unamortized debt issuance costs	16.0		20.9
Long-term debt	$	2,174.2	$	2,557.4

The Company’s aggregate scheduled maturities of debt by fiscal year, excluding finance lease obligations, are as follows:

2025	$	50.0
2026	50.0
2027	775.0
2028	—
2029	—
Thereafter	1,350.0
	$	2,225.0

Credit Facilities

On April 8, 2022, the Company entered into the Sixth A&R Credit Agreement, providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2,500.0, comprised of a revolving credit facility of $1,500.0 and a term loan in the original principal amount of $1,000.0. The Sixth A&R Credit Agreement will terminate on April 8, 2027. The Sixth A&R Credit Facilities are available for the issuance of letters of credit up to $100.0. The terms of the Sixth A&R Credit Agreement include customary representations and warranties, affirmative and negative covenants, financial covenants, and events of default.

Under the terms of the Sixth A&R Credit Agreement, loans bear interest, at the Company’s election, at a rate per annum equal to either (i) the Alternate Base Rate plus the Applicable Spread (each, as defined in the Sixth A&R Credit Agreement) or (ii) the Adjusted Term SOFR Rate for the Interest Period in effect for such borrowing plus the Applicable Spread (all as defined in the Sixth A&R Credit Agreement). Swingline Loans bear interest at the applicable Swingline Rate set forth in the Sixth A&R Credit Agreement. Interest rates for other select non-U.S. dollar borrowings, including borrowings denominated in euro, Pounds Sterling and Canadian dollars, are based on separate interest rate indices, as set forth in the Sixth A&R Credit Agreement.

On June 8, 2022, the Company entered into Amendment No. 1 to the Sixth A&R Credit Agreement. Amendment No. 1 increased the maximum permitted leverage ratio for the quarterly leverage covenant until April 1, 2024. Amendment No. 1 also increased the interest rate applicable to borrowings under the revolving credit facility by 35 bps and the term loan facility by 50 bps, and increased the annual facility fee rate on the revolving credit facility by 15 bps, in each case, when the Company’s quarterly-tested leverage ratio exceeded 4.75.

On July 31, 2023, the Company entered into Amendment No. 2 to the Sixth A&R Credit Agreement. Amendment No. 2 (i) reduces the revolving loan commitments by $250.0; (ii) increases the maximum permitted leverage ratio for the quarterly leverage covenant during the Leverage Adjustment Period; (iii) replaces the interest coverage covenant with a fixed charge coverage covenant; (iv) increases the interest rate applicable to borrowings under the revolving credit facility and the term loan facility by 25 bps for each existing pricing tier and adds a pricing tier applicable to periods when the leverage ratio exceeds 6.00; (v) limits the amount of certain incremental investments, loans and advances to $25.0 during the Leverage Adjustment Period; and (vi) adds the Company’s intellectual property (subject to certain exceptions) as collateral to secure its obligations under the Sixth A&R Credit Agreement. Additionally, Amendment No. 2 limits the Company’s ability to declare or pay any discretionary dividends, distributions or other restricted payments during the Leverage Adjustment Period to only the payment of (i) regularly scheduled cash dividends to holders of its Common Shares in an aggregate amount not to exceed $225.0 per fiscal year and (ii) other dividends, distributions or restricted payments in an aggregate amount not to exceed $25.0. Amendment No. 2 also subjects the Company’s ability to make certain investments to pro forma compliance with certain leverage levels specified in Amendment No. 2. Pursuant to Amendment No. 2, the Sixth A&R Credit Agreement is secured by (i) a perfected first priority security interest in all of the accounts receivable, inventory, equipment and intellectual property (subject to certain exceptions) of Scotts Miracle-Gro and certain of its domestic subsidiaries and (ii) the pledge of all of the capital stock of certain of Scotts Miracle-Gro’s domestic subsidiaries and a portion of the capital stock of certain of its foreign subsidiaries.

At September 30, 2024, the Company had letters of credit outstanding in the aggregate principal amount of $83.0, and had $1,167.0 of borrowing availability under the Sixth A&R Credit Agreement. The weighted average interest rates on average borrowings under the credit facilities, excluding the impact of interest rate swaps, were 9.1%, 7.6% and 2.8% for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

During fiscal 2024, the Company used available cash on hand to make repayments on the term loan of the Sixth A&R Credit Agreement in the amount of $250.0, which was applied to the outstanding principal amount.

The Sixth A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio determined as of the end of each of its fiscal quarters calculated as average total indebtedness, divided by the Company’s Adjusted EBITDA. Pursuant to Amendment No. 2, the maximum permitted leverage ratio is (i) 6.00 for the fourth quarter of fiscal 2024, (ii) 5.50 for the first quarter of fiscal 2025, (iii) 5.25 for the second quarter of fiscal 2025, (iv) 5.00 for the third quarter of fiscal 2025, (v) 4.75 for the fourth quarter of fiscal 2025 and (vi) 4.50 for the first quarter of fiscal 2026 and thereafter. The Company’s leverage ratio was 4.86 at September 30, 2024. Pursuant to Amendment No. 2, the Sixth A&R Credit Agreement also contains an affirmative covenant regarding the Company’s fixed charge coverage ratio determined as of the end of each of its fiscal quarters, calculated as Adjusted EBITDA minus capital expenditures and expense for taxes paid in cash, divided by the sum of interest expense plus restricted payments, as described in Amendment No. 2. The minimum required fixed charge coverage ratio is 1.00. The Company’s fixed charge coverage ratio was 1.27 for the twelve months ended September 30, 2024.

As of September 30, 2024, the Company was in compliance with all applicable covenants in the agreements governing its debt. Based on the Company’s projections of its financial performance for the twelve-month period subsequent to the date of the filing of this Form 10-K, the Company expects to remain in compliance with the financial covenants under the Sixth A&R Credit Agreement. However, the Company’s assessment of its ability to meet its future obligations is inherently subjective, judgment-based, and susceptible to change based on future events. A covenant violation may result in an event of default. Such a default would allow the lenders under the Sixth A&R Credit Agreement to accelerate the maturity of the indebtedness thereunder and would also implicate cross-default provisions under the Senior Notes, and cause the Senior Notes to become due and payable at that time. As of September 30, 2024, the Company’s indebtedness under the Sixth A&R Credit Agreement and Senior Notes was $2,225.0. The Company does not have sufficient cash on hand or available liquidity that can be utilized to repay these outstanding amounts in the event of default.

As part of its contingency planning to address potential future circumstances that could result in noncompliance, the Company has contemplated alternative plans including additional restructuring activities to reduce operating expenses and certain cash management strategies that are within the Company’s control. Additionally, the Company has contemplated alternative plans that are subject to market conditions and not in the Company’s control, including, among others, discussions with its lenders to amend the terms of its financial covenants under the Sixth A&R Credit Agreement and generating cash by completing other financing transactions, which may include issuing equity. There is no assurance that the Company will be successful in implementing these alternative plans.

Senior Notes

On December 15, 2016, Scotts Miracle-Gro issued $250.0 aggregate principal amount of 5.250% Senior Notes due 2026. The 5.250% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 5.250% Senior Notes have interest payment dates of June 15 and December 15 of each year.

On October 22, 2019, Scotts Miracle-Gro issued $450.0 aggregate principal amount of 4.500% Senior Notes due 2029. The 4.500% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.500% Senior Notes have interest payment dates of April 15 and October 15 of each year.

On March 17, 2021, Scotts Miracle-Gro issued $500.0 aggregate principal amount of 4.000% Senior Notes due 2031. The 4.000% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.000% Senior Notes have interest payment dates of April 1 and October 1 of each year.

On August 13, 2021, Scotts Miracle-Gro issued $400.0 aggregate principal amount of 4.375% Senior Notes due 2032. The 4.375% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.375% Senior Notes have interest payment dates of February 1 and August 1 of each year.

Substantially all of Scotts Miracle-Gro’s directly and indirectly owned domestic subsidiaries serve as guarantors of the 5.250% Senior Notes, the 4.500% Senior Notes, the 4.000% Senior Notes and the 4.375% Senior Notes.

The Senior Notes contain an affirmative covenant regarding the Company’s interest coverage ratio determined as of the end of each of its fiscal quarters, calculated as Adjusted EBITDA divided by interest expense excluding costs related to refinancings. The minimum required interest coverage ratio is 2.00. The Company’s interest coverage ratio was 3.57 for the twelve months ended September 30, 2024.

Receivables Facility

On April 7, 2017, the Company entered into the Receivables Facility, under which the Company could sell a portfolio of available and eligible outstanding customer accounts receivable to the purchasers subject to agreeing to repurchase the receivables on a weekly basis. The eligible accounts receivable consisted of accounts receivable generated by sales to three specified customers. The eligible amount of customer accounts receivables which could be sold under the Receivables Facility was $400.0. The Receivables Facility expired on August 18, 2023. The sale of receivables under the Receivables Facility was accounted for as short-term debt and the Company continued to carry the receivables on its Consolidated Balance Sheets, primarily as a result of its requirement to repurchase receivables sold.

Interest Rate Swap Agreements

The Company enters into interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest payments made between the effective date and expiration date are hedged by the swap agreements. Swap agreements that were hedging interest payments as of September 30, 2024 and 2023 had a maximum total U.S. dollar equivalent notional amount of $450.0 and $600.0, respectively. During fiscal 2024, the Company terminated an interest rate swap agreement in exchange for a cash payment of $11.0. The notional amount, effective date, expiration date and rate of each of the swap agreements outstanding at September 30, 2024 are shown in the table below:

Notional Amount ($)		Effective Date (a)	Expiration Date	Fixed Rate
150		6/7/2023	4/7/2027	3.37	%
50		6/7/2023	4/7/2027	3.34	%
100	(b)	11/20/2023	3/22/2027	4.74	%
150	(b)	9/20/2024	9/20/2029	4.25	%

(a)The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b)Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

Weighted Average Interest Rate

The weighted average interest rates on the Company’s debt, including the impact of interest rate swaps, were 5.8%, 5.4% and 3.6% for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

XML

EQUITY

12 Months Ended

Sep. 30, 2024

Equity [Abstract]

EQUITY

EQUITY (DEFICIT)

Authorized and issued shares consisted of the following (in millions):

	September 30,
	2024	2023
Preferred shares, no par value:
Authorized	0.2 shares	0.2 shares
Issued	0.0 shares	0.0 shares
Common shares, no par value, $0.01 stated value per share:
Authorized	100.0 shares	100.0 shares
Issued	68.1 shares	68.1 shares

In fiscal 1995, The Scotts Company merged with Stern’s Miracle-Gro Products, Inc. (“Miracle-Gro”). At September 30, 2024, the former shareholders of Miracle-Gro, including the Hagedorn Partnership, L.P., owned approximately 24% of Scotts Miracle-Gro’s outstanding Common Shares and, therefore, have the ability to significantly influence the election of directors and other actions requiring the approval of Scotts Miracle-Gro’s shareholders.

Under the terms of the merger agreement with Miracle-Gro, the former shareholders of Miracle-Gro may not collectively acquire, directly or indirectly, beneficial ownership of Voting Stock (as that term is defined in the Miracle-Gro merger agreement) representing more than 49% of the total voting power of the outstanding Voting Stock, except pursuant to a tender offer for 100% of that total voting power, which tender offer is made at a price per share which is not less than the market price per share on the last trading day before the announcement of the tender offer and is conditioned upon the receipt of at least 50% of the Voting Stock beneficially owned by shareholders of Scotts Miracle-Gro other than the former shareholders of Miracle-Gro and their affiliates and associates.

Accumulated Other Comprehensive Loss

Changes in AOCL by component were as follows for the fiscal years ended September 30:

	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Loss On Securities		Pension and Other Post- Retirement Benefit Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance at September 30, 2021	$	(1.7)	$	10.2	$	(2.3)	$	(72.5)	$	(66.4)
Other comprehensive income (loss) before reclassifications	(27.2)		40.1		(102.0)		(7.3)		(96.4)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.1)		—		11.7		2.6
Income tax benefit (expense)	—		(7.9)		24.6		(1.1)		15.6
Net current period other comprehensive income (loss)	(27.2)		23.1		(77.4)		3.3		(78.2)
Balance at September 30, 2022	(28.9)		33.3		(79.7)		(69.3)		(144.6)
Other comprehensive income (loss) before reclassifications	7.0		5.6		(34.9)		(2.5)		(24.8)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(23.3)		101.3		(1.6)		76.4
Income tax benefit (expense)	—		4.5		(25.3)		1.0		(19.8)
Net current period other comprehensive income (loss)	7.0		(13.2)		41.1		(3.1)		31.8
Balance at September 30, 2023	(21.9)		20.1		(38.6)		(72.4)		(112.8)
Other comprehensive income (loss) before reclassifications	0.6		(10.6)		(40.4)		(2.8)		(53.2)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.7)		64.6		(2.7)		52.2
Income tax benefit (expense)	—		5.1		—		1.4		6.5
Net current period other comprehensive income (loss)	0.6		(15.2)		24.2		(4.1)		5.5
Balance at September 30, 2024	$	(21.3)	$	4.9	$	(14.4)	$	(76.5)	$	(107.3)

The sum of the components may not equal due to rounding.

Share Repurchases

On February 6, 2020, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $750.0 of Common Shares from April 30, 2020 through March 25, 2023. There were no share repurchases under this share repurchase authorization during fiscal 2023 through its expiration on March 25, 2023. During fiscal 2022, Scotts Miracle-Gro repurchased 1.1 million Common Shares under this share repurchase authorization for $175.0. Treasury share purchases also include cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation of $5.1, $9.3 and $82.9 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Share-Based Awards

In January 2024, the shareholders of Scotts Miracle-Gro approved an amendment and restatement of The Scotts Miracle-Gro Company Long-Term Incentive Plan. As of September 30, 2024, the Company is authorized under this plan to grant up to approximately 7.9 million Common Shares, which includes an estimate of the number of Common Shares subject to outstanding awards under the plan that terminate, expire, or are cancelled, forfeited, exchanged, or surrendered without having been exercised, vested, or paid. At September 30, 2024, approximately 3.6 million Common Shares were not subject to outstanding awards and were available to underlie the grant of new share-based awards. Common Shares held in treasury totaling 0.3 million, 0.4 million and 0.9 million were reissued in support of share-based compensation awards under this plan and employee purchases under the employee stock purchase plan during fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Subsequent to September 30, 2024, the Company awarded stock options representing 0.3 million Common Shares to associates with an estimated grant date fair value of $9.8.

Total share-based compensation was as follows for each of the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Share-based compensation	$	79.8	$	68.1	$	30.3
Related tax benefit recognized	14.8		15.6		4.9

Excess tax benefit (tax deficiency) related to share-based compensation was $(3.0), $(1.5) and $14.8 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Stock Options

Stock option activity was as follows:

	No. of   Options	Wtd. Avg. Exercise Price		Wtd Avg Remaining Life	Aggregate Intrinsic Value
Awards outstanding at September 30, 2023	1,191,183	$	76.64	6.6 years
Granted	1,356,698	53.75
Exercised	(35,027)	58.52
Forfeited	(135,182)	55.69
Awards outstanding at September 30, 2024	2,377,672	65.03		7.5 years	$	71.4
Exercisable	493,832	108.97		2.6 years	8.9

The weighted average fair value per share of each option granted during fiscal 2024 and fiscal 2023 was $15.25 and $14.25, respectively. There were no options granted during fiscal 2022. The total intrinsic value of options exercised during fiscal 2024 was $0.6. There were no options exercised during fiscal 2023 or fiscal 2022. As of September 30, 2024, there was $9.4 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options that is expected to be recognized over a weighted-average period of 2.0 years. Cash received from the exercise of stock options, including amounts received from employee purchases under the employee stock purchase plan, was $3.8, $2.3 and $3.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

The weighted average assumptions used in the estimation of fair value for awards granted in fiscal 2024 are as follows:

Expected volatility	38.8	%
Risk-free interest rate	4.7	%
Expected dividend yield	4.1	%
Expected life	6.1 years

Restricted share-based awards

Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:

	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at September 30, 2023	611,838	$	89.10
Granted	363,264	55.12
Vested	(77,826)	182.87
Forfeited	(130,892)	59.40
Awards outstanding at September 30, 2024	766,384	68.54

The weighted-average grant-date fair value of restricted stock-based awards granted during fiscal 2024, fiscal 2023 and fiscal 2022 was $55.12, $59.48 and $109.10 per share, respectively. As of September 30, 2024, there was $9.9 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted stock-based awards that is expected to be recognized over a weighted-average period of 1.7 years. The total fair value of restricted stock units and deferred stock units vested during fiscal 2024, fiscal 2023 and fiscal 2022 was $4.6, $11.2 and $28.2, respectively.

Performance-based awards

Performance-based award activity was as follows (based on target award amounts):

	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at September 30, 2023	544,790	$	76.85
Granted	240,677	74.57
Vested (a)	(181,791)	59.88
Forfeited	(194,246)	65.89
Awards outstanding at September 30, 2024	409,430	86.61

(a)Vested at a weighted average of 100% of the target performance share units granted.

The weighted-average grant-date fair value of performance-based award units granted during fiscal 2024, fiscal 2023 and fiscal 2022 was $74.57, $66.00 and $132.74 per share, respectively. As of September 30, 2024, there was $7.6 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based award units that is expected to be recognized over a weighted-average period of 2.1 years. The total fair value of performance-based award unit vested during fiscal 2024, fiscal 2023 and fiscal 2022 was $10.6, $17.4 and $182.5, respectively.

During fiscal 2024, the Company granted performance-based award units with a three-year vesting period that include a performance target based on the Company’s total shareholder return relative to a Company selected peer group, among other financial targets. Details of the assumptions used in the estimation of fair value for these awards are as follows:

Expected volatility	36.6	%
Risk-free interest rate	4.5	%

For fiscal 2024, the Company is granting short-term equity incentive compensation awards to certain associates in the form of performance-based award units in lieu of cash-based annual incentive awards. Subsequent to September 30, 2024, awards representing 0.3 million Common Shares were granted and vested on the incentive payout date. The number of performance-based award units that the Company ultimately issued to participating associates was based on the incentive payout amount determined for each employee that was then converted into a variable number of performance-based award units based on the fair value of the Common Shares on the grant date. The awards were classified as liability awards and, as of September 30, 2024, the Company had accrued $20.2 in the “Other current liabilities” line in the Consolidated Balance Sheets and there was $0.0 unrecognized pre-tax compensation cost associated with these awards. The units associated with these awards are excluded from the table above.

Restricted shares issued to vendor

During fiscal 2024 and fiscal 2023, the Company issued 0.3 million and 0.8 million restricted shares, respectively, with a weighted-average grant date fair value of $69.88 and $52.44 per share, respectively, out of its treasury shares to a vendor in exchange for advertising services. As of September 30, 2024, there was $20.0 of total unrecognized pre-tax compensation cost related to these restricted shares that is expected to be recognized during fiscal 2025, when the services are performed.

XML

EARNINGS PER COMMON SHARE

12 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

EARNINGS PER COMMON SHARE

EARNINGS PER COMMON SHARE

The following table presents information necessary to calculate basic and diluted net loss per Common Share for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Net loss	$	(34.9)	$	(380.1)	$	(437.5)
Basic net loss per common share:
Weighted-average common shares outstanding during the period	56.8		56.0		55.5
Basic net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)
Diluted net loss per common share:
Weighted-average common shares outstanding during the period	56.8		56.0		55.5
Dilutive potential common shares	—		—		—
Weighted-average number of common shares outstanding and dilutive potential common shares	56.8		56.0		55.5
Diluted net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)
Antidilutive stock options outstanding	0.4		0.4		0.2

Diluted average common shares used in the diluted loss per common share calculation for fiscal 2024, fiscal 2023 and fiscal 2022 were 56.8 million, 56.0 million and 55.5 million, respectively, which excluded potential common shares of 0.9 million, 0.4 million and 0.6 million, respectively, because the effect of their inclusion would be anti-dilutive as the Company incurred a net loss for fiscal 2024, 2023 and 2022.

XML

INCOME TAXES

12 Months Ended

Sep. 30, 2024

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

The provision (benefit) for income taxes consisted of the following:

	Year Ended September 30,
	2024		2023		2022
Current:
Federal	$	2.4	$	3.7	$	22.8
State	2.5		0.6		9.3
Foreign	(5.3)		1.6		8.7
Total current	(0.4)		5.9		40.8
Deferred:
Federal	11.6		(62.1)		(125.5)
State	(3.8)		(5.2)		(23.3)
Foreign	3.9		(11.8)		(12.6)
Total deferred	11.7		(79.1)		(161.4)
Income tax expense (benefit)	$	11.3	$	(73.2)	$	(120.6)

The domestic and foreign components of loss before income taxes were as follows:

	Year Ended September 30,
	2024		2023		2022
Domestic	$	(10.8)	$	(376.2)	$	(427.3)
Foreign	(12.8)		(77.1)		(130.8)
Loss before income taxes	$	(23.6)	$	(453.3)	$	(558.1)

A reconciliation of the federal corporate income tax rate and the effective tax rate on loss before income taxes is summarized below:

	Year Ended September 30,
	2024		2023		2022
Statutory income tax rate	21.0	%	21.0	%	21.0	%
Effect of foreign operations	(2.0)		0.2		(1.6)
State taxes, net of federal benefit	8.0		3.2		2.6
Effect of other permanent differences	(32.8)		(0.8)		2.8
Research and Experimentation and other federal tax credits	2.9		0.2		0.2
Effect of tax contingencies	3.7		0.1		(1.8)
Change in valuation allowances	(57.4)		(8.7)		(0.9)
Other	8.7		1.0		(0.7)
Effective income tax rate	(47.9)	%	16.2	%	21.6	%

Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the deferred income tax assets and liabilities were as follows:

	September 30,
	2024		2023
DEFERRED TAX ASSETS
Lease liabilities	$	67.6	$	70.0
Intangible assets	62.2		79.2
Net operating loss carryovers	56.4		67.3
Interest limitation carryforward	55.9		35.9
Convertible debt investments	43.6		33.4
Accrued liabilities	43.2		48.7
Outside basis difference in equity investments	23.1		10.4
Inventories	16.1		26.1
Foreign tax credit carryovers	15.2		16.3
Other	22.4		23.8
Gross deferred tax assets	405.7		411.1
Valuation allowance	(96.5)		(87.7)
Total deferred tax assets	309.2		323.4
DEFERRED TAX LIABILITIES
Lease right-of-use assets	(62.0)		(62.1)
Property, plant and equipment	(58.5)		(62.7)
Other	(4.4)		(9.9)
Total deferred tax liabilities	(124.9)		(134.7)
Net deferred tax asset	$	184.3	$	188.7

At September 30, 2024 and 2023, after netting by taxing jurisdiction, net deferred tax assets of $191.3 and $189.8, respectively, were recorded in the “Other assets” line in the Consolidated Balance Sheets, and net deferred tax liabilities of $7.0 and $1.1, respectively, were recorded in the “Other liabilities” line in the Consolidated Balance Sheets.

GAAP requires that a valuation allowance be recorded against a deferred tax asset if it is more likely than not that the tax benefit associated with the asset will not be realized in the future. As shown in the table above, valuation allowances were recorded against $96.5 and $87.7 of deferred tax assets as of September 30, 2024 and 2023, respectively. Most of these valuation allowances relate to losses on convertible debt investments, credits, and net operating losses (“NOLs”), as explained further below.

Deferred tax assets related to unrealized losses on convertible debt investments were $43.6 and $33.4 at September 30, 2024 and 2023, respectively. A full valuation allowance was recorded against these losses at September 30, 2024 and 2023 as the Company does not expect to utilize them prior to their expiration.

Deferred tax assets related to foreign tax credits were $15.2 and $16.3 at September 30, 2024 and 2023, respectively. A full valuation allowance was recorded against these credits as of September 30, 2024 and 2023 as the Company does not expect to utilize them prior to their expiration. Tax benefits associated with state tax credits will also expire if not utilized and amounted to $1.0 and $1.4 at September 30, 2024 and 2023, respectively. A valuation allowance in the amount of $0.8 and $1.3 was recorded at September 30, 2024 and 2023, respectively, related to state credits the Company does not expect to utilize.

Deferred tax assets related to certain federal NOLs subject to limitation under IRC §382 from current and prior ownership changes were $9.9 and $10.5 at September 30, 2024 and 2023, respectively. These NOLs will be subject to expiration gradually from fiscal year end 2024 through fiscal year end 2032. The Company determined that a portion of these deferred tax assets will expire unutilized due to the closing of statutes of limitation and has recorded a valuation allowance of $9.7 and $10.2 at September 30, 2024 and 2023, respectively. The Company had deferred tax assets related to federal NOLs not subject to limitation of $20.6 at September 30, 2024, which can be utilized to reduce future years’ tax liabilities.

Deferred tax assets related to foreign NOLs of certain controlled foreign corporations were $6.8 and $8.3 as of September 30, 2024 and 2023, respectively. Due to a history of losses, a valuation allowance of $4.6 and $6.4 has been recorded against these deferred tax assets as of September 30, 2024 and 2023, respectively. A valuation allowance has also been recorded against deferred tax assets related to other foreign items of $13.0 and $11.0 at September 30, 2024 and 2023, respectively.

Deferred tax assets related to state NOLs were $19.1 and $15.2 as of September 30, 2024 and 2023, respectively, with carryforward periods ranging from 5 to unlimited years. Any losses not utilized within a specific state’s carryforward period will expire. A valuation allowance was recorded against $7.0 and $6.9 of these deferred tax assets as of September 30, 2024 and 2023, respectively, for state NOLs that the Company does not expect to realize within their respective carryforward periods. A valuation allowance has also been recorded against deferred tax assets related to other state items of $2.6 and $2.2 at September 30, 2024 and 2023, respectively.

As of September 30, 2024, the Company maintains its assertions of indefinite reinvestment of the earnings of all material foreign subsidiaries.

The Company had $25.7, $34.6 and $35.8 of gross unrecognized tax benefits related to uncertain tax positions at September 30, 2024, 2023 and 2022, respectively. Included in the September 30, 2024, 2023 and 2022 balances were $23.1, $31.1 and $31.5, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate.

A reconciliation of the unrecognized tax benefits is as follows:

	Year Ended September 30,
	2024		2023		2022
Balance at beginning of year	$	34.6	$	35.8	$	24.1
Additions for tax positions of the current year	0.2		0.2		11.3
Additions for tax positions of prior years	0.1		3.8		2.2
Reductions for tax positions of prior years	(3.7)		(0.2)		(2.5)
Settlements with tax authorities	(0.7)		(0.1)		1.3
Expiration of statutes of limitation	(4.8)		(4.9)		(0.6)
Balance at end of year	$	25.7	$	34.6	$	35.8

The Company continues to recognize accrued interest and penalties related to unrecognized tax benefits as a component of the provision for income taxes. As of September 30, 2024, 2023 and 2022, the Company had $5.8, $3.9 and $3.2, respectively, accrued for the payment of interest that, if recognized, would impact the effective tax rate. The Company had $1.1, $1.3 and $1.6 accrued for the payment of penalties as of September 30, 2024, 2023 and 2022, respectively.

Scotts Miracle-Gro or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. Subject to the following exceptions, the Company is no longer subject to examination by these tax authorities for fiscal years prior to 2021. There are currently no ongoing audits with respect to the U.S. federal jurisdiction. With respect to the foreign jurisdictions, a Canadian audit covering fiscal years 2020 through 2021 is in process. The Company is currently under examination by certain U.S. state and local tax authorities covering various periods from fiscal years 2018 through 2023. In addition to the aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.

The Company currently anticipates that few of its open and active audits will be resolved within the next twelve months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although the outcomes of such examinations and the timing of any payments required upon the conclusion of such examinations are subject to significant uncertainty, the Company does not anticipate that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows.

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

12 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.

Exchange Rate Risk Management

The Company uses currency forward contracts to manage the exchange rate risk associated with intercompany loans and certain other balances denominated in foreign currencies. Currency forward contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. The notional amount of outstanding currency forward contracts was $148.4 and $123.1 at September 30, 2024 and 2023, respectively. Contracts outstanding at September 30, 2024 will mature over the next fiscal quarter.

Interest Rate Risk Management

The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Swap agreements that were hedging interest payments as of September 30, 2024 and 2023 had a maximum total U.S. dollar equivalent notional amount of $450.0 and $600.0, respectively. Refer to “NOTE 11. DEBT” for the terms of the swap agreements outstanding at September 30, 2024. Included in the AOCL balance at September 30, 2024 was a gain of $4.7 related to interest rate swap agreements that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.

Commodity Price Risk Management

The Company enters into hedging arrangements designed to fix the price of a portion of its projected future urea and diesel requirements. Commodity contracts are valued using observable commodity exchange prices in active markets. Included in the AOCL balance at September 30, 2024 was a gain of $0.7 related to commodity hedges that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.

The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:

	September 30,
	2024	2023
Commodity
Urea	51,000 tons	52,500 tons
Diesel	1,092,000 gallons	1,974,000 gallons
Heating Oil	42,000 gallons	966,000 gallons

Fair Values of Derivative Instruments

The fair values of the Company’s derivative instruments, which represent Level 2 fair value measurements, were as follows:

		Assets / (Liabilities)
		2024		2023
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value
Interest rate swap agreements	Prepaid and other current assets	$	0.9	$	16.7
	Other assets	—		14.7
	Other current liabilities	(0.2)		—
	Other liabilities	(5.1)		—
Commodity hedging instruments	Prepaid and other current assets	0.8		2.3
Total derivatives designated as hedging instruments		$	(3.6)	$	33.7
Derivatives Not Designated as Hedging Instruments	Balance Sheet Location
Currency forward contracts	Prepaid and other current assets	$	0.1	$	5.6
	Other current liabilities	(4.0)		—
Commodity hedging instruments	Prepaid and other current assets	—		0.9
Total derivatives not designated as hedging instruments		(3.9)		6.5
Total derivatives		$	(7.5)	$	40.2

The effect of derivative instruments on AOCL, net of tax, and the Consolidated Statements of Operations for the years ended September 30 was as follows:

 

	Amount of Gain / (Loss) Recognized in AOCL
Derivatives in Cash Flow Hedging Relationships	2024		2023
Interest rate swap agreements	$	(7.1)	$	11.3
Commodity hedging instruments	(0.8)		(7.1)
Total	$	(7.9)	$	4.2

 

	Reclassified from AOCL into	Amount of Gain / (Loss)
Derivatives in Cash Flow Hedging Relationships	Statement of Operations	2024		2023
Interest rate swap agreements	Interest expense	$	11.7	$	11.5
Commodity hedging instruments	Cost of sales	(4.4)		5.9
Total		$	7.3	$	17.4

 

	Recognized in	Amount of Gain / (Loss)
Derivatives Not Designated as Hedging Instruments	Statement of Operations	2024		2023
Currency forward contracts	Other income / expense, net	$	(9.6)	$	(14.7)
Commodity hedging instruments	Cost of sales	(2.0)		1.2
Total		$	(11.6)	$	(13.5)

XML

FAIR VALUE MEASUREMENTS

12 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following describes the valuation methodologies used for financial assets and liabilities measured or disclosed at fair value on a recurring basis, as well as the general classification within the valuation hierarchy.

Cash Equivalents

Cash equivalents consist of highly liquid financial instruments with original maturities of three months or less. The carrying value of these cash equivalents approximates fair value due to their short-term maturities.

Other

Investment securities in non-qualified retirement plan assets are valued using observable market prices in active markets.

The fair values of convertible debt investments are determined using scenario-based internally developed valuation models that consider a probability-weighted assessment of possible future cash flows related to the debt component and the conversion component of the instruments, discounted to present value using an appropriate discount rate. The probability of amendments to federal laws in the United States to allow for the general cultivation, distribution, and possession of cannabis, and the impact of such amendments on the value of the underlying investments are important assumptions in the fair value estimates. The valuation models and related assumptions require significant judgment. These and other assumptions are impacted by economic conditions and expectations of management and may change in the future based on period specific facts and circumstances.

Debt Instruments

Debt instruments are recorded at cost. The interest rate on borrowings under the Sixth A&R Credit Agreement fluctuates in accordance with the terms of the Sixth A&R Credit Agreement and thus the carrying value is a reasonable estimate of fair value. The fair values of the 4.000% Senior Notes, 4.375% Senior Notes, 4.500% Senior Notes and 5.250% Senior Notes are determined based on quoted market prices.

The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required:

		2024				2023
	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Cash equivalents	Level 1	$	51.2	$	51.2	$	1.2	$	1.2
Other
Investment securities in non-qualified retirement plan assets	Level 1	32.4		32.4		36.3		36.3
Convertible debt investments	Level 3	45.8		45.8		85.8		85.8
Liabilities
Debt instruments
Credit facilities – revolving loans	Level 2	—		—		88.3		88.3
Credit facilities – term loans	Level 2	625.0		625.0		925.0		925.0
Senior Notes due 2031 – 4.000%	Level 2	500.0		456.3		500.0		380.0
Senior Notes due 2032 – 4.375%	Level 2	400.0		370.0		400.0		304.0
Senior Notes due 2029 – 4.500%	Level 2	450.0		432.0		450.0		366.8
Senior Notes due 2026 – 5.250%	Level 2	250.0		248.8		250.0		233.1
Other debt	Level 2	—		—		0.4		0.4

Changes in the balance of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3.

	Year Ended September 30,
	2024		2023
Fair value at beginning of year	$	85.8	$	117.0
Total realized / unrealized gains (losses) included in net earnings	(64.2)		(97.6)
Total realized / unrealized gains / losses included in / reclassified from OCI	24.2		66.4
Fair value at end of year	$	45.8	$	85.8

Convertible debt investments include, among other minority non-equity investments, convertible notes issued to The Hawthorne Collective, Inc. (“THC”), a wholly-owned subsidiary of the Company, by RIV Capital (CSE: RIV) (OTC: CNPOF). Assuming full conversion of the RIV Capital convertible notes, THC would be entitled to receive approximately 123.0 million common shares of RIV Capital, representing approximately 47% of RIV Capital’s outstanding shares as of September 30, 2024. The RIV Capital convertible notes are convertible into common shares of RIV Capital either (i) at the election of THC or (ii) at the election of RIV Capital after the date on which federal laws in the United States are amended to allow for the general cultivation, distribution, and possession of cannabis. In connection with issuance of the RIV Capital convertible notes, the Company entered into an investor rights agreement with RIV Capital providing for, among other things, customary registration rights, participation rights, as well as certain standstill and transfer restrictions. In addition, THC is entitled to designate three nominees to the RIV Capital board of directors for so long as the board is comprised of seven directors, and will be entitled to designate four nominees to the RIV Capital board of directors if the size of the board is increased to nine directors. The Company or THC will not have control of or an active day-to-day role in any entity in which THC has a convertible debt investment. The convertible notes include restrictions that the funds received from the Company will be used for general corporate and other lawful purposes, which could include acquisitions, and that the funds will not be used in connection with or for any cannabis or cannabis-related operations in the U.S. unless and until such operations comply with all applicable U.S. federal laws.

During fiscal 2023, the Company recognized a non-cash, pre-tax other-than-temporary impairment charge related to its convertible debt investments of $101.3 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. This charge was driven by revisions to the Company’s internal forecasts of cash flows expected to be collected from its convertible debt investments resulting from the accumulation of adverse conditions impacting the cannabis market, including both federal and state level regulatory considerations and persistent industry oversupply conditions.

On May 30, 2024, RIV Capital and Cansortium Inc. (“Cansortium”) (CSE: TIUM.U) (OTCQB: CNTMF) announced they have entered into a definitive agreement pursuant to which Cansortium will acquire all of the issued and outstanding common shares of RIV Capital in exchange for Cansortium shares (the “Transaction”). The closing of the Transaction is subject to various conditions, including shareholder and court approvals, the receipt of all required regulatory approvals, and the exchange of THC’s existing convertible debt investment in RIV Capital for a new class of non-voting exchangeable shares of Cansortium. These exchangeable shares would be convertible, at THC’s discretion, into approximately 23% of the common shares of Cansortium on a pro forma basis as of the closing of the Transaction. During the fourth quarter of fiscal 2024, the shareholders of RIV Capital and Cansortium voted in favor of the resolutions associated with the Transaction. At September 30, 2024, the Company concluded it had the intent to exchange its RIV Capital convertible notes for non-voting exchangeable shares of Cansortium in connection with the Transaction, and remeasured the investment at the fair value of the non-voting exchangeable shares that the Company expects to receive. This resulted in the recognition of a non-cash, pre-tax other-than-temporary impairment charge of $64.6 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. In addition, the previously recorded allowance for credit losses associated with the RIV Capital convertible notes of $99.4 was written off and the amortized cost basis was written down to the investment’s fair value.

The amortized cost basis of convertible debt investments was $62.1 and $225.8 at September 30, 2024 and 2023, respectively. At September 30, 2024 and 2023, gross unrealized losses on convertible debt investments were $16.4 and $140.0, respectively, and there were no gross unrealized gains. These investments have been in a continuous unrealized loss position for greater than 12 months as of September 30, 2024. The allowance for expected credit losses was $1.9 and $101.3 at September 30, 2024 and 2023, respectively. At September 30, 2024, the period until scheduled maturity of the Company’s convertible debt investments was between 2.9 and 5.0 years.

Credit losses on convertible debt investments are measured based on the present value of expected future cash flows compared to amortized cost. Impairment losses are recognized through an allowance and recoveries of previously impaired amounts are recorded as an immediate reversal of all or a portion of the allowance. In addition, the allowance for expected credit losses cannot cause the amortized cost net of the allowance to be below fair value. A progression of the allowance for expected credit losses on convertible debt investments is shown below:

	Year Ended September 30,
	2024		2023
Balance at beginning of year	$	101.3	$	—
Provision for expected credit losses on securities with no previous allowance	—		101.3
Reductions for securities intended to be sold / exchanged	(99.4)		—
Balance at end of year	$	1.9	$	101.3

XML

LEASES

12 Months Ended

Sep. 30, 2024

Leases [Abstract]

LEASES

LEASES

The Company leases certain property and equipment from third parties under various non-cancelable lease agreements, including industrial, commercial and office properties and equipment that support the management, manufacturing, distribution and research and development of products marketed and sold by the Company. The lease agreements generally require that the Company pay taxes, insurance and maintenance expenses related to the leased assets. At September 30, 2024, the Company had entered into operating leases that were yet to commence with a combined total expected lease liability of $29.6. From time to time, the Company will sublease portions of its facilities, resulting in sublease income. Sublease income and the related cash flows were not material to the consolidated financial statements for fiscal 2024.

The Company leases certain vehicles (primarily cars and light trucks) under agreements that are cancellable after the first year, but typically continue on a month-to-month basis until canceled by the Company. The vehicle leases and certain other non-cancelable operating leases contain residual value guarantees that create a contingent obligation on the part of the Company to compensate the lessor if the leased asset cannot be sold for an amount in excess of a specified minimum value at the conclusion of the lease term. If all such vehicle leases had been canceled as of September 30, 2024, the Company’s residual value guarantee would have approximated $6.3.

Supplemental balance sheet information related to the Company’s leases was as follows:

	Balance Sheet Location	September 30, 2024		September 30, 2023
Operating leases:
Right-of-use assets	Other assets	$	265.4	$	262.6
Current lease liabilities	Other current liabilities	75.3		76.4
Non-current lease liabilities	Other liabilities	215.8		220.1
Total operating lease liabilities		$	291.1	$	296.5
Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	15.2	$	14.5
Current lease liabilities	Current portion of debt	2.6		1.9
Non-current lease liabilities	Long-term debt	15.2		15.0
Total finance lease liabilities		$	17.8	$	16.9

Components of lease cost were as follows:

	Year Ended September 30,
	2024		2023		2022
Operating lease cost (a)	$	85.8	$	92.3	$	86.7
Variable lease cost	30.3		28.6		35.9
Finance lease cost
Amortization of right-of-use assets	2.6		3.0		6.4
Interest on lease liabilities	0.8		0.8		1.2
Total finance lease cost	$	3.4	$	3.8	$	7.6

(a)Operating lease cost includes amortization of right-of-use assets of $70.4, $81.0 and $75.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Short-term lease expense is excluded from operating lease cost and was $6.1, $6.6 and $19.1 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:

	Year Ended September 30,
	2024		2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net	$	99.2	$	93.0	$	83.9
Operating cash flows from finance leases	0.8		0.8		1.2
Financing cash flows from finance leases	2.3		2.7		5.9
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	77.0	$	90.4	$	71.9
Finance leases	3.4		—		1.5

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:

	September 30, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	5.2		5.4
Finance leases	8.1		9.5
Weighted-average discount rate:
Operating leases	5.9	%	5.2	%
Finance leases	4.7	%	4.4	%

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2024 were as follows:

Year	Operating Leases		Finance Leases
2025	$	89.8	$	3.4
2026	73.5		3.0
2027	49.2		2.6
2028	38.8		2.2
2029	27.1		1.7
Thereafter	62.5		8.6
Total lease payments	340.9		21.5
Less: Imputed interest	(49.8)		(3.7)
Total lease liabilities	$	291.1	$	17.8

LEASES

LEASES

The Company leases certain property and equipment from third parties under various non-cancelable lease agreements, including industrial, commercial and office properties and equipment that support the management, manufacturing, distribution and research and development of products marketed and sold by the Company. The lease agreements generally require that the Company pay taxes, insurance and maintenance expenses related to the leased assets. At September 30, 2024, the Company had entered into operating leases that were yet to commence with a combined total expected lease liability of $29.6. From time to time, the Company will sublease portions of its facilities, resulting in sublease income. Sublease income and the related cash flows were not material to the consolidated financial statements for fiscal 2024.

The Company leases certain vehicles (primarily cars and light trucks) under agreements that are cancellable after the first year, but typically continue on a month-to-month basis until canceled by the Company. The vehicle leases and certain other non-cancelable operating leases contain residual value guarantees that create a contingent obligation on the part of the Company to compensate the lessor if the leased asset cannot be sold for an amount in excess of a specified minimum value at the conclusion of the lease term. If all such vehicle leases had been canceled as of September 30, 2024, the Company’s residual value guarantee would have approximated $6.3.

Supplemental balance sheet information related to the Company’s leases was as follows:

	Balance Sheet Location	September 30, 2024		September 30, 2023
Operating leases:
Right-of-use assets	Other assets	$	265.4	$	262.6
Current lease liabilities	Other current liabilities	75.3		76.4
Non-current lease liabilities	Other liabilities	215.8		220.1
Total operating lease liabilities		$	291.1	$	296.5
Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	15.2	$	14.5
Current lease liabilities	Current portion of debt	2.6		1.9
Non-current lease liabilities	Long-term debt	15.2		15.0
Total finance lease liabilities		$	17.8	$	16.9

Components of lease cost were as follows:

	Year Ended September 30,
	2024		2023		2022
Operating lease cost (a)	$	85.8	$	92.3	$	86.7
Variable lease cost	30.3		28.6		35.9
Finance lease cost
Amortization of right-of-use assets	2.6		3.0		6.4
Interest on lease liabilities	0.8		0.8		1.2
Total finance lease cost	$	3.4	$	3.8	$	7.6

(a)Operating lease cost includes amortization of right-of-use assets of $70.4, $81.0 and $75.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Short-term lease expense is excluded from operating lease cost and was $6.1, $6.6 and $19.1 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:

	Year Ended September 30,
	2024		2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net	$	99.2	$	93.0	$	83.9
Operating cash flows from finance leases	0.8		0.8		1.2
Financing cash flows from finance leases	2.3		2.7		5.9
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	77.0	$	90.4	$	71.9
Finance leases	3.4		—		1.5

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:

	September 30, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	5.2		5.4
Finance leases	8.1		9.5
Weighted-average discount rate:
Operating leases	5.9	%	5.2	%
Finance leases	4.7	%	4.4	%

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2024 were as follows:

Year	Operating Leases		Finance Leases
2025	$	89.8	$	3.4
2026	73.5		3.0
2027	49.2		2.6
2028	38.8		2.2
2029	27.1		1.7
Thereafter	62.5		8.6
Total lease payments	340.9		21.5
Less: Imputed interest	(49.8)		(3.7)
Total lease liabilities	$	291.1	$	17.8

XML

COMMITMENTS

12 Months Ended

Sep. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS

COMMITMENTS

At September 30, 2024, the Company had the following unconditional purchase obligations by purchase date that have not been recognized in the Consolidated Balance Sheet:

 

2025	$	310.9
2026	193.5
2027	79.2
2028	39.3
2029	24.6
Thereafter	33.7
	$	681.2

Purchase obligations primarily represent commitments for materials used in the Company’s manufacturing processes, including urea and packaging, as well as commitments for warehouse services, grass seed, marketing services and information technology services.

XML

CONTINGENCIES

12 Months Ended

Sep. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

CONTINGENCIES

CONTINGENCIES

Management regularly evaluates the Company’s contingencies, including various judicial and administrative proceedings and claims arising in the ordinary course of business, including product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals are adequate, both individually and in the aggregate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows.

Regulatory Matters

At September 30, 2024, the Company had recorded liabilities of $2.6 for environmental actions, the majority of which are for site remediation. The Company believes that the amounts accrued are adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.

Other

The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. The Company has not recorded any accruals in its consolidated financial statements as the likelihood of a loss from these cases is not probable at this time. The Company does not believe a reasonably possible loss would be material to the Company’s financial condition, results of operations or cash flows. In addition, the Company does not believe the ultimate resolution of these cases will have a material adverse effect on the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows.

On June 6, 2024, a purported shareholder filed a lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03132) on behalf of a proposed class of purchasers of Common Shares between November 3, 2021, and August 1, 2023. On July 26, 2024, another purported shareholder filed a lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03766) on behalf of a proposed class of purchasers of Common Shares between June 2, 2021, and August 1, 2023. These lawsuits, which will likely be consolidated with any subsequently filed lawsuits alleging similar facts, assert claims under Section 10(b), Rule 10b-5 and Section 20(a) of the Securities Exchange Act against the Company and certain of its current and former officers based on alleged misstatements about the Company’s inventories, sales and business prospects. The actions seek, among other things, unspecified monetary damages, reasonable costs and expenses and equitable/injunctive or other relief as deemed appropriate by the Court. The Company believes that the claims asserted are without merit and intends to vigorously defend the actions.

On July 3, 2024, a purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03636), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On July 30, 2024, a second purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No.1:24-cv-00402), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On August 23, 2024, a third purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03880), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On September 9, 2024, a fourth purported shareholder filed a shareholder derivative lawsuit in the Union County (Ohio) Court of Common Pleas (Case No. 24CV0193), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On September 26, 2024, a fifth purported shareholder filed a shareholder derivative lawsuit in the Union County (Ohio) Court of Common Pleas (Case No. 24CV0203), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On November 19, 2024, a sixth purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-04180), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On November 22, 2024, a seventh purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-04190), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. The federal lawsuits will likely be consolidated with one another, along with any subsequently filed federal lawsuits alleging similar facts, and the state court lawsuits will likely be consolidated with one another, along with any subsequently filed state lawsuits alleging similar facts. All of the lawsuits include allegations that generally mirror those asserted in the securities lawsuits described above and assert claims for breaches of fiduciary duties and unjust enrichment, as well as abuse of control, gross mismanagement, and waste of corporate assets. The federal lawsuits also assert claims under Section 10(b), Rule 10b-5, Section 14(a), Rule 14a-9, and Section 20(a) of the Securities Exchange Act, and contribution under Sections 10(b) and 21D of the Securities Exchange Act. The actions seek a judgment in favor of the Company for damages in an unspecified amount, disgorgement, interest, and costs and expenses, including attorneys’ and experts’ fees.

The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to have a material effect on the Company’s financial condition, results of operations or cash flows.

XML

SEGMENT INFORMATION

12 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

The Company divides its operations into three reportable segments: U.S. Consumer, Hawthorne and Other. U.S. Consumer consists of the Company’s consumer lawn and garden business in the United States. Hawthorne consists of the Company’s indoor and hydroponic gardening business. Other primarily consists of the Company’s consumer lawn and garden business in Canada. This identification of reportable segments is consistent with how the segments report to and are managed by the chief operating decision maker of the Company. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the reportable business segments.

The performance of each reportable segment is evaluated based on several factors, including income (loss) before income taxes, amortization, impairment, restructuring and other charges (“Segment Profit (Loss)”). Senior management uses Segment Profit (Loss) to evaluate segment performance because the Company believes this measure is indicative of performance trends and the overall earnings potential of each segment.

The following tables present financial information for the Company’s reportable segments for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Net Sales:
U.S. Consumer	$	3,013.7	$	2,843.7	$	2,928.8
Hawthorne	294.7		467.3		716.2
Other	244.3		240.3		279.1
Consolidated	$	3,552.7	$	3,551.3	$	3,924.1
Segment Profit (Loss):
U.S. Consumer	$	498.0	$	454.1	$	568.6
Hawthorne	(14.2)		(48.1)		(21.1)
Other	4.7		12.4		20.2
Total Segment Profit	488.5		418.4		567.7
Corporate	(117.7)		(101.6)		(112.4)
Intangible asset amortization	(15.7)		(25.2)		(37.1)
Impairment, restructuring and other	(146.3)		(466.0)		(852.2)
Equity in loss of unconsolidated affiliates	(68.1)		(101.1)		(12.9)
Interest expense	(158.8)		(178.1)		(118.1)
Other non-operating income (expense), net	(5.5)		0.3		6.9
Loss before income taxes	$	(23.6)	$	(453.3)	$	(558.1)
Depreciation and amortization:
U.S. Consumer	$	56.2	$	58.2	$	55.8
Hawthorne	16.7		25.8		34.8
Other	5.9		5.6		7.0
Corporate	1.8		2.9		7.6
	$	80.6	$	92.5	$	105.2
Capital expenditures:
U.S. Consumer	$	81.5	$	79.6	$	97.4
Hawthorne	—		8.5		12.4
Other	2.5		4.7		3.7
	$	84.0	$	92.8	$	113.5

	September 30,
	2024		2023
Total assets:
U.S. Consumer	$	2,022.7	$	2,296.2
Hawthorne	387.3		581.6
Other	189.3		189.8
Corporate	272.6		346.1
Consolidated	$	2,871.9	$	3,413.7

The following table presents net sales by product category for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
U.S. Consumer:
Growing media and mulch	$	1,310.6	$	1,223.7	$	1,192.6
Lawn care	929.6		897.4		973.6
Controls	414.6		362.9		382.2
Roundup® marketing agreement	162.4		138.7		132.3
Other, primarily gardening	196.5		221.0		248.1
Hawthorne:
Lighting	108.2		165.9		200.0
Nutrients	87.2		105.3		148.0
Growing media	37.3		67.5		119.0
Growing environment	27.7		72.5		143.7
Other, primarily hardware	34.3		56.1		105.5
Other:
Growing media	91.3		93.0		96.6
Lawn care	80.2		75.8		92.9
Other, primarily gardening and controls	72.8		71.5		89.6
Total net sales	$	3,552.7	$	3,551.3	$	3,924.1

The Company’s two largest customers accounted for the following percentages of net sales for the fiscal years ended September 30: 

	Percentage of Net Sales
	2024		2023		2022
The Home Depot	30	%	29	%	28	%
Lowe’s	18	%	18	%	15	%

Accounts receivable for these two largest customers as a percentage of consolidated accounts receivable were 18% and 41% as of September 30, 2024 and 2023, respectively. The decrease was due to the impact of accounts receivable sold under the Master Receivables Purchase Agreement.

The following table presents net sales by geographic area for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Net sales:
United States	$	3,247.8	$	3,209.5	$	3,554.6
International	304.9		341.8		369.5
	$	3,552.7	$	3,551.3	$	3,924.1

Other than the United States, no other country accounted for more than 10% of the Company’s net sales for any period presented above.

The following table presents long-lived assets (property, plant and equipment and finite-lived intangibles) by geographic area: 

	September 30,
	2024		2023
Long-lived assets:
United States	$	630.5	$	644.4
International	73.9		78.7
	$	704.4	$	723.1

XML

SUBSEQUENT EVENT	12 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENT	SUBSEQUENT EVENTOn November 26, 2024, the Company announced that Matthew Garth, Executive Vice President, Chief Financial Officer & Chief Administrative Officer, will be departing the Company effective December 31, 2024 (the “Termination Date”). In connection with Mr. Garth’s departure on the Termination Date, the Company entered into a Separation Agreement and Release of All Claims (the “Separation Agreement”) with Mr. Garth on November 25, 2024. The Separation Agreement addresses the payments and benefits to which Mr. Garth is entitled in connection with his departure. The Company will pay or make the following benefits available to Mr. Garth in connection with his departure: (a) pay equal to 24 months of salary, at Mr. Garth’s regular monthly base pay, payable in accordance with the Company’s standard payroll procedures; (b) in lieu of outplacement services, a lump sum payment of $0.03; (c) for a period of 24 months, a benefits offset payment in an amount equal to the excess of the COBRA premium charged by the Company to terminated employees over the premium Mr. Garth paid as an active employee; and (d) an amount equal to two times Mr. Garth’s target bonus opportunity for the fiscal year ending September 30, 2025, 50% of which is payable on the first scheduled pay date following the first anniversary of Mr. Garth’s Termination Date and 50% of which is payable on the first scheduled pay date following the second anniversary of Mr. Garth’s Termination Date, subject to Mr. Garth’s continued compliance as of the payment date with all of his post-employment obligations to the Company. Additionally, Mr. Garth will fully and partially vest in certain equity-based awards upon his departure from the Company. The Company will record charges associated with these payments and benefits during fiscal 2025.

XML

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Sep. 30, 2024

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Schedule II - Valuation and Qualifying Accounts

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2024

Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Additions Other		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for expected credit losses	$	116.4	$	—	$	3.7	$	(108.6)	$	11.5
Income tax valuation allowance	87.7		3.6		13.7		(8.5)		96.5

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2023

Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Additions Other		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for expected credit losses	$	14.4	$	—	$	109.6	$	(7.6)	$	116.4
Income tax valuation allowance	40.7		9.5		37.8		(0.3)		87.7

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2022

Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Additions Other		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for expected credit losses	$	16.8	$	—	$	5.8	$	(8.2)	$	14.4
Income tax valuation allowance	32.3		—		9.0		(0.6)		40.7

XML

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net income (loss)	$ (34.9)	$ (380.1)	$ (437.5)

XML

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Insider Trading Policies and Procedures	12 Months Ended
	Sep. 30, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

Nature of Operations

Nature of Operations

The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor and hydroponic gardening. The Company’s products are sold in North America, Europe and Asia.

The Company’s North America consumer lawn and garden business is highly seasonal, with approximately 75% of its annual net sales occurring in the second and third fiscal quarters. The Company’s Hawthorne segment is also impacted by seasonal sales patterns for certain product categories due to the timing of growing patterns in North America during the second and third fiscal quarters, and the timing of certain controlled agricultural lighting project sales during the third and fourth fiscal quarters.

Organization and Basis of Presentation

Organization and Basis of Presentation

The Company’s consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.

Advertising

Advertising

Advertising costs incurred during the year are expensed to interim periods in relation to revenues. Advertising costs, except for external production costs, are generally expensed within the fiscal year in which such costs are incurred. External production costs for advertising programs are deferred until the period in which the advertising is first aired, and deferrals of these costs were not material at September 30, 2024 and 2023.

Research and Development

Research and Development

Costs associated with research and development are generally charged to expense as incurred.

Environmental Costs

Environmental Costs

The Company recognizes environmental liabilities when conditions requiring remediation are probable and the amounts can be reasonably estimated. Expenditures which extend the life of the related property or mitigate or prevent future environmental contamination are capitalized. Environmental liabilities are not discounted or reduced for possible recoveries from insurance carriers.

Earnings per Common Share

Earnings per Common Share

Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding each period. Diluted income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus all dilutive potential common shares (stock options, restricted stock units, deferred stock units and performance-based award units) outstanding each period.

Share-Based Compensation Awards

Share-Based Compensation Awards

Scotts Miracle-Gro grants share-based awards annually to officers and certain other associates and to the non-employee directors of Scotts Miracle-Gro. The share-based awards have consisted of stock options, restricted stock units, deferred stock units and performance-based award units. Performance-based award units are subject to performance and service conditions, and certain awards contain a market condition based on the Company’s total shareholder return relative to a Company selected peer group. All of these share-based awards have been made under plans approved by the shareholders. The fair value of awards is expensed over the requisite service period which is typically the vesting period, generally three years for awards granted to officers and other associates and one year for awards granted to non-employee directors.

For restricted stock units, deferred stock units and performance-based award units that do not contain a market condition, the fair value of each award is estimated on the grant date based on the current market price of the Common Shares. For performance-based award units that contain a market condition, the fair value of each award is estimated using a Monte Carlo simulation model. Expected market price volatility is based on historical volatility specific to the Common Shares. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The grant date fair value of stock option awards is estimated using a binomial model. Expected market price volatility is based on implied volatilities from traded options on Common Shares and historical volatility specific to the Common Shares. Historical data, including demographic factors impacting historical exercise behavior, is used to estimate stock option exercises and employee terminations within the valuation model. The risk-free rate for periods within the contractual life of the stock option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected life of stock options is based on historical experience and expectations for grants outstanding.

Vesting of performance-based award units depends on service and achievement of specified performance targets. Based on the extent to which the targets are achieved, vested shares may range from 0% to 325% of the target award amount. For performance-based award units that do not contain a market condition, the total amount of compensation expense recognized reflects management’s assessment of the probability that performance goals will be achieved. A cumulative adjustment is recognized to compensation expense in the current period to reflect any changes in the probability of achievement of performance goals. For performance-based award units that contain a market condition, compensation expense is recognized regardless of the extent to which the targets are achieved.

Restricted stock units, deferred stock units and performance-based award units receive dividend equivalents equal to the cash dividends earned during the vesting period that are only paid out upon vesting. Share-based award units are generally forfeited if a holder terminates employment or service with the Company prior to the vesting date, except in cases where associates are eligible for accelerated vesting based on having satisfied retirement requirements relating to age and years of service. The Company estimates that 15% of its share-based awards will be forfeited based on an analysis of historical trends. The Company evaluates the estimated forfeiture rate on an annual basis and makes adjustments as appropriate. Stock options have exercise prices equal to the market price of the underlying Common Shares on the grant date and a term of 10 years. If available, Scotts Miracle-Gro typically uses treasury shares, or if not available, newly-issued Common Shares, to settle vested share-based awards. The Company classifies share-based compensation expense within cost of sales or selling, general and administrative expenses to correspond with the same line item as cash compensation paid to associates. Cash flows resulting from tax deductions in excess of the cumulative compensation cost recognized for share-based awards (excess tax benefits) are classified as operating cash inflows.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents are held in cash depository accounts with major financial institutions around the world or invested in high quality, short-term liquid investments. The Company considers all highly liquid financial instruments with original maturities of three months or less to be cash equivalents. The Company maintains cash deposits in banks which from time to time exceed the amount of deposit insurance available. Management periodically assesses the financial condition of the Company’s banks and believes that the risk of any potential credit loss is minimal.

Accounts Receivable and Allowances

Accounts Receivable and Allowances

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Allowances for doubtful accounts reflect the Company’s estimate of amounts in its existing accounts receivable that may not be collected due to customer claims or customer inability or unwillingness to pay. The allowance is determined based on a combination of factors, including the Company’s ongoing risk assessment regarding the credit worthiness of its customers, historical collection experience and length of time the receivables are past due. Account balances are charged off against the allowance when the Company believes it is probable the receivable will not be recovered.

Inventories

Inventories

Inventories are stated at the lower of cost or net realizable value and include the cost of raw materials, labor, manufacturing overhead and freight and inbound handling costs incurred to pre-position goods in the Company’s warehouse network. The Company makes provisions for obsolete or slow-moving inventories as necessary to properly reflect inventory at the lower of cost or net realizable value. Inventories are valued using the first in, first out method.

Investment in Unconsolidated Affiliates

Investment in Unconsolidated Affiliates

Non-marketable equity investments in which the Company has the ability to exercise significant influence, but does not control, are accounted for using the equity method of accounting, with the Company’s proportionate share of the earnings and losses of these entities reflected in the Consolidated Statements of Operations. The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may be impaired. If a decline in the value of an equity method investment is determined to be other than temporary, an impairment loss is recognized in earnings for the amount by which the carrying amount of the investment exceeds its estimated fair value.

Long-lived Assets

Long-Lived Assets

Property, plant and equipment are stated at cost. Interest capitalized in property, plant and equipment amounted to $1.1, $2.1 and $2.2 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Expenditures for maintenance and repairs are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost of the asset and the related accumulated depreciation are removed from the accounts with the resulting gain or loss being reflected in income (loss) from operations.

Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows: 

Land improvements	10 – 25 years
Buildings	10 – 40 years
Machinery and equipment	3 – 15 years
Furniture and fixtures	6 – 10 years
Software	3 – 8 years

Intangible assets subject to amortization include technology, patents, customer relationships, non-compete agreements and certain trade names. These intangible assets are amortized over their estimated useful economic lives, which typically range from 3 to 25 years. The Company’s fixed assets and intangible assets subject to amortization are required to be tested for recoverability whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group would be compared to the asset group carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.

Internal Use Software

Internal Use Software

The Company capitalizes certain qualifying costs incurred in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest and payroll and payroll-related costs for associates during the application development stage. Internal and external costs incurred during the preliminary project stage and post implementation-operation stage, mainly training and maintenance costs, are expensed as incurred. Once the application is substantially complete and ready for its intended use, qualifying costs are amortized on a straight-line basis over the software’s estimated useful life. Capitalized internal use software is included in the “Property, plant and equipment, net” line in the Consolidated Balance Sheets. Capitalized software as a service is included in the “Prepaid and other current assets” line in the Consolidated Balance Sheets and is amortized using the straight-line method over the term of the hosting arrangement which typically ranges from 3 to 8 years.

Goodwill and Indefinite-lived Intangible Assets

Goodwill and Indefinite-lived Intangible Assets

Goodwill and indefinite-lived intangible assets are not subject to amortization. These assets are reviewed for impairment by applying a fair-value based test on an annual basis as of the first day of the Company’s fiscal fourth quarter or more frequently if circumstances indicate impairment may have occurred. With respect to goodwill, the Company performs either a qualitative or quantitative evaluation for each of its reporting units. Factors considered in the qualitative test include reporting unit specific operating results as well as new events and circumstances impacting the operations or cash flows of the reporting units. For the quantitative test, the Company assesses goodwill for impairment by comparing the carrying value of its reporting units to their respective fair values. A reporting unit is defined as an operating segment or one level below an operating segment. The Company determines the fair value of its reporting units using an income-based approach incorporating assumptions it believes market participants would utilize. The income-based approach utilizes discounted cash flows that depend upon internally-developed forecasts based on annual budgets and longer-range strategic plans. The Company uses discount rates that are commensurate with the risks and uncertainties inherent in the respective reporting units and in the internally-developed forecasts. To further substantiate fair value, the Company compares the aggregate fair value of the reporting units to the Company’s total market capitalization.

With respect to indefinite-lived intangible assets, the Company performs either a qualitative or quantitative evaluation for each asset. Factors considered in the qualitative test include asset specific operating results as well as new events and circumstances impacting the cash flows of the assets. For the quantitative test, the fair value of the Company’s indefinite-lived intangible assets is determined using an income-based approach utilizing discounted cash flows and incorporating assumptions the Company believes market participants would utilize. For trade names, fair value is determined using a relief-from-royalty methodology similar to that employed when the associated businesses were acquired but using updated estimates of sales, cash flow and profitability.

If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the reporting unit or intangible asset exceeds its estimated fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.

Investments in Securities

Investments in Securities

Convertible debt investments are classified as “available for sale,” are reported at fair value and are presented in the “Other assets” line in the Consolidated Balance Sheets. If the fair value of an available for sale investment is less than its amortized cost basis at the balance sheet date, the impairment is either temporary or other-than-temporary. If a decline in fair value is considered to be temporary at the balance sheet date, unrealized gains and losses are included in accumulated other comprehensive loss (“AOCL”) in the Consolidated Balance Sheets. If management intends to sell the security or if it is more likely than not that the Company will have to sell the security, an other-than-temporary impairment is considered to have occurred and an amount equal to the difference between the investment’s amortized cost basis and its fair value at the balance sheet date will be charged to earnings. If a decline in fair value is considered to be other-than-temporary at the balance sheet date and management can assert that it does not intend to sell the security and it is not more likely than not that it will have to sell the security before recovering its amortized cost basis (net of allowance), an allowance for credit losses (impairment), including any write-off of accrued interest receivable, is charged to earnings. This impairment allowance is separated into two components: (i) the amount related to credit losses (recorded in earnings) and (ii) the amount related to all other factors (recorded in other comprehensive income / loss). Interest income is recorded on an accrual basis and is classified in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations.

Supplier Finance Program

Supplier Finance Program

The Company has an agreement to provide a supplier finance program which facilitates participating suppliers’ ability to finance payment obligations of the Company with a designated third-party financial institution. Participating suppliers may, at their sole discretion, elect to finance payment obligations of the Company prior to their scheduled due dates at a discounted price to the participating financial institution. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under this arrangement. The payment terms that the Company negotiates with its suppliers are consistent, regardless of whether a supplier participates in the program. The Company’s current payment terms with a majority of its suppliers generally range from 30 to 60 days, which the Company deems to be commercially reasonable.

Insurance and Self-Insurance

Insurance and Self-Insurance

The Company maintains insurance for certain risks, including property damage, management liability, cargo liability, cyber threats, workers compensation and general liability losses, and is self-insured for employee-related health care benefits up to a specified level for individual claims. The Company accrues for the expected costs associated with these risks by considering historical claims experience, demographic factors, severity factors and other relevant information. Costs are recognized in the period the claim is incurred, and accruals include an actuarially determined estimate of claims incurred but not yet reported.

Income Taxes

Income Taxes

The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax bases. Management reviews the Company’s deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change.

The Company establishes a liability for tax return positions in which there is uncertainty as to whether or not the position will ultimately be sustained. Amounts for uncertain tax positions are adjusted in quarters when new information becomes available or when positions are effectively settled. The Company recognizes interest expense and penalties related to these unrecognized tax benefits within income tax expense. GAAP provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits of the position. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

U.S. income tax expense and foreign withholding taxes are provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.

Translation of Foreign Currencies

Translation of Foreign Currencies

The functional currency for each Scotts Miracle-Gro subsidiary is generally its local currency. Assets and liabilities of these subsidiaries are translated at the exchange rate in effect at each fiscal year-end. Income and expense accounts are translated at the average rate of exchange prevailing during the year. Translation gains and losses arising from the use of differing exchange rates from period to period are included in AOCL within shareholders’ equity (deficit). Foreign exchange transaction gains and losses are included in the determination of net income and classified as “Other (income) expense, net” in the Consolidated Statements of Operations.

Derivative Instruments

Derivative Instruments

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. A variety of financial instruments, including forwards, futures and swap contracts, are used to manage these exposures. These financial instruments are recognized at fair value in the Consolidated Balance Sheets, and all changes in fair value are recognized in net income (loss) or shareholders’ equity (deficit) through AOCL. The Company’s objective in managing these exposures is to better control these elements of cost and mitigate the earnings and cash flow volatility associated with changes in the applicable rates and prices.

The Company has established policies and procedures that encompass risk-management philosophy and objectives, guidelines for derivative instrument usage, counterparty credit approval, and the monitoring and reporting of derivative activity. The Company does not enter into derivative instruments for the purpose of speculation.

The Company formally designates and documents instruments at inception that qualify for hedge accounting of underlying exposures in accordance with GAAP. The Company formally assesses, both at inception and at least quarterly, whether the financial instruments used in hedging transactions are effective at offsetting changes in cash flows of the related underlying exposure. Fluctuations in the value of these instruments generally are offset by changes in the expected cash flows of the underlying exposures being hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument. The Company designates certain commodity hedges as cash flow hedges of forecasted purchases of commodities and interest rate swap agreements as cash flow hedges of interest payments on variable rate borrowings. Changes in the fair value of derivative contracts that qualify for hedge accounting are recorded in AOCL. For commodity hedges, realized gains or losses remain as a component of AOCL until the related inventory is sold. Cash flows associated with commodity and interest rate swap hedges are classified as operating activities in the Consolidated Statements of Cash Flows.

Leases

Leases

The Company determines whether an arrangement contains a lease at inception by determining if the contract conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration and other facts and circumstances. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets are calculated based on the lease liability adjusted for any lease payments paid to the lessor at or before the commencement date and initial direct costs incurred by the Company and exclude any lease incentives received from the lessor. Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. The lease term may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date based on the lease term. The Company considers its credit rating and the current economic environment in determining this collateralized rate. Variable lease payments are the portion of lease payments that are not fixed over the lease term. Variable lease payments are expensed as incurred and include certain non-lease components, such as maintenance and other services provided by the lessor, and other charges included in the lease, as applicable. The Company elected to exclude short-term leases, defined as leases with initial terms of 12 months or less, from its Consolidated Balance Sheets.

Recently Adopted and Recently Issued Accounting Pronouncements

RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS

In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-04, “Liabilities — Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” This ASU requires disclosure of the key terms of outstanding supplier finance programs and a roll-forward of the related obligations. ASU No. 2022-04 is effective for fiscal years beginning after December 15, 2022, except for the amendment on roll-forward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted the ASU as of October 1, 2023. The adoption relates to disclosures only and does not have any impact on the Company’s consolidated financial position, results of operations or cash flows.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU requires enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker that are included within each reported measure of segment profit or loss, and also requires all annual disclosures currently required by Topic 280 to be included in interim periods. ASU No. 2023-07 is to be applied retrospectively for all periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU primarily requires enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative and qualitative disclosures regarding income taxes paid. ASU No. 2023-09 is to be applied prospectively, with the option to apply the standard retrospectively, effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

In November 2024, the FASB issued ASU No. 2024-03, “Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” This ASU requires disaggregated disclosures on an annual and interim basis, in the notes to the financial statements, of certain categories of expenses that are included in expense line items on the face of the statement of operations. ASU No. 2024-03 is to be applied prospectively, with the option to apply the standard retrospectively, effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

Revenue Recognition

Nature of Goods and Services

The Company’s revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers. In addition to product sales, the Company acts as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, and performs certain other services under ancillary agreements with Monsanto. Refer to “NOTE 20. SEGMENT INFORMATION” for disaggregated revenue information and “NOTE 6. MARKETING AGREEMENT” for revenue information related to the Monsanto agreements.

Identification and Satisfaction of Performance Obligations

The Company recognizes product sales at a point in time when it transfers control of products to customers and has no further obligation to provide services related to such products. Control is the ability of customers to direct the “use of” and “obtain” the benefit from the Company’s products. In evaluating the timing of the transfer of control of products to customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are typically recognized when products are delivered to or picked up by the customer. The Company is generally the principal in a transaction and, therefore, primarily records revenue on a gross basis. When the Company is a principal in a transaction, it has determined that it controls the ability to direct the use of the product prior to transfer to a customer, is primarily responsible for fulfilling the promise to provide the product or service to the customer, has discretion in establishing prices, and ultimately controls the transfer of the product or services provided to the customer.

Under the terms of the Third Restated Agreement, pursuant to which the Company serves as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The Third Restated Agreement also requires the Company to make annual payments to Monsanto as a contribution against the overall expenses of its consumer Roundup® business. The gross commission earned under the Third Restated Agreement and the contribution payments to Monsanto are included in the “Net sales” line in the Consolidated Statements of Operations. The Company performs other services, including conversion services, pursuant to ancillary agreements with Monsanto. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross margin dollars or net income.

Transactional Price and Promotional Allowances

Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that the Company expects to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns. Commission income related to the Monsanto agreements is recognized over the program year as the services are performed based upon the commission income formula in the agreements.

The Company’s promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotional costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Accruals for expected payouts under these programs are included in the “Other current liabilities” line in the Consolidated Balance Sheets. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Consolidated Statements of Operations. The Company excludes from revenue any amounts collected from customers for sales or other taxes.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

Schedule of Estimated Useful Economic Lives of Property, Plant and Equipment

Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows: 

Land improvements	10 – 25 years
Buildings	10 – 40 years
Machinery and equipment	3 – 15 years
Furniture and fixtures	6 – 10 years
Software	3 – 8 years

Schedule of Supplemental Cash Flow Information

Supplemental cash flow information was as follows:

	Year Ended September 30,
	2024		2023		2022
Interest paid	$	157.7	$	173.5	$	112.5
Income taxes paid (refunded), net	9.4		(18.2)		27.2

XML

IMPAIRMENT, RESTRUCTURING AND OTHER (Tables)

12 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

Schedule of Impairment, Restructuring, and Other Charges

The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:

	Year Ended September 30,
	2024		2023		2022
Cost of sales—impairment, restructuring and other:
Restructuring and other charges, net	$	72.9	$	148.5	$	143.6
Property, plant and equipment impairments	5.3		11.4		16.6
Right-of-use asset impairments	5.3		25.8		—
Operating expenses—impairment, restructuring and other:
Convertible debt other-than-temporary impairments	64.6		101.3		—
Goodwill and intangible asset impairments	2.5		127.9		668.3
Restructuring and other charges (recoveries), net	(4.3)		51.2		40.9
Gains on sale of property, plant and equipment	—		—		(16.2)
Total impairment, restructuring and other charges	$	146.3	$	466.1	$	853.2

Schedule of Reserve

The following table summarizes the activity related to liabilities associated with restructuring activities for each of the periods presented:

	Year Ended September 30,
	2024		2023		2022
Amounts accrued at beginning of year	$	40.5	$	31.5	$	1.9
Restructuring charges	11.8		55.6		47.1
Payments	(33.4)		(46.6)		(17.5)
Amounts accrued at end of year	$	18.9	$	40.5	$	31.5

XML

GOODWILL AND INTANGIBLE ASSETS, NET (Tables)

12 Months Ended

Sep. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Rollforward of Carrying Amount of Goodwill by Reportable Segment

The following table displays a rollforward of the carrying amount of goodwill by reportable segment:

	U.S. Consumer		Hawthorne		Other		Total
Goodwill	$	245.7	$	617.0	$	10.1	$	872.8
Accumulated impairment losses	(1.8)		(617.0)		—		(618.8)
Balance at September 30, 2022	243.9		—		10.1		254.0
Foreign currency translation	—		—		0.2		0.2
Impairment	—		—		(10.3)		(10.3)
Goodwill	245.7		617.0		10.3		873.0
Accumulated impairment losses	(1.8)		(617.0)		(10.3)		(629.1)
Balance at September 30, 2023	243.9		—		—		243.9
Goodwill	245.7		617.0		10.3		873.0
Accumulated impairment losses	(1.8)		(617.0)		(10.3)		(629.1)
Balance at September 30, 2024	$	243.9	$	—	$	—	$	243.9

Schedule of Finite-lived Intangible Assets

The following table presents intangible assets, net of accumulated amortization and impairment charges:

	September 30, 2024						September 30, 2023
	Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount
Finite-lived intangible assets:
Trade names	$	325.8	$	(272.8)	$	53.0	$	322.4	$	(260.7)	$	61.7
Customer relationships	253.1		(223.9)		29.2		251.5		(216.1)		35.4
Technology	50.2		(45.5)		4.7		50.1		(44.5)		5.6
Other	35.0		(27.0)		8.0		34.9		(24.8)		10.1
Total finite-lived intangible assets, net					94.9						112.8
Indefinite-lived intangible assets:
Indefinite-lived trade names					168.2						168.2
Roundup® marketing agreement amendment					155.7						155.7
Total indefinite-lived intangible assets					323.9						323.9
Total intangible assets, net					$	418.8					$	436.7

Schedule of Indefinite-lived Intangible Assets

The following table presents intangible assets, net of accumulated amortization and impairment charges:

	September 30, 2024						September 30, 2023
	Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount
Finite-lived intangible assets:
Trade names	$	325.8	$	(272.8)	$	53.0	$	322.4	$	(260.7)	$	61.7
Customer relationships	253.1		(223.9)		29.2		251.5		(216.1)		35.4
Technology	50.2		(45.5)		4.7		50.1		(44.5)		5.6
Other	35.0		(27.0)		8.0		34.9		(24.8)		10.1
Total finite-lived intangible assets, net					94.9						112.8
Indefinite-lived intangible assets:
Indefinite-lived trade names					168.2						168.2
Roundup® marketing agreement amendment					155.7						155.7
Total indefinite-lived intangible assets					323.9						323.9
Total intangible assets, net					$	418.8					$	436.7

Schedule of Future Estimates of Amortization Expense

Amortization expense is estimated to be as follows for the years ending September 30:

2025	$	12.6
2026	11.5
2027	10.7
2028	9.1
2029	6.9

XML

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS (Tables)

12 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Detail of Certain Financial Statement Accounts

The following presents detail regarding certain financial statement accounts:

	September 30,
	2024		2023
INVENTORIES:
Raw materials	$	256.8	$	272.5
Finished goods	246.6		506.2
Work-in-progress	84.1		101.6
	$	587.5	$	880.3
PROPERTY, PLANT AND EQUIPMENT, NET:
Machinery and equipment	$	683.6	$	651.7
Buildings	305.8		277.1
Land and improvements	152.9		149.0
Software	107.2		109.9
Construction in progress	78.7		104.6
Furniture and fixtures	62.6		62.3
Finance leases	24.1		21.1
	1,414.9		1,375.7
Less: accumulated depreciation	(805.4)		(765.4)
	$	609.5	$	610.3
OTHER ASSETS:
Operating lease right-of-use assets	$	265.4	$	262.6
Net deferred tax assets	191.3		189.8
Accrued pension, postretirement and executive retirement assets	62.7		64.1
Convertible debt investments	45.8		85.8
Other	8.9		30.8
	$	574.1	$	633.1

	September 30,
	2024		2023
OTHER CURRENT LIABILITIES:
Advertising and promotional accruals	$	131.2	$	143.0
Current operating lease liabilities	75.3		76.4
Payroll and other compensation accruals	72.0		51.2
Accrued interest	29.4		31.9
Accrued taxes	16.7		28.5
Other	118.4		119.2
	$	443.0	$	450.2
OTHER NON-CURRENT LIABILITIES:
Non-current operating lease liabilities	$	215.8	$	220.1
Accrued pension, postretirement and executive retirement liabilities	73.0		76.7
Net deferred tax liabilities	7.0		1.1
Other	42.2		52.0
	$	338.0	$	349.9

XML

MARKETING AGREEMENT (Tables)

12 Months Ended

Sep. 30, 2024

Marketing Agreement [Abstract]

Marketing Agreement

The elements of the net commission and reimbursements earned under the Third Restated Agreement and included in the “Net sales” line in the Consolidated Statements of Operations are as follows:

	Year Ended September 30
	2024		2023		2022
Gross commission	$	90.8	$	75.7	$	83.4
Contribution expenses	(18.0)		(18.0)		(18.0)
Net commission	72.8		57.7		65.4
Reimbursements associated with Roundup® marketing agreement	91.2		82.5		67.9
Total net sales associated with Roundup® marketing agreement	$	164.0	$	140.2	$	133.3

XML

RETIREMENT PLANS (Tables)

12 Months Ended

Sep. 30, 2024

Retirement Benefits [Abstract]

Schedule of Defined Benefit Pension Plans

The defined benefit pension plans are valued using a September 30 measurement date.

	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2024		2023		2024		2023
Change in projected benefit obligation:
Benefit obligation at beginning of year	$	71.8	$	77.7	$	108.5	$	109.2
Interest cost	3.7		3.6		5.9		6.2
Actuarial (gain) loss	5.5		(2.5)		5.1		(11.0)
Benefits paid	(6.8)		(6.9)		(6.6)		(5.9)
Foreign currency translation	—		—		10.3		10.0
Projected benefit obligation (“PBO”) at end of year	$	74.2	$	71.8	$	123.2	$	108.5
Accumulated benefit obligation (“ABO”) at end of year	$	74.2	$	71.8	$	123.2	$	108.5
Change in plan assets:
Fair value of plan assets at beginning of year	$	54.1	$	59.1	$	124.8	$	128.9
Actual return on plan assets	7.1		1.7		10.0		(11.5)
Employer contribution	2.9		0.2		0.9		1.2
Benefits paid	(6.8)		(6.9)		(6.6)		(5.9)
Foreign currency translation	—		—		12.3		12.1
Fair value of plan assets at end of year	$	57.3	$	54.1	$	141.4	$	124.8
Overfunded (underfunded) status at end of year	$	(16.9)	$	(17.7)	$	18.2	$	16.3

	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2024		2023		2024		2023
Information for pension plans with an ABO in excess of plan assets:
Accumulated benefit obligation	$	74.2	$	71.8	$	12.0	$	11.5
Fair value of plan assets	57.3		54.1		—		—
Information for pension plans with a PBO in excess of plan assets:
Projected benefit obligation	$	74.2	$	71.8	$	12.0	$	11.5
Fair value of plan assets	57.3		54.1		—		—
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	$	—	$	—	$	30.2	$	27.8
Current liabilities	(0.2)		(0.2)		(0.9)		(0.9)
Non-current liabilities	(16.7)		(17.5)		(11.1)		(10.6)
Total amount accrued	$	(16.9)	$	(17.7)	$	18.2	$	16.3
Amounts recognized in AOCL consist of:
Actuarial loss	$	34.1	$	35.2	$	64.1	$	60.0
Prior service cost	—		—		2.3		2.1
Total amount recognized	$	34.1	$	35.2	$	66.4	$	62.1

	U.S. Defined Benefit Pension Plans						International Defined Benefit Pension Plans
	2024			2023			2024			2023
Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	$	(0.5)		$	1.8		$	(0.7)		$	(6.0)
Reclassification to net earnings	1.7			1.8			2.3			2.0
Foreign currency translation	—			—			(5.9)			(4.8)
Total change in other comprehensive loss	$	1.2		$	3.6		$	(4.3)		$	(8.8)
Weighted average assumptions used in development of projected benefit obligation:
Discount rate	4.62		%	5.54		%	4.86		%	5.38		%

Components of Net Periodic Benefit Cost

	U.S. Defined Benefit Pension Plans									International Defined Benefit Pension Plans
	2024			2023			2022			2024			2023			2022
Components of net periodic benefit cost (income):
Interest cost	$	3.7		$	3.6		$	1.7		$	5.9		$	6.2		$	3.0
Expected return on plan assets	(2.2)			(2.5)			(2.8)			(5.7)			(5.5)			(5.1)
Net amortization	1.7			1.8			1.7			2.3			2.0			1.3
Net periodic benefit cost (income)	$	3.2		$	2.9		$	0.6		$	2.5		$	2.7		$	(0.8)
Weighted average assumptions used in development of net periodic benefit cost (income):
Weighted average discount rate - interest cost	5.46		%	4.87		%	1.74		%	5.38		%	5.29		%	1.64		%
Expected return on plan assets	4.25		%	4.50		%	3.50		%	4.42		%	3.91		%	2.37		%

Schedule of Other Information

	U.S. Defined Benefit Pension Plans			International Defined Benefit Pension Plans
Other information:
Plan asset allocations:
Target for September 30, 2025:
Equity securities	19		%	—		%
Debt securities	76		%	—		%
Real estate securities	3		%	—		%
Cash and cash equivalents	2		%	15		%
Insurance contracts	—		%	85		%
September 30, 2024
Equity securities	19		%	—		%
Debt securities	74		%	—		%
Real estate securities	2		%	—		%
Cash and cash equivalents	5		%	15		%
Insurance contracts	—		%	85		%
September 30, 2023
Equity securities	18		%	—		%
Debt securities	75		%	5		%
Real estate securities	3		%	—		%
Cash and cash equivalents	4		%	11		%
Insurance contracts	—		%	84		%
Expected company contributions in fiscal 2025	$	2.7		$	0.9
Expected future benefit payments:
2025	$	7.5		$	7.3
2026	7.0			7.4
2027	6.9			7.4
2028	6.7			7.6
2029	6.5			7.8
2030 – 2034	28.4			40.5

Fair Value of The Company's Pension Plan Asset

The following tables set forth the fair value of the Company’s pension plan assets, segregated by level within the fair value hierarchy:

	Fair Value Hierarchy Level	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
		2024		2023		2024		2023
Cash and cash equivalents	Level 1	$	2.6	$	2.2	$	21.9	$	14.0
Insurance contracts	Level 3	—		—		119.5		104.3
Total assets in the fair value hierarchy		$	2.6	$	2.2	$	141.4	$	118.3
Common collective trusts measured at net asset value
Real estate		$	1.4	$	1.8	$	—	$	—
Equities		10.9		10.0		—		—
Fixed income		42.4		40.1		—		6.5
Total common collective trusts measured at net asset value		54.7		51.9		—		6.5
Total assets at fair value		$	57.3	$	54.1	$	141.4	$	124.8

XML

ASSOCIATE MEDICAL BENEFITS (Tables)

12 Months Ended

Sep. 30, 2024

Defined Benefit Plan, Postretirement Medical Plan with Prescription Drug Benefits [Abstract]

Schedule of Changes in Accumulated Postemployment Benefit Obligations

The following tables set forth information about the retiree medical plan for domestic associates. The retiree medical plan is valued using a September 30 measurement date.

	2024		2023
Change in Accumulated Plan Benefit Obligation (“APBO”):
Benefit obligation at beginning of year	$	13.3	$	15.7
Service cost	0.1		0.1
Interest cost	0.8		0.8
Plan participants’ contributions	0.3		0.4
Actuarial (gain) loss	1.5		(2.2)
Benefits paid	(2.2)		(1.5)
Benefit obligation at end of year	$	13.8	$	13.3
Change in plan assets:
Fair value of plan assets at beginning of year	$	—	$	—
Employer contribution	1.9		1.1
Plan participants’ contributions	0.3		0.4
Gross benefits paid	(2.2)		(1.5)
Fair value of plan assets at end of year	$	—	$	—
Unfunded status at end of year	$	(13.8)	$	(13.3)

	2024			2023
Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities	$	(1.3)		$	(1.4)
Non-current liabilities	(12.5)			(11.9)
Total amount accrued	$	(13.8)		$	(13.3)
Amounts recognized in accumulated other comprehensive (income) loss consist of:
Actuarial gain	$	(1.3)		$	(3.4)
Total accumulated other comprehensive income	$	(1.3)		$	(3.4)
Total change in other comprehensive income attributable to:
Gain (loss) during the period	$	(1.5)		$	2.2
Reclassification to net earnings	(0.6)			(0.2)
Total change in other comprehensive income	$	(2.1)		$	2.0
Discount rate used in development of APBO	4.86		%	5.98		%

Schedule of Expected Benefit Payments

The following benefit payments under the plan are expected to be paid by the Company and the retirees for the fiscal years indicated:

	Gross Benefit Payments		Retiree Contributions		Net Company Payments
2025	$	1.6	$	(0.3)	$	1.3
2026	1.8		(0.4)		1.3
2027	1.9		(0.6)		1.4
2028	2.0		(0.7)		1.3
2029	2.1		(0.7)		1.3
2030 – 2034	9.5		(3.7)		5.7

XML

DEBT (Tables)

12 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Schedule of Components of Long-Term Debt

The components of debt are as follows:

	September 30,
	2024		2023
Credit Facilities:
Revolving loans	$	—	$	88.3
Term loans	625.0		925.0
Senior Notes due 2031 – 4.000%	500.0		500.0
Senior Notes due 2032 – 4.375%	400.0		400.0
Senior Notes due 2029 – 4.500%	450.0		450.0
Senior Notes due 2026 – 5.250%	250.0		250.0
Finance lease obligations	17.8		16.9
Other	—		0.4
Total debt	2,242.8		2,630.6
Less current portions	52.6		52.3
Less unamortized debt issuance costs	16.0		20.9
Long-term debt	$	2,174.2	$	2,557.4

Schedule of Company's Debt Maturities

The Company’s aggregate scheduled maturities of debt by fiscal year, excluding finance lease obligations, are as follows:

2025	$	50.0
2026	50.0
2027	775.0
2028	—
2029	—
Thereafter	1,350.0
	$	2,225.0

Schedule of Derivative Instruments

Notional Amount ($)		Effective Date (a)	Expiration Date	Fixed Rate
150		6/7/2023	4/7/2027	3.37	%
50		6/7/2023	4/7/2027	3.34	%
100	(b)	11/20/2023	3/22/2027	4.74	%
150	(b)	9/20/2024	9/20/2029	4.25	%

(a)The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b)Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

XML

EQUITY (Tables)

12 Months Ended

Sep. 30, 2024

Equity [Abstract]

Schedule of Authorized and Issued Shares

Authorized and issued shares consisted of the following (in millions):

	September 30,
	2024	2023
Preferred shares, no par value:
Authorized	0.2 shares	0.2 shares
Issued	0.0 shares	0.0 shares
Common shares, no par value, $0.01 stated value per share:
Authorized	100.0 shares	100.0 shares
Issued	68.1 shares	68.1 shares

Schedule of Accumulated Other Comprehensive Loss

Changes in AOCL by component were as follows for the fiscal years ended September 30:

	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Loss On Securities		Pension and Other Post- Retirement Benefit Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance at September 30, 2021	$	(1.7)	$	10.2	$	(2.3)	$	(72.5)	$	(66.4)
Other comprehensive income (loss) before reclassifications	(27.2)		40.1		(102.0)		(7.3)		(96.4)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.1)		—		11.7		2.6
Income tax benefit (expense)	—		(7.9)		24.6		(1.1)		15.6
Net current period other comprehensive income (loss)	(27.2)		23.1		(77.4)		3.3		(78.2)
Balance at September 30, 2022	(28.9)		33.3		(79.7)		(69.3)		(144.6)
Other comprehensive income (loss) before reclassifications	7.0		5.6		(34.9)		(2.5)		(24.8)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(23.3)		101.3		(1.6)		76.4
Income tax benefit (expense)	—		4.5		(25.3)		1.0		(19.8)
Net current period other comprehensive income (loss)	7.0		(13.2)		41.1		(3.1)		31.8
Balance at September 30, 2023	(21.9)		20.1		(38.6)		(72.4)		(112.8)
Other comprehensive income (loss) before reclassifications	0.6		(10.6)		(40.4)		(2.8)		(53.2)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.7)		64.6		(2.7)		52.2
Income tax benefit (expense)	—		5.1		—		1.4		6.5
Net current period other comprehensive income (loss)	0.6		(15.2)		24.2		(4.1)		5.5
Balance at September 30, 2024	$	(21.3)	$	4.9	$	(14.4)	$	(76.5)	$	(107.3)

The sum of the components may not equal due to rounding.

Schedule of Share-Based Compensation

Total share-based compensation was as follows for each of the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Share-based compensation	$	79.8	$	68.1	$	30.3
Related tax benefit recognized	14.8		15.6		4.9

Schedule of Aggregate Stock Option Activity

Stock option activity was as follows:

	No. of   Options	Wtd. Avg. Exercise Price		Wtd Avg Remaining Life	Aggregate Intrinsic Value
Awards outstanding at September 30, 2023	1,191,183	$	76.64	6.6 years
Granted	1,356,698	53.75
Exercised	(35,027)	58.52
Forfeited	(135,182)	55.69
Awards outstanding at September 30, 2024	2,377,672	65.03		7.5 years	$	71.4
Exercisable	493,832	108.97		2.6 years	8.9

Schedule of Share-Based Awards Granted

The weighted average assumptions used in the estimation of fair value for awards granted in fiscal 2024 are as follows:

Expected volatility	38.8	%
Risk-free interest rate	4.7	%
Expected dividend yield	4.1	%
Expected life	6.1 years

Details of the assumptions used in the estimation of fair value for these awards are as follows:

Expected volatility	36.6	%
Risk-free interest rate	4.5	%

Schedule of Restricted Share-Based Award Activity

Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:

	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at September 30, 2023	611,838	$	89.10
Granted	363,264	55.12
Vested	(77,826)	182.87
Forfeited	(130,892)	59.40
Awards outstanding at September 30, 2024	766,384	68.54

Schedule of Performance-Based Award Activity

Performance-based award activity was as follows (based on target award amounts):

	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at September 30, 2023	544,790	$	76.85
Granted	240,677	74.57
Vested (a)	(181,791)	59.88
Forfeited	(194,246)	65.89
Awards outstanding at September 30, 2024	409,430	86.61

(a)Vested at a weighted average of 100% of the target performance share units granted.

XML

EARNINGS PER COMMON SHARE (Tables)

12 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Information to Calculate Basic and Diluted Earnings (Loss) Per Common Share

The following table presents information necessary to calculate basic and diluted net loss per Common Share for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Net loss	$	(34.9)	$	(380.1)	$	(437.5)
Basic net loss per common share:
Weighted-average common shares outstanding during the period	56.8		56.0		55.5
Basic net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)
Diluted net loss per common share:
Weighted-average common shares outstanding during the period	56.8		56.0		55.5
Dilutive potential common shares	—		—		—
Weighted-average number of common shares outstanding and dilutive potential common shares	56.8		56.0		55.5
Diluted net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)
Antidilutive stock options outstanding	0.4		0.4		0.2

XML

INCOME TAXES (Tables)

12 Months Ended

Sep. 30, 2024

Income Tax Disclosure [Abstract]

Provision (Benefit) For Income Taxes Allocated to Continuing Operations

The provision (benefit) for income taxes consisted of the following:

	Year Ended September 30,
	2024		2023		2022
Current:
Federal	$	2.4	$	3.7	$	22.8
State	2.5		0.6		9.3
Foreign	(5.3)		1.6		8.7
Total current	(0.4)		5.9		40.8
Deferred:
Federal	11.6		(62.1)		(125.5)
State	(3.8)		(5.2)		(23.3)
Foreign	3.9		(11.8)		(12.6)
Total deferred	11.7		(79.1)		(161.4)
Income tax expense (benefit)	$	11.3	$	(73.2)	$	(120.6)

The Domestic and Foreign Components of Income From Continuing Operations Before Income Taxes

The domestic and foreign components of loss before income taxes were as follows:

	Year Ended September 30,
	2024		2023		2022
Domestic	$	(10.8)	$	(376.2)	$	(427.3)
Foreign	(12.8)		(77.1)		(130.8)
Loss before income taxes	$	(23.6)	$	(453.3)	$	(558.1)

Reconciliation of the Federal Corporate Income Tax Rate and the Effective Tax Rate

A reconciliation of the federal corporate income tax rate and the effective tax rate on loss before income taxes is summarized below:

	Year Ended September 30,
	2024		2023		2022
Statutory income tax rate	21.0	%	21.0	%	21.0	%
Effect of foreign operations	(2.0)		0.2		(1.6)
State taxes, net of federal benefit	8.0		3.2		2.6
Effect of other permanent differences	(32.8)		(0.8)		2.8
Research and Experimentation and other federal tax credits	2.9		0.2		0.2
Effect of tax contingencies	3.7		0.1		(1.8)
Change in valuation allowances	(57.4)		(8.7)		(0.9)
Other	8.7		1.0		(0.7)
Effective income tax rate	(47.9)	%	16.2	%	21.6	%

Components of Deferred Income Tax Assets and Liabilities

Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the deferred income tax assets and liabilities were as follows:

	September 30,
	2024		2023
DEFERRED TAX ASSETS
Lease liabilities	$	67.6	$	70.0
Intangible assets	62.2		79.2
Net operating loss carryovers	56.4		67.3
Interest limitation carryforward	55.9		35.9
Convertible debt investments	43.6		33.4
Accrued liabilities	43.2		48.7
Outside basis difference in equity investments	23.1		10.4
Inventories	16.1		26.1
Foreign tax credit carryovers	15.2		16.3
Other	22.4		23.8
Gross deferred tax assets	405.7		411.1
Valuation allowance	(96.5)		(87.7)
Total deferred tax assets	309.2		323.4
DEFERRED TAX LIABILITIES
Lease right-of-use assets	(62.0)		(62.1)
Property, plant and equipment	(58.5)		(62.7)
Other	(4.4)		(9.9)
Total deferred tax liabilities	(124.9)		(134.7)
Net deferred tax asset	$	184.3	$	188.7

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the unrecognized tax benefits is as follows:

	Year Ended September 30,
	2024		2023		2022
Balance at beginning of year	$	34.6	$	35.8	$	24.1
Additions for tax positions of the current year	0.2		0.2		11.3
Additions for tax positions of prior years	0.1		3.8		2.2
Reductions for tax positions of prior years	(3.7)		(0.2)		(2.5)
Settlements with tax authorities	(0.7)		(0.1)		1.3
Expiration of statutes of limitation	(4.8)		(4.9)		(0.6)
Balance at end of year	$	25.7	$	34.6	$	35.8

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)

12 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Outstanding Commodity Contracts that Hedge Forecasted Purchases

The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:

	September 30,
	2024	2023
Commodity
Urea	51,000 tons	52,500 tons
Diesel	1,092,000 gallons	1,974,000 gallons
Heating Oil	42,000 gallons	966,000 gallons

Summary of Fair Values of the Company's Derivative Instruments

The fair values of the Company’s derivative instruments, which represent Level 2 fair value measurements, were as follows:

		Assets / (Liabilities)
		2024		2023
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value
Interest rate swap agreements	Prepaid and other current assets	$	0.9	$	16.7
	Other assets	—		14.7
	Other current liabilities	(0.2)		—
	Other liabilities	(5.1)		—
Commodity hedging instruments	Prepaid and other current assets	0.8		2.3
Total derivatives designated as hedging instruments		$	(3.6)	$	33.7
Derivatives Not Designated as Hedging Instruments	Balance Sheet Location
Currency forward contracts	Prepaid and other current assets	$	0.1	$	5.6
	Other current liabilities	(4.0)		—
Commodity hedging instruments	Prepaid and other current assets	—		0.9
Total derivatives not designated as hedging instruments		(3.9)		6.5
Total derivatives		$	(7.5)	$	40.2

Schedule of the Effect of Derivative Instruments on AOCI and Operations

The effect of derivative instruments on AOCL, net of tax, and the Consolidated Statements of Operations for the years ended September 30 was as follows:

 

	Amount of Gain / (Loss) Recognized in AOCL
Derivatives in Cash Flow Hedging Relationships	2024		2023
Interest rate swap agreements	$	(7.1)	$	11.3
Commodity hedging instruments	(0.8)		(7.1)
Total	$	(7.9)	$	4.2

 

	Reclassified from AOCL into	Amount of Gain / (Loss)
Derivatives in Cash Flow Hedging Relationships	Statement of Operations	2024		2023
Interest rate swap agreements	Interest expense	$	11.7	$	11.5
Commodity hedging instruments	Cost of sales	(4.4)		5.9
Total		$	7.3	$	17.4

 

	Recognized in	Amount of Gain / (Loss)
Derivatives Not Designated as Hedging Instruments	Statement of Operations	2024		2023
Currency forward contracts	Other income / expense, net	$	(9.6)	$	(14.7)
Commodity hedging instruments	Cost of sales	(2.0)		1.2
Total		$	(11.6)	$	(13.5)

XML

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements, Recurring Basis

The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required:

		2024				2023
	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Cash equivalents	Level 1	$	51.2	$	51.2	$	1.2	$	1.2
Other
Investment securities in non-qualified retirement plan assets	Level 1	32.4		32.4		36.3		36.3
Convertible debt investments	Level 3	45.8		45.8		85.8		85.8
Liabilities
Debt instruments
Credit facilities – revolving loans	Level 2	—		—		88.3		88.3
Credit facilities – term loans	Level 2	625.0		625.0		925.0		925.0
Senior Notes due 2031 – 4.000%	Level 2	500.0		456.3		500.0		380.0
Senior Notes due 2032 – 4.375%	Level 2	400.0		370.0		400.0		304.0
Senior Notes due 2029 – 4.500%	Level 2	450.0		432.0		450.0		366.8
Senior Notes due 2026 – 5.250%	Level 2	250.0		248.8		250.0		233.1
Other debt	Level 2	—		—		0.4		0.4

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation

Changes in the balance of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3.

	Year Ended September 30,
	2024		2023
Fair value at beginning of year	$	85.8	$	117.0
Total realized / unrealized gains (losses) included in net earnings	(64.2)		(97.6)
Total realized / unrealized gains / losses included in / reclassified from OCI	24.2		66.4
Fair value at end of year	$	45.8	$	85.8

Debt Securities, Available-for-Sale, Allowance for Credit Loss

A progression of the allowance for expected credit losses on convertible debt investments is shown below:

	Year Ended September 30,
	2024		2023
Balance at beginning of year	$	101.3	$	—
Provision for expected credit losses on securities with no previous allowance	—		101.3
Reductions for securities intended to be sold / exchanged	(99.4)		—
Balance at end of year	$	1.9	$	101.3

XML

LEASES (Tables)

12 Months Ended

Sep. 30, 2024

Leases [Abstract]

Supplemental Balance Sheet Information Schedule and Weighted-average remaining lease term

Supplemental balance sheet information related to the Company’s leases was as follows:

	Balance Sheet Location	September 30, 2024		September 30, 2023
Operating leases:
Right-of-use assets	Other assets	$	265.4	$	262.6
Current lease liabilities	Other current liabilities	75.3		76.4
Non-current lease liabilities	Other liabilities	215.8		220.1
Total operating lease liabilities		$	291.1	$	296.5
Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	15.2	$	14.5
Current lease liabilities	Current portion of debt	2.6		1.9
Non-current lease liabilities	Long-term debt	15.2		15.0
Total finance lease liabilities		$	17.8	$	16.9

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:

	September 30, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	5.2		5.4
Finance leases	8.1		9.5
Weighted-average discount rate:
Operating leases	5.9	%	5.2	%
Finance leases	4.7	%	4.4	%

Components of lease cost

Components of lease cost were as follows:

	Year Ended September 30,
	2024		2023		2022
Operating lease cost (a)	$	85.8	$	92.3	$	86.7
Variable lease cost	30.3		28.6		35.9
Finance lease cost
Amortization of right-of-use assets	2.6		3.0		6.4
Interest on lease liabilities	0.8		0.8		1.2
Total finance lease cost	$	3.4	$	3.8	$	7.6

(a)Operating lease cost includes amortization of right-of-use assets of $70.4, $81.0 and $75.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Short-term lease expense is excluded from operating lease cost and was $6.1, $6.6 and $19.1 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:

	Year Ended September 30,
	2024		2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net	$	99.2	$	93.0	$	83.9
Operating cash flows from finance leases	0.8		0.8		1.2
Financing cash flows from finance leases	2.3		2.7		5.9
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	77.0	$	90.4	$	71.9
Finance leases	3.4		—		1.5

Maturities of Operating Lease Liabilities by Fiscal Year Schedule

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2024 were as follows:

Year	Operating Leases		Finance Leases
2025	$	89.8	$	3.4
2026	73.5		3.0
2027	49.2		2.6
2028	38.8		2.2
2029	27.1		1.7
Thereafter	62.5		8.6
Total lease payments	340.9		21.5
Less: Imputed interest	(49.8)		(3.7)
Total lease liabilities	$	291.1	$	17.8

Maturities of Finance Lease Liabilities by Fiscal Year Schedule

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2024 were as follows:

Year	Operating Leases		Finance Leases
2025	$	89.8	$	3.4
2026	73.5		3.0
2027	49.2		2.6
2028	38.8		2.2
2029	27.1		1.7
Thereafter	62.5		8.6
Total lease payments	340.9		21.5
Less: Imputed interest	(49.8)		(3.7)
Total lease liabilities	$	291.1	$	17.8

XML

COMMITMENTS (Tables)

12 Months Ended

Sep. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Unconditional Purchase Obligations That Have Not Been Recognized

At September 30, 2024, the Company had the following unconditional purchase obligations by purchase date that have not been recognized in the Consolidated Balance Sheet:

 

2025	$	310.9
2026	193.5
2027	79.2
2028	39.3
2029	24.6
Thereafter	33.7
	$	681.2

XML

SEGMENT INFORMATION (Tables)

12 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Segment Financial Information

The following tables present financial information for the Company’s reportable segments for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Net Sales:
U.S. Consumer	$	3,013.7	$	2,843.7	$	2,928.8
Hawthorne	294.7		467.3		716.2
Other	244.3		240.3		279.1
Consolidated	$	3,552.7	$	3,551.3	$	3,924.1
Segment Profit (Loss):
U.S. Consumer	$	498.0	$	454.1	$	568.6
Hawthorne	(14.2)		(48.1)		(21.1)
Other	4.7		12.4		20.2
Total Segment Profit	488.5		418.4		567.7
Corporate	(117.7)		(101.6)		(112.4)
Intangible asset amortization	(15.7)		(25.2)		(37.1)
Impairment, restructuring and other	(146.3)		(466.0)		(852.2)
Equity in loss of unconsolidated affiliates	(68.1)		(101.1)		(12.9)
Interest expense	(158.8)		(178.1)		(118.1)
Other non-operating income (expense), net	(5.5)		0.3		6.9
Loss before income taxes	$	(23.6)	$	(453.3)	$	(558.1)
Depreciation and amortization:
U.S. Consumer	$	56.2	$	58.2	$	55.8
Hawthorne	16.7		25.8		34.8
Other	5.9		5.6		7.0
Corporate	1.8		2.9		7.6
	$	80.6	$	92.5	$	105.2
Capital expenditures:
U.S. Consumer	$	81.5	$	79.6	$	97.4
Hawthorne	—		8.5		12.4
Other	2.5		4.7		3.7
	$	84.0	$	92.8	$	113.5

	September 30,
	2024		2023
Total assets:
U.S. Consumer	$	2,022.7	$	2,296.2
Hawthorne	387.3		581.6
Other	189.3		189.8
Corporate	272.6		346.1
Consolidated	$	2,871.9	$	3,413.7

Net sales by product category

The following table presents net sales by product category for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
U.S. Consumer:
Growing media and mulch	$	1,310.6	$	1,223.7	$	1,192.6
Lawn care	929.6		897.4		973.6
Controls	414.6		362.9		382.2
Roundup® marketing agreement	162.4		138.7		132.3
Other, primarily gardening	196.5		221.0		248.1
Hawthorne:
Lighting	108.2		165.9		200.0
Nutrients	87.2		105.3		148.0
Growing media	37.3		67.5		119.0
Growing environment	27.7		72.5		143.7
Other, primarily hardware	34.3		56.1		105.5
Other:
Growing media	91.3		93.0		96.6
Lawn care	80.2		75.8		92.9
Other, primarily gardening and controls	72.8		71.5		89.6
Total net sales	$	3,552.7	$	3,551.3	$	3,924.1

Percentages of Largest Customers Consolidated Net Sales

The Company’s two largest customers accounted for the following percentages of net sales for the fiscal years ended September 30: 

	Percentage of Net Sales
	2024		2023		2022
The Home Depot	30	%	29	%	28	%
Lowe’s	18	%	18	%	15	%

Net Sales and Long-lived Assets by Geographic Area

The following table presents net sales by geographic area for the periods indicated:

	Year Ended September 30,
	2024		2023		2022
Net sales:
United States	$	3,247.8	$	3,209.5	$	3,554.6
International	304.9		341.8		369.5
	$	3,552.7	$	3,551.3	$	3,924.1

The following table presents long-lived assets (property, plant and equipment and finite-lived intangibles) by geographic area: 

	September 30,
	2024		2023
Long-lived assets:
United States	$	630.5	$	644.4
International	73.9		78.7
	$	704.4	$	723.1

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($) shares in Millions, $ in Millions		6 Months Ended	12 Months Ended
	Sep. 04, 2024	Jul. 01, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Sep. 01, 2024	Oct. 27, 2023	Apr. 22, 2022
Significant Accounting Policies [Line Items]
Percentage of annual net sales from combined second and third quarter sales		75.00%
Number of restricted shares issued (in shares)	0.3
Deferred advertising costs			$ 20.0
Advertising expenses			141.0	$ 123.7	$ 120.3
Research and development charge			34.6	35.7	45.3
Product registration costs			9.0	12.4	13.0
Accounts Receivable, Held-for-Sale						$ 750.0	$ 600.0
Derecognition of net receivables			186.6
Proceeds from sale of net receivables			1,938.6
Total discount recorded on sale			24.6
Interest capitalized on capital projects			1.1	2.1	2.2
Noncash investing activities for unpaid liabilities incurred			16.3	32.1	33.3
Outstanding payment obligations			12.5	18.3
Supplier finance payment			245.5	185.3
Recognition of accumulated foreign currency translation (gain) loss			$ (0.4)	$ 1.3	1.3
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]			Other Liabilities, Current	Other Liabilities, Current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]			Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Other investing, net			$ 2.6	$ (12.4)	29.3
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]			Accounts Payable, Current	Accounts Payable, Current
Investments in unconsolidated affiliates			$ (21.4)	$ 0.0	0.0
Proceeds from loans receivable			$ 0.0	$ 37.0	$ 0.0
RIV Capital, Inc. | Convertible Notes Payable
Significant Accounting Policies [Line Items]
Aggregate principal amount								$ 25.0
Standby Letters of Credit
Significant Accounting Policies [Line Items]
Maximum borrowing capacity							$ 75.0
Performance-Based Units
Significant Accounting Policies [Line Items]
Award vesting period (in years)			3 years
Officer | Options
Significant Accounting Policies [Line Items]
Expiration period (in years)			10 years
Director
Significant Accounting Policies [Line Items]
Award vesting period (in years)			1 year
Minimum
Significant Accounting Policies [Line Items]
Award vesting period (in years)			3 years
Expected forfeiture rate			15.00%
Intangible assets amortization period			3 years
Payment timing, period			30 days
Minimum | Software
Significant Accounting Policies [Line Items]
Intangible assets amortization period			3 years
Minimum | Officer | Performance-Based Units
Significant Accounting Policies [Line Items]
Vesting percent of target award			0.00%
Maximum
Significant Accounting Policies [Line Items]
Intangible assets amortization period			25 years
Payment timing, period			60 days
Maximum | Software
Significant Accounting Policies [Line Items]
Intangible assets amortization period			8 years
Maximum | Officer | Performance-Based Units
Significant Accounting Policies [Line Items]
Vesting percent of target award			325.00%

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Economic Lives of Assets (Details)	Sep. 30, 2024
Land improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	10 years
Land improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	25 years
Buildings | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	10 years
Buildings | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	40 years
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	15 years
Furniture and fixtures | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	6 years
Furniture and fixtures | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	10 years
Software | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	3 years
Software | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	8 years

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Accounting Policies [Abstract]
Interest paid	$ 157.7	$ 173.5	$ 112.5
Income taxes paid (refunded), net	$ 9.4	$ (18.2)	$ 27.2

XML

IMPAIRMENT, RESTRUCTURING AND OTHER - Schedule of Impairment, Restructuring, and Other Charges (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges, net	$ 62.8	$ 280.5	$ 693.1
Total impairment, restructuring and other charges	146.3	466.1	853.2
Restructuring Reserve
Amounts accrued at beginning of year	40.5	31.5	1.9
Restructuring charges	11.8	55.6	47.1
Payments	(33.4)	(46.6)	(17.5)
Amounts accrued at end of year	18.9	40.5	31.5
Operating expenses
Restructuring Cost and Reserve [Line Items]
Goodwill and intangible asset impairments	2.5	127.9	668.3
Convertible debt other-than-temporary impairments	64.6	101.3	0.0
Gains on sale of property, plant and equipment	0.0	0.0	(16.2)
Restructuring and other charges (recoveries), net | Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges, net	72.9	148.5	143.6
Restructuring and other charges (recoveries), net | Operating expenses
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges, net	(4.3)	51.2	40.9
Property, plant and equipment impairments | Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges, net	5.3	11.4	16.6
Right-of-use Asset Impairment | Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges, net	$ 5.3	$ 25.8	$ 0.0

XML

IMPAIRMENT, RESTRUCTURING AND OTHER - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring reserves classified as long-term	$ 5.7
Restructuring Incurred Cost, Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag	false	false	false
Impairment of intangible assets			$ 35.3
Impairment of goodwill		$ 10.3
Inventory write-down charges			$ 120.9
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]			Impairment, restructuring and other
Operating Expenses, Impairment, Restructuring And Other
Restructuring Cost and Reserve [Line Items]
Gain on resolution of dispute	$ 12.1
Restructuring Initiative Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs	89.4	229.0	$ 65.2
U.S. Consumer
Restructuring Cost and Reserve [Line Items]
Impairment of goodwill		0.0
U.S. Consumer | Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs	11.3	16.3	9.7
U.S. Consumer | Operating Expenses, Impairment, Restructuring And Other
Restructuring Cost and Reserve [Line Items]
Restructuring costs	1.5	7.7	11.9
U.S. Consumer | Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring costs	58.3
Hawthorne
Restructuring Cost and Reserve [Line Items]
Goodwill and intangible asset impairments		127.9	632.4
Impairment of intangible assets		117.7	110.0
Impairment of goodwill		0.0	522.4
Hawthorne | Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs	71.8	168.5	27.1
Hawthorne | Operating Expenses, Impairment, Restructuring And Other
Restructuring Cost and Reserve [Line Items]
Restructuring costs	1.0	20.7	8.1
Hawthorne | Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring costs	297.2
Other
Restructuring Cost and Reserve [Line Items]
Restructuring costs	1.1	0.8	0.7
Impairment of goodwill		10.3
Other | Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring costs	2.9
Corporate Segment
Restructuring Cost and Reserve [Line Items]
Restructuring costs	2.4	$ 14.9	$ 7.7
Corporate Segment | Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 25.1

XML

GOODWILL AND INTANGIBLE ASSETS, NET - Rollforward of Carrying Amount of Goodwill by Reportable Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2024
Goodwill [Line Items]
Goodwill	$ 873.0	$ 872.8	$ 873.0
Accumulated impairment losses	(629.1)	(618.8)	(629.1)
Goodwill, net	243.9	254.0	243.9
Foreign currency translation	0.2
Impairment	(10.3)
U.S. Consumer
Goodwill [Line Items]
Goodwill	245.7	245.7	245.7
Accumulated impairment losses	(1.8)	(1.8)	(1.8)
Goodwill, net	243.9	243.9	243.9
Foreign currency translation	0.0
Impairment	0.0
Hawthorne
Goodwill [Line Items]
Goodwill	617.0	617.0	617.0
Accumulated impairment losses	(617.0)	(617.0)	(617.0)
Goodwill, net	0.0	0.0	0.0
Foreign currency translation	0.0
Impairment	0.0	(522.4)
Other
Goodwill [Line Items]
Goodwill	10.3	10.1	10.3
Accumulated impairment losses	(10.3)	0.0	(10.3)
Goodwill, net		$ 10.1	$ 0.0
Foreign currency translation	0.2
Impairment	$ (10.3)

XML

GOODWILL AND INTANGIBLE ASSETS, NET - Schedule of Intangible Assets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Indefinite-lived Intangible Assets [Line Items]
Total indefinite-lived intangible assets	$ 323.9	$ 323.9
Total intangible assets, net	418.8	436.7
Intangible Assets [Line Items]
Total finite-lived intangible assets, net	94.9	112.8
Trade names
Indefinite-lived Intangible Assets [Line Items]
Total indefinite-lived intangible assets	168.2	168.2
Roundup® marketing agreement amendment
Indefinite-lived Intangible Assets [Line Items]
Total indefinite-lived intangible assets	155.7	155.7
Trade names
Intangible Assets [Line Items]
Gross Carrying Amount	325.8	322.4
Accumulated Amortization/ Impairment Charges	(272.8)	(260.7)
Total finite-lived intangible assets, net	53.0	61.7
Customer relationships
Intangible Assets [Line Items]
Gross Carrying Amount	253.1	251.5
Accumulated Amortization/ Impairment Charges	(223.9)	(216.1)
Total finite-lived intangible assets, net	29.2	35.4
Technology
Intangible Assets [Line Items]
Gross Carrying Amount	50.2	50.1
Accumulated Amortization/ Impairment Charges	(45.5)	(44.5)
Total finite-lived intangible assets, net	4.7	5.6
Other
Intangible Assets [Line Items]
Gross Carrying Amount	35.0	34.9
Accumulated Amortization/ Impairment Charges	(27.0)	(24.8)
Total finite-lived intangible assets, net	$ 8.0	$ 10.1

XML

GOODWILL AND INTANGIBLE ASSETS, NET - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Goodwill [Line Items]
Amortization expense	$ 15.7	$ 25.2	$ 37.1
Goodwill	243.9	243.9	254.0
Trade names
Goodwill [Line Items]
Impairment charge		72.0
Customer relationships
Goodwill [Line Items]
Impairment charge		45.7
Hawthorne
Goodwill [Line Items]
Goodwill	0.0	0.0	0.0
U.S. Consumer
Goodwill [Line Items]
Goodwill	243.9	$ 243.9	243.9
Other
Goodwill [Line Items]
Goodwill	$ 0.0		$ 10.1

XML

GOODWILL AND INTANGIBLE ASSETS, NET - Schedule of Amortization Expense (Details) $ in Millions	Sep. 30, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 12.6
2026	11.5
2027	10.7
2028	9.1
2029	$ 6.9

XML

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS - Summary of Balance Sheet Accounts (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
INVENTORIES:
Finished goods	$ 246.6	$ 506.2
Raw materials	256.8	272.5
Work-in-progress	84.1	101.6
Inventories	587.5	880.3
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	1,414.9	1,375.7
Less: accumulated depreciation	(805.4)	(765.4)
Property, plant and equipment, net	609.5	610.3
OTHER ASSETS:
Operating lease right-of-use assets	265.4	262.6
Net deferred tax assets	191.3	189.8
Convertible debt investments	45.8	85.8
Accrued pension, postretirement and executive retirement assets	62.7	64.1
Other	8.9	30.8
Other assets	574.1	633.1
OTHER CURRENT LIABILITIES:
Current lease liabilities	75.3	76.4
Advertising and promotional accruals	131.2	143.0
Payroll and other compensation accruals	72.0	51.2
Accrued taxes	16.7	28.5
Accrued interest	29.4	31.9
Other	118.4	119.2
Other current liabilities	443.0	450.2
OTHER NON-CURRENT LIABILITIES:
Non-current operating lease liabilities	215.8	220.1
Accrued pension, postretirement and executive retirement liabilities	73.0	76.7
Net deferred tax liabilities	7.0	1.1
Other	42.2	52.0
Other non-current liabilities	338.0	349.9
Machinery and equipment
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	683.6	651.7
Buildings
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	305.8	277.1
Land and improvements
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	152.9	149.0
Construction in progress
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	78.7	104.6
Software
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	107.2	109.9
Furniture and fixtures
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	62.6	62.3
Finance leases
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	$ 24.1	$ 21.1

XML

MARKETING AGREEMENT - Additional Information (Details)	Aug. 01, 2019 USD ($)
Restated Marketing Agreement
Schedule of Costs Related to Purchase Obligations [Line Items]
Commission threshold, percentage of program earnings	50.00%
Annual contribution payment	$ 18,000,000.0
Third Restated Agreement
Schedule of Costs Related to Purchase Obligations [Line Items]
Minimum EBIT to avoid reduction of contribution payment	36,000,000.0
Minimum EBIT	50,000,000.0
Minimum termination fee payable	175,000,000.0
Brand decommissioning event payable	$ 375,000,000.0
Minimum termination fee payable, multiple of average program earnings, prior 3 years	4
Minimum termination fee payable, threshold	$ 186,400,000

XML

MARKETING AGREEMENT - Net Commission Earned Under the Marketing Agreement (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Marketing Agreement [Line Items]
Contribution expenses	$ (2,618.7)	$ (2,708.3)	$ (2,891.1)
Monsanto Marketing Agreement
Marketing Agreement [Line Items]
Gross commission	90.8	75.7	83.4
Contribution expenses	(18.0)	(18.0)	(18.0)
Net commission	72.8	57.7	65.4
Reimbursements associated with Roundup® marketing agreement	91.2	82.5	67.9
Total net sales associated with Roundup® marketing agreement	$ 164.0	$ 140.2	$ 133.3

XML

ACQUISITIONS AND INVESTMENTS - Cyco (Details) - USD ($) $ in Millions	Apr. 28, 2022	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Business Acquisition [Line Items]
Goodwill		$ 243.9	$ 243.9	$ 254.0
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Maximum
Business Acquisition [Line Items]
Intangible assets amortization period		25 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 0.0	$ 0.0
Cyco
Business Acquisition [Line Items]
Maximum payout	$ 10.0
Cyco | Hawthorne
Business Acquisition [Line Items]
Total consideration transferred	37.3
Contingent consideration	3.1
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Inventory And Other Current Assets	1.3
Finite-lived intangible assets acquired	10.5
Goodwill	$ 25.6
Cyco | Hawthorne | Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	5 years
Cyco | Hawthorne | Maximum
Business Acquisition [Line Items]
Intangible assets amortization period	25 years

XML

ACQUISITIONS AND INVESTMENTS - Luxx Lighting (Details) - USD ($) shares in Millions, $ in Millions	Dec. 30, 2021	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Business Acquisition [Line Items]
Goodwill		$ 243.9	$ 243.9	$ 254.0
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Maximum
Business Acquisition [Line Items]
Intangible assets amortization period		25 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 0.0	$ 0.0
Luxx Lighting, Inc. | Hawthorne
Business Acquisition [Line Items]
Total consideration transferred	$ 213.2
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	0.1
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned	$ 21.0
Inventory and accounts receivable acquired	32.8
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets	5.7
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities	(24.2)
Finite-lived intangible assets acquired	47.3
Goodwill	$ 151.6
Luxx Lighting, Inc. | Hawthorne | Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	5 years
Luxx Lighting, Inc. | Hawthorne | Maximum
Business Acquisition [Line Items]
Intangible assets amortization period	25 years

XML

ACQUISITIONS AND INVESTMENTS - True Liberty Bags (Details) - USD ($) $ in Millions	Dec. 23, 2021	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Business Acquisition [Line Items]
Goodwill		$ 243.9	$ 243.9	$ 254.0
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 0.0	$ 0.0
True Liberty Bags | Hawthorne
Business Acquisition [Line Items]
Total consideration transferred	$ 10.1
Inventory and accounts receivable acquired	1.1
Finite-lived intangible assets acquired	5.8
Goodwill	$ 3.2
True Liberty Bags | Hawthorne | Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	15 years

XML

INVESTMENT IN UNCONSOLIDATED AFFILIATES (Details) - USD ($) $ in Millions		12 Months Ended
	Nov. 07, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2020
Investments in and Advances to Affiliates [Line Items]
Payments to acquire equity interest		$ 21.4	$ 0.0	$ 0.0
Investment in unconsolidated affiliates		45.2	91.9
Equity in loss of unconsolidated affiliates		(68.1)	(101.1)	$ (12.9)
Pre-tax impairment charges		$ 61.9	$ 94.7
Bonnie Plants, LLC
Investments in and Advances to Affiliates [Line Items]
Percent ownership	50.00%				45.00%	50.00%
Payments to acquire equity interest	$ 21.4
Ownership percentage increase (decrease)	5.00%

XML

RETIREMENT PLANS - Additional Information (Details) $ in Millions	12 Months Ended
	Sep. 30, 2024 USD ($) plan	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Compensation charges | $	$ 23.7	$ 24.1	$ 28.3
401(K) | Company matches 200% of associates’ initial 3% contribution
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer match of employee contribution (percent)	200.00%
Employee contribution of gross pay (percent)	3.00%
401(K) | Company matches 50% of associates' contribution up to 6%
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer match of employee contribution (percent)	50.00%
Employee contribution of gross pay (percent)	6.00%
Deferred Profit Sharing
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employee contribution of gross pay (percent)	4.00%
Defined Benefit Pension Plan | International Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of frozen defined benefit pension plans associated with former international businesses | plan	3
Premium payment | $	$ 76.3		$ 67.7
Defined Benefit Pension Plan | U.S. Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of defined benefit plans for certain U.S. associates | plan	2

XML

RETIREMENT PLANS - Benefit Obligations, Plan Assets, Annual Expense, Assumptions and Other Information of the Company's Defined Benefit Pension Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	$ 62.7	$ 64.1
Non-current liabilities	(73.0)	(76.7)
International Plan | Defined Benefit Pension Plan
Change in projected benefit obligation:
Benefit obligation at beginning of year	108.5	109.2
Interest cost	5.9	6.2
Actuarial (gain) loss	5.1	(11.0)
Benefits paid	(6.6)	(5.9)
Foreign currency translation	10.3	10.0
Projected benefit obligation (“PBO”) at end of year	123.2	108.5
Accumulated benefit obligation (“ABO”) at end of year	123.2	108.5
Change in plan assets:
Fair value of plan assets at beginning of year	124.8	128.9
Actual return on plan assets	10.0	(11.5)
Employer contribution	0.9	1.2
Benefits paid	(6.6)	(5.9)
Foreign currency translation	12.3	12.1
Fair value of plan assets at end of year	141.4	124.8
Overfunded (underfunded) status at end of year	18.2	16.3
Information for pension plans with an ABO in excess of plan assets:
Accumulated benefit obligation	12.0	11.5
Fair value of plan assets	0.0	0.0
Projected benefit obligation	12.0	11.5
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	30.2	27.8
Current liabilities	(0.9)	(0.9)
Non-current liabilities	(11.1)	(10.6)
Total amount accrued	18.2	16.3
Amounts recognized in AOCL consist of:
Actuarial loss	64.1	60.0
Prior service cost	2.3	2.1
Total amount recognized	66.4	62.1
Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	(0.7)	(6.0)
Reclassification to net earnings	2.3	2.0
Foreign currency translation	(5.9)	(4.8)
Total change in other comprehensive loss	$ (4.3)	$ (8.8)
Weighted average assumptions used in development of projected benefit obligation:
Discount rate	4.86%	5.38%
U.S. Plan | Defined Benefit Pension Plan
Change in projected benefit obligation:
Benefit obligation at beginning of year	$ 71.8	$ 77.7
Interest cost	3.7	3.6
Actuarial (gain) loss	5.5	(2.5)
Benefits paid	(6.8)	(6.9)
Foreign currency translation	0.0	0.0
Projected benefit obligation (“PBO”) at end of year	74.2	71.8
Accumulated benefit obligation (“ABO”) at end of year	74.2	71.8
Change in plan assets:
Fair value of plan assets at beginning of year	54.1	59.1
Actual return on plan assets	7.1	1.7
Employer contribution	2.9	0.2
Benefits paid	(6.8)	(6.9)
Foreign currency translation	0.0	0.0
Fair value of plan assets at end of year	57.3	54.1
Overfunded (underfunded) status at end of year	(16.9)	(17.7)
Information for pension plans with an ABO in excess of plan assets:
Accumulated benefit obligation	74.2	71.8
Fair value of plan assets	57.3	54.1
Projected benefit obligation	74.2	71.8
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	0.0	0.0
Current liabilities	(0.2)	(0.2)
Non-current liabilities	(16.7)	(17.5)
Total amount accrued	(16.9)	(17.7)
Amounts recognized in AOCL consist of:
Actuarial loss	34.1	35.2
Prior service cost	0.0	0.0
Total amount recognized	34.1	35.2
Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	(0.5)	1.8
Reclassification to net earnings	1.7	1.8
Foreign currency translation	0.0	0.0
Total change in other comprehensive loss	$ 1.2	$ 3.6
Weighted average assumptions used in development of projected benefit obligation:
Discount rate	4.62%	5.54%

XML

RETIREMENT PLANS - Components of Net Periodic Benefit Cost and Weighted Average Assumptions (Details) - Defined Benefit Pension Plan - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
International Plan
Components of net periodic benefit cost (income):
Interest cost	$ 5.9	$ 6.2	$ 3.0
Expected return on plan assets	(5.7)	(5.5)	(5.1)
Net amortization	2.3	2.0	1.3
Net periodic benefit cost (income)	$ 2.5	$ 2.7	$ (0.8)
Weighted average assumptions used in development of net periodic benefit cost (income):
Weighted average discount rate - interest cost	5.38%	5.29%	1.64%
Expected return on plan assets	4.42%	3.91%	2.37%
U.S. Plan
Components of net periodic benefit cost (income):
Interest cost	$ 3.7	$ 3.6	$ 1.7
Expected return on plan assets	(2.2)	(2.5)	(2.8)
Net amortization	1.7	1.8	1.7
Net periodic benefit cost (income)	$ 3.2	$ 2.9	$ 0.6
Weighted average assumptions used in development of net periodic benefit cost (income):
Weighted average discount rate - interest cost	5.46%	4.87%	1.74%
Expected return on plan assets	4.25%	4.50%	3.50%

XML

RETIREMENT PLANS - Plan Asset Allocations and Expected Future Benefit Payments (Details) - Defined Benefit Pension Plan - USD ($) $ in Millions	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2023
International Plan
Plan asset allocations:
Expected company contributions in fiscal 2025		$ 0.9
Expected future benefit payments:
2025		7.3
2026		7.4
2027		7.4
2028		7.6
2029		7.8
2030 – 2034		$ 40.5
International Plan | Equity securities
Plan asset allocations:
Plan asset allocations		0.00%	0.00%
International Plan | Equity securities | Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%
International Plan | Debt securities
Plan asset allocations:
Plan asset allocations		0.00%	5.00%
International Plan | Debt securities | Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%
International Plan | Real estate securities
Plan asset allocations:
Plan asset allocations		0.00%	0.00%
International Plan | Real estate securities | Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%
International Plan | Cash and cash equivalents
Plan asset allocations:
Plan asset allocations		15.00%	11.00%
International Plan | Cash and cash equivalents | Scenario, Forecast
Plan asset allocations:
Plan asset allocations	15.00%
International Plan | Insurance contracts
Plan asset allocations:
Plan asset allocations		85.00%	84.00%
International Plan | Insurance contracts | Scenario, Forecast
Plan asset allocations:
Plan asset allocations	85.00%
U.S. Plan
Plan asset allocations:
Expected company contributions in fiscal 2025		$ 2.7
Expected future benefit payments:
2025		7.5
2026		7.0
2027		6.9
2028		6.7
2029		6.5
2030 – 2034		$ 28.4
U.S. Plan | Equity securities
Plan asset allocations:
Plan asset allocations		19.00%	18.00%
U.S. Plan | Equity securities | Scenario, Forecast
Plan asset allocations:
Plan asset allocations	19.00%
U.S. Plan | Debt securities
Plan asset allocations:
Plan asset allocations		74.00%	75.00%
U.S. Plan | Debt securities | Scenario, Forecast
Plan asset allocations:
Plan asset allocations	76.00%
U.S. Plan | Real estate securities
Plan asset allocations:
Plan asset allocations		2.00%	3.00%
U.S. Plan | Real estate securities | Scenario, Forecast
Plan asset allocations:
Plan asset allocations	3.00%
U.S. Plan | Cash and cash equivalents
Plan asset allocations:
Plan asset allocations		5.00%	4.00%
U.S. Plan | Cash and cash equivalents | Scenario, Forecast
Plan asset allocations:
Plan asset allocations	2.00%
U.S. Plan | Insurance contracts
Plan asset allocations:
Plan asset allocations		0.00%	0.00%
U.S. Plan | Insurance contracts | Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%

XML

RETIREMENT PLANS - Fair Value of The Company's Pension Plan Asset (Details) - Defined Benefit Pension Plan - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
International Plan
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 141.4	$ 124.8	$ 128.9
International Plan | Fair Value, Inputs, Level 1 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	141.4	118.3
International Plan | Fair value, inputs, level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	21.9	14.0
International Plan | Fair value, inputs, level 3 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	119.5	104.3
International Plan | Total common collective trusts measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	6.5
International Plan | Total common collective trusts measured at net asset value | Common collective trusts—real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
International Plan | Total common collective trusts measured at net asset value | Common collective trusts—equities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
International Plan | Total common collective trusts measured at net asset value | Common collective trusts—fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	6.5
U.S. Plan
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	57.3	54.1	$ 59.1
U.S. Plan | Fair Value, Inputs, Level 1 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.6	2.2
U.S. Plan | Fair value, inputs, level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.6	2.2
U.S. Plan | Fair value, inputs, level 3 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
U.S. Plan | Total common collective trusts measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	54.7	51.9
U.S. Plan | Total common collective trusts measured at net asset value | Common collective trusts—real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1.4	1.8
U.S. Plan | Total common collective trusts measured at net asset value | Common collective trusts—equities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	10.9	10.0
U.S. Plan | Total common collective trusts measured at net asset value | Common collective trusts—fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 42.4	$ 40.1

XML

ASSOCIATE MEDICAL BENEFITS - Additional Information (Details) $ in Millions	12 Months Ended
	Sep. 30, 2024 USD ($) Year	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Self-insurance per occurrence	$ 1.0
Benefits cost recognized	$ 42.5	$ 40.1	$ 46.6
Health care cost trend rate (percent)	6.50%
Ultimate trend rate (percent)	4.50%
U.S. Plan | Postretirement Medical Benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Minimum retirement age (in years) | Year	55
Number of years of service (in years)	10 years
Net periodic benefit (income)	$ 0.3	$ 0.7	$ (0.2)

XML

ASSOCIATE MEDICAL BENEFITS - Retiree Medical Plan for Domestic Associates (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current liabilities	$ (73.0)	$ (76.7)
Postretirement Medical Benefits | U.S. Plan
Change in projected benefit obligation:
Benefit obligation at beginning of year	13.3	15.7
Service cost	0.1	0.1
Interest cost	0.8	0.8
Plan participants’ contributions	0.3	0.4
Actuarial (gain) loss	1.5	(2.2)
Benefits paid	(2.2)	(1.5)
Projected benefit obligation (“PBO”) at end of year	13.8	13.3
Change in plan assets:
Fair value of plan assets at beginning of year	0.0	0.0
Employer contribution	1.9	1.1
Plan participants’ contributions	0.3	0.4
Gross benefits paid	(2.2)	(1.5)
Fair value of plan assets at end of year	0.0	0.0
Overfunded (underfunded) status at end of year	(13.8)	(13.3)
Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities	(1.3)	(1.4)
Non-current liabilities	(12.5)	(11.9)
Total amount accrued	(13.8)	(13.3)
Amounts recognized in AOCL consist of:
Actuarial gain	(1.3)	(3.4)
Total amount recognized	(1.3)	(3.4)
Total change in other comprehensive income attributable to:
Gain (loss) during the period	(1.5)	2.2
Reclassification to net earnings	(0.6)	(0.2)
Total change in other comprehensive income	$ (2.1)	$ 2.0
Discount rate used in development of APBO	4.86%	5.98%

XML

ASSOCIATE MEDICAL BENEFITS - Expected Benefit Payments Under the Plan By The Company and Retirees (Details) $ in Millions	Sep. 30, 2024 USD ($)
Gross Benefit Payments
Defined Benefit Plan Disclosure [Line Items]
2025	$ 1.6
2026	1.8
2027	1.9
2028	2.0
2029	2.1
2030 – 2034	9.5
Retiree Contribution
Defined Benefit Plan Disclosure [Line Items]
2025	0.3
2026	0.4
2027	0.6
2028	0.7
2029	0.7
2030 – 2034	3.7
Net Company Payments
Defined Benefit Plan Disclosure [Line Items]
2025	1.3
2026	1.3
2027	1.4
2028	1.3
2029	1.3
2030 – 2034	$ 5.7

XML

DEBT - Components of Long-Term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
Debt Instrument [Line Items]
Total debt	$ 2,242.8	$ 2,630.6
Finance lease obligations	17.8	16.9
Less current portions	52.6	52.3
Long-term debt	2,174.2	2,557.4
Credit Facilities | Revolving loans
Debt Instrument [Line Items]
Total debt	0.0	88.3
Credit Facilities | Term loans
Debt Instrument [Line Items]
Total debt	625.0	925.0
Senior Notes | Senior Notes due 2031 – 4.000%
Debt Instrument [Line Items]
Total debt	$ 500.0	$ 500.0
Interest rate (percent)	4.00%	4.00%		4.00%
Senior Notes | Senior Notes due 2032 – 4.375%
Debt Instrument [Line Items]
Total debt	$ 400.0	$ 400.0
Interest rate (percent)	4.375%	4.375%	4.375%
Senior Notes | Senior Notes - 4.500%
Debt Instrument [Line Items]
Total debt	$ 450.0	$ 450.0
Interest rate (percent)	4.50%	4.50%			4.50%
Senior Notes | Senior Notes due 2026 – 5.250%
Debt Instrument [Line Items]
Total debt	$ 250.0	$ 250.0
Interest rate (percent)	5.25%	5.25%				5.25%
Other
Debt Instrument [Line Items]
Total debt	$ 0.0	$ 0.4
Long-term Debt
Debt Instrument [Line Items]
Less unamortized debt issuance costs	$ 16.0	$ 20.9

XML

DEBT - Company's Debt Maturing in Next Fiscal Years (Details) $ in Millions	Sep. 30, 2024 USD ($)
Debt Disclosure [Abstract]
2025	$ 50.0
2026	50.0
2027	775.0
2028	0.0
2029	0.0
Thereafter	1,350.0
Total debt	$ 2,225.0

XML

DEBT - Credit Facilities (Details) $ in Millions			12 Months Ended
	Jul. 31, 2023 USD ($)	Apr. 08, 2022 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023	Sep. 30, 2022	Jun. 08, 2022
Debt Instrument [Line Items]
Debt, weighted average interest rate (percentage)			5.80%	5.40%	3.60%
Fixed charge coverage ratio			1.27
Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Fixed charge coverage ratio, minimum			1.00
Debt Instrument, Redemption, Period Five
Debt Instrument [Line Items]
Maximum leverage ratio			6.00
Debt Instrument, Redemption, Period Six
Debt Instrument [Line Items]
Maximum leverage ratio			5.50
Debt Instrument, Redemption, Period Seven
Debt Instrument [Line Items]
Maximum leverage ratio			5.25
Debt Instrument, Redemption, Period Eight
Debt Instrument [Line Items]
Maximum leverage ratio			5.00
Debt Instrument, Redemption, Period Nine
Debt Instrument [Line Items]
Maximum leverage ratio			4.75
Debt Instrument, Redemption, Period Ten
Debt Instrument [Line Items]
Maximum leverage ratio			4.50
Fifth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Leverage ratio			4.86
Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 2,500.0
Outstanding debt			$ 2,225.0
Credit Facilities
Debt Instrument [Line Items]
Senior secured credit facilities, available borrowing capacity			$ 1,167.0
Credit Facilities | Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Debt, maturity period (in years)		5 years
Revolving loans
Debt Instrument [Line Items]
Debt, weighted average interest rate (percentage)			9.10%	7.60%	2.80%
Revolving loans | Sixth Amended And Restated Senior Secured Credit Agreement, Amendment One
Debt Instrument [Line Items]
Interest rate, increase (decrease)						35
Annual facility fee rate increase (decrease)						15
Maximum leverage ratio						4.75
Cash dividends, annual maximum	$ 225.0
Maximum other dividends and distributions	25.0
Revolving loans | Sixth Amended And Restated Senior Secured Credit Agreement, Amendment Two
Debt Instrument [Line Items]
Line Of Credit Facility, Commitment, Increase (Decrease)	$ 250.0
Debt Instrument, Interest Rate, Increase (Decrease)	0.25%
Debt Instrument, Covenant, Leverage Ratio, Minimum Threshold For Additional Pricing Tier	6.00
Debt Instrument, Covenant, Incremental Investments, Loans, And Advances, Maximum	$ 25.0
Letter of Credit | Credit Facilities
Debt Instrument [Line Items]
Aggregate face amount of letters of credit outstanding			$ 83.0
Term loans | Credit Facilities
Debt Instrument [Line Items]
Repayments of debt			$ 250.0
Revolving loans | Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 1,500.0
Letters of credit		100.0
Secured Term Loan | Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 1,000.0
Secured Term Loan | Sixth Amended And Restated Senior Secured Credit Agreement, Amendment One
Debt Instrument [Line Items]
Interest rate, increase (decrease)						50

XML

DEBT - Senior Notes (Details) - Senior Notes $ in Millions	Aug. 13, 2021 USD ($)	Mar. 17, 2021 USD ($)	Oct. 22, 2019 USD ($)	Sep. 30, 2024	Sep. 30, 2023	Dec. 15, 2016 USD ($)
Debt Instrument [Line Items]
Debt Instrument, Covenant, Interest Coverage Ratio, Minimum				2.00
Debt Instrument, Covenant, Interest Coverage Ratio				3.57
Senior Notes due 2026 – 5.250%
Debt Instrument [Line Items]
Interest rate (percent)				5.25%	5.25%	5.25%
Face amount of debt						$ 250.0
Senior Notes - 4.500%
Debt Instrument [Line Items]
Proceed from issuance of unsecured debt			$ 450.0
Interest rate (percent)			4.50%	4.50%	4.50%
Senior Notes due 2031 – 4.000%
Debt Instrument [Line Items]
Proceed from issuance of unsecured debt		$ 500.0
Interest rate (percent)		4.00%		4.00%	4.00%
Senior Notes due 2032 – 4.375%
Debt Instrument [Line Items]
Proceed from issuance of unsecured debt	$ 400.0
Interest rate (percent)	4.375%			4.375%	4.375%

XML

DEBT - Receivables Facility (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Apr. 07, 2017
Debt Instrument [Line Items]
Borrowings or receivables pledged as collateral	$ 2,242.8	$ 2,630.6
Amendments
Debt Instrument [Line Items]
Maximum aggregate amount			$ 400.0

XML

DEBT - Interest Rate Swap Agreements (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Interest Rate Swap, Instrument 1
Derivative [Line Items]
Notional amount	$ 150.0
Fixed rate (percentage)	3.37%
Interest Rate Swap, Instrument 2
Derivative [Line Items]
Notional amount	$ 50.0
Fixed rate (percentage)	3.34%
Interest Rate Swap, Instrument 3
Derivative [Line Items]
Notional amount	$ 100.0
Fixed rate (percentage)	4.74%
Interest Rate Swap, Instrument 4
Derivative [Line Items]
Notional amount	$ 150.0
Fixed rate (percentage)	4.25%
Designated as Hedging Instruments | Interest rate swap agreements
Derivative [Line Items]
Cash payment from terminated interest rate swap agreement	$ 11.0
Notional amount	$ 450.0	$ 600.0

XML

DEBT - Weighted Average Interest Rate (Details)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt, weighted average interest rate (percentage)	5.80%	5.40%	3.60%

XML

EQUITY - Schedule of Authorized and Issued Shares (Details) - $ / shares	Sep. 30, 2024	Sep. 30, 2023
Preferred shares, no par value:
Authorized (in shares)	200,000	200,000
Issued (in shares)	0.0	0.0
Common shares, no par value, $0.01 stated value per share:
Authorized (in shares)	100,000,000.0	100,000,000.0
Issued (in shares)	68,100,000	68,100,000
Common shares, stated value per share (USD per share)	$ 0.01	$ 0.01

XML

EQUITY - Additional Information (Details) - Miracle-Gro	Sep. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ownership of outstanding common shares (percent)	24.00%
Condition for ownership of voting stock (percent)	49.00%
Tender offer for ownership of voting power (as a percent)	100.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Condition for ownership of voting stock (percent)	50.00%

XML

EQUITY - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Other comprehensive income (loss) before reclassifications	$ (53.2)	$ (24.8)	$ (96.4)
Amounts reclassified from accumulated other comprehensive net income (loss)	52.2	76.4	2.6
Income tax benefit (expense)	6.5	(19.8)	15.6
Net current period other comprehensive income (loss)	5.5	31.8	(78.2)
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(112.8)	(144.6)	(66.4)
Equity ending balance	(107.3)	(112.8)	(144.6)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(21.9)	(28.9)	(1.7)
Other comprehensive income (loss) before reclassifications	0.6	7.0	(27.2)
Amounts reclassified from accumulated other comprehensive net income (loss)	0.0	0.0	0.0
Income tax benefit (expense)	0.0	0.0	0.0
Net current period other comprehensive income (loss)	0.6	7.0	(27.2)
Equity ending balance	(21.3)	(21.9)	(28.9)
Net Unrealized Gain (Loss) On Derivative Instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	20.1	33.3	10.2
Other comprehensive income (loss) before reclassifications	(10.6)	5.6	40.1
Amounts reclassified from accumulated other comprehensive net income (loss)	(9.7)	(23.3)	(9.1)
Income tax benefit (expense)	5.1	4.5	(7.9)
Net current period other comprehensive income (loss)	(15.2)	(13.2)	23.1
Equity ending balance	4.9	20.1	33.3
Net Unrealized Loss On Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(38.6)	(79.7)	(2.3)
Other comprehensive income (loss) before reclassifications	(40.4)	(34.9)	(102.0)
Amounts reclassified from accumulated other comprehensive net income (loss)	64.6	101.3	0.0
Income tax benefit (expense)	0.0	(25.3)	24.6
Net current period other comprehensive income (loss)	24.2	41.1	(77.4)
Equity ending balance	(14.4)	(38.6)	(79.7)
Pension and Other Post- Retirement Benefit Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(72.4)	(69.3)	(72.5)
Other comprehensive income (loss) before reclassifications	(2.8)	(2.5)	(7.3)
Amounts reclassified from accumulated other comprehensive net income (loss)	(2.7)	(1.6)	11.7
Income tax benefit (expense)	1.4	1.0	(1.1)
Net current period other comprehensive income (loss)	(4.1)	(3.1)	3.3
Equity ending balance	$ (76.5)	$ (72.4)	$ (69.3)

XML

EQUITY - Dividends (Details) - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Equity [Abstract]
Dividends declared (USD per share)	$ 2.64	$ 2.64	$ 2.64

XML

EQUITY - Share Repurchases (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Feb. 06, 2020
Accelerated Share Repurchases [Line Items]
Number of common shares repurchased (in shares)			1.1
Value of common shares repurchased to be held in treasury			$ 175.0
Tax withholding	$ 5.1	$ 9.3	$ 82.9
February 6, 2020 Program
Accelerated Share Repurchases [Line Items]
Stock repurchase authorization				$ 750.0

XML

EQUITY - Share-Based Awards, Additional Information (Details) - USD ($) shares in Millions, $ in Millions	2 Months Ended	12 Months Ended
	Nov. 22, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Common share available for issue under share-based plan (in shares)		7.9
Common shares were available to underlie the grant of new share-based award (in shares)		3.6
Tax benefit realized from tax deduction associated with exercise of stock options and vesting of restricted share awards		$ (3.0)	$ (1.5)	$ 14.8
Treasury Shares
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Treasury shares reissued (in shares)		0.7	1.3	1.5
Share-Based Compensation Awards and Employee Stock Purchase Plan | Treasury Shares
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Treasury shares reissued (in shares)		0.3	0.4	0.9
Restricted Stock Units, Performance Shares, And Stock Options
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Options and equity instruments other than options, grants in period (in shares)	0.3
Options and equity instruments other than options, grants in period, fair value	$ 9.8

XML

EQUITY - Schedule of Share-Based Compensation (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Equity [Abstract]
Share-based compensation	$ 79.8	$ 68.1	$ 30.3
Related tax benefit recognized	$ 14.8	$ 15.6	$ 4.9

XML

EQUITY - Schedule of Aggregate Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
No. of   Options
Granted (in shares)	1,356,698
Exercised (in shares)	(35,027)
Wtd. Avg. Exercise Price
Granted (in USD per share)	$ 53.75
Exercised (USD per share)	$ 58.52
Aggregate intrinsic value, exercisable	$ 8.9
Options
No. of   Options
Beginning balance (shares)	1,191,183
Forfeited (shares)	(135,182)
Ending balance (shares)	2,377,672	1,191,183
Exercisable (shares)	493,832
Wtd. Avg. Exercise Price
Beginning balance (USD per share)	$ 76.64
Forfeited (in USD per share)	55.69
Ending balance (USD per share)	65.03	$ 76.64
Exercisable (USD per share)	$ 108.97
Wtd. Avg. Remaining Life (in years)	7 years 6 months	6 years 7 months 6 days
Wtd. Avg. Remaining Life, Exercisable	2 years 7 months 6 days
Aggregate intrinsic value for awards outstanding	$ 71.4

XML

EQUITY - Stock Options, Additional Information (Details) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Cash received from exercise of stock options	$ 3,800,000	$ 2,300,000	$ 3,300,000
Options
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Weighted average fair value, granted (in dollars per share)	$ 15.25	$ 14.25
Intrinsic value of stock options exercised	$ 600,000
Compensation costs not yet recognized, net	$ 9,400,000
Expected weighted average period for unrecognized compensation cost (in years)	2 years

XML

EQUITY - Summary of Certain Information Pertaining to Stock Option Awards Outstanding and Exercisable (Details) - Options - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]
No. of Options (in shares)	2,377,672	1,191,183
Wtd. Avg. Remaining Life (in years)	7 years 6 months	6 years 7 months 6 days
WTD. Avg. Exercise Price (USD per share)	$ 65.03	$ 76.64
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
No. of Options (in shares)	493,832
WTD. Avg. Exercise Price (USD per share)	$ 108.97

XML

EQUITY - Schedule of Valuation Assumptions (Details)	12 Months Ended
	Sep. 30, 2024
Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	38.80%
Risk-free interest rate	4.70%
Expected dividend yield	4.10%
Expected life	6 years 1 month 6 days
Performance-Based Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	36.60%
Risk-free interest rate	4.50%

XML

EQUITY - Restricted Share-Based Award Activity (Details) - Restricted Stock Units (RSUs) - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
No. of Units
Beginning Balance (in shares)	611,838
Granted (in shares)	363,264
Vested (in shares)	(77,826)
Forfeited (in shares)	(130,892)
Ending Balance (in shares)	766,384	611,838
Wtd. Avg. Grant Date Fair Value per Unit
Beginning Balance (USD per share)	$ 89.10
Granted (USD per share)	55.12	$ 59.48	$ 109.10
Vested (USD per share)	182.87
Forfeited (USD per share)	59.40
Ending Balance (USD per share)	$ 68.54	$ 89.10

XML

EQUITY - Restricted Share-Based Awards, Additional Information (Details) - Restricted Stock Units (RSUs) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Weighted average grant date fair value (in USD per share)	$ 55.12	$ 59.48	$ 109.10
Compensation costs net yet recognized	$ 9.9
Expected weighted average period for unrecognized compensation cost (in years)	1 year 8 months 12 days
Total fair value of share-based payment awards vested	$ 4.6	$ 11.2	$ 28.2

XML

EQUITY - Performance-Based Award Activity (Details) - Performance-Based Units - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
No. of Units
Beginning Balance (in shares)	544,790
Granted (in shares)	240,677
Vested (in shares)	(181,791)
Forfeited (in shares)	(194,246)
Ending Balance (in shares)	409,430	544,790
Wtd. Avg. Grant Date Fair Value per Unit
Beginning Balance (USD per share)	$ 76.85
Granted (USD per share)	74.57	$ 66.00	$ 132.74
Vested (USD per share)	59.88
Forfeited (USD per share)	65.89
Ending Balance (USD per share)	$ 86.61	$ 76.85
Shares vested (as a percentage of shares granted)	100.00%

XML

EQUITY - Performance-Based Awards, Additional Information (Details) - Performance-Based Units - USD ($) $ / shares in Units, $ in Millions	2 Months Ended	12 Months Ended
	Nov. 22, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Weighted average grant date fair value (in USD per share)		$ 74.57	$ 66.00	$ 132.74
Compensation costs net yet recognized		$ 7.6
Total fair value of share-based payment awards vested		$ 10.6	$ 17.4	$ 182.5
Expected weighted average period for unrecognized compensation cost (in years)		2 years 1 month 6 days
Award vesting period (in years)		3 years
Share-based compensation awards granted, other than options (in shares)		240,677
Liability awards accrued		$ 20.2
Cost not yet recognized		$ 0.0
Subsequent Event
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Share-based compensation awards granted, other than options (in shares)	300,000

XML

EQUITY - Restricted Shares Issued to Vendor (Details) - Restricted Stock Units (RSUs) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted, other than options (in shares)	363,264
Weighted average grant date fair value (in USD per share)	$ 55.12	$ 59.48	$ 109.10
Compensation costs net yet recognized	$ 9.9
Vendor
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted, other than options (in shares)	300,000	800,000
Weighted average grant date fair value (in USD per share)	$ 69.88	$ 52.44
Compensation costs net yet recognized	$ 20.0

XML

EARNINGS PER COMMON SHARE - Schedule of Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Earnings Per Share [Abstract]
Net income (loss)	$ (34.9)	$ (380.1)	$ (437.5)
Basic net loss per common share:
Weighted-average Common Shares outstanding during the period (in shares)	56.8	56.0	55.5
Basic net income (loss) per common share (USD per share)	$ (0.61)	$ (6.79)	$ (7.88)
Diluted net loss per common share:
Weighted-average Common Shares outstanding during the period (in shares)	56.8	56.0	55.5
Dilutive potential Common Shares (in shares)	0.0	0.0	0.0
Weighted-average number of Common Shares outstanding and dilutive potential Common Shares (in shares)	56.8	56.0	55.5
Diluted net income (loss) per common share (USD per share)	$ (0.61)	$ (6.79)	$ (7.88)

XML

EARNINGS PER COMMON SHARE - Additional Information (Details) - shares shares in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average number of shares outstanding, diluted (in shares)	56.8	56.0	55.5
Dilutive potential Common Shares (in shares)	0.0	0.0	0.0
Number of common shares covered by out-of-the-money stock options (in shares)	0.9	0.4	0.6
Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of common shares covered by out-of-the-money stock options (in shares)	0.4	0.4	0.2

XML

INCOME TAXES - Provision (Benefit) For Income Taxes Allocated to Continuing Operation (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Current:
Federal	$ 2.4	$ 3.7	$ 22.8
State	2.5	0.6	9.3
Foreign	(5.3)	1.6	8.7
Total Current	(0.4)	5.9	40.8
Deferred:
Federal	11.6	(62.1)	(125.5)
State	(3.8)	(5.2)	(23.3)
Foreign	3.9	(11.8)	(12.6)
Total Deferred	11.7	(79.1)	(161.4)
Provision (benefit) for income taxes	$ 11.3	$ (73.2)	$ (120.6)

XML

INCOME TAXES - Domestic and Foreign Components of Income From Continuing Operations Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Domestic	$ (10.8)	$ (376.2)	$ (427.3)
Foreign	(12.8)	(77.1)	(130.8)
Loss before income taxes	$ (23.6)	$ (453.3)	$ (558.1)

XML

INCOME TAXES - Reconciliation of The Federal Corporate Income Tax Rate and The Effective Tax Rate (Details)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Statutory income tax rate	21.00%	21.00%	21.00%
Effect of foreign operations	(2.00%)	0.20%	(1.60%)
State taxes, net of federal benefit	8.00%	3.20%	2.60%
Effect of other permanent differences	(32.80%)	(0.80%)	2.80%
Research and Experimentation and other federal tax credits	2.90%	0.20%	0.20%
Effect of tax contingencies	3.70%	0.10%	(1.80%)
Change in valuation allowances	(57.40%)	(8.70%)	(0.90%)
Other	8.70%	1.00%	(0.70%)
Effective income tax rate	(47.90%)	16.20%	21.60%

XML

INCOME TAXES - Components of Deferred Income Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
DEFERRED TAX ASSETS
Lease liabilities	$ 67.6	$ 70.0
Intangible assets	62.2	79.2
Net operating loss carryovers	56.4	67.3
Interest limitation carryforward	55.9	35.9
Convertible debt investments	43.6	33.4
Accrued liabilities	43.2	48.7
Outside basis difference in equity investments	23.1	10.4
Inventories	16.1	26.1
Foreign tax credit carryovers	15.2	16.3
Other	22.4	23.8
Gross deferred tax assets	405.7	411.1
Valuation allowance	(96.5)	(87.7)
Total deferred tax assets	309.2	323.4
DEFERRED TAX LIABILITIES
Lease right-of-use assets	(62.0)	(62.1)
Property, plant and equipment	(58.5)	(62.7)
Other	(4.4)	(9.9)
Total deferred tax liabilities	(124.9)	(134.7)
Net deferred tax asset	$ 184.3	$ 188.7

XML

INCOME TAXES - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2021
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Net of Valuation Allowance	$ 309.2	$ 323.4
Deferred Tax Assets, Valuation Allowance	(96.5)	(87.7)
Convertible debt investments	43.6	33.4
Foreign tax credit carryovers	15.2	16.3
Deferred tax assets subject to limitation	9.9	10.5
Statutory tax benefit of net operating loss carryovers and related valuation allowances	9.7	10.2
Net operating loss carryovers	56.4	67.3
Gross unrecognized tax benefits	25.7	34.6	$ 35.8	$ 24.1
Unrecognized tax benefits that would have an impact on the effective tax rate	23.1	31.1	31.5
Unrecognized tax benefits accrued payment of interest	5.8	3.9	3.2
Unrecognized tax benefits accrued payment of penalties	1.1	1.3	$ 1.6
Other assets
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Net of Valuation Allowance	191.3	189.8
Other liabilities
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Liabilities, Net	7.0	1.1
Foreign Country
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Valuation Allowance	(4.6)	(6.4)
Foreign tax credit carryovers	15.2	16.3
Deferred Tax Assets, Operating Loss Carryforwards, Foreign	6.8	8.3
U.S. state and local tax authorities
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Valuation Allowance	(7.0)	(6.9)
State tax credit carryovers	1.0	1.4
Valuation allowance for state credits	0.8	1.3
State net operating losses carryforward	$ 19.1	15.2
State net operating losses carryforward period, minimum	5 years
Valuation allowance related to other state items	$ 2.6	2.2
Domestic Tax Authority
Investments, Owned, Federal Income Tax Note [Line Items]
Net operating loss carryovers	20.6
Foreign Tax Jurisdiction, Other
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Valuation Allowance	$ (13.0)	$ (11.0)

XML

INCOME TAXES - Reconciliation of the Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 34.6	$ 35.8	$ 24.1
Additions for tax positions of the current year	0.2	0.2	11.3
Additions for tax positions of prior years	0.1	3.8	2.2
Reductions for tax positions of prior years	(3.7)	(0.2)	(2.5)
Settlements with tax authorities	(0.7)	(0.1)	1.3
Expiration of statutes of limitation	(4.8)	(4.9)	(0.6)
Balance at end of year	$ 25.7	$ 34.6	$ 35.8

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Derivatives not designated as Hedging Instruments | Currency forward contracts
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional amount	$ 148.4	$ 123.1
Designated as Hedging Instruments | Interest rate swap agreements
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional amount	450.0	$ 600.0
Interest rate gain amount expected to be reclassified to earnings during the next 12 months	4.7
Designated as Hedging Instruments | Commodity hedging instruments
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Commodity gain amount expected to be reclassified to earnings during the next 12 months	$ 0.7

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Commodity Contracts that Hedge Forecasted Purchases (Details)	12 Months Ended
	Sep. 30, 2024 T gal	Sep. 30, 2023 T gal
Urea
Derivative [Line Items]
Outstanding commodity contracts, mass | T	51,000	52,500
Diesel
Derivative [Line Items]
Outstanding commodity contracts, volume	1,092,000	1,974,000
Heating Oil
Derivative [Line Items]
Outstanding commodity contracts, volume	42,000	966,000

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Fair Values of the Company's Derivative Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives instruments	$ (7.5)	$ 40.2
Designated as Hedging Instruments | Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives instruments	(3.6)	33.7
Designated as Hedging Instruments | Interest rate swap agreements | Other assets
Derivatives, Fair Value [Line Items]
Derivative asset	0.0	14.7
Designated as Hedging Instruments | Interest rate swap agreements | Prepaid and other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	0.9	16.7
Designated as Hedging Instruments | Interest rate swap agreements | Other current liabilities | Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative liability	(0.2)	0.0
Designated as Hedging Instruments | Interest rate swap agreements | Other liabilities | Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative liability	(5.1)	0.0
Designated as Hedging Instruments | Commodity hedging instruments | Prepaid and other current assets | Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative asset	0.8	2.3
Derivatives not designated as Hedging Instruments | Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives instruments	(3.9)	6.5
Derivatives not designated as Hedging Instruments | Commodity hedging instruments | Prepaid and other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	0.0	0.9
Derivatives not designated as Hedging Instruments | Currency forward contracts | Prepaid and other current assets | Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative asset	0.1	5.6
Derivatives not designated as Hedging Instruments | Currency forward contracts | Other current liabilities | Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative liability	$ (4.0)	$ 0.0

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Derivative Instruments on OCI and the Condensed, Consolidated Statements of Operations (Details) - Fair value, inputs, level 2 - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Derivatives not designated as Hedging Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Statement of Operations	$ (11.6)	$ (13.5)
Derivatives not designated as Hedging Instruments | Currency forward contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Statement of Operations	$ (9.6)	$ (14.7)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Operating Income (Expense), Net	Other Operating Income (Expense), Net
Derivatives not designated as Hedging Instruments | Commodity hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Statement of Operations	$ (2.0)	$ 1.2
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales	Cost of sales
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	$ (7.9)	$ 4.2
Amount of Gain/(Loss) Reclassified From AOCI Into Statement of Operations	7.3	17.4
Cash Flow Hedging | Interest rate swap agreements
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	(7.1)	11.3
Amount of Gain/(Loss) Reclassified From AOCI Into Statement of Operations	$ 11.7	$ 11.5
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Interest expense	Interest expense
Cash Flow Hedging | Commodity hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	$ (0.8)	$ (7.1)
Amount of Gain/(Loss) Reclassified From AOCI Into Statement of Operations	$ (4.4)	$ 5.9
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales	Cost of sales

XML

FAIR VALUE MEASUREMENTS - Additional Information (Details) shares in Millions, $ in Millions			12 Months Ended
	Sep. 30, 2024 USD ($) shares	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	May 30, 2024	Apr. 22, 2022 board_member nominee director	Aug. 24, 2021 board_member	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
RIV Capital, Inc.
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of company nominees added to the board | nominee							4
Number of members of Board of Directors that can be nominated							9	7
Debt Instrument, Ownership After Conversion, Common Shares | shares	123.0
Percentage of ownership after debt conversion		47.00%
RIV Capital, Inc. | The Hawthorne Colective
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of members of Board of Directors that can be nominated | board_member							3
Operating expenses
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Convertible debt other-than-temporary impairments			$ 64.6	$ 101.3	$ 0.0
Senior Notes | Senior Notes due 2031 – 4.000%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	4.00%	4.00%	4.00%	4.00%						4.00%
Senior Notes | Senior Notes due 2032 – 4.375%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	4.375%	4.375%	4.375%	4.375%					4.375%
Senior Notes | Senior Notes - 4.500%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	4.50%	4.50%	4.50%	4.50%							4.50%
Senior Notes | Senior Notes due 2026 – 5.250%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	5.25%	5.25%	5.25%	5.25%								5.25%
Convertible Notes Payable | RIV Capital, Inc.
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Conversion ratio on exchangeable shares						0.23
Convertible debt investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Reductions for securities intended to be sold			$ 99.4	$ 0.0
Cost basis of investment	$ 62.1	$ 225.8	62.1	225.8
Unrealized loss on investment			16.4	140.0
Allowance for credit loss	$ 1.9	$ 101.3	$ 1.9	$ 101.3	$ 0.0
Convertible debt investments | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt term (in years)			5 years
Convertible debt investments | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt term (in years)			2 years 10 months 24 days

XML

FAIR VALUE MEASUREMENTS - Summary of Fair Value of Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
Senior Notes | Senior Notes due 2031 – 4.000%
Liabilities
Interest rate (percent)	4.00%	4.00%			4.00%
Senior Notes | Senior Notes due 2032 – 4.375%
Liabilities
Interest rate (percent)	4.375%	4.375%		4.375%
Senior Notes | Senior Notes - 4.500%
Liabilities
Interest rate (percent)	4.50%	4.50%				4.50%
Senior Notes | Senior Notes due 2026 – 5.250%
Liabilities
Interest rate (percent)	5.25%	5.25%					5.25%
Reported Value Measurement | Fair value, inputs, level 2 | Senior Notes | Senior Notes due 2031 – 4.000%
Liabilities
Long-term debt	$ 500.0	$ 500.0
Reported Value Measurement | Fair value, inputs, level 2 | Senior Notes | Senior Notes due 2032 – 4.375%
Liabilities
Long-term debt	400.0	400.0
Reported Value Measurement | Fair value, inputs, level 2 | Senior Notes | Senior Notes - 4.500%
Liabilities
Long-term debt	450.0	450.0
Reported Value Measurement | Fair value, inputs, level 2 | Senior Notes | Senior Notes due 2026 – 5.250%
Liabilities
Long-term debt	250.0	250.0
Reported Value Measurement | Fair value, inputs, level 2 | Credit Facilities | Revolving loans
Liabilities
Long-term debt	0.0	88.3
Reported Value Measurement | Fair value, inputs, level 2 | Credit Facilities | Term loans
Liabilities
Long-term debt	625.0	925.0
Estimate of Fair Value Measurement | Fair value, inputs, level 2 | Senior Notes | Senior Notes due 2031 – 4.000%
Liabilities
Long-term debt	456.3	380.0
Estimate of Fair Value Measurement | Fair value, inputs, level 2 | Senior Notes | Senior Notes due 2032 – 4.375%
Liabilities
Long-term debt	370.0	304.0
Estimate of Fair Value Measurement | Fair value, inputs, level 2 | Senior Notes | Senior Notes - 4.500%
Liabilities
Long-term debt	432.0	366.8
Estimate of Fair Value Measurement | Fair value, inputs, level 2 | Senior Notes | Senior Notes due 2026 – 5.250%
Liabilities
Long-term debt	248.8	233.1
Estimate of Fair Value Measurement | Fair value, inputs, level 2 | Credit Facilities | Revolving loans
Liabilities
Long-term debt	0.0	88.3
Estimate of Fair Value Measurement | Fair value, inputs, level 2 | Credit Facilities | Term loans
Liabilities
Long-term debt	625.0	925.0
Fair Value, Measurements, Recurring | Reported Value Measurement | Fair value, inputs, level 1
Assets
Cash equivalents	51.2	1.2
Fair Value, Measurements, Recurring | Reported Value Measurement | Fair value, inputs, level 1 | Investment securities in non-qualified retirement plan assets
Assets
Other	32.4	36.3
Fair Value, Measurements, Recurring | Reported Value Measurement | Fair value, inputs, level 2 | Other Long-term Debt
Liabilities
Long-term debt	0.0	0.4
Fair Value, Measurements, Recurring | Reported Value Measurement | Fair value, inputs, level 3 | Convertible debt investments
Assets
Convertible debt investments	45.8	85.8
Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Fair value, inputs, level 1
Assets
Cash equivalents	51.2	1.2
Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Fair value, inputs, level 1 | Investment securities in non-qualified retirement plan assets
Assets
Other	32.4	36.3
Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Fair value, inputs, level 2 | Other Long-term Debt
Liabilities
Long-term debt	0.0	0.4
Fair Value, Measurements, Recurring | Estimate of Fair Value Measurement | Fair value, inputs, level 3 | Convertible debt investments
Assets
Convertible debt investments	$ 45.8	$ 85.8	$ 117.0

XML

FAIR VALUE MEASUREMENTS - Changes in Level 3 Convertible Debt Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Other comprehensive income (loss) before reclassifications	$ (53.2)	$ (24.8)	$ (96.4)
Net Unrealized Loss On Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Other comprehensive income (loss) before reclassifications	(40.4)	(34.9)	(102.0)
Fair value, inputs, level 3 | Fair Value, Measurements, Recurring | Convertible debt investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total realized / unrealized gains (losses) included in net earnings	(64.2)	(97.6)
Fair value, inputs, level 3 | Fair Value, Measurements, Recurring | Convertible debt investments | Net Unrealized Loss On Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Other comprehensive income (loss) before reclassifications	24.2	66.4
Fair value, inputs, level 3 | Estimate of Fair Value Measurement | Fair Value, Measurements, Recurring | Convertible debt investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value at beginning of year	85.8	117.0
Fair value at end of year	$ 45.8	$ 85.8	$ 117.0

XML

FAIR VALUE MEASUREMENTS - Changes in Allowance For Expected Credit Losses on Convertible Debt Instruments (Details) - Convertible debt investments - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Balance at beginning of year	$ 101.3	$ 0.0
Provision for expected credit losses on securities with no previous allowance	0.0	101.3
Reductions for securities intended to be sold / exchanged	(99.4)	0.0
Balance at end of year	$ 1.9	$ 101.3

XML

LEASES - Narrative (Details) $ in Millions	Sep. 30, 2024 USD ($)
Lessee, Lease, Description [Line Items]
Total expected lease liability	$ 681.2
Residual value of leased asset	6.3
Operating Lease, Lease Not yet Commenced
Lessee, Lease, Description [Line Items]
Total expected lease liability	$ 29.6

XML

LEASES - (Supplemental Balance Sheet Information Schedule) (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Leases [Abstract]
Operating lease right-of-use assets	$ 265.4	$ 262.6
Current lease liabilities	75.3	76.4
Non-current operating lease liabilities	215.8	220.1
Total operating lease liabilities	291.1	296.5
Finance lease right-of-use assets	15.2	14.5
Finance lease current lease liabilities	2.6	1.9
Finance lease non-current lease liabilities	15.2	15.0
Total finance lease liabilities	$ 17.8	$ 16.9
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets	Other assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other Liabilities, Current	Other Liabilities, Current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property, plant and equipment, net	Property, plant and equipment, net
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Current portion of debt	Current portion of debt
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Long-term debt	Long-term debt

XML

LEASES - (Components of Lease Cost Schedule) (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Operating lease cost	$ 85.8	$ 92.3	$ 86.7
Variable lease cost	30.3	28.6	35.9
Amortization of right-of-use assets	2.6	3.0	6.4
Interest on lease liabilities	0.8	0.8	1.2
Total finance lease cost	3.4	3.8	7.6
Operating lease amortization of ROU assets	70.4	81.0	75.3
Short-term lease expense	$ 6.1	$ 6.6	$ 19.1

XML

LEASES - (Supplemental Cash Flow Information and Non-Cash Activity Schedule) (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Lease, Cost [Abstract]
Operating cash flows from operating leases, net	$ 99.2	$ 93.0	$ 83.9
Operating cash flows from finance leases	0.8	0.8	1.2
Financing cash flows from finance leases	2.3	2.7	5.9
Right-of-use assets obtained in exchange for lease obligations, operating leases	77.0	90.4	71.9
Right-of-use assets obtained in exchange for lease obligations, finance leases	$ 3.4	$ 0.0	$ 1.5

XML

LEASES - (Weighted-Average Remaining Lease Term and Discount Rate Schedule) (Details)	Sep. 30, 2024	Sep. 30, 2023
Leases [Abstract]
Operating leases, weighted average remaining term (in years)	5 years 2 months 12 days	5 years 4 months 24 days
Finance leases, weighted average remaining term (in years)	8 years 1 month 6 days	9 years 6 months
Operating leases, weighted average discount rate (percent)	5.90%	5.20%
Finance leases, weighted average discount rate (percent)	4.70%	4.40%

XML

LEASES - (Maturities of Lease Liabilities by Fiscal Year Schedule) (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2025	$ 89.8
2026	73.5
2027	49.2
2028	38.8
2029	27.1
Thereafter	62.5
Total lease payments	340.9
Less: Imputed interest	(49.8)
Total lease liabilities	291.1	$ 296.5
Finance Lease, Liability, Payment, Due [Abstract]
2025	3.4
2026	3.0
2027	2.6
2028	2.2
2029	1.7
Thereafter	8.6
Total lease payments	21.5
Less: Imputed interest	(3.7)
Total lease liabilities	$ 17.8	$ 16.9

XML

COMMITMENTS (Details) $ in Millions	Sep. 30, 2024 USD ($)
Unrecorded Unconditional Purchase Obligation, Fiscal Year Maturity [Abstract]
2025	$ 310.9
2026	193.5
2027	79.2
2028	39.3
2029	24.6
Thereafter	33.7
Unrecognized unconditional purchase obligations due	$ 681.2

XML

CONTINGENCIES (Details) $ in Millions	Sep. 30, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Accrued liabilities related to other regulatory matters which are accounted for in the Other liabilities	$ 2.6

XML

SEGMENT INFORMATION - Additional Information (Details)	12 Months Ended
	Sep. 30, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	3

XML

SEGMENT INFORMATION - Segment Financial Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Net sales	$ 3,552.7	$ 3,551.3	$ 3,924.1
Intangible asset amortization	(15.7)	(25.2)	(37.1)
Impairment, restructuring and other	(62.8)	(280.5)	(693.1)
Equity in loss of unconsolidated affiliates	(68.1)	(101.1)	(12.9)
Interest expense	(158.8)	(178.1)	(118.1)
Other non-operating income (expense), net	(5.5)	0.3	6.9
Depreciation and amortization	80.6	92.5	105.2
Capital expenditures	84.0	92.8	113.5
Assets	2,871.9	3,413.7
Corporate
Segment Reporting Information [Line Items]
Depreciation and amortization	1.8	2.9	7.6
Assets	272.6	346.1
U.S. Consumer
Segment Reporting Information [Line Items]
Net sales	3,013.7	2,843.7	2,928.8
Capital expenditures	81.5	79.6	97.4
U.S. Consumer | Operating Segments
Segment Reporting Information [Line Items]
Depreciation and amortization	56.2	58.2	55.8
Assets	2,022.7	2,296.2
Hawthorne
Segment Reporting Information [Line Items]
Net sales	294.7	467.3	716.2
Capital expenditures	0.0	8.5	12.4
Hawthorne | Operating Segments
Segment Reporting Information [Line Items]
Depreciation and amortization	16.7	25.8	34.8
Assets	387.3	581.6
Other
Segment Reporting Information [Line Items]
Net sales	244.3	240.3	279.1
Capital expenditures	2.5	4.7	3.7
Other | Operating Segments
Segment Reporting Information [Line Items]
Depreciation and amortization	5.9	5.6	7.0
Assets	189.3	189.8
Continuing Operations
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(23.6)	(453.3)	(558.1)
Intangible asset amortization	(15.7)	(25.2)	(37.1)
Impairment, restructuring and other	(146.3)	(466.0)	(852.2)
Equity in loss of unconsolidated affiliates	(68.1)	(101.1)	(12.9)
Interest expense	(158.8)	(178.1)	(118.1)
Other non-operating income (expense), net	(5.5)	0.3	6.9
Continuing Operations | Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	488.5	418.4	567.7
Continuing Operations | Corporate
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(117.7)	(101.6)	(112.4)
Continuing Operations | U.S. Consumer | Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	498.0	454.1	568.6
Continuing Operations | Hawthorne | Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(14.2)	(48.1)	(21.1)
Continuing Operations | Other | Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	$ 4.7	$ 12.4	$ 20.2

XML

SEGMENT INFORMATION - Net Sales by Product Category (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Revenue from External Customer [Line Items]
Net sales	$ 3,552.7	$ 3,551.3	$ 3,924.1
U.S. Consumer | Growing media and mulch
Revenue from External Customer [Line Items]
Net sales	1,310.6	1,223.7	1,192.6
U.S. Consumer | Lawn care
Revenue from External Customer [Line Items]
Net sales	929.6	897.4	973.6
U.S. Consumer | Controls
Revenue from External Customer [Line Items]
Net sales	414.6	362.9	382.2
U.S. Consumer | Roundup marketing agreement
Revenue from External Customer [Line Items]
Net sales	162.4	138.7	132.3
U.S. Consumer | Other, primarily gardening
Revenue from External Customer [Line Items]
Net sales	196.5	221.0	248.1
Hawthorne
Revenue from External Customer [Line Items]
Net sales	294.7	467.3	716.2
Hawthorne | Lighting
Revenue from External Customer [Line Items]
Net sales	108.2	165.9	200.0
Hawthorne | Nutrients
Revenue from External Customer [Line Items]
Net sales	87.2	105.3	148.0
Hawthorne | Growing environment
Revenue from External Customer [Line Items]
Net sales	27.7	72.5	143.7
Hawthorne | Growing media
Revenue from External Customer [Line Items]
Net sales	37.3	67.5	119.0
Hawthorne | Other, primarily hardware
Revenue from External Customer [Line Items]
Net sales	34.3	56.1	105.5
Other
Revenue from External Customer [Line Items]
Net sales	244.3	240.3	279.1
Other | Lawn care
Revenue from External Customer [Line Items]
Net sales	80.2	75.8	92.9
Other | Growing media
Revenue from External Customer [Line Items]
Net sales	91.3	93.0	96.6
Other | Other, primarily gardening and controls
Revenue from External Customer [Line Items]
Net sales	$ 72.8	$ 71.5	$ 89.6

XML

SEGMENT INFORMATION - Concentrations of Credit Risk (Details) - Customer Concentration Risk	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Net Sales | Home Depot
Revenue, Major Customer [Line Items]
Concentration risk (percent)	30.00%	29.00%	28.00%
Net Sales | Lowe's
Revenue, Major Customer [Line Items]
Concentration risk (percent)	18.00%	18.00%	15.00%
Net Accounts Receivable | Two Largest Customers
Revenue, Major Customer [Line Items]
Concentration risk (percent)	18.00%	41.00%

XML

SEGMENT INFORMATION - Net sales and long-lived assets by geographic area (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 3,552.7	$ 3,551.3	$ 3,924.1
Long-lived assets	704.4	723.1
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	3,247.8	3,209.5	3,554.6
Long-lived assets	630.5	644.4
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	304.9	341.8	$ 369.5
Long-lived assets	$ 73.9	$ 78.7

XML

SUBSEQUENT EVENT (Details) - Subsequent Event - Chief Financial Officer & Chief Administrative Officer $ in Thousands	Nov. 26, 2024 USD ($)
Subsequent Event [Line Items]
Salary payment term	24 months
Lump sum payment	$ 30
Lump sum payment term	24 months
Tranche One
Subsequent Event [Line Items]
Target bonus, payable percentage	50.00%
Tranche Two
Subsequent Event [Line Items]
Target bonus, payable percentage	50.00%

XML

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Allowance for expected credit losses
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	$ 116.4	$ 14.4	$ 16.8
Additions Other	0.0	0.0	0.0
Additions Charged to Expense	3.7	109.6	5.8
Deductions Credited and Write-Offs	(108.6)	(7.6)	(8.2)
Balance at End of Period	11.5	116.4	14.4
Income tax valuation allowance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	87.7	40.7	32.3
Additions Other	3.6	9.5	0.0
Additions Charged to Expense	13.7	37.8	9.0
Deductions Credited and Write-Offs	(8.5)	(0.3)	(0.6)
Balance at End of Period	$ 96.5	$ 87.7	$ 40.7